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ABSTRACT 
Background: In 2008, the health departments of the United Kingdom implemented a 
routine and catch-up HPV immunization programme in schools to reduce the incidence 
of cervical cancer. European studies conducted from 2007 to 2012 showed inconsistent 
results on HPV vaccine uptake in relation to ethnicity and girls’ age. 
 
Aim: To examine the relationship between area deprivation and the take-up of 
informative materials related to HPV vaccination in secondary schools in England. 
Another aim was to investigate the association between uptake of HPV vaccine and area 
deprivation, ethnicity and religion and to explore the views and experiences of girls, 
teachers and health providers on the HPV vaccine to understand how mechanisms of 
programme delivery, strategies and practices contributed to HPV vaccine uptake in a 
city in the West Midlands. 
 
Methods: Secondary data about uptake of professionally developed teaching materials 
by 4,750 schools in England was employed to explain the relationship between the take-
up of the materials and the level of social deprivation of the area within which the 
school was located using logistic regression. Other secondary data about uptake of the 
third dose of HPV vaccine by year 8 girls in a city in the West Midlands was used to 
explain the variability of uptake across 20 schools between 2008 and 2012. Analytic 
statistics included simple and multivariate linear regressions. Qualitative data was 
collected through 47 semi-structured individual interviews with nine nurses, four school 
staff and 34 year 8 girls as well as through non-participant observations in 12 secondary 
schools between February and September 2013. Thematic analysis identified major 
themes related to the school context of implementation of the HPV vaccine programme 
as well as facilitators and barriers to uptake of HPV vaccine in the city of the study. 
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Results: Of all secondary schools in England invited to receive the HPV educational 
materials, 1,395 schools (30.17%) responded. These schools were in the largest quintile 
of school size as well as maintained schools. After controlling for other covariates, it 
was found that schools in the least deprived quintile had 1.31 the odds of requesting 
materials compared with the schools in the most deprived areas (95% CI=1.05-2.53). 
Deprivation of school address postcode remained statistically significantly associated 
with uptake of HPV vaccine after controlling for ethnicity, school type and academic 
year. Similarly, the academic year 2009/10 remained statistically significantly 
associated with uptake of HPV vaccine adjusting for geographic and school factors. 
Deprivation of school catchment area was no longer statistically significantly associated 
with uptake of HPV vaccine when the other variables were held constant and the same 
was true for the association between ethnicity and uptake. 
Thematic analysis showed that school based HPV vaccination programme was accepted 
by most of the schools in the city of study and was delivered by a mobile clinic aiming 
to vaccinate all eligible girls. Chasing up the consent forms and communication with the 
parents were the most challenging activities in the HPV vaccination administration. 
However, they were essential for a high HPV vaccine uptake. The manner in which the 
school staff and nurses sought parents’ and girls’ consent before and on the day of 
vaccination was often very persuasive and not entirely ethically justified. The HPV 
vaccine was poorly promoted in the school environment because of tight curriculum for 
compulsory subjects and the lack of adequate staff. A number of other influences 
affected girls’ choices about receiving the vaccine. The family played the most 
important role for daughters’ emotional support as also did the provision of information 
to help girls understand and make their own decision about the vaccine. The interactions 
with friends and nurses were beneficial for girls’ confidence and feelings on the day of 
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vaccination. Girls’ fear of injection caused by their poor knowledge, rumors spread by 
peers and parental negative attitudes about HPV vaccine were major obstacles to uptake 
before and on the day of vaccination. The main parental reasons for vaccine refusal 
were lack of understanding of the information about HPV vaccine, which they received 
from the school, their inadequate information, obtained from sources other than health 
professionals, their misconceptions about the safety of the vaccine and their religious 
beliefs related to their daughters’ sexual activity in the future. 
 
Conclusion: The impact of the HPV vaccination education campaign suggests 
differential level of exposure due to unevenly distributed requests for the materials 
across England. At local level, the HPV programme was not equally well implemented 
across the schools in the city. This was mainly due to school factors, including the 
location as well as the organization of delivery. The findings highlight the need for 
further investigation of factors associated with uptake of HPV vaccine to guide health 
policy and public health interventions for effective implementation of the HPV 
vaccination programme in all schools.  
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CHAPTER 1: INTRODUCTION  
I am a public health specialist and a medical doctor from Romania. Before this doctoral 
programme, I graduated a Master in Public Health course at the Braun School of Public 
Health and Community Medicine in Jerusalem, Israel. Further, I started a Doctorate in 
Public Health at Brunel University in the UK, which was interrupted in the mid-year 
2009 because both supervisors moved to Monash University in Malaysia. Subsequently, 
I was awarded a Postgraduate Diploma in Public Health for partial doctoral study at 
Brunel University that helped me to strengthen my knowledge and to hone my research 
competence. Later, I transferred the research element of the work in Brunel University, 
which was completed there, to the University of Warwick. While I was doing my PhD 
at the University of Warwick, I registered with the General Medical Council and with 
the Faculty of Public Health, as a Fellow, in the UK in 2011. 
My interest in the topic of this research began at Brunel University when I undertook 
the placement at the Royal Society of Public Health (RSPH) to evaluate its national 
education campaign to support teachers, school nurses and health professionals in 
introducing and raising awareness of the HPV vaccine in secondary schools. This public 
health programme was launched two months before the implementation of the national 
HPV immunization programme for the first time in the UK. Based on my previous 
work, which was a systematic review about interventions to increase awareness, 
knowledge about, and folic acid uptake before and during pregnancy, carried out during 
my Master’s research, I was thinking, at the end of the placement, of designing my 
doctoral research around evidence related both to knowledge about the HPV vaccine 
and to factors associated with uptake. It was possible to put my idea into practice taking 
the opportunity of the implementation of HPV vaccination, which followed immediately 
after the education campaign of the RSPH.  
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1. 1. Background 
Human papillomavirus affects a high proportion (70%) of sexually active women and 
men during their lifetime, usually shortly after sexual debut. (Cutts et al., 2007) Almost 
all cervical cancer cases are linked with genital infection with HPV (Wheeler, 2008) 
(Department of Health, 2008b). Two HPV types (16 and 18) are thought to be 
responsible for 70% of cervical cancer cases worldwide (Tota et al., 2011; European 
Centre for Disease Prevention and Control, 2008; Department of Health, 2008b).  
Across Europe there are wide health inequalities in cervical cancer (European Cervical 
Cancer Association, 2009). Health inequalities refer to disparities in the health 
achievements of individuals and groups (Kawachi et al., 2002) due to free choice, 
unavoidable factors (i.e., biologic or genetic) or external environment  (World Health 
Organization, 2012a). Ethnic inequalities in health are largely a consequence of 
socioeconomic differentials (Cooper, 2002; Nazroo and Williams, 2006) such as lower 
family income and education (United Nations Research Institute for Social 
Development, 2006). Areas with high concentration of ethnic groups seem to have 
fewer health services although they are most needed (Whitehead, 1992) and a worse 
environment (Bartley, 2004). Inequalities in access to cancer screening for people from 
ethnic minority groups were reported in several studies conducted both in the UK and in 
the US (Szczepura et al., 2008). The main reasons were attributed to language barriers, a 
lack of knowledge about screening services (Szczepura, 2005; Thomas et al., 2005), 
individual’s cultural values and beliefs, individual’s misconceptions about perceived 
risk (Thomas et al., 2005), inaccurate screening registers (Szczepura, 2005), a lack of 
recommendations by health care professionals (Szczepura, 2005), poor attitudes of GPs 
(Thomas et al., 2005), and lack of local access to services (Thomas et al., 2005). 
The European Medicines Agency licensed a quadrivalent and a bivalent HPV vaccine 
which are safe (World Health Organization, 2009), effective (Lu et al., 2011) and cost-
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effective (Westra et al., 2011) for prevention of cervical cancer for females aged 9 to 26  
(D'Souza and Dempsey, 2011; Chaturvedi, 2010). In Europe, the vaccine was 
implemented at national level based on evidence related to existence or lack of cervical 
cancer screening and vaccine acceptability by adolescents and their parents as well as 
by health professionals (World Health Organization, 2008). Schools have been deemed 
a good medium for HPV vaccination because of other immunization programmes 
already in place and presumably because of existing education programs about HPV 
vaccine (Ramet et al., 2011). Equitable delivery of health services does not guarantee 
equality of uptake (von Wagner et al., 2011). 
 
This thesis is based on two pieces of empirical work. I carried out the first study at 
Brunel University between October 2007 and June 2009 and based on the findings of 
that work I undertook the second study at the University of Warwick between October 
2011 and June 2014.   
 
Research questions  
1. Is there an association between uptake of educational materials about HPV 
vaccine by secondary schools and area level, social deprivation in England? 
2. Is there an association between uptake of the HPV vaccine by secondary schools 
in a city in the West Midlands and area deprivation, ethnicity or religion?  
3. What are the mechanisms, strategies and practices that influence uptake of HPV 
vaccine? 
 
1. 2. Overview of the Thesis Structure  
This thesis comprises eight chapters.  
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In the first section of Chapter Two I present a review of literature on the epidemiology 
of sexually transmitted infections with special emphasis on infection with Human 
papillomavirus. The next section presents information about the theory of vaccines with 
a focus on herd immunity. Particular aspects of the vaccine such as effectiveness, cost-
effectiveness, doses and adverse effects are mentioned in relation to HPV vaccine. 
Finally, some strategies to improve vaccination rates are presented. The last section 
contains a description of the HPV vaccination programme in Europe, including the 
context of HPV vaccination and the method of its delivery to target populations. The 
literature review refers to the European context because this research is conducted in the 
UK. Another reason is that the HPV vaccination policy developed at European Union 
level has been implemented differently at country level.   
 
Chapter Three is divided into two parts. Part one presents the conceptual framework of 
the “right to health” and part two presents the conceptual framework of evaluation of 
quality of care. In part one, first, I introduce the concept of right to health. Then, I 
present and discuss the concept of access to health services. Because this concept is 
mostly related to the utilization of health services, I focused the discussion on barriers to 
access to health care among different ethnic groups mostly in the UK.  
 
Part two of this chapter presents a conceptual framework of evaluation of quality care. 
Firstly, I discuss an equity concept and then I provide full details about the relationship 
between equity and access. Secondly, I introduce the concept of health inequality and 
then I focus the discussion on the explanations of health inequalities and ethnic 
inequalities in health. In the next two sections, I present equity in health service delivery 
and equity in access to health care with a particular example of equity in access to 
vaccination. 
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Chapter Four presents three sections, including health promotion and models, a scoping 
literature review related to awareness and knowledge about HPV vaccine and a national 
study based on a mass campaign distributing teaching materials about HPV vaccine to 
secondary schools in the UK. The first section introduces the concept of health 
promotion, approaches to health promotion and three categories of models related to 
individual, interpersonal and community health behaviour. In the next section, I present 
the findings of scoping literature review. In the last section, I describe a national study, 
which is an evaluation of a mass campaign using printed materials for use in formal 
education in the secondary schools. Then, I present an evaluation approach to this HPV 
education programme based on quantitative research, which addressed research question 
1. I also present the methodology of the study including data sources and the techniques 
which I used for data analysis. Finally, I present the results of the study including 
descriptive and inferential statistics. 
 
Chapter Five includes two sections, one that describes the city of the study and another 
one that provides details about the methodology of the study.  
 
The first section, which presents the health profile of the city of study, is structured in 
three parts. Part one contains statistical data about the population including aspects of 
demography, ethnicity and employment. Part two gives information about area 
deprivation and part three presents health programmes provided since 2008 with special 
emphasis on sexual health services. 
 
The second section of this chapter contains two parts. In part one, I present the research 
design and the justification for doing a case study, and I also mention the philosophical 
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position of the researcher. In part two, I discuss the methodology based on mixed 
methods research, providing details about its rationale, purpose, design and mixing 
strategies.  
 
In Chapter Six, I describe the methods and the results of the quantitative component of 
mixed methods which addressed research question 2. First, I describe my methods 
including data sources and the techniques which I used to prepare the data for analysis. 
Second, I provide a detailed description of the methods of analysis, including 
descriptive and inferential statistics, and lastly I present the results of the study. 
 
In Chapter Seven, I describe how I obtained ethical approval for the qualitative 
component of the mixed methods research in schools which addressed research question 
3. Then, I describe my methods of data collection: individual face-to-face interviews 
and non-participant observation. Next, I present how I collected data, including the 
recruitment of the participants, the conduct of the interviews, the transcription of the 
interviews, reflexivity and the procedures to minimize possible researcher effect and 
researcher bias and thematic analysis and in the end, I present the results. 
 
In Chapter Eight, I summarise the main findings from each section of the thesis in 
relation to the original research questions, highlight the strengths and limitations of the 
present study, discuss the relationship between the findings and the results of previous 
research, discuss the implications for policy, practice and future research, and end with 
a broad conclusion. 
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1.3 Summary  
In this chapter, I have presented the introduction to this thesis and information 
underpinning the basis of the present study. I also presented the description of the origin 
of my interest in the research topic, and the structure of the thesis. In the next chapter, I 
will present the literature review related to HPV and HPV vaccine and the delivery of 
the HPV vaccination programme in Europe. 
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CHAPTER 2: LITERATURE REVIEW   
The literature review is presented in three sections, including general aspects about 
HPV and the HPV vaccine as well as about the delivery of the HPV vaccination 
programme in Europe.  
In this section, first I present a review of literature on the epidemiology of sexually 
transmitted infections with special emphasis on infection with Human papillomavirus. 
Then, I present information about the theory of vaccines with focus on herd immunity. 
Particular aspects of the vaccine such as effectiveness, cost-effectiveness, doses and 
adverse effects are mentioned in relation to the HPV vaccine. Finally, some strategies to 
improve vaccination rates are discussed.  
 
2.1 Epidemiology of sexually transmitted infections  
Sexually transmitted infections (STIs) (World Health Organization, 2011b) or sexually 
transmitted diseases (STDs) (Shim, 2011) are infections that are spread primarily 
through person-to-person sexual contact (World Health Organization, 2011b). STIs are 
a public health problem and economic burden (World Health Organization, 2007; Da 
Ros and Schmitt Cda, 2008; Shim, 2011). Almost a million people have been estimated 
by WHO to acquire STIs, including the human immunodeficiency virus (HIV) every 
day (World Health Organization, 2007). Most affected people are in developing 
countries (World Health Organization, 2007; Shim, 2011). However, trends in STIs 
have increased in developed countries due to changes in sexual behavior and increased 
travel (World Health Organization, 2007). Young adults (15-24 years old) account for 
50% of all new STIs (Da Ros and Schmitt Cda, 2008). Their high risk is associated with 
unprotected sex with an infected partner (Shim, 2011), higher susceptibility to infection 
(e.g. women (Low et al., 2006)), short term sexual relationships and difficult access to 
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prevention services (Workowski and Berman, 2006) (i.e., screening) (Da Ros and 
Schmitt Cda, 2008). STIs are caused by over 35 pathogens represented by bacteria, 
viruses and parasites (World Health Organization, 2011b; Shim, 2011). The virulence of 
the pathogen and the duration of infection determine the spread of STIs (Low et al., 
2006). Some STIs are asymptomatic (e.g. herpes simplex virus type 2, HIV, hepatitis B, 
gonorrhea) and difficult to control (Da Ros and Schmitt Cda, 2008); therefore, they are 
disseminated further (Anderson and Garnett, 2000). STIs are under-reported (Da Ros 
and Schmitt Cda, 2008). In addition, STIs can have severe long-term consequences (e.g. 
infertility, cervical cancer, ectopic pregnancy) (World Health Organization, 2012b).  
 
Human papillomavirus (HPV) is considered the commonest agent of STIs (Kim et al., 
2011). It has been estimated that 15-20% of people with STIs have HPV (Da Ros and 
Schmitt Cda, 2008).  
Human papillomavirus vaccination and/or HPV testing as well as screening for cervical 
cancer are complementary (European Centre for Disease Prevention and Control, 2008)  
public health interventions put in practice for primary and secondary prevention of 
cervical cancer, respectively.  
 
2.1.1. Epidemiology of human papillomavirus infection 
More than 100 human papillomavirus (HPV) types have been identified (Wheeler, 
2008) but approximately 40 HPV types infect the anogenital region (Pandhi and 
Sonthalia, 2011; Haupt and Sings, 2011). There are 15 HPV types associated with an 
increased risk of various cancers of cervix, vulva, vagina, penis and anus, and some 
cancers of the head and neck (Department of Health, 2008c; Tota et al., 2011; 
Chaturvedi, 2010; D'Souza and Dempsey, 2011). Among “high-risk” types there are 
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oncogenic HPV-16 and HPV-18 which are associated with cervical cancer 
(Castellsague, 2008; Schiffman et al., 2005). Several other carcinogenic HPV types (31, 
33, 35, 45, 52, and 58) have been found which have a similar structure to the HPV-16 
and HPV-18 types (Pandhi and Sonthalia, 2011). There are 12 types with “low risk” 
including HPV-6 and HPV-11 types which are associated with genital warts 
(Castellsague, 2008; Ramet et al., 2011) and warts in the throat  (D'Souza and Dempsey, 
2011). 
 
Human papillomavirus affects a high proportion (70%) of sexually active women and 
men during their lifetime, usually shortly after sexual debut  (Cutts et al., 2007). 30% of 
women are infected within two years after start of sexual activity (Department of 
Health, 2008c). The peak incidence of HPV infection occurs between the ages of 14 and 
24 years (Pandhi and Sonthalia, 2011).  
 
Almost all cervical cancer cases are linked with genital infection with HPV (Wheeler, 
2008; Department of Health, 2008b) and HPV types 16 and 18 are thought to be 
responsible for 70% of cervical cancer cases worldwide  (Tota et al., 2011; European 
Centre for Disease Prevention and Control, 2008; Department of Health, 2008b). 
 
Human papillomavirus is a common virus that is easily spread during vaginal, anal and 
oral sex (Tota et al., 2011), between heterosexual (Burchell et al., 2011) and 
homosexual partners (Graham and Mishra, 2011) even when the infected partner has no 
signs or symptoms. A person can be infected with one (Burchell et al., 2011) or less 
often with more than one HPV type (Cutts et al., 2007). It is possible to acquire HPV 
even if sexual contact happens only once and even if a condom is used (Cutts et al., 
2007; Tota et al., 2011). However, the risk of infection is lower in women whose 
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partners use a condom or who are circumcised (Cutts et al., 2007; Tota et al., 2011). 
Another reported mode of HPV transmission is from mother to child in the case of 
vaginal delivery (Tota et al., 2011). 
The acquired HPV infections can be asymptomatic (Kerkar et al., 2011) and 90% of 
new infections with HPV disappear within two years (Department of Health, 2008c) 
(Tota et al., 2011). Also, up to 30% genital warts disappear in the short term after 
infection even without treatment (Department of Health, 2008c).  
It has been shown that cervical cancer develops under circumstances of persistent 
infection with HPV type (Chaturvedi, 2010) as HPV-16 or HPV-18 (Ramet et al., 
2011). There are various factors thought to increase the risk of persistent HPV infection 
or development of cancer such as increasing age and immunosuppression as well as 
infections with multiple HPV types (Ramet et al., 2011).  
The period between infection with HPV and the development of cervical cancer varies 
from one year to one decade (Department of Health, 2008c; Pandhi and Sonthalia, 2011; 
D'Souza and Dempsey, 2011). 
 
2.2 Vaccine  
The World Health Organization (WHO) defines a vaccine as “any preparation intended 
to produce immunity to a disease by stimulating the production of antibodies” (World 
Health Organization, 2011a).  
 
2.2.1. HPV vaccine  
Two HPV vaccines have been licensed in the US (Chaturvedi, 2010), in Australia  and 
in Europe (European Centre for Disease Prevention and Control, 2008). The vaccine 
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made by Merck and licensed by European Medicines Agency (EMEA) in 2006 (World 
Health Organization, 2008) is a quadrivalent vaccine which protects against HPV types 
16, 18, 6 and 11 (Joint Committee on Vaccination and Immunisation, 2008b). The other 
vaccine made by GlaxoSmithKline and licensed by the EMEA in 2007 (World Health 
Organization, 2008) is a bivalent vaccine, offering protection against HPV types 16 and 
18 (Joint Committee on Vaccination and Immunisation, 2008b). By October 2007, 38 
countries of the European Region licensed the quadrivalent vaccine but only 30 
countries approved the bivalent vaccine (World Health Organization, 2008). Both 
vaccines are made from the major protein of the viral-coat of HPV called virus-like 
particles (VLPs) which imitate the structure of HPV but do not contain any HPV DNA 
(Department of Health, 2008c). These VLPs in the vaccine attach to human cells and 
stimulate the immune system to produce antibodies (Chaturvedi, 2010). The two 
vaccines differ not only in valency but also in substances added to the vaccine (Ramet et 
al., 2011) to increase the body’s immune response. Currently it is known that the 
duration of vaccine-induced immunity is “at least” 5 (Wheeler, 2008) – 6 years 
(Department of Health, 2008a).   
 
2.2.2. Effectiveness of vaccine 
Vaccine effectiveness is a measure of vaccine efficacy (see below), reflecting the 
potency to reduce disease in a population in the “real world” (Weinberg and Szilagyi, 
2010). 
 
2.2.3. Herd immunity 
Herd immunity (Kim et al., 2011), herd effect or herd protection (Goncalves, 2008) is 
the most effective way to control a disease through vaccination (Bonita et al., 2006). 
Vaccine is given to individuals with high risk of infection with a pathogen and who are 
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most likely to transmit the infection forward (i.e., children) (Smith et al., 2011). At 
individual level, vaccination protects immunized person through acquired immunity 
(Smith et al., 2011) against bacterial or viral disease (Kim et al., 2011) and 
infectiousness (Fine et al., 2011). At population level, vaccine reduces human to human 
transmission of infectious disease (John and Samuel, 2000) and indirectly protects 
unvaccinated people (Kim et al., 2011; Brisson and Edmunds, 2003; Smith et al., 2011). 
Indirect protection is the result of vaccine’s effect on transmission (Fine et al., 2011). 
Some unvaccinated people are those thought not to respond to vaccines (i.e., elderly) or 
those who have medical reasons (i.e., immunosuppressed) (Smith et al., 2011) or those 
who refuse the vaccine (Fine et al., 2011). There is evidence that high-risk groups (i.e., 
elderly) who have suboptimal immune response to the vaccine could be protected 
indirectly by vaccinating those who respond well to vaccine (i.e., children) (Kim et al., 
2011; Smith et al., 2011). Parents’ refusal to vaccinate children could increase their risk 
of infection through contact with other members of the community (Fine et al., 2011). 
The induced herd immunity could be influenced by vaccine efficacy, duration of 
protection and vaccine coverage (Brisson et al., 2011; John and Samuel, 2000). Herd 
immunity is important because vaccine efficacy is not 100% (Yip et al., 2007). 
Therefore, the proportion of the population to be vaccinated should be determined 
taking into consideration vaccine efficacy (Yip et al., 2007). Vaccine efficacy is best 
measured by double-blind, randomized, clinical controlled trials. It is expressed as a 
proportionate reduction in disease attack rate
1
 (Bonita et al., 2006) between the 
unvaccinated and vaccinated study cohorts. It can be calculated from the relative risk
2
 
                                                          
1
 The term “attack rate” is often used instead of incidence during a disease outbreak. It can be calculated 
as the number of people affected divided by the number exposed  
2
 Relative risk is the ratio of the risk of occurrence of a disease among exposed people to that among the 
unexposed  
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(RR) (Bonita et al., 2006) of disease among the vaccinated group according to formula 
(1-RR) x 100 (Weinberg and Szilagyi, 2010). 
Herd immunity could decline over time because of the waning vaccine-induced 
immunity. Under these circumstance the vaccine coverage should target higher levels 
(Kim et al., 2011; Fine et al., 2011) than if immunity is lifelong (Scherer and McLean, 
2002). Loss of vaccine efficacy due to new strains of the infectious agent (Kim et al., 
2011; Scherer and McLean, 2002) could be addressed using regular booster vaccine 
(Fine et al., 2011).  
The coverage rate necessary to stop transmission of infection depends on the basic 
reproductive number (Andre et al., 2008) whose symbolic expression in literature is R0 
and defined as the average number of new infections caused by one infected individual 
in an wholly susceptible (non-immune) population (Garnett, 2005; Scherer and McLean, 
2002) at the start of a new outbreak (Fine et al., 2011). The effective reproductive 
number is the product of basic reproductive number and the proportion susceptible in 
the population (Garnett, 2005; Scherer and McLean, 2002). There is a mathematical 
formula (1- 1/ R0) based on the basic reproductive number to express the herd immunity 
threshold which is used as a target for immunization coverage (Fine et al., 2011). Ro 
must exceed 1 for an infection to persist (Bogaards et al., 2011; Anderson and Garnett, 
2000). R0 could be different between populations (Fine et al., 2011); therefore, vaccine 
coverage could vary geographically (John and Samuel, 2000). Also, R0 is different for 
different diseases (Scherer and McLean, 2002). The magnitude of R0 influences the 
speed and the scale of spread of infection (Anderson and Garnett, 2000). The higher the 
basic reproductive number, the higher the coverage should be to achieve herd immunity 
(e.g. measles) (Andre et al., 2008). Herd immunity is low when the proportion of 
vaccinated people is under a certain threshold (Gay, 2004); as a result the transmission 
of infection continues in the community (Kim et al., 2011). Incidence of infection 
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declines if the proportion of vaccinated people is higher than the herd immunity 
threshold (Fine et al., 2011; Kim et al., 2011). This means that each case should 
generate on average less than one other case (Scherer and McLean, 2002). An infection 
could be eliminated if there is no sustained transmission in the population, even if the 
vaccine coverage is less than 100% (Andre et al., 2008; Wallinga et al., 2005). Herd 
immunity has been significant in the eradication of smallpox, in the reduction of 
pertussis, in influenza protection and the prevention of pneumococcal disease (Kim et 
al., 2011).  
One of the consequences of increased herd immunity is the shift in the age of infection. 
The more immunized individuals in a cohort, the less likelihood that infection is 
transmitted in the population (Brisson and Edmunds, 2003). But the non-vaccinated 
people from that cohort accumulate in older age groups when they become fully 
susceptible to infection if they were exposed (Fine et al., 2011). There is evidence of 
cases of measles and pertussis in older age groups (Fine et al., 2011) in developing 
countries (Brisson and Edmunds, 2003). Infections in older age are more severe (e.g. 
polio, hepatitis A, mumps (Brisson and Edmunds, 2003) and rubella in the first 
trimester of pregnancy (Fine et al., 2011)). 
The level of vaccine-induced herd immunity depends on several factors: 
 type of vaccine used [live attenuated or inactivated (Kim et al., 2011)]  
 force of transmission of infection in the community (John and Samuel, 2000; 
Garnett, 2005) 
 pattern of mixing in heterogeneous population (Fine et al., 2011) 
 distribution of vaccine (Fine et al., 2011) 
 immunity in the population (Fine et al., 2011). 
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2.2.3.1. Pattern of mixing in heterogeneous population  
A range of factors place some people at greater risk for STIs such as cultural values (sex 
roles, norms for sexual behavior (Adimora and Schoenbach, 2005)), lack of information 
about STIs transmission, lack of adult supervision (especially of boys), the number of 
sexual partners (Da Ros and Schmitt Cda, 2008) and sexual mixing by ethnic origin, age 
and country (Adimora and Schoenbach, 2005; Testa and Coleman, 2006; Liljeros et al., 
2003). Men are more often the primary source of STIs than women. Therefore, 
transmission rates from men to women are higher than from women to men (Low et al., 
2006). Individuals with no partners or individuals in long-term monogamous 
relationship (Adimora and Schoenbach, 2005) (e.g. Asian men and women in California 
(Mocello et al., 2008)) are least likely to propagate STIs (Adimora and Schoenbach, 
2005). Mixing between people occur within sexual networks which characterize 
structural and temporal links between individuals through sexual relationships (Low et 
al., 2006). A group of individuals with high-risk behavior represents a core group 
(Gesink et al., 2011). Mixing “like with like” could limit the spread of infection to the 
core group with highly sexually active individuals (Anderson and Garnett, 2000). A 
particular concern represents concurrent sexual partnerships defined as sexual 
relationships that overlap over time (Adimora and Schoenbach, 2005). This kind of 
network spreads the STIs more quickly than sequential partnerships (Adimora and 
Schoenbach, 2005). The spread and persistence of STIs could be influenced by the 
number of simultaneous partners and with the number of sex acts with each partner 
(Anderson and Garnett, 2000). 
Sexual networks play a key role in the transmission and persistence of STIs in 
population (Adimora and Schoenbach, 2005) due to several determinants such as 
individual factors (e.g. uncircumcised men (Da Ros and Schmitt Cda, 2008)), 
demography (Low et al., 2006) (e.g. scarcity of men (Adimora and Schoenbach, 2005), 
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young age, single marital status (Fenton et al., 2005)), health-seeking behavior within 
networks (Fenton et al., 2005), poverty (Adimora and Schoenbach, 2005) (Low et al., 
2006). Spatial patterns of STIs are influenced by neighborhood-level of sociocultural 
factors and/or local sexual partner selection (Gesink et al., 2011). For example, black 
people tend to choose other black persons as sex partners (Adimora and Schoenbach, 
2005). This could be the consequence of social segregation in schools (as seen in the 
US) which influences the social and sexual networks of adolescents (Adimora and 
Schoenbach, 2005). Patterns of sexual networks among black people (e.g. Black 
Caribbean and Black African men and women in the UK (Fenton et al., 2005)) could 
promote faster dissemination of STIs than in white population (Adimora and 
Schoenbach, 2005). This is because of early sexual debut (before the age 16 years old) 
(Testa and Coleman, 2006), repeated change of partners (Anderson and Garnett, 2000) 
and mixing between individuals with low risk of STIs and people with high risk of STIs 
(Turner et al., 2004). 
A study on sexual health knowledge, attitudes and behaviors among black and minority 
ethnic youth in London revealed that Asians, especially females, aged 15-18 years old 
hold more conservative attitudes about sex in comparison with White adolescents. 
Despite this fact, a small proportion of teenage Asians (males and females) experienced 
sexual relationships (e.g. anal sex) (Testa and Coleman, 2006). 
 
2.2.4. Effectiveness of HPV vaccine 
Vaccination of one sex against STIs could indirectly protect the other sex (Garnett, 
2005). Studies showed that vaccination should target individuals with the highest 
prevalence of infection (Bogaards et al., 2011). Herd effect of HPV vaccine has been 
estimated through modeling analyses (Brisson et al., 2011). Herd effect of HPV vaccine 
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has been observed in real life context in Australia where HPV vaccination programme 
of girls aged 12 years produced herd immunity in males (Haupt and Sings, 2011; 
Brisson et al., 2011; Bogaards et al., 2011). Herd effect seems to be greater for HPV 
types 6 and 11 in comparison with HPV types 16 and 18  (Brisson et al., 2011).  
Ideally, females should be vaccinated before the onset of sexual activity, when they may 
be exposed to HPV for the first time (Wheeler, 2008; Cutts et al., 2007).  
It has been shown that vaccine-induced immunity is stronger than the immunity 
acquired by natural infection (Pandhi and Sonthalia, 2011).The vaccine has been found 
to produce a stronger immune response in young adolescents than in women over 15 
years (Keam and Harper, 2008; Joint Committee on Vaccination and Immunisation, 
2008b). 
Immunogenicity studies have indicated that it is safe to administer HPV vaccine at the 
same time with other types of vaccines (Pandhi and Sonthalia, 2011). 
 
Bivalent and quadrivalent vaccines are safe (World Health Organization, 2009), 
effective (Lu et al., 2011) and cost-effective (Westra et al., 2011) for prevention of 
cervical cancer for females aged 9 to 26 (D'Souza and Dempsey, 2011; Chaturvedi, 
2010). No vaccination trials have yet been conducted in children less than 9 years old 
(Saslow et al., 2007). Quadrivalent vaccine is also safe and effective for males aged 9 to 
26 (D'Souza and Dempsey, 2011; Chaturvedi, 2010). The US as well as the UK do not 
administer routinely vaccine to males (D'Souza and Dempsey, 2011; Department of 
Health, 2008a) because the direct benefit to males is not certain (i.e., what proportion of 
penile and anal cancers might be prevented).  
Both vaccines protect against persistent infections and precancerous cervical lesions 
produced by HPV types 16 and 18 (Lu et al., 2011). Only quadrivalent vaccine protects 
additionally against most genital warts in females and males and cancers of the vulva, 
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vagina, and anus (D'Souza and Dempsey, 2011). It is not known if bivalent vaccine 
protects against these other anogenital cancers as it has not been tested for this purpose 
in the trials (D'Souza and Dempsey, 2011). Both vaccines also offer “cross-protection” 
against other infections caused by HPV types 31, 33 and 45 (Pandhi and Sonthalia, 
2011; Wheeler, 2011) conditional upon immunization with three doses (Wheeler, 2011).    
It is thought that about 30% (Lexchin et al., 2010) of cervical cancers are not prevented 
by the vaccines (Department of Health, 2008b). Therefore, it is important for both 
vaccinated and unvaccinated women to be screened for cervical cancer (Department of 
Health, 2008b). The Advisory Committee on Immunization Practices (ACIP) in the US 
recommended that women with abnormal cervical screening test results should be 
vaccinated, if they meet eligibility criteria, presuming that the HPV vaccine may protect 
them against “high-risk” HPV types to which they have not yet been exposed (Haupt 
and Sings, 2011; Joint Committee on Vaccination and Immunisation, 2008b). In 
addition, women with a history of HPV infection in the past can be vaccinated (Haupt 
and Sings, 2011) if they have no DNA marker of active HPV infection at the time of 
vaccination (Pandhi and Sonthalia, 2011; Haupt and Sings, 2011). 
HPV vaccines do not treat existing active HPV infections (Cervical Cancer Action, 
2009; Chaturvedi, 2010), do not treat abnormal cytology and do not prevent other 
sexually transmitted infections (STIs).  
 
2.2.5. Cost-effectiveness of HPV vaccination 
The cost-effectiveness of HPV vaccine is determined by the magnitude and treatment 
cost of the cervical cancer, vaccine effectiveness and uptake (Cutts et al., 2007). 
HPV vaccination costs include the actual cost of the HPV vaccine as well as 
administration and invitation costs (Rozenbaum et al., 2010). The actual cost of the 
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HPV vaccine in Europe ranges from €97 (Dee and Howell, 2010) to €118 (de Kok et al., 
2009) per dose. In the US the price of the HPV vaccine is about $130 per dose (Graham 
and Mishra, 2011). A Dutch study found that the administration cost of the HPV 
vaccine is €7.50 and invitation cost is €6.00 (Rozenbaum et al., 2010). The Health 
Protection Agency (HPA) showed that the administration cost of the HPV vaccine in the 
UK is £3.56 (Department of Health, 2008b). 
A cost-utility analysis of adding HPV vaccine to the Irish cervical screening programme 
concluded that the quadrivalent vaccine is more cost effective than the bivalent vaccine 
(Dee and Howell, 2010). In November 2011, the Department of Health decided to move 
to the quadrivalent vaccine in September 2012 (Salisbury, 2011). 
Studies which have explored the cost-effectiveness of adding HPV vaccination to the 
current cervical cancer screening programme have different results. HPV vaccination 
was considered to be potentially cost effective in Ireland (Dee and Howell, 2010) and 
Slovenia (Obradovic et al., 2010), but not in the Netherlands (de Kok et al., 2009). A 
few studies have shown that cost-effectiveness depends on vaccine price (Westra et al., 
2011) and extent of long-term protection by vaccination (de Kok et al., 2009). For 
example, in the UK the HPV vaccination is cost-effective if protection lasts 20 years or 
more (Department of Health, 2008b). Cost-effectiveness is low if both females and 
males are vaccinated (Haupt and Sings, 2011). A cost-effectiveness analysis in the 
Netherlands pointed out that HPV vaccination is highly effective in girls aged 12 years 
and declines in older cohorts up to the age 30 years old (Westra et al., 2011). 
Vaccinating girls is more cost effective than vaccinating boys (Pandhi and Sonthalia, 
2011; Brisson et al., 2011). Low coverage with HPV vaccine of females (as in the US 
(Haupt and Sings, 2011)) increases cost-effectiveness of HPV vaccination in males 
(D'Souza and Dempsey, 2011).   
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2.2.6. Doses of HPV vaccine 
It is necessary to administer three doses of vaccine (Wheeler, 2011). The Centers for 
Disease Control and Prevention (CDC) recommends that the second dose is given one 
to two months after the first, and the third dose six months after the first dose 
(Department of Health, 2008c). People who started vaccination with one type of vaccine 
but cannot complete the three doses with the same vaccine, could benefit from 
vaccination with the other type of vaccine i.e., one dose of quadrivalent vaccine and two 
doses of bivalent vaccine or two doses of quadrivalent vaccine and one dose of bivalent 
vaccine (Department of Health, 2008c). In fact, two doses of bivalent vaccine allow for 
the development of a level of immunity similar to vaccination with three doses 
(Wheeler, 2011) 
 
2.2.7. Adverse effects of HPV vaccination 
Before licensing, the safety of both vaccines was studied in clinical trials in over 25,000 
people females and males for the quadrivalent vaccine (Lexchin et al., 2010) and over 
30,000 females for the bivalent vaccine. Several agencies (in the US, Europe, Australia 
and WHO) have monitored the safety of vaccines (Cervical Cancer Action, 2009). The 
adverse effects of the two vaccines reported are mostly mild (Ramet et al., 2011; Haupt 
and Sings, 2011) (Table 1). 
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Table 1.Side effects of HPV vaccines 
 
Vaccine Common Rare 
 
quadrivalent  
 
 pyrexia  
 erythema, pain, swelling, 
bruising, pruritus at the 
injection site 
 
 respiratory, thoracic and 
mediastinal disorders 
 bronchospasm 
 urticaria 
 blood clots in the heart, 
lungs, and legs 
 
bivalent   headache 
 nausea, vomiting, 
Diarrhea and abdominal 
pain 
 itching/pruritus, rash, 
urticaria 
 myalgia, arthralgia 
 pain, redness, swelling at 
the injection site 
 fatigue, fever (≥38°C) 
 dizziness 
 induration,  local 
paraesthesia at the 
injection site 
 
Some categories of people are excluded by the ACIP from receiving HPV vaccines such 
as pregnant women (Lu et al., 2011; World Health Organization, 2009) or those who 
could develop a life-threatening allergic reaction to HPV vaccine (World Health 
Organization, 2009) . 
 
2.2.8. Successful strategies to improve vaccination rates 
There are several strategies to tackle the inadequate delivery of preventive services. 
Some are patient-related strategies (e.g. reminder and recall systems), others focus on 
providers (e.g. reducing missed opportunities, provider prompts) and others use a 
system-wide approach (e.g.financial interventions) (Jacobson and Szilagyi, 2005). 
Patient-related strategies as well as those focused on providers have improved 
vaccination coverage in children, adolescent and adults (Jacobson and Szilagyi, 2005; 
Task Force on Community Preventive Services, 2000). 
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Patient reminder and recall systems represent successful strategies to improve 
vaccination uptake in all types of primary care settings (Jacobson and Szilagyi, 2005; 
Task Force on Community Preventive Services, 2000) in developed countries (Jacobson 
and Szilagyi, 2005). These systems could be delivered through telephone, letters, 
postcards and face to face patient care (Jacobson and Szilagyi, 2005). The choice of the 
system is dependent on computer systems (Cockman et al., 2011), staff, accuracy of 
patient telephone numbers, and patient responsiveness to each type of reminders 
(Jacobson and Szilagyi, 2005). The most effective systems are those sent by telephone 
(Jacobson and Szilagyi, 2005). Repeated reminders appear to be more successful than 
single reminders (Jacobson and Szilagyi, 2005). Patient reminder and recall 
interventions could be used alone or as part of a multicomponent intervention (Task 
Force on Community Preventive Services, 2000). An example of a multicomponent 
intervention is a home-visiting intervention which includes education, assessment of 
need, referral and provision of vaccination in patients’ homes (Task Force on 
Community Preventive Services, 2000).  
There is strong evidence that physician reminder systems for preventive care are 
effective at increasing vaccination coverage (Task Force on Community Preventive 
Services, 2000). These systems could be delivered in patient charts (e.g. checklists or 
flowcharts), by computer or by mail as single reminders or as part of a multicomponent 
intervention (Task Force on Community Preventive Services, 2000). Nurse standing 
orders have been shown to be more effective than physician reminders to improve the 
uptake of vaccine when it is offered in hospital (Dexter et al., 2004). Other provider-
related strategies that improve immunization rates include provider assessment and 
feedback based on performance evaluation of providers via retrospective data on 
delivering one or more vaccinations (Task Force on Community Preventive Services, 
2000).  
45 
 
The next section contains a description of the HPV vaccination programme in Europe, 
including the context of HPV vaccination and the method of its delivery to target 
populations. The literature review refers to the European context because this research 
is conducted in the UK. Another reason is that the HPV vaccination policy developed at 
European Union level has been implemented differently at country level.   
 
2. 3. Description of HPV vaccination program in 
Europe 
 
Relevant research evidence is based on a literature review which, included:    
 Reports of relevant organizations (i.e., WHO, CDC, DH, ONS) 
 Published articles and editorials in different databases: Medline (OVID), Web of 
Science (former Web of Knowledge), Embase, CINAHL  
 The review included studies performed in Europe between 2007 to 2012 which 
addressed uptake of the HPV vaccine. 
 Relevant textbooks  
 
2.3.1. Cervical cancer incidence and mortality rates  
Cervical cancer is the second commonest type of cancer in women aged 15-44 years in 
the European Union (EU) (European Centre for Disease Prevention and Control, 2008) 
(European Cervical Cancer Association, 2009). Across Europe there are wide health 
inequalities (European Cervical Cancer Association, 2009) in cervical cancer, according 
to an analysis by the International Agency for Research (IARC) on Cancer in 2008 
(Table 2 (GLOBOCAN, 2008)).  
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Table 2.Age standardized incidence and mortality rates by cervical cancer/ 100,000 
population by country 
 
Age 
standardized 
rates 
by cervical 
cancer 
Country 
Age standardized 
incidence rates per 
100,000 
Country 
Age 
standardized 
mortality rates 
per 100,000 
Highest Romania 23.9 Romania 11.8 
FYR 
Macedonia 
22 FYR 
Macedonia 
9.9 
Bulgaria 21.9 Serbia 9.2 
Lithuania 21 Lithuania 8.3 
Serbia 20.9 Latvia 7.3 
 UK 7.2 UK 2 
Lowest Switzerland 4 Switzerland 0.9 
Finland 4.5 Finland 1.2 
 
Cervical cancer incidence and mortality rates are higher in countries which lack (King 
et al., 2008) or which have ineffective screening programmes (Tota et al., 2011) (e.g. in 
Eastern Europe (World Health Organization, 2008)) where the introduction of 
vaccination is conditional upon vaccine cost. Cervical cancer rates are lower in 
countries with a good infrastructure, well organized screening programs (e.g. Finland, 
the Netherlands, the United Kingdom (European Centre for Disease Prevention and 
Control, 2008)) and resources to fund the vaccine (King et al., 2008; World Health 
Organization, 2008).  
 
Cervical cancer age-standardised incidence rates by Strategic Health Authorities (SHA) 
in England showed that the rates were lower than the national average 
in the south and east of England but higher in the north and the Midlands. Data between 
2005 and 2009 showed that five SHAs had higher rates than the national level (8.7%) 
including North East (11.3%), Yorkshire and The Humber (10.7%), East Midlands 
(10.4%), North West (9.9%) and West Midlands (9.6%). Four SHAs (London, South 
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East Coast, East of England and South Central) had lower rates than the national level, 
ranging from 6.8% to 8% (Trent Cancer Registry et al., 2012). 
 
The introduction of the HPV vaccine has raised hopes of making an impact on cervical 
cancer incidence and mortality in “hard to reach groups” (e.g. women from lower 
socioeconomic groups and minorities) that have had low access to organized screening 
programme (European Centre for Disease Prevention and Control, 2008; Marlow et al., 
2008; European Cervical Cancer Association, 2009). 
 
2.3.2. Context of HPV vaccination  
The introduction of the HPV vaccine in Europe was the result of collaboration between 
scientific societies, the European Centre for Disease Prevention and Control (ECDC), 
insurance funds and civil societies. The EU actions in favor of vaccination were 
supported by the European Council, and the European Public Health Alliance as well as 
a group of policy makers against cervical cancer established by the European Cancer 
Patient’s Coalition and the European Cervical Cancer Association (Laurent-Ledru et al., 
2011). In 2008 the World Health Organization (WHO) and ECDC issued strategic 
papers to guide the introduction of HPV vaccine (World Health Organization, 2008; 
Sakou et al., 2011). At the national level, introduction of HPV vaccine has been 
recommended by a variety of national advisory body, health councils and professionals 
groups (World Health Organization, 2008) and decided by boards of health and 
vaccination committees (King et al., 2008; Jeannot et al., 2011; Dahlstrom et al., 2010; 
Kumar and Whynes, 2011). The vaccine has been implemented based on evidence 
related to burden of disease (King et al., 2008), safety (Ramet et al., 2011), efficacy, 
effectiveness (anticipated impact on precancerous and cancerous lesions) and cost-
effectiveness of vaccine (King et al., 2008), existence or lack of cervical cancer 
48 
 
screening and vaccine acceptability by adolescents and their parents as well as by health 
professionals (World Health Organization, 2008). Austria has been reluctant to 
introduce HPV vaccine in the national immunization programme on the grounds that 
cervical screening appears more cost-effective than vaccination (Graham and Mishra, 
2011). 
 
In each country, various patients’ and women’s groups have taken actions to support 
policy makers and to involve healthcare professionals in the implementation of vaccine 
as well as to inform people about and to build public trust in vaccination (Laurent-Ledru 
et al., 2011). Furthermore, introduction of the HPV vaccine was facilitated by a 
European integrated collaboration effort within European Commission DG SANCO 
project called VENICE
3
 which created a web-based network for exchange of experience 
between European countries (EU Members and Iceland and Norway) from 2006 to 2008 
(King et al., 2008). In July 2010, a survey (VENICE 2 project) on HPV vaccination 
status in Europe was conducted within the ECDC (Dorleans et al., 2010). All the 27 EU 
countries as well as Iceland and Norway participated in the study (Dorleans et al., 
2010). Eighteen countries have integrated routine HPV vaccination into the national 
immunisation schedules (Dorleans et al., 2010). Eleven countries have not introduced 
HPV vaccination into the national immunisation programme due to financial constraints 
(Dorleans et al., 2010). 
 
European countries have adopted vaccination policies, which vary in relation to target 
population, vaccine delivery strategies and health services infrastructure (King et al., 
2008). Target populations have been decided according to WHO recommendations e.g., 
that the vaccine should be given before sexual debut (European Centre for Disease 
                                                          
3
 Vaccine European New Integrated Collaboration Effort 
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Prevention and Control, 2008) and the age for starting vaccination should be in 
accordance with national data on sexual behavior (World Health Organization, 2008). A 
global perspective on sexual behavior in 59 countries worldwide indicated that most 
adolescents start their sexual activity around the ages 15-19 years (Ramet et al., 2011). 
In addition, ECDC suggested that countries should consider the acceptability of vaccine 
to targeted girls and their parents as well as the feasibility of delivering the vaccine in 
determining the age of the target population. Subsequently, two target populations were 
established. Most countries decided to adopt a primary target population, which 
includes girls at the age just before sexual debut for routine vaccination. The other 
target population was referred as the ‘catch-up group’, comprising birth cohorts who 
start to be vaccinated at the time of programme implementation but whose age is older 
than the age of girls vaccinated routinely (European Centre for Disease Prevention and 
Control, 2008, p. 26). Of eighteen European countries which implemented routine 
immunization, nine countries decided to introduce a catch-up programme (Dorleans et 
al., 2010). 
 
2.3.3. Target populations for HPV vaccine 
The recommended age ranges for the primary target population (routine cohort) for 
HPV vaccination in European countries included either one age group or several birth 
cohorts as presented in Table 3 (Dorleans et al., 2010). France decided to offer the 
vaccination to girls aged 14 years, reasoning that at this age the discussion about 
sexually transmitted infections (STIs) and their prevention would be much easier than at 
younger ages (Lutringer-Magnin et al., 2011).  
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Table 3. Age ranges for the primary routine vaccination strategy by country 
 
Age groups Country* 
11 years old Italy 
10-12 years old Sweden 
11-12 years old Slovenia 
12 years old Denmark 
 Latvia 
 Luxemburg 
 Netherlands 
 Norway 
 Romania 
11-14 years old Spain 
12-13 years old UK 
 Ireland 
13 years old Portugal 
14 years old France 
12-15 years old Greece 
12-17 years old Germany 
12-18 years old Belgium 
* The country has HPV vaccination in the national immunization schedule 
Source: (Dorleans et al., 2010) 
 
Nine countries initiated a catch-up immunization schedule for adolescents/ young adults 
aged 13 to 24 years (World Health Organization, 2008; Dorleans et al., 2010). But, age 
ranges for catch-up vaccination were heterogeneous as shown in Table 4 (Dorleans et 
al., 2010). 
 
Table 4. Age ranges for catch-up vaccination strategy by country 
 
Age groups  Country  
13-16 years old Netherlands  
13-18 years old UK 
15-17 years old Denmark  
17 years old Portugal  
13-18 years old Luxemburg, Belgium 
12-24 years old Romania  
14-17 years old  
24 years old 
Italy  
Italy 
15-23 years old France  
  Source: (Dorleans et al., 2010) 
  
51 
 
Routine and catch-up HPV vaccination strategies were introduced and integrated in the 
national immunization programme in European countries at different times as presented 
in Table 5 and in Figure 1 (Dorleans et al., 2010). 
 
Table 5. Start of HPV vaccination by year, by country and by cohort in Europe 
 
Year 2007 2008 2009 2010 
HPV 
vaccination 
by country 
Belgium* (Lefevere 
et al., 2011) 
Belgium** 
(Dorleans et al., 
2010) 
Netherlands** 
(Rondy et al., 2010) 
Netherlands* 
(Rondy et al., 2010)  
France*, ** 
(Woodhall et al., 
2007) (Dorleans et 
al., 2010) 
Denmark** 
(Mortensen, 2010) 
Denmark* 
(Mortensen, 2010) 
Sweden*  (Rondy et 
al., 2010) 
Germany* (Mosina 
et al., 2010) 
Luxembourg*,**  
(Tozzi et al., 2009) 
(Dorleans et al., 
2010) 
Norway*  (Mosina 
et al., 2010) 
Ireland* (Dorleans 
et al., 2010) 
Italy** (Dorleans et 
al., 2010) 
Italy*, **  (Tozzi et 
al., 2009) (Dorleans 
et al., 2010) 
Italy** (Dorleans et 
al., 2010) 
Italy** (Dorleans et 
al., 2010) 
 Romania*  (Mosina 
et al., 2010) 
Slovenia* (Dorleans 
et al., 2010) 
Romania** 
(Dorleans et al., 
2010) 
 Spain*  (Mosina et 
al., 2010) 
Portugal*,**   
(Mosina et al., 2010) 
(Dorleans et al., 
2010) 
Latvia* (Dorleans et 
al., 2010) 
 Switzerland*  
(Mosina et al., 2010)  
  
 UK*, **  (Kumar 
and Whynes, 2011) 
(Dorleans et al., 
2010) 
  
  Greece* (Tozzi et 
al., 2009) 
  
* for routine cohort, ** for catch up cohort, () = reference 
In Italy catch-up vaccination was introduced from 2007 to 2010 depending on the 
region. 
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Figure 1. Human papillomavirus vaccination integration in the national 
immunization schedules in Europe  
 
 
Source: (Dorleans et al., 2010) 
 
2.3.4. HPV vaccine delivery 
Many European countries have introduced HPV vaccination into their childhood 
immunization programmes (Ramet et al., 2011; Forster et al., 2010). Different 
approaches have been chosen for implementation. Some countries decided to offer HPV 
vaccination in the public sector while others chose to deliver HPV vaccination in the 
private sector (Dorleans et al., 2010). In Italy, Spain, Switzerland and England the 
delivery system have followed strategies decided at local level (European Cervical 
Cancer Association, 2009; King et al., 2008; Kumar and Whynes, 2011). The HPV 
vaccine has been provided for the routine cohort through schools, health services and/or 
through health professionals and in public health clinics and some of the countries 
which adopted these strategies are shown in Table 6 (European Cervical Cancer 
Association, 2009; Dorleans et al., 2010). Norway and Sweden delivered HPV vaccine 
only in schools (Mosina et al., 2010). In Latvia, Romania, Spain, and UK, HPV 
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vaccinations were performed both in school and in public health clinics (Dorleans et al., 
2010). The nine countries with catch-up campaigns delivered the HPV vaccine through 
public health infrastructures, private sector and/or schools (Dorleans et al., 2010). 
 
Table 6. HPV vaccine for routine cohort in public sector by country 
 
Public sector 
Schools Health professionals’ 
practice 
Public health 
clinics 
   Spain Italy Italy 
Belgium Belgium Spain 
Sweden Netherlands Netherlands 
Ireland Denmark Denmark 
Norway Portugal Portugal 
Slovenia Luxembourg UK 
UK  Latvia 
Latvia  Romania 
Romania   
 
It was assumed that adolescents could be targeted more easily in schools than in health 
facilities (Ramet et al., 2011) because just a few teenagers visit health providers given 
their “good health” (Sakou et al., 2011). Schools have been deemed a good medium for 
HPV vaccination because of other immunization programmes already in place and 
presumably because of existing education programmes about HPV vaccine (Ramet et 
al., 2011). In France the vaccine has been provided by general practitioners (Lutringer-
Magnin et al., 2011) where it has been given on demand (European Cervical Cancer 
Association, 2009). In Germany, Greece, Luxembourg, and Spain, family information 
about HPV immunization is sent by health professionals by letter which invites families 
to request the vaccine for their daughters (European Cervical Cancer Association, 
2009). Other countries have used combined delivery systems. For example, in Geneva 
between 2007 and 2009, the vaccination programme was delivered by the School Health 
Service, by pediatricians, gynecologists, internists and general practitioners (GP) in 
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private practice and by a vaccination centre in Geneva University Hospital (Jeannot et 
al., 2011).  
Fifteen European countries have offered routine HPV vaccination free of charge to girls 
in different age groups. Table 7 presents some of these countries. 
 
Table 7. Routine HPV vaccination offered free of charge by girls’ age group and 
by country  
 
Girls’ age group Country 
girls 11/12 years old Sweden (Sundstrom et al., 2010) 
Italy (World Health Organization, 2008) 
 
girls 12 - 15 years old Belgium (World Health Organization, 2008) (Mortensen, 2010) 
Denmark (World Health Organization, 2008) (Mortensen, 2010)  
 
girls 12 - 16 years old Netherlands  (Rondy et al., 2010)  
 
girls 12 - 17 years old Germany (European Cervical Cancer Association, 2009) (World Health 
Organization, 2008) 
Luxembourg (European Cervical Cancer Association, 2009) (World Health 
Organization, 2008)  
 
girls 12 - 18 years old United Kingdom (World Health Organization, 2008) 
girls 11 - 19 years old Switzerland (Jeannot et al., 2011) 
girls 12 - 26 years old Greece (European Cervical Cancer Association, 2009) 
    () = reference 
 
Austria has offered routine HPV vaccination fully at the expense of the vaccinee 
(Dorleans et al., 2010). France has covered only 65% of the vaccine cost (King et al., 
2008) and Sweden has reimbursed up to 50% of the cost for girls aged 13-17 years old 
(Sundstrom et al., 2010).  
The next section shows uptake of the HPV vaccine across Europe based on a literature 
review.  
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2.3.5. Literature review about HPV vaccination uptake in 
Europe 
 
I took a systematic approach to the following literature review including a 
comprehensive systematic search of databases, systematic application of exclusion and 
inclusion criteria and systematic narrative synthesis of findings. This was not a formal 
systematic review because of lack of dual study inclusion/exclusion and data extraction. 
In addition, I did not undertake hand searching of key journals, or searches of 
conference proceedings or theses. 
Four electronic databases were searched: Medline, Embase, Cumulative Index to 
Nursing and Allied Health Literature (CINAHL) and ISI Web of Knowledge/Science. A 
comprehensive search strategy was developed using the following indexing terms 
(MeSH) to search Medline and Embase: ‘papillomavirus vaccines.mp. or exp 
Papillomavirus Vaccines/’, ‘human papilloma virus vaccines.mp.’, ‘human papilloma 
virus.mp.’, ‘hpv.mp.’, ‘exp Vaccination/ or exp Mass Vaccination/ or vaccination.mp.’, 
‘exp Immunization/ or immunisation.mp. or exp Immunization Programs/’, 
‘immunization.mp.’, ‘vaccin*.mp.’, ‘great britain.mp. or exp Great Britain/’, ‘exp 
Europe/ or europe.mp.’, ‘uptake.mp.’. I used similar search terms in both Medline and 
Embase. The terms and search strategies used were adapted accordingly for the other 
two databases, CINAHL and Web of Knowledge/Science. The search strategy for each 
database is presented in Appendix 1 (including Table 1, Table 2 and Table 3). Abstracts 
were saved using EndNote basic X7. There were no restrictions placed on the language 
of publication.  
The PRISMA
4
 flow diagram in Appendix 1 depicts the flow of information through the 
different phases of this review. It maps out the number of records identified, included 
and excluded, and the reasons for exclusions. The review inclusion criteria were in 
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 Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
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relation to the populations, interventions, outcomes and types of studies. Inclusion 
criteria in relation to outcome and interventions were uptake of HPV vaccine (both 
quadrivalent and bivalent vaccine) provided in any setting (public/private healthcare 
sector as well as public/ private education sector) in Europe. Only studies conducted in 
Europe were considered for review because of several reasons. European countries 
introduced the HPV immunization programme almost at the same time around 2007 – 
2008. The implementation of the HPV programme was supported by exchange of 
experience between European countries. The UK is part of Europe and it was intended 
to make a comparison between the HPV programme rolled out in the UK and the other 
European countries. Studies were eligible if HPV vaccine uptake one dose or two doses 
or all three doses in young women aged 9-26 years were reported. The searches were 
carried out between 2011 and 2012 and included literature dating from 2007 to 2012. 
The search was limited to 2007 because the HPV vaccination programme was firstly 
implemented in some European countries at that time. No restrictions were set 
according to study design. Both quantitative and qualitative studies were included. 
The review exclusion criteria were in relation to any country which implemented the 
HPV vaccination programme but was not in Europe (for example, the US, Australia, 
Canada and the developing countries in other parts of the world).  
Studies reporting attitudes/intention to receive the HPV vaccine were excluded as well 
as those studies related to awareness/knowledge about HPV vaccine, epidemiology of 
HPV infection, genital warts, cervical cancer, cervical cancer screening, only HPV 
vaccine, HPV vaccine and boys, cost effectiveness of HPV vaccine and modeling 
analyses, HPV vaccine and media, STIs, vaccination/immunization, sexual health. 
Study selection was conducted in two stages: Initially, I assessed titles and abstracts of 
all identified studies according to the above mentioned inclusion criteria. Then, I 
included and I assessed twelve relevant full texts in English. The review is based on 
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these twelve studies of uptake of HPV vaccine in Europe. I undertook a narrative 
synthesis because of heterogeneity of study design, participants, and outcomes.  
Some studies reported vaccination rates while others looked at the factors associated 
with the uptake. A summary of HPV vaccination uptake across European countries 
indicates that the uptake of one or more doses of HPV vaccine by routine and catch-up 
cohorts at local and national level varied from 4% to 81% between 2007 and 2010 
(Table 8) although WHO recommended coverage of 70% of the target population 
(World Health Organization, 2008).  
Table 8. Uptake of HPV vaccine in European countries by dose, by age group and 
by year 
Location Number 
of doses 
Proportion of 
vaccinated 
girls/adolescent 
females 
Age range Year 
Portugal (Dorleans et al., 
2010) 
Not 
reported 
81% 
56% 
13 years old 
17 years old 
2009 
2009 
United Kingdom (Dorleans et 
al., 2010) 
Not 
reported 
80% 12-13 years old 2009 
  32% 13-17 years old 2009 
Denmark (Dorleans et al., 
2010) 
Not 
reported 
58% 
73% 
12 years old 
15-17 years old 
2010 
2010 
Italy (Dorleans et al., 2010) Not 
reported 
56% 11 years old 2009 
Belgium - Flanders (Lefevere 
et al., 2011) 
1 dose 53% 12-18 years old 2007-2009 
Netherlands (Rondy et al., 
2010) 
1 dose 49.9% 13-16 years old 2009 
Switzerland - Geneva 
(Jeannot et al., 2011) 
3 doses 41.6% 11-21 years old 2007-2009 
France - Paris (Rouzier and 
Giordanella, 2010) 
3 doses 43% 14-23 years old Not 
reported 
France (Lutringer-Magnin et 
al., 2011) 
Not 
reported 
38% Not reported 2008-2010 
Norway (Dorleans et al., 
2010) 
Not 
reported 
30% 12 years old 2010 
Luxemburg (Dorleans et al., 
2010) 
Not 
reported 
17% 
29% 
12 years old 
13-18 years old 
2009 
 
2009 
 
Sweden (Dahlstrom et al., 
2010) 
Not 
reported 
13% Not reported Not 
reported 
Greece - Athens (Sakou et al., 
2011) 
Not 
reported 
11.9% 11-19 years old Not 
reported 
Austria (Schneider, 2010) Not 
reported 
4% Not reported Not 
reported 
()=reference 
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The review presents the results of studies which addressed common determinants of 
HPV vaccine uptake.  
Two studies showed a significant association between age and the HPV vaccine uptake 
[1 dose (p-value=0.000) (Rondy et al., 2010) and 3 doses (p-value<0.001) (Rouzier and 
Giordanella, 2010)]. A study (Lefevere et al., 2011) reported that the hazard of HPV 
vaccination (1 dose) was higher for older girls (20 years old) (HR
5
=19.39; CI=17.47-
21.52) than younger girls (13 years old) (HR
1
=0.23; CI=0.20-0.25). However, two 
studies (Fagot et al., 2011; Jeannot et al., 2011) showed lower HPV vaccine uptake (3 
doses) in catch-up cohorts than in routine cohorts. 
Four studies using correlation and multivariate analyses reported a significant 
association between ethnicity (measured by UK Census or country of birth) and low 
HPV vaccine uptake (1-2 doses) in routine and catch-up cohorts (Rondy et al., 2010; 
Roberts et al., 2011; Widgren et al., 2011; Kumar and Whynes, 2011). Two out of four 
studies showed imprecise effects of ethnicity because of small number of participants 
(Roberts et al., 2011; Widgren et al., 2011). One study out of four (population based) 
(Rondy et al., 2010) found a significant association of low HPV vaccine uptake (1 dose) 
and ethnicity (measured by country of birth). The lowest uptake was reported for girls 
having both parents born in a different country than the country of residence (p-
value=0.000).  
Four studies found a significant association between uptake of HPV vaccine and uptake 
of MMR (Rondy et al., 2010; Roberts et al., 2011; Widgren et al., 2011; Kumar and 
Whynes, 2011). Only one out of four studies (Rondy et al., 2010) adjusted for 
confounders and showed that the likelihood of HPV vaccine uptake was 6.26 higher for 
                                                          
5
 HR = Hazard Ratio, Reference group: girls aged 17 years  
59 
 
those who have received a previous MMR
6
 (NHS Choices, 2013a) (measles, mumps 
and rubella) than those who have not received it (CI=5.87-6.68; p-value=0.000).  
Two studies showed a significant association between low uptake of the HPV vaccine 
(2 doses) and deprivation (measured by IMD) in routine (Roberts et al., 2011) and 
catch-up cohorts (Kumar and Whynes, 2011). Similarly, one study reported a significant 
association of low HPV vaccine uptake (1 dose) and socioeconomic level (based on 
income estimation at postcode level) (p-value=0.000) (Rondy et al., 2010). Another 
study found that the hazard of the HPV vaccination (1 dose) was higher for girls with a 
higher socioeconomic level (based on median income of the neighborhood) (HR=1.10; 
CI=1.07-1.12) (Lefevere et al., 2011). 
Included studies were critically appraised according to Cochrane methodology to 
identify the strengths and the factors which may have introduced bias or limited the 
generalizability of the results. The strength of the studies came from the use of an HPV 
vaccine register (Rondy et al., 2010; Widgren et al., 2011), the measures to increase 
response rate (Rondy et al., 2010), the techniques to increase the validity of the findings 
[i.e., triangulation (Mortensen, 2010)], the adjustment for confounders (Rondy et al., 
2010; Lefevere et al., 2011; Roberts et al., 2011; Widgren et al., 2011; Chadenier et al., 
2011) and large sample size including eligible girls for the HPV vaccine (between 435 
and 4.2 million). 
 Methodological problems included variation in reported HPV vaccine uptake: unknown 
dose (Mortensen, 2010; Sakou et al., 2011; Dorleans et al., 2010), 1 dose (Rondy et al., 
2010; Lefevere et al., 2011; Widgren et al., 2011), 2 doses (Roberts et al., 2011; Kumar 
                                                          
6 MMR is a vaccine that protects against three infectious diseases – measles, mumps and rubella. The 
vaccine is given routinely to children in two doses and is administered as a single injection. The first dose 
is administered when babies are 12 and 13 months old and the second dose is given to pre school children  
aged 3- 5 years. In case of measles outbreak it is reccomemnded that MMR vaccine should be given to 
babies who are over 6 months old to older children and adults. 
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and Whynes, 2011; Brabin et al., 2008), and 3 doses [(Rouzier and Giordanella, 2010; 
Fagot et al., 2011; Jeannot et al., 2011; Chadenier et al., 2011). Some studies were 
conducted soon after the start of the programme (Roberts et al., 2011; Brabin et al., 
2008) and reported the initiation of HPV vaccination with one-two doses although 
WHO guidelines indicate that three doses are effective. Reporting of the HPV vaccine 
uptake rates varied e.g. using reimbursement data (Rouzier and Giordanella, 2010; 
Lefevere et al., 2011; Fagot et al., 2011), a local health authority dataset (Chadenier et 
al., 2011), a PCT
7
 (Roberts et al., 2011; Kumar and Whynes, 2011; Brabin et al., 2008), 
or a state health office (Jeannot et al., 2011), introducing the possibility of bias. 
Reimbursement data might not indicate the actual uptake. The use of aggregate data 
(Rondy et al., 2010; Kumar and Whynes, 2011) could introduce an ecological fallacy. 
There was inconsistency of classification of ethnicity across studies because of 
insufficient data (not recorded in health system) or different definitions across countries 
(Rondy et al., 2010; Roberts et al., 2011; Widgren et al., 2011). Varying measures of 
socioeconomic level were used based on area indicators (Rondy et al., 2010; Lefevere et 
al., 2011; Roberts et al., 2011; Kumar and Whynes, 2011; Brabin et al., 2008). No study 
measured socioeconomic level by individual income, education or occupation. 
Although studies were large, some findings could not be generalized beyond the study 
population because of limitations of datasets [missing data, loss of follow up for 3 doses 
                                                          
7 Primary care trusts (PCTs) were organizational structures of NHS and were responsible for 
management, delivery of and access to health and social care services to people in their geographic area 
according to people’s needs. PCTs controlled 80% of the NHS budget (NHS Choices, 2013b). It planned 
and purchased healthcare services for local populations (NHS England, 2014). A range of services were 
provided at primary care level through GPs, dentists, opticians, pharmacists, screening, mental health 
services, NHS walk-in centres, NHS Direct, patient transport (including accident and emergency). PCTs 
commissioned hospital services also. 
There were 152 PCTs in England. In April 2013, they were replaced with 211 Clinical Commissioning 
Groups (CCG) (NHS England, 2014). and local area teams (LATs). which have taken the responsibility to 
commission hospital and community NHS services for the people in their area (NHS Choices, 2013b). 
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(Rondy et al., 2010; Fagot et al., 2011; Widgren et al., 2011)] or participants’ low 
response rate (Roberts et al., 2011). 
In summary, the quality of included studies limits the conclusions which could be 
drawn about the determinants of the HPV vaccine uptake and their effect size. There 
were inconsistent results related to the association between the HPV vaccine uptake and 
girls’ age and ethnicity. It appeared consistently that low HPV vaccine uptake was 
associated with deprivation and childhood vaccination uptake respectively.  
There was a gap in literature related to the influence of ethnicity on HPV vaccine uptake 
due to inconclusive evidence.  
 
2.4. Summary  
Human papillomavirus is considered the commonest agent of STIs. It affects a high 
proportion (70%) of sexually active women and men during their lifetime, usually 
shortly after sexual debut. Almost all cervical cancer cases are linked with genital 
infection with HPV. Two HPV types (16 and 18) are thought to be responsible for 70% 
of cervical cancer cases worldwide. The period between infection with HPV and the 
development of cervical cancer varies from one year to one decade. 
The European Medicines Agency has licensed two HPV vaccines: a quadrivalent 
vaccine and a bivalent vaccine which are safe, effective and cost-effective for 
prevention of cervical cancer for females aged 9 to 26. Only quadrivalent vaccine 
protects additionally against most genital warts in females and males and cancers of the 
vulva, vagina, and anus. Ideally, females should be vaccinated before the onset of 
sexual activity with three doses of vaccine. Currently it is known that the duration of 
vaccine-induced immunity is “at least” 5 - 6 years. Vaccinating girls is more cost 
effective than vaccinating boys.   
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In Europe, the vaccine was implemented at national level based on evidence related to 
burden of disease, safety, efficacy, effectiveness (anticipated impact on precancerous 
and cancerous lesions) and cost-effectiveness of vaccine, existence or lack of cervical 
cancer screening and vaccine acceptability by adolescents and their parents as well as 
by health professionals. European countries adopted HPV vaccination policies, which 
vary in relation to target population, vaccine delivery strategies and health services 
infrastructure. Two target populations were established for HPV vaccination, which was 
integrated in the national immunization programme: a routine and a catch-up group. The 
routine and catch-up HPV vaccination was provided in the public sector (i.e., in schools, 
health professionals’ practices, public health clinics) and/or in the private sector, but 
only in some countries was it free of charge.  
A literature review that addressed common determinants of the HPV vaccine uptake 
showed the HPV vaccine uptake a gap in relation to the influence of ethnicity and girls’ 
age on HPV vaccine uptake due to inconclusive evidence.  
In the next chapter, I discuss access to health services with emphasis on barriers faced 
by different ethnic groups mostly in the UK. 
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CHAPTER 3: PART 1 PRINCIPLES AND 
FRAMEWORK OF “RIGHT TO HEALTH” 
 
Chapter 3 is divided into two parts. Part one presents the conceptual framework of the 
“right to health” and part two presents the conceptual framework of evaluation of 
quality of care. 
In the part one of this chapter, first I introduce the concept of right to health. Then I 
present and discuss the concept of access to health services. Because this concept is 
mostly related to the utilization of health services, I focused the discussion on barriers to 
access to health care faced by different ethnic groups mostly in the UK. 
 
3(1). 1. Right to health 
The United Nations (UN) elaborated the General Comment No.14 - The Right to the 
highest attainable standard of health - in 2000 based on the Article 12 of the 
International Covenant on Economic, Social and Cultural Rights. The right to health 
requires available, accessible, acceptable and good quality health services. Available 
services are defined as those offered in sufficient quantity in the country (United 
Nations.Economic and Social Council, 2000) to meet people’s needs (Obrist et al., 
2007). Accessibility was defined by WHO in terms of reaching the population with 
health services (Tamsma, 2009). Accessible services are characterized by the fact that 
everyone (without discrimination), especially the most vulnerable or marginalized 
sections of the population should benefit from health services in the country. Any 
discrimination in access to health care and underlying determinants of health “on the 
grounds of race, color, sex, language, religion, political or other opinion, national or 
social origin, property, birth, physical or mental disability, health status (including 
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HIV/AIDS), sexual orientation and civil, political, social or other status” (United 
Nations.Economic and Social Council, 2000, p. 5) is prohibited. Accessibility includes 
physical accessibility so that services can be reached by all sections of the population 
such as ethnic minorities and indigenous populations. Accessibility also includes 
economic accessibility in order that everyone can afford payment (United 
Nations.Economic and Social Council, 2000) i.e., user’s fees and transportation cost 
(Gulliford et al., 2002).  
In addition, accessibility includes information accessibility which refers to “the right to 
seek, receive and impart information and ideas concerning health issues” (United 
Nations.Economic and Social Council, 2000, p. 4). Access to information about 
medicines is a determinant of the right to health (Lemmens and Telfer, 2012). Medical 
information is created in a context dominated by conflicting interests between various 
stakeholders such as civil society groups, patient advocacy groups, researchers, 
government regulators and others. Transparent scientific debate and scrutiny of 
government regulatory decisions play an important role in promoting reliable 
information for the public (Lemmens and Telfer, 2012). Accurate and appropriate 
information about the safety and effectiveness of medical therapy must be accessible to 
patients and health professionals. Thus, an informed individual could make their own 
health and health care choices (Lemmens and Telfer, 2012).  
The UN General Comment No.14 specifically addressed women, children and 
adolescents. Paragraph 21 states that “the realization of women’s right to health requires 
[among other interventions] information, including in the area of sexual and 
reproductive health” (United Nations.Economic and Social Council, 2000, p. 6). 
Paragraph 23 mentions that adolescents should benefit from a “supportive 
environment.., that ensures the opportunity to acquire appropriate information and to 
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participate in decisions affecting their health” (United Nations.Economic and Social 
Council, 2000, p.6). 
To be acceptable, services should respect the culture of individuals and communities 
including minorities (United Nations.Economic and Social Council, 2000) and be 
adapted to meet user’s preferences (e.g. opening hours, walk-in, booking facilities 
(Gulliford et al., 2001)). Health services must also be scientifically and medically 
appropriate and of good quality (United Nations.Economic and Social Council, 2000). 
The assurance of good quality medicines and medical therapy necessitates government 
regulation (Lemmens and Telfer, 2012), “skilled medical personnel, scientific approval 
and unexpired drugs and hospital equipment, safe and potable water, and adequate 
sanitation” (United Nations.Economic and Social Council, 2000, p. 4).  
 
Some EU member states have implemented legislation that recognizes and guarantees 
the right to health (Petrova and Clifford, 2009). In these countries, the right to health has 
been guaranteed through various mechanisms such as constitutional protections, social 
policy and the implementation of healthcare institutions which provide free public 
healthcare (e,g, the NHS in the UK) (Petrova and Clifford, 2009). 
 
3(1).1.1. The National Health Service Constitution  
The National Health Service 
The National Health Service (NHS) was launched in 1948. It is a publicly funded health 
service through taxation and is largely free at the point of delivery. It is efficient, 
egalitarian, based on need not the ability to pay, and comprehensive (including antenatal 
screening, treatments for long-term conditions, transplants, emergency treatment and 
end-of-life care). Although the majority of services are free, there is a patient co-
payment for some prescriptions, optical and dental services.  
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NHS England is a commissioning organisation that has commissioned services at 
national level including primary care, specialised healthcare services, health services for 
serving personnel and families in the armed forces, health services for people who are in 
prison or other secure accommodation, and for victims of sexual assault (adults and 
children) (NHS England, 2014a).  
In April 2013, the NHS in England was reformed (NHS Choices, 2013c) (NHS 
England, 2014a). PCTs and SHAs were abolished and from that time the new NHS has 
included in its structure new organizations such as clinical commissioning groups (NHS 
Choices, 2013c) made up of GP practices in the area which they cover. CCGs have 
commissioned various NHS services such as urgent and emergency care, elective 
hospital care, community health services, maternity and newborn, mental health and 
learning disabilities. CCGs manage a budget which is allocated on a 'weighted 
capitation' basis according to the size of the population, and adjusted for the age profile 
of the population; the health of the population; and the location of the population (NHS 
England, 2014a). 
NHS services have been delivered by different providers represented by NHS 
foundation trusts (not directed by government) or NHS trusts (directed by government). 
There are several organizations monitoring these trusts and professionals. For example, 
Monitor is the financial regulator of foundation trusts to make sure that they provide 
quality care. The equivalent for the regulation of non-foundation trusts is the Trust 
Development Authority. The Care Quality Commission (CQC) is the independent 
regulator for quality in health and social care in hospitals, care homes, GP surgeries, 
dental practices and other healthcare services including private providers. The National 
Institute for Health and Care Excellence (NICE) has been responsible with the 
development of guidance and quality standards for social care. Public Health England 
(PHE) is a structure of the Department of Health that replaced the Health Protection 
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Agency and it has been responsible for health protection and health improvement 
addressing health inequalities, knowledge and information. Health and Wellbeing 
Boards (HWBs) are part of local government authorities (LGAs) and work in 
partnership with other health organizations and local government to improve the health 
and wellbeing of their local population. Each local authority in England has a 
Healthwatch organization which is responsible for patient involvement in healthcare. 
(NHS England, 2014a). 
Each Government in the four nations of the UK has the responsibility of the NHS (NHS 
Choices, 2013c). There are some differences between the NHS in England and in the 
other countries in the way the health services are commissioned and delivered. Thus, in 
Northern Ireland there are separate organizations, some responsible for commissioning 
(Local Commissioning Groups) and others responsible for delivery of integrated health 
and social care (Health and Social Care Trusts). In Scotland and Wales there are boards 
that not only plan and commission but deliver NHS services for their area also (NHS 
England, 2014a).  
 
The primary aims of the NHS Constitution is to set out rights and pledges applied to 
those who receive services NHS and work in NHS in England. A right is protected by 
law and is derived from obligations imposed on NHS healthcare providers. The pledge 
represents a commitment but is not obligatory and is supported by management and 
regulatory systems.  
 
This is patients’ right to receive NHS services free of charge in a GP’s surgery, a 
hospital or a clinic, except some prescriptions, visits to the dentist, and when they are 
overseas visitors. People have the right to benefit from NHS services without 
discrimination on the grounds of their gender, race, religion or belief, sexual orientation, 
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disability (including learning disability or mental illness) or age. Since 2008, patients 
have had easy access to services within a maximum of 18 weeks from referral for non-
urgent conditions. Since 2009, any member of the public has had access to GP services, 
regardless of which local GP practice that person has been registered with, from 8am to 
8pm, seven days a week. People from the UK could access curative health services in 
other European Economic Area countries or Switzerland with NHS funding before the 
treatment or NHS reimbursement after the treatment. 
Access to health care includes community needs assessment by the local NHS.  The 
NHS has had to work in partnership with local authorities to provide effective, 
integrated and personalised services to meet the health and well-being needs of the local 
population. PCTs have been held responsible for involving their local populations in 
decisions about the local services that they commission.  
 
Nationally approved programmes 
Everyone has the right to receive the vaccinations recommended by the Joint Committee 
on Vaccination and Immunisation (JCVI) and provided through a national immunisation 
programme (a new or existing one). The JCVI is an advisory body responsible for 
advising the Secretary of State for Health on issues regarding vaccination and 
immunisation. The Secretary of State has the responsibility to arrange the 
implementation of the national immunisation programme in England so that eligible 
people have access to the vaccine and receive it free of charge on the NHS. Also, the 
NHS has the duty to provide screening programmes as recommended by the UK 
National Screening Committee. 
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Quality of care 
There are pledges relating to quality of care. High Quality Care for All defined quality 
as having three dimensions: that care is safe, that it is effective, and that it provides 
patients with a positive experience. The NHS has had the responsibility to have 
arrangements in place to make continuous improvement in the quality of healthcare. 
 
Respect, consent and confidentiality 
Everyone has the right to be treated with dignity and respect according to the European 
Convention on Human Rights. People need to be informed about the benefits and the 
risks of a health service before any physical examinations or treatment to be able to 
decide if they accept or refuse the treatment. 
 
Informed choice 
Everyone has the right to make choices about NHS care. For example, everyone has the 
right to choose a GP practice, and to be accepted by that practice as well as to express a 
preference for using a particular doctor within that GP practice. A major priority for the 
NHS is to provide information to support people’s choice. NHS Choices is a website 
that has been set out to provide information on services, treatments and lifestyles. It 
helps patients to understand what services are available and where these services can be 
accessed (Department of Health, 2009).  
 
3(1).2. Access to health care 
Access to health care is a multi-faceted concept (Gulliford et al., 2001). Some studies on 
health services have used availability, affordability, accessibility, and acceptability 
dimensions all together to define the concept of access to health care (Obrist et al., 
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2007). Maxwell considered access as one of the dimensions of quality of care (Gulliford 
et al., 2001). 
Access to health care is a human right concept (Gulliford and Morgan, 2003) and has 
been defined from human rights perspective, health policy viewpoint, the organization 
and delivery of services standpoint (Raine et al., 2010). Access to health services 
presumes two steps, firstly, entering the health system and secondly, using the services 
(Raine et al., 2010). To have access to a service means that the service exists and that 
the service could be utilized if required. People could have access to services and 
choose not to utilize them because they do not accept them. To gain access means that 
the service has been utilized (Gulliford et al., 2001).  Access to health care is “the actual 
use of … health services and everything that facilitates or impedes the use of … health 
services” (Sibley and Weiner, 2011, p. 21). The conceptual framework for this study is 
based on this definition. 
 
Perhaps erroneously, access to health care is usually measured by utilization of health 
services as a proxy measure (Gulliford et al., 2002). Alternatively, access could be 
measured by indicators of service utilization (e.g. vaccination coverage) (Tamsma, 
2009). 
Utilization of health services reflects the perceived need for care (Norman, 2008) which 
is determined by severity of a condition (Sibley and Weiner, 2011; Sassi et al., 2001a). 
Utilization of health care results from the relation between people’s biological and 
psychosocial perceptions of needs and their previous experiences with health services 
(Gulliford et al., 2001). There are four types of need described in literature: (1) 
“normative need” established by a professional, (2) patients’ “felt need”, (3) patients’ 
“expressed need” as  demand for care, and (4) “comparative need” based on a 
comparison of care use rates of different groups of people (Boeckxstaens et al., 2011). 
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3(1). 2. 1. Need  
Need has been defined as the capacity or ability to benefit or use a needed intervention 
to reduce disease or disability or to improve health. Need is different from demand or 
want. Need is the ability to benefit from an intervention recommended by a health 
professional to a person with a certain severity of a condition. If the person cannot 
benefit from the intervention according to professionally-defined need, then the person 
has an unmet need. Want is the belief held by a person that they have the capacity to 
benefit from an intervention. Demand represents a request for an intervention. 
Utilization of health services could occur in the absence of need. When supplier induces 
demand, the rates of provided intervention exceed those expected, given levels of need. 
Supplier-induced demand could occur in the health systems with fee-for-service 
payments. Utilization of health services is influenced by population demography, need 
and supplier-induced demand, the availability and accessibility of services (Clarke et al., 
2009). 
 
3(1). 2. 2. Need assessment 
Need assessment is a systematic method of identifying need for health interventions and 
its distribution in a population. Need assessment is part of the process of planning health 
care, taking into consideration various aspects such as: effectiveness, affordability, 
allocative efficiency, equity and access. The aim of need assessment is to provide 
information on how “to maximize the appropriate delivery of effective health 
interventions and to minimize both the provision of ineffective health intervention and 
the existence of unmet need for health care in an evidence-based way; and to maximize 
equity” (Clarke et al., 2009, p.1558). 
There are several models of needs assessment. An epidemiological needs assessment 
model of a problem (i.e., health condition) in the local population is developed 
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according to demographic information about the local population, welfare, public health 
issues, health status (i.e., incidence and prevalence of health condition and levels of 
severity), socioeconomic status, inequalities, demand for health care and underlying risk 
factors. Data about demography can be accessed easily, but information about the other 
enumerated aspects may be difficult to obtain. Gathering appropriate and sufficient data 
informs the process of identifying appropriate interventions (e.g. ranked according to 
evidence of effectiveness and cost-effectiveness) that will address the need in the local 
population. A comparative needs assessment model has the aim to identify 
organizational models and patterns of care for the identified need (health condition) in 
other areas (other systems and other populations). A corporate needs assessment model 
offers a clear understanding of current practice. It considers current service provision 
and compares it with expected service provision suggested by evidence on incidence 
and prevalence of the health condition in the local population. In addition, the model 
compares current service provision with the evidence of effectiveness of service 
provision. The model allows for identification of gaps in services, considering 
underserved groups in the local population as well as aspects of unmet needs, 
inequalities, equity and access to services. Gathering appropriate and sufficient data 
informs the process of planning a change (e.g. reorganization of services or change in 
patient care pathways within a service) (Clarke et al., 2009). 
 
3(1). 2. 3. Utilization of health services 
The factors which could influence utilization of health services are availability, 
affordability, physical accessibility, and acceptability of services as well as information 
about health services (Gulliford et al., 2002; Gulliford et al., 2001). Travel time, costs 
and availability of transport could play a more important role than distance in the use of 
care (Gulliford et al., 2001). Access is highly dynamic (Department of Health, 2006). 
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The interaction of different factors such as socio-demographic (e.g. age, ethnicity, 
culture, religion, education) and health services related (e.g. quality, cost, location) 
causes variable use of health care (Say and Raine, 2007).  
Most studies on access to health care have focused on the differential receipt of care or 
uptake of services (Szczepura, 2005). There is little evidence about the barriers to 
access to health care and factors influencing these (Szczepura, 2005). Disparities in 
access to health care for ethnic minority populations cannot be reduced to 
socioeconomic factors (Szczepura, 2005).   
Health services research has identified several hurdles to access to health care due to 
financial and non-financial barriers. Some of these barriers manifest themselves at the 
demand side and others at the supply side (Table 9). 
 
Table 9. Barriers to access to health care 
 
Demand side Supply side 
 language (Szczepura et al., 2005; Crepaldi et 
al., 2009) 
 cultural preferences (Worz et al., 2006)  
 cultural differences (Crepaldi et al., 2009)  
 health beliefs (Tamsma, 2009; Say and Raine, 
2007) 
 perceived quality of care (Say and Raine, 
2007) 
 attitudes to health services (von Wagner et al., 
2011)  
 religious practices (Say and Raine, 2007) 
 discrimination (Norman, 2008; Say and Raine, 
2007) 
 income (Boeckxstaens et al., 2011) 
 socioeconomic status (Gulliford et al., 2001) 
 age (Boeckxstaens et al., 2011; Say and Raine, 
2007) 
 gender (Gulliford et al., 2001) 
 health status (Boeckxstaens et al., 2011) 
 level of education (Say and Raine, 2007; 
Crepaldi et al., 2009) 
 information (Norman, 2008) 
 providers’ language (Szczepura et al., 2005) 
 providers’ culture (Szczepura et al., 2005) 
 quality of health services (Say and Raine, 
2007) 
 design and delivery of health care 
(Boeckxstaens et al., 2011)  
 geographical factors (distribution of providers) 
(Norman, 2008) 
 geographical factors (distance (Tamsma, 
2009)) 
 organizational factors (waiting lists) (Tamsma, 
2009) 
 skills of the providers (Boeckxstaens et al., 
2011) 
 lack of information (Tamsma, 2009) 
 
() = reference 
Barriers to utilization of services should be appraised considering that various groups of 
people have different health needs and culture (Gulliford et al., 2001). There is evidence 
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that vulnerable groups in the UK such as less wealthy people, BME (black and minority 
ethnic)
8
 (Williams and Johnson, 2010) groups as well as elderly have faced difficulties 
in accessing health care (Department of Health, 2006). There are two categories of 
factors influencing access to health care by ethnic minority groups such as personal and 
organizational factors (Szczepura, 2005). Personal factors include cultural differences, 
language and literacy, and user ignorance (Szczepura, 2005). Examples of cultural 
differences include gender as an obstacle to service access for women, and family 
dynamics such as family support to attend or take up services (Szczepura, 2005). 
Linguistic competence could be an impediment in gaining information about what 
services are available due to poor knowledge or understanding of English (especially 
women and elderly from South Asian ethnic minorities) (Szczepura et al., 2005) 
(Department of Health, 2006). For example, the language barrier has been cited as a 
significant obstacle to accessing maternal and child health care, and for utilization of 
primary health care services among South Asians (Szczepura et al., 2005). User 
ignorance refers to poor access to health care for new populations as they first come into 
contact with different services such as antenatal care, obstetric care, and services for 
older people (Szczepura, 2005). 
One of the organizational factors is related to staff’s needs for cultural competency 
training (Szczepura, 2005). It seems that sometimes when linguistically appropriate 
services existed, they were rarely used because health professionals were not aware of 
patients’ language proficiency in English (Szczepura et al., 2005). Health information 
from reliable sources may be processed differently by ethnic groups because of their 
beliefs and cultural practices (Szczepura et al., 2005). Access and use of services could 
                                                          
8
 BME (black and minority ethnic) is a term used in the majority publications and government policy 
documents in the UK suggesting the minority status rather than the ethnicity because not all minority 
ethnic groups are Black. 
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be obstructed when care providers and people from ethnic minorities do not share the 
same language and culture (Szczepura et al., 2005). 
The next section provides some evidence about access of minority ethnic groups to 
services for cancer screening and immunization. 
 
3(1). 2. 4. Uptake of preventive health services in ethnic 
groups 
 
Inequalities in access to cancer screening for people from ethnic minority groups were 
reported in several studies conducted both in the UK and in the US (Szczepura et al., 
2008). A cross-sectional analysis of colorectal cancer screening uptake in England 
indicated that the most ethnically diverse areas had lower uptake (38%) than other areas 
(52–58%) independent of socioeconomic status, age, gender and regional screening 
center (Department of Health, 2011; von Wagner et al., 2011). Another study conducted 
in England, in Coventry and Warwickshire, compared uptake patterns for breast and 
bowel cancer screening programmes among South Asian subgroups (Hindu – Gujarati; 
Other Hindu; Muslim; Sikh; other South Asian) and the majority population over a 
period of 15 years. The findings indicated significantly lower cancer screening uptakes 
for the South Asian population, which could not be attributed to socioeconomic, age and 
gender population differences. The major uptake differences between South Asian 
population and non-Asian group were related to ethnicity. Uptake rates for breast and 
bowel cancer screening were particularly lower for Muslim subgroup (51%-53%) 
between 1989 and 2004 in comparison with any other South Asian subgroup (60%-
76%) in the same period. One of the barriers could be low literacy rates among Muslims 
and older South Asian women who could not read the written instructions to collect 
samples for bowel cancer screening (Szczepura et al., 2008). These findings were 
consistent with the results of other studies on cervical and breast cancer screening in the 
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UK. The main reasons for low uptake in both programmes were attributed to language 
barriers, a lack of knowledge about screening services (Szczepura, 2005; Thomas et al., 
2005), individual’s cultural values and beliefs, individual’s misconceptions about 
perceived risk (Thomas et al., 2005), inaccurate screening registers (Szczepura, 2005), a 
lack of recommendations by health care professionals (Szczepura, 2005), poor attitudes 
of GPs (Thomas et al., 2005), and lack of local access to services (Thomas et al., 2005). 
Particularly, South Asian women in the UK had low uptake of breast and cervical 
screening (Gulliford et al., 2001). Nevertheless, a population-based cross-sectional 
study on uptake of cervical screening by ethnicity in Manchester indicated that uptake 
varied according to the relative size of the South Asian population. Thus, uptake of 
cervical screening was lower in areas with small South Asian populations (<5% of all 
women): 68.8% for South Asians versus 75.1% for other women. In areas where half or 
more of all women were South Asian, South Asians had higher uptake than other 
women (70.1% versus 51.6%). The same study showed also large variation in uptake 
(‘screened in the last 5 years’) by place-of-birth (Webb et al., 2004). Uptake for those 
born overseas was 57.4% compared to 75.6% for those born in Great Britain. Those 
born overseas who had uptake below 50% were from Greece/Turkey/Cyprus (47.3%), 
South East Asia (45%), and North Africa (43.8%) (Webb et al., 2004). A qualitative 
study of barriers to uptake of breast and cervical screening conducted among African 
Caribbean, African, Gujarati, Pakistani, Greek and Arabic groups in Brent and Harrow 
in the UK revealed various cultural attitudes to screening.  For example, some cancers 
seemed to be taboo or important to be screened only for younger women (i.e., cervical 
cancer). If young women were Muslim or Greek orthodox, they tended to avoid cervical 
screening before marriage. Other women (i.e., African and Caribbean) turned to 
traditional medicines if they lacked confidence in screening and its outcome. Fear of 
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their own susceptibility to cancer was the greatest barrier to take up of screening 
(Thomas et al., 2005). 
There is also evidence about inequalities in access to screening and immunization in the 
US. A National Health Interview Survey conducted by the CDC compared racial/ethnic 
disparities in adult cancer screening and immunization. The results indicated 
significantly lower colorectal and breast cancer screening rates for blacks and Hispanics 
(English- and Spanish-speaking) than for whites due to differences in personal and 
health characteristics as well as socioeconomic status (i.e., education and poverty). In 
contrast with disparities seen in cancer screening, the racial/ethnic (blacks and 
Hispanics versus whites) inequalities in influenza and pneumococcal vaccination uptake 
appeared to be independent of personal and health characteristics, socioeconomic 
factors, and measures of access to and utilization of care (i.e., number of visits to doctor 
and insurance status) (Lees et al., 2005).  
 
3(1). 3. Summary  
The right to health requires available, accessible, acceptable and good quality health 
services. The right to access safe and effective health services and nationally approved 
programmes as well as to make informed choices about one’s own health care has been 
recognized and guaranteed through legislation in addition to implementation of 
healthcare institutions in some EU member states. Access to health care, often measured 
by utilization of health services, reflects the need for care and is determined by the 
interaction of different factors such as socio-demographic (e.g. age, ethnicity, culture, 
religion, education) and health services related (e.g. supplier-induced demand, 
availability and accessibility). There is little evidence about the barriers to access to 
health care and factors influencing these. Health services research has identified several 
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hurdles to access to health care due to financial and non-financial barriers. There is 
evidence that vulnerable groups in the UK such as less wealthy people, black and ethnic 
minorities as well as elderly have faced difficulties in accessing health care due to 
personal (e.g. cultural differences, language and literacy, and user ignorance) and 
organizational (e.g. health professionals’ cultural competency) factors. 
In the next chapter, I discuss equity, health inequality, equity in health service delivery 
and equity in access to health care. 
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CHAPTER 3 PART 2: CONCEPTUAL 
FRAMEWORK OF EVALUATION OF 
QUALITY OF CARE 
 
Part two of this chapter presents a conceptual framework of evaluation of quality care. 
Firstly, I discuss the equity concept and then I provide full details about the relationship 
between equity and access. Secondly, I introduce the concept of health inequality and 
then I focus the discussion on the explanations of health inequalities and ethnic 
inequalities in health. In the next two sections, I present equity in health service delivery 
and equity in access to health care with a particular example of equity in access to 
vaccination. 
 
3(2). 1. Approach to evaluation - quality of care  
Generally, evaluation is a way to judge the importance of something (e.g. a health 
intervention) (Ovretveit, 1998; Milstein et al., 1999). Ovretveit defines evaluation as “a 
comparative assessment of the value of the intervention, using systematically collected 
and analyzed data, in order to decide how to act” (Ovretveit, 1998, p. 274). 
Quality was defined by Ovretveit as “meeting the health needs of those most in need at 
the lowest cost, and within regulations” (Ovretveit, 1998, p. 275). The concept of 
quality is multidimensional. There are different viewpoints from which frameworks for 
assessment of quality were constructed such as the population perspective, the external 
auditor or evaluator’s perspective, the practitioner’s perspective, and the payer’s 
perspective (Clarke and Rao, 2004). The assessment of quality is not only technical, but 
it includes the consumer’s opinion also (Maxwell, 1984). The views of patients have 
been that issues related to humanity, acceptability, equity and the holistic nature of 
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health care should be included in the quality assessment. It has been suggested that 
more consideration should be given to effectiveness of care rather than to these issues 
because it does not bring any benefit to offer ineffective care more equitably or more 
humanly (Clarke and Rao, 2004).  
A comprehensive definition of service quality was developed by Maxwell on the basis 
of six dimensions (Maxwell, 1992; Ovretveit, 1998) which need to be distinguished 
(Maxwell, 1984) because each one provides a partial picture of quality (Campbell et al., 
2000). Maxwell’s definition of each dimension (Maxwell, 1992) is presented in Table 
10.  
 
Table 10. Dimensional definition of quality of care 
 
 Source : Maxwell, 1992, p. 171 
 
Maxwell’s framework does not include key aspects of health care described by 
Donabedian (i.e., structure, process, outcome). Also, it omits the aspect of anticipatory 
Dimension Definition  
Access  “Can people get this treatment/service when they need it? Are there any identifiable 
barriers to service – for example, distance, inability to pay, waiting list and waiting 
times – or straightforward breakdowns in supply?” 
 
Acceptability  “How humanely and considerately is this treatment/service delivered? What does the 
patient think of it? What would an observant third party think of it? What is the setting 
like? Are privacy and confidentiality safeguarded?” 
 
Effectiveness “Is the treatment given the best available in a technical sense, according to those best 
equipped to judge? What is their evidence? What is the overall result of the treatment?” 
 
Efficiency “Is the output maximised for a given input or (conversely) is the input minimised for a 
given level of output? How does the unit cost compare with the unit cost elsewhere for 
the same treatment/service?” 
 
Equity  “Is this group of patients fairly treated relative to others? Are some people dealt with 
less favorably or less appropriately in their own eyes than others?”   
 
Relevance “Is the overall pattern and balance of services the best that could be achieved, taking 
account of the needs and wants of the population as a whole?” 
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health care which relates to supply of care for expressed demand and unmet needs 
(Clarke and Rao, 2004).  
Some of Maxwell’s dimensions and other components have been used by other 
researchers to develop frameworks for quality of care (Campbell et al., 2000). These 
frameworks do not overlap entirely as shown in Table 11. 
 
Table 11. Dimensions of quality of care 
 
Maxwell 1992 HSRG 1992 Donabedian 
1990 
O’Leary&O’Leary 
1992 
JCAHO 
Access Access  Access Access 
Acceptability  Acceptability   
Effectiveness Effectiveness Effectiveness Effectiveness Effectiveness 
Efficiency Efficiency Efficiency Efficiency Efficiency 
Equity  Equity   
Relevance Continuity  Continuity Continuity 
 Comprehensiveness Efficacy Efficacy Efficacy 
 Patient-centredness Legitimacy Patient perspective Appropriateness 
Source: (Ovretveit, 1998); (Campbell et al., 2000) 
HSRG = Health Services Research Group; JCAHO = Joint Commission for Accreditation of 
Healthcare Organizations
9
 (The Joint Commission, 2014) 
 
Campbell et. al defined the concept of quality of care through two dimensions: access 
and effectiveness (Campbell et al., 2000). They suggested that these aspects are very 
important for provision of health care to individual patients. The patients want to access 
effective health care, according to their need (Campbell et al., 2000). The effectiveness 
includes the effectiveness of clinical care and the effectiveness of inter-personal care 
(Campbell et al., 2000). The effectiveness of clinical care depends on evidence-based 
medicine and professional standards of care (Campbell et al., 2000). Campbell et. al 
used other two dimensions to define the concept of quality of care: equity and efficiency 
(Campbell et al., 2000). They suggested that these aspects are very important for 
provision of health care to populations (Campbell et al., 2000). Quality of care for 
                                                          
9 Joint Commission for Accreditation of Healthcare Services is an independent, not-for-profit 
organization in the US, which evaluates and certifies more than 20,500 health care organizations and 
programs in the US based on measurement of certain performance standards and quality of health care. 
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populations represents “the ability to access effective care on an efficient and equitable 
basis for the optimization of health benefit for the whole population” (Campbell et al., 
2000, p. 1622). In the framework developed by Campbell et. al, equity is viewed as a 
sub-component of access (Campbell et al., 2000) and thus access to health care could be 
evaluated through equity (Sibley and Weiner, 2011). 
 
3(2). 2. Equity – definition 
There is no standard definition for equity (Tamsma, 2009; McIntyre and Mooney, 
2007). Equity is an ethical concept related to the principles of human right and 
distributive justice (Braveman and Gruskin, 2003). Equity is defined as a fair 
distribution of good things within a society (Mulholland et al., 2008). A few theoretical 
definitions were used for equity. Thus, the utilitarian theory promoted the idea that 
greatest good to be offered to the greatest number of people. Egalitarianism put 
emphasis on equal health for everybody, which could be attained through improvement 
of the access to health care for those who are ill. According to the theory of social 
justice the poorest people’s health should be improved through action on the 
determinants of health such as their income and wealth (Sassi et al., 2001a).  
The equity concept has been used in literature in various forms related to equity in 
health, equity in health service delivery and equity in access to health care.  
 
3(2). 3. Health equity 
Health equity is defined as “the absence of systematic differences in health and its 
determinants, between and within countries that are avoidable by reasonable action” 
(Ostlin et al., 2011, p. 1; Zere et al., 2007, p. 80). Thus, eliminating health disparities 
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between groups associated with “socially unfair and unjust factors” (e.g. poverty, 
ethnicity, religion, education, occupation, gender, deprived and rural neighborhoods, 
age, disability) result in equity in health (Braveman and Gruskin, 2003, p. 254; Zere et 
al., 2007, p. 80).  
People could choose not to use a health service because of their religious belief or for 
ethical reasons. Under this circumstance excess in disease which might happen in that 
group is not considered unfair (Whitehead, 1992). From a human rights perspective, 
equity in health should be created giving all people without discrimination equal 
opportunities to be healthy (Whitehead, 1992; Braveman and Gruskin, 2003). 
Evaluation of health equity presumes comparative judgment of health status and its 
determinants between groups placed at different levels in the socioeconomic hierarchy 
(Braveman and Gruskin, 2003) as well as quantification of the degree of health 
inequality (Zere et al., 2007).  
 
3(2). 4. Health inequity versus health inequality  
The distinction between inequity and inequality has been very much debated (Kawachi 
et al., 2002). Health inequity refers to those inequalities in health that are considered to 
be unfair or stemming from some form of injustice (Kawachi et al., 2002). Thus, 
identifying health inequities involves normative judgment based on theories of justice, 
theories of society or reasoning underlying the origins of health inequalities (Kawachi et 
al., 2002). This makes the distinction between equity and equality (Kawachi et al., 
2002). 
Health inequalities refer to differences, variations, and disparities in the health 
achievements of individuals and groups (Kawachi et al., 2002). It does not imply moral 
judgment (Kawachi et al., 2002). The reason is that some health inequalities are 
attributable to free choice (i.e., voluntarily assumed risk) while others to biological 
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variations (e.g. a random genetic mutation) (World Health Organization, 2012a; 
Kawachi et al., 2002). Health inequalities due to unavoidable factors (e.g. biologic or 
genetic) do not result in inequities in health (Zere et al., 2007). Other health inequalities 
are attributable to the external environment (e.g. political, cultural, institutional) and 
conditions over which individuals have less control (World Health Organization, 2012a) 
(e.g. less healthy lifestyle, unsafe and overcrowded housing, dangerous and dirty work, 
unemployment) (Whitehead, 1992).  
 
3(2). 5. Explanations of health inequality 
Marmot claimed that socioeconomic inequalities are influenced by the interaction of the 
determinants of health such as material circumstances, the social environment, 
psychosocial factors, behaviors and biological factors (Marmot, 2010). The 
socioeconomic circumstances of persons (e.g. ethnicity, national identity, religious 
affiliation, shared history, kinship system, etc.) and the places where they live and work 
(e.g. social cohesion, social capital) influence their health (Macintyre et al., 2002; 
Centers for Disease Control and Prevention, 2011) and their healthy choices (Macintyre 
et al., 2002). The socioeconomic gradient in health refers to the worse health of those 
who are at a lower level of socioeconomic position measured by income, occupation, or 
education (Kawachi et al., 2002; Marmot, 2010; Cooper, 2002).  
 
3(2). 5. 1. Area socioeconomic status 
Area-based socioeconomic measures could be applied equally to all persons, regardless 
of age, gender, and employment status (Krieger et al., 2003). These measures are not 
affected by problems associated with occupation-based measures (e.g. people not 
employed) and education-based measures (i.e., those who have not completed their 
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education) (Krieger et al., 2003). Geographical variations in health have been explained 
considering compositional, and contextual factors. Compositional factors relate to the 
characteristics of individuals living in particular places. Contextual factors relate to 
features of the local physical environment (material infrastructure) and to socio-cultural 
features of communities (shared norms, traditions, values, and interests). Macintyre et. 
al pointed out that socio-cultural characteristics mostly used to explain the area 
differences in health comprised psychosocial constructs (i.e., social cohesion, social 
capital). They stressed that other features of non-material culture should be considered 
to reveal the area differences in health (e.g. ethnicity, national identity, religious 
affiliation, shared history, kinship system, etc.). The socio-cultural characteristics of a 
community should not be restricted to residential neighborhoods. For example, “the 
norms, values and shared economic interests of the descendents of immigrants might be 
more similar to those of current residents in the area of origin than to those of their 
neighbors in the current area of residence” (Macintyre et al., 2002, p. 131). Context 
might influence health, health-related behaviors or health risks, controlling for the 
characteristics of individuals (e.g. age, education, ethnicity, social class) or area (i.e., 
geographical classification) (Macintyre et al., 2002).  
Individual and area deprivation are independently associated with poor health. It has 
been claimed that area characteristics (i.e., neighbourhood socioeconomic status) have 
relatively small effects on health and individual socioeconomic position have larger 
effects on health (Stafford and Marmot, 2003). A multilevel analysis of health 
differences between areas within Amsterdam in the Netherlands reported that the impact 
of area deprivation on the size of the differences in health does not depend on the 
geographical classification (area size). But, the geographical classification affects the 
degree of clustering of poor health by area. Thus, the independent area effect on the 
clustering of poor health is the largest in very small areas and smallest in bigger areas 
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(postcode sectors and boroughs). These area effects could be explained by individual 
health differences that are associated with individual socioeconomic status (Reijneveld 
et al., 2000). Small areas are relatively homogeneous with respect to population 
characteristics, economic status, and living conditions (Krieger et al., 2003). In such 
homogeneous areas the contextual factors have a greater impact on health (Reijneveld et 
al., 2000).   
 
People in a higher employment grade are more likely to live in less-deprived areas. 
Having better health in non-deprived areas could be the effect of the availability of 
collective resources (e.g. services, job opportunities, and social supports) in these areas 
in comparison with deprived areas. Also, health could be affected by the local social 
inequality due to the discrepancy between individual and neighborhood socioeconomic 
position (Stafford and Marmot, 2003).  
 
Some studies using multilevel models have considered the interaction between 
individual (e.g. gender, race, social class) and neighborhood deprivation to show how 
this interaction could influence health (e.g. morbidity, body mass index, serum 
cholesterol) and health-related behavior (Stafford and Marmot, 2003; Macintyre et al., 
2002). It has been argued that health differences between individuals with higher and 
lower socioeconomic position are larger in more affluent areas. In contrast, other 
findings suggested that such disparities are larger in more deprived areas (Stafford and 
Marmot, 2003). Conflicting evidence about the extent and magnitude of area effects on 
health may be due to numerous factors. Different conceptualizations and 
operationalisations of area effects were used (Macintyre et al., 2002). Some features of 
individuals (e.g. health related behaviors, physical and mental functioning) were used in 
multivariate analyses either as intervening variables or as confounders to explain the 
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relationship between place and health (Macintyre et al., 2002). This might have been the 
consequence of a lack of a theoretical framework for the influence of area of residence 
on health and health behaviors (Macintyre et al., 2002). The contradictory findings may 
also be the result of the different geographical coverage as well as the different size of 
areas analyzed (i.e., small areas such as enumeration district in the UK, census tract in 
the US or large areas such as electoral wards in the UK, zip codes in the US and 
Australia) (Stafford and Marmot, 2003; Reijneveld et al., 2000). Administrative and 
postal delivery areas may not be appropriate scales to use in studies related to different 
types of human needs and activities (e.g. the provision of grocery stores) (Macintyre et 
al., 2002). Various studies, which investigated different health outcomes (i.e., mortality, 
cancer incidence, low birth weight, self-rated health, mental and physical symptoms, 
long term functional limitations, non-fatal weapons-related injuries) (Krieger et al., 
2003; Reijneveld et al., 2000), used different measures of both individual and area 
deprivation (i.e., Townsend and Carstairs deprivation indices, income taxation data) 
(Stafford and Marmot, 2003; Reijneveld et al., 2000). Most studies of area effects on 
health had a cross-sectional design. The drawback of using this study design is that it 
does not consider the appropriate time interval between environmental exposures (e.g. 
food, tobacco, air pollution) and the effects on health, and results in an ecological 
fallacy, inferring individual level relationships from relationships observed at aggregate 
level (Macintyre et al., 2002). 
 
There are four main types of explanations of the pathways and mechanisms underlying 
the social gradient: behavioral/cultural, material, psychosocial and life course.  
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3(2). 5. 2. Individual socioeconomic position 
Educational attainment and household income are two indicators used commonly to 
assess the influence of individual socioeconomic circumstances on health (Centers for 
Disease Control and Prevention, 2011). Poverty, wealth and crowding have also been 
used to define individual socioeconomic position (Krieger et al., 2003). Educational 
level is based on the highest educational qualification (Cooper, 2002; Reijneveld et al., 
2000). Education is a strong determinant of future employment and income (Centers for 
Disease Control and Prevention, 2011). It forms the cognitive skills that are important 
for maintaining good health (Cooper, 2002). It reflects both the long-term influence of 
early life circumstances and the influence of adult circumstances on adult health 
(Centers for Disease Control and Prevention, 2011). Education has been considered a 
more inclusive measure of socioeconomic circumstances than occupation because 
education can represent adults who have never had a paid job. On this ground education 
has been considered more appropriate to investigate the ethnic inequality in health 
(Cooper, 2002). Occupational social class is based on the present occupation of people 
(Reijneveld et al., 2000). This measure was the commonest used in the UK health 
research to assess the extent and magnitude of socioeconomic inequality in health. 
Occupational social class is not inclusive of those who have never had a job. 
Employment (full-time and part-time) is another variable suggested for analyses of 
health given the variation in employment status between gender and ethnic groups 
(Cooper, 2002). Income is the indicator that most directly measures material resources 
(Centers for Disease Control and Prevention, 2011). Income is associated with personal 
(e.g. car access) and household circumstances (i.e., housing tenure). These two aspects 
were used in the UK census 2001 to measure individual deprivation. Given that 
individual deprivation is related to income, it was argued in the literature that area-based 
measures of deprivation could not be proxies of individual deprivation (Macintyre et al., 
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2002). Income can influence health by its direct effect on living standards (e.g., access 
to better quality food and housing, leisure-time activities and health-care services) 
(Centers for Disease Control and Prevention, 2011) 
 
3(2). 5. 3. Behavioral/cultural explanation 
The behavioral/cultural explanation refers to health inequalities which are the result of 
social variations in health-related behaviors, such as smoking, diet and lack of exercise 
(Bartley, 2004; Bradby, 2008). Health inequalities are assumed to be the result of 
individual choice. Explanations of health inequalities in terms of individual behaviors 
have been criticized for ignoring the context (Bradby, 2008). Most environmental 
exposures (e.g. targeting of tobacco advertising to low income children (Kawachi et al., 
2002), lack of parks and sport centers in deprived areas (Bradby, 2008)) or the cultural 
background (e.g. ethnic, religious, linguistic) could influence how people make choices 
(e.g. the decision to start smoking or take exercise). Culture defined by education plays 
a role in social differences in risky behavior (Bartley, 2004). Any relationship between a 
damaging behavior (e.g. smoking) and social position does not depend only on attitudes 
but on habits developed over time (Bartley, 2004). 
 
3(2). 5. 4. Health–related behaviors 
Health–related behaviors cannot account for all the current patterns of health 
inequalities (Bartley, 2004). The materialist explanation refers to health inequalities 
which are the result of social differences in material circumstances related to income, 
such as poorer housing, nutrition, and working environments (Bartley, 2004). Blane et 
al. defined materialist explanations as those which refer to experiences arising as a 
consequence of social structure and organization, over which the individual has no 
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control (Bartley, 2004). This could occur because psychological and social survival 
compete with biological needs (Bartley, 2004).   
 
3(2). 5. 5. Psychosocial explanations 
Psychosocial explanations focus on the psychological effects of stressful conditions at 
work/home (Bartley, 2004) and the damaging effects of perceiving oneself to be poorer 
in an affluent society, which in turn harms health via the mechanism of stress hormones. 
A criticism of this explanation was that the problem lies in people’s attitudes to their 
situation (Bradby, 2008). 
 
3(2). 5. 6. Life course events 
Life course events such as the intensity and duration of exposure to unfavorable 
environments (stressful (Bradby, 2008)) as well as the exposure to different childhood 
conditions could result in health inequalities (Kawachi et al., 2002). The patterns of 
social, psychological and biological advantages and disadvantages combine over the life 
course and influence an individual’s health (Bartley, 2004). 
 
Before I discuss ethnic inequalities in health, I define two concepts, ethnicity and 
religion, in the next two sections. 
 
3(2). 6. Ethnicity  
Ethnicity is a socially constructed concept (Ford and Harawa, 2010). Ethnic identity is 
subjective (Forsyth and Gardener, 2006). A person could self-identify (Bhopal, 2004) 
and self-report (Department of Health, 2011) belonging to a social group considering 
language, lifestyle, religion, food and origins (Szczepura et al., 2005). Also, others 
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could identify a person as belonging to a social group (Bhopal, 2004). However, the 
individual’s view of his/her own identity is more important than other people’s opinions 
(Department of Health, 2011; Agyemang et al., 2005). Ethnicity is a multidimensional 
(Agyemang et al., 2005) concept related to a social group (Bhopal, 2004) with “shared 
geographical and ancestral origins (Bhopal, 2004, p. 441) or social background;” and/or 
“a common language or religious traditions;” and/or “shared culture and traditions that 
are distinctive, maintained between generations and lead to a sense of identity and 
group” (Woolf et al., 2011, p. 2) within a larger community (Department of Health, 
2011). Culture is made up of the beliefs, values and attitudes that underlie the behavior 
in a group of people (Szczepura et al., 2005). “Ethnicity differs from race, nationality, 
religion and migrant status…, but may include facets of these other concepts” (Bhopal, 
2004, p. 442). Although race and ethnicity were used as synonyms, they are two distinct 
concepts (Agyemang et al., 2005). It has been agreed that race has social origins rather 
than genetic ones. This is because genetic studies showed that all humans have common 
genetic characteristics (Szczepura et al., 2005). Thus, the concept of race was used to 
indicate the differences between people based on their physical characteristics (e.g. 
facial features, hair, skin color (Szczepura et al., 2005)) and ancestral roots (Bhopal, 
2004). There are four human races defined in anthropology as “Caucasian” (“white” or 
European), “Negroid” (Black or African), “Mongoloid” (Asian, Chinese, Indic), and 
“Australoid” (“Aboriginal” to Australia) (Szczepura et al., 2005).  
It was difficult to use and to measure the concept of ethnicity in research because its 
dimensions could change over time (Agyemang et al., 2005). It is helpful to use precise 
and descriptive terms to address an ethnic group such as first, second or third generation 
as well as the country of birth (Agyemang et al., 2005). However, information based on 
country of birth could identify less than the real proportion of black and minority ethnic 
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(BME) people (Szczepura et al., 2005). For example, the 2001 Census showed that 79% 
of the Mixed group in Great Britain were born in the UK (Bradford, 2006). 
In this research, ethnicity is used because it is a broader concept than race and it 
includes aspects of race (Szczepura et al., 2005; Department of Health, 2011) (Table 
12). The terminology of ethnic group populations reflects the politics of the state 
(Aspinall, 2002). The chosen ethnic categories and definitions (Table 13) which are the 
most appropriate for the purpose and the context of this study are those for which there 
is a consensus in the UK (Bhopal, 2004; Agyemang et al., 2005). It is important to use 
precise ethnic categorization for culturally appropriate delivery of health care (Bhopal, 
2004). There is a mix of ethnic and racial terms in the overarching terminology used in 
Britain which is different from that in the US and Canada (Aspinall, 2002).  
 
Table 12. Aspects that define ethnicity 
 
Epidemiology and public health literature ONS* guidance on national standards 
Ancestral origin  Descent from common ancestors  
Culture  Common geographical origin  
Language  Shared history  
Religion  Common cultural tradition  
 Language  
 Religion  
       *ONS = Office for National Statistics 
 
Ethnic groups cover people from all communities. According to the proportion of 
people in an ethnic group in relation to the population at national level, the group is 
called majority ethnic group (i.e., “White British” in England) or minority ethnic group. 
For example, “White Irish” people represent 1.3% of the population, so that they are a 
minority ethnic group at the national level (Department of Health, 2011).  
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Table 13. Ethnic categories and definitions 
 
Ethnic group Definition 
White-European Person with ancestral origins in Europe (Agyemang et al., 2005), who self-
identifies, or is identified, as White (Bhopal, 2004). In the UK, it refers to 
“White British”, “White Irish”, and “Any other White background” 
(Department of Health, 2011). 
Ethnic minority group Minority populations of non-European origin (Bhopal, 2004) and 
characterized by their non-White status (Agyemang et al., 2005). In Britain, 
non-White is a collective descriptor for the minority ethnic group 
population that is not white (Aspinall, 2002) 
Black Person with ancestral origins in Africa, who self-identifies, or is identified, 
as Black, African or Afro-Caribbean (Bhopal, 2004). 
Black and minority ethnic  Collective term used in the UK for non-White (Aspinall, 2002) 
 African Person with ancestral origins who self-identifies, or is identified, as 
African, and excludes other ancestral origins (Europeans, South Asians, 
North Africans) (Agyemang et al., 2005; Bhopal, 2004). 
African American Person with ancestral origins who self-identifies, or is identified, as African 
American.  The term most applies to those with origins in sub-Saharan 
Africa.  Most African Americans are descendants of slavery (Agyemang et 
al., 2005). 
African 
Caribbean/ Afro-
Caribbean 
Person with ancestral origins in Africa, with history of familial settlement 
in the Caribbean prior to emigrating who self-identifies, or is identified as 
Afro-Caribbean (Bhopal, 2004). Culture is different from other African 
populations in terms of language, diet, customs, beliefs, and migration 
history (Agyemang et al., 2005). 
Asian Person with ancestral origins in the Asian continent. In the UK, it usually 
refers to persons with ancestral origins in the Indian subcontinent (Bhopal, 
2004). 
 South Asian Person with ancestry in countries of the Indian subcontinent, including 
India, Pakistani, Bangladesh, and Sri Lanka (Agyemang et al., 2005). 
Bangladeshi Person with ancestral origins in the Indian subcontinent who self-identifies, 
or is identified, as Bangladeshi (Bhopal, 2004). 
Indian Person with ancestral origins in the Indian subcontinent who self-identifies, 
or is identified, as Indian (Bhopal, 2004). 
Pakistani Person with ancestral origins in the Indian subcontinent who self-identifies, 
or is identified, as Pakistani (Bhopal, 2004).  
Chinese Person with ancestral origins in China, who self-identifies, or is identified, 
as Chinese (Bhopal, 2004). 
Mixed ethnicity People whose ancestors are not of a single ethnicity (Agyemang et al., 
2005). The groups are not well defined (Bradford, 2006). In the UK, mixed 
ethnicity refers to “White and Black Caribbean”, “White and Black 
African”, “White and Asian”, “Any other mixed background” (Department 
of Health, 2011). 
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One of the limitations of the Census is that it distinguishes people with Asian origins 
(Indian, Pakistani, Bangladeshi cultural background), but it cannot make a distinction 
between people speaking different languages within a specific ethnic group (e.g. 
Punjabi, Saraiki, Sindhi, Pashto, Urdu, Kashmiri, etc.) (Woolf et al., 2011). Black 
Africans encounter similar problems because they have origins in different countries in 
Africa and speak a variety of languages (Bradford, 2006). 
 
3(2). 7. Religion 
3(2). 7. 1. Definition  
Religion, spirituality and religiousness are often used interchangeably in literature 
although they do not overlap entirely (Thoresen and Harris, 2002; Hill et al., 2000). 
Both religion and spirituality are multidimensional concepts and complex phenomena 
(Thoresen and Harris, 2002; Hill et al., 2000). There has been inconsistency among the 
various definitions for religion and spirituality in psychological and sociological 
research (Hill et al., 2000). Religion is considered a social phenomenon which involves 
social institutions attended by members who adhere to formal rules (e.g. church 
membership, church attendance), rituals (e.g prayer), and covenants (e.g. commitment 
to belief system of a church or organized religion) (Thoresen and Harris, 2002; Hill et 
al., 2000). Religiousness refers to individual’s personal experience as part of an 
organized religion (Thoresen and Harris, 2002). Thus, it includes both personal and 
institutional beliefs and practices (Hill et al., 2000). But religiousness is distinct from 
spirituality (Hill et al., 2000). Spirituality refers to individual’s personal belief and 
experience (e.g. looking for meaning and purpose in life, peace, hopefulness, 
compassion) and is independent of any traditional organized religion (Thoresen and 
Harris, 2002; Hill et al., 2000).  
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Religion is difficult to measure because it includes different aspects such as religious 
background, belief and practice. It could vary from one religion to another and from one 
person to another. In 2001, ONS measured religion by religious identity rather than 
practice and produced eight categories of religious groups. Religion data from the 
Northern Ireland could not be combined with data from the other countries in the UK 
because of different questions and answer categories. ONS produced religion statistics 
for Great Britain, combining data for England, Wales and Scotland. In England and 
Wales, 83.1% of people self-identified as having a religion and 16.1% of people self-
identified as having no religion. Among those who self-identified as having a religion, 
the majority were Christians (77.7%), Muslims (3.2%), and Hindus (1.2%). Others were 
Sikh (0.7%), Jewish (0.5%), Buddhist (0.3%) or had any other religion (0.3%). In 
Scotland 68.9% were Christian and 29.1% had no religion. Religious identity was 
subjective. It was stronger among people from non-Christian groups such as Muslims, 
Hindus and Sikhs. 
An ethnic group in Great Britain includes people of different religions. For example, an 
Indian population included Hindus (45%), Sikhs (29%), Muslims (13%) and Christians 
(5%). Similarly, a religion in Great Britain included people from different ethnic 
groups. For instance, the majority of White British, Black Caribbean and Black African 
people were Christian and the majority of Pakistani and Bangladeshi were Muslim. The 
distribution of religious groups in Great Britain by country indicated that all religious 
groups other than Christian were more concentrated in England than in Scotland and 
Wales. The most numerous among these groups in England were Hindus (98%), Sikhs 
(97.4%) and Muslims (96%). Distribution of religious groups in England by the 
Government Office Region (GOR)
10
 (Office for National Statistics, [2014]) indicated 
                                                          
10 Until April 2011, there were nine government office regions (GOR) which represented the primary 
statistical subdivisions of England. GORs reflected administrative areas made up of complete 
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that Christians were relatively evenly spread across the regions. Hindus were 
concentrated in London (52%), in the East Midlands (12%) and in the West Midlands 
(10%). Sikhs lived in London (31%) and in the West Midlands (31%). Muslims were 
the most widely spread religious population at regional level. They were concentrated in 
London (39%), in the West Midlands (14%), in the North West (13%) and in Yorkshire 
and the Humber (12%). More than half of Jews lived in London (56%), 11% lived in 
East of England and 10% in North West. In 2001, Hindus, Sikhs, Jews and Muslims 
tended to live in small areas
11
 with higher religious diversity than Buddhists, Christians 
and people from other religions. Christians tended to live in small areas of relatively 
low religious diversity. The geographic distribution of the Indian population in England 
and Wales by religion showed that in the West Midlands there were 32.2% of all Indian 
Sikhs, 11.4% of all Indian Hindus, 9.3% of all Indian Christians and 8.2% of all Indian 
Muslims. The geographic distribution of the Muslim population in England and Wales 
by ethnic group showed that in the West Midlands there were 21.9% of all Pakistani 
Muslims, 11.2% of all Bangladeshi Muslims, and 8.2% of all Indian Muslims.  
Households had ethnic homogeneity when all members of the household shared the 
same ethnicity or religion as the household reference person (i.e., head of the house). 
Households had ethnic diversity when members of the household had different ethnicity 
or religion than the household reference person. The majority of households (85%) in 
England and Wales were religiously homogeneous in 2001. Highly homogeneous 
households were Christian (90%), Sikh (85%), Hindu (84%) and Muslim (83%). Most 
of the households with religious diversity were Buddhist (22%) and Jewish (16%). 
Heterogeneity within households was the consequence of inter-ethnic marriages or 
ethnic differences between parents and children (Forsyth and Gardener, 2006). 
                                                                                                                                                                          
counties/unitary authorities, metropolitan counties and London boroughs. In each GOR there were 
Government Offices aiming to maximise prosperity and people’s quality of life within that area. 
 
11
 Middle-layer Super Output areas with an average of 7,200 people 
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3(2). 7. 2. Religion and immunization  
Religions are distinguished by beliefs and practices and modes of organization 
(Thoresen and Harris, 2002). Religious and spiritual beliefs and practices could 
influence a person’s choices, attitudes, and values which could impact health (Thoresen 
and Harris, 2002). Religion and spirituality have been shown to be effective in coping 
with disability, illness, and negative life events (Hill et al., 2000). Religion could have a 
negative impact on health when medical services are refused on religious grounds (e.g. 
parents do not accept medical services for their children) (Thoresen and Harris, 2002). 
An ecological study was conducted in the Netherlands in a “Bible belt” area populated 
by orthodox protestant groups and other inhabitants. It aimed to determine the 
difference in coverage with Diphteria Tetanus Pertussis Polio vaccine administered to 
two year old children between municipalities with and without orthodox protestant 
denominations. The findings indicated that low vaccination coverage in municipalities 
with orthodox protestant denominations was influenced by the presence of these 
religious groups (Ruijs et al., 2011). A qualitative study was conducted in Indiana, US, 
among congregation members to explore their attitudes to measles immunization after a 
measles outbreak. It was found that vaccine refusal by some church members was 
attributed to a combination of personal religious beliefs and concerns about vaccine 
safety (Kennedy and Gust, 2008).   
When the HPV immunization programme was launched in 2008 some religious 
institutions such as the Catholic Church in the Netherlands and Muslim organizations in 
the UK opposed the provision of HPV vaccination for preadolescent girls. The Catholic 
Church opposed the vaccination policy on the grounds that young people would engage 
in sexual activity at an earlier age. Muslim organizations expressed reluctance on the 
grounds that administering the HPV vaccine would coincide with Ramadan (Petrova 
and Clifford, 2009).  
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3(2). 8. Ethnic inequalities in health 
Ethnic inequalities were explained by genetic/biological, cultural, migratory, social 
deprivation and racism factors (Kelly and Nazroo, 2008). There is a consensus that 
ethnic inequalities in health are largely a consequence of socioeconomic differentials 
(Cooper, 2002; Nazroo and Williams, 2006). Ethnic minorities are more likely to have 
lower socioeconomic status due to family income and education levels (United Nations 
Research Institute for Social Development, 2006). Health inequalities result from social 
inequalities (Marmot, 2010). The diversity in health experience across ethnic groups in 
the UK is influenced by differences in migration history, patterns of settlement in the 
UK and economic disparities (Nazroo and Williams, 2006). Socioeconomic inequalities 
faced by ethnic groups include more aspects than measures of socioeconomic position 
(i.e., class or education). It is important to assess socioeconomic inequalities over the 
life course (i.e., accumulation of risk across the life course and differences between first 
and second generation migrants) as well as other factors related to ethnicity (e.g. racism 
and geographical segregation) (Bradby, 2008; Nazroo and Williams, 2006) and the 
environments where people live (Bartley, 2004). There are explanations of health 
differences between first and second generation migrants. First, childhood experiences 
of first migrants may be very different from second generation. Second, experience of 
migration occurs alongside social and economic upheaval which might have a direct 
impact on health. Third, contemporary social and economic experiences might be 
different for the migrant and non-migrant generation. Fourth, generational differences 
are driven by particular political and historical events (Nazroo and Williams, 2006). 
Health Surveys for England (1999-2004) suggested consistent rates of poor health 
across generations, despite the health benefits resulting from upward social mobility 
(Smith et al., 2009).  
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In the UK, minority ethnic men are more likely to have low paid jobs and job insecurity 
(Cooper, 2002). Minority ethnic women tend to be more disadvantaged relative to men. 
For example, women of working age with higher rates of economic inactivity (“never 
worked” or “long term unemployment”) were from South Asian groups such as 
Bangladeshi (49%), Pakistani (44%), and Indian (13%) (Forsyth and Gardener, 2006). 
Gender inequality is much greater for Pakistanis and Bangladeshis than for other ethnic 
groups. This is because Pakistani and Bangladeshi women are much more involved in 
domestic and child-care activities (Cooper, 2002). In contrast, Black Caribbean women 
had a higher rate of economic activity than South Asian women and 54% of them 
worked in public administration, education and health (Forsyth and Gardener, 2006). It 
was shown that within any given occupational group, ethnic minorities are 
disproportionately represented in the less prestigious occupational grades, having poorer 
security and more stressful conditions (Bradby, 2008). Low status and low-paid 
occupations could be the effect of discriminatory treatment of minority groups (Cooper, 
2002). Discrimination as well as perceptions of living in a discriminatory society 
contribute to ethnic inequalities in health (Nazroo and Williams, 2006). The Open 
Society Institute studied Muslims in 11 EU cities and the findings suggested that 
religious discrimination against Muslims represents a barrier to equal participation in 
society and that apart from discrimination many Muslims experience social and 
economic disadvantages, live in poorer housing and the poorer districts of large 
industrial cities, and face higher unemployment rates and higher poverty rates than the 
general population (Open Society Institute, 2010). 
Social cohesion and social capital are socio-cultural characteristics mostly used to 
explain the area differences in health (Macintyre et al., 2002). Areas with high 
concentration of ethnic groups seem to have fewer services and a worse environment 
(Bartley, 2004). However, ethnic groups perceive the facilities (e.g. shops, schools, 
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place of worship) in these areas more positively than White people (Nazroo and 
Williams, 2006). The local area can confer psycho-social benefits which are important 
for groups who experience discrimination in the wider society (Nazroo and Williams, 
2006; Graham, 2009). It was claimed that area characteristics (i.e., neighborhood 
socioeconomic status) have relatively small effects on health and that individual 
socioeconomic position has larger effects on health (Stafford and Marmot, 2003). The 
association between socioeconomic position and health persists over time and place 
because socioeconomic position determines the access to resources which promote 
health and the exposure to risk which damage it (Graham, 2009).  
 
3(2). 9. Equity in health service delivery  
Equity has been a goal of health policy in many countries and international health 
organizations (WHO Task Force on Research Priorities for Equity in Health & the 
WHO Equity Team, 2005). Some definitions of equity are equal treatment for equal 
need (McIntyre and Mooney, 2007; Boeckxstaens et al., 2011), and equal treatment 
outcomes for people in equal need (Boeckxstaens et al., 2011). The concept of equal 
quality of care implies that every person should have an equal opportunity of being 
admitted for care through a fair procedure based on need rather than social influence 
(e.g. race, ethnicity) and of having the same standard of professional care as all sections 
of the population (Whitehead, 1992).  
The equity–efficiency trade-off has been used as a framework for the consideration of 
equity in the allocation of healthcare resources (Sassi et al., 2001a). Efficiency 
represents the ratio between benefit and costs. Efficiency has two dimensions: allocative 
efficiency, which refers to use of those procedures that produce maximum benefit, and 
technical efficiency which refers to use of procedures in the most technically competent 
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manner. Achieving maximum benefit for all individuals in the population could not be 
affordable (Campbell et al., 2000). Equity concerns could occur when a particular 
technology is cost-effective for some subgroups of people but not for others (Culyer and 
Bombard, 2011). The health needs of individuals must be weighed against the 
possibility of optimising health outcomes for the population. Therefore, the resources 
should be distributed efficiently to particular subgroups in the population according to 
principles of need and equity (Campbell et al., 2000). There is a conflict between the 
goals of equity and efficiency. When improving efficiency, health inequalities increase 
(Sassi et al., 2001b). When increasing equity, more people would use the services 
including those who would benefit little, and this would lower the efficiency of services 
(Gulliford et al., 2001).  
The literature describes the equity-effectiveness loop used as a framework to evaluate 
the impact of population health policies and programmes on health inequities to ensure 
that interventions benefit the disadvantaged. The WHO Collaborating Centre on Health 
Technology Assessment used this framework, which consists of five steps to develop 
and evaluate population health policies and programmes: burden of disease, community 
effectiveness, cost-effectiveness, knowledge translation into interventions and 
monitoring. The framework assesses the potential for health inequity at each step in 
order to determine if the intervention benefits the underprivileged. The framework 
assesses barriers and facilitators for improving health equity using four factors: 
diagnostic accuracy, coverage/access, provider compliance, and consumer adherence. 
All these factors could be lower in disadvantaged groups. All these factors as well as the 
efficacy of the intervention have impact on the community effectiveness, which is 
defined as the benefit obtained from an intervention implemented in the community. 
This framework assesses only the interventions supplied by a clinician provider. Also, it 
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measures the gap between the most advantaged and the most disadvantaged, but it does 
not measure the gradient in health across all levels of disadvantage (Welch et al., 2008).  
 
Equitable delivery of health care is an essential aspect of the NHS in the UK 
(Department of Health, 2009). Health equity audit (HEA), developed and used in the 
NHS since 2003, has aimed at a fair distribution of services in relation to health need of 
different groups and areas in order to improve services and to reduce health inequalities 
between social classes (by area, gender, age, minority ethnic groups, vulnerable groups 
and the majority of population) (Department of Health, 2003). 
 
3(2). 10. Equity in access to health care  
The commonest definitions of equity found in the literature are (1) equal access to 
available care for equal need (Obrist et al., 2007), and (2) equal utilization for equal 
need (Whitehead, 1992; Boeckxstaens et al., 2011; Sibley and Weiner, 2011; van 
Doorslaer and Masseria, 2004) irrespective of other characteristics, such as income, 
place of residence or ethnicity (Tamsma, 2009; van Doorslaer and Masseria, 2004). 
These definitions define the concept of horizontal equity used in economic evaluation 
(Sassi et al., 2001a). Also, health economists use the concept of vertical equity to define 
unequal access for unequal need, which indicates that those with less need have lower 
utilization rates (Sibley and Weiner, 2011).  
Organization of health systems in the EU Member States and in OECD countries is 
based on the principles of equity and equitable distribution of health care (Tamsma, 
2009) and adequate access to health care by all people according to their need (van 
Doorslaer and Masseria, 2004; Sassi et al., 2001a).  
Equity in access to health care could be influenced by  
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 the availability of services (fair allocation of resources (Braveman and Gruskin, 
2003) based on health care needs in each geographical area (Whitehead, 1992)),  
 people’s ability to make informed decisions about the therapies (Norman, 2008),  
 the availability of information about language support services for ethnic 
minorities  
 the availability of information about out-of-hours health services (Szczepura et 
al., 2005),  
 equitable distribution of income among social groups (Norman, 2008) and  
 externalities (benefit from others’ consumption of health care) (Sassi et al., 
2001a).  
Equity in access to health care could be measured through availability and utilization as 
well as outcome of services (Gulliford et al., 2002; Gulliford et al., 2001). Deprived 
areas have the least available health services although they are most needed (the inverse 
care law) (Whitehead, 1992). But availability of services is not evidence of access to 
health care (Worz et al., 2006). In addition, equitable delivery does not guarantee 
equality of uptake (von Wagner et al., 2011). Evaluation of equitable access to care 
presumes a comparison between users and non-users of health services (Boeckxstaens et 
al., 2011) to distribute limited resources to those most in need of care (e.g. the poor) 
(Zere et al., 2007). 
 
3(2). 10. 1. Equity in access to vaccination 
Universal coverage in immunization (Gilson et al., 2007) 
12
 and equity are principles of 
human and child rights. The rationale for reaching equity is to create herd immunity and 
to minimize as much as possible the likelihood of infection (Delamonica et al., 2005).  
                                                          
12
 Universal coverage means that the whole population of a country has access to good quality of care, 
regardless of income, social status, or residency. 100% population coverage is achieved through equity in 
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Inequitable delivery of HPV vaccination has occurred in developing countries due to 
various barriers including cost and inadequate delivery infrastructure (Graham and 
Mishra, 2011). Other evidence has suggested that different types of immunization were 
delivered unequally to some groups (Mulholland et al., 2008) in developed countries. In 
England, the consequence of barriers in access to immunization was low uptake of the 
vaccines (e.g. DTP, polio, flu) especially among poorer families, living in deprived 
areas, among children with physical and learning difficulties and among ethnic groups 
(Department of Health, 2005). A social context with dominant family members (i.e., 
husbands, brothers, fathers) (Cain et al., 2009) in some ethnic groups was another 
reported barrier which limited women’s access to information and their ability to make 
their own choices for their children for HPV immunization to prevent cervical cancer.  
 
3(2). 11. Summary  
Quality of care is multidimensional, including aspects of access, acceptability, 
effectiveness, efficiency, equity and relevance. Access and effectiveness are important 
dimensions for provision of quality care to individual patients while equity and 
efficiency are essential for provision of quality care to populations. Equity is viewed as 
a sub-component of access and thus access to health care could be evaluated through 
equity. Equity has been a goal of health policy in many countries and international 
health organizations. Inequity refers to those inequalities in health that are considered to 
be unfair. Health inequalities refer to disparities in the health achievements of 
individuals and groups due to free choice, unavoidable factors (i.e., biologic or genetic) 
or external environment. There are four main types of explanations of the pathways and 
mechanisms underlying the social gradient in health: behavioral/cultural, material, 
                                                                                                                                                                          
payments, the rich paying more than the poor, financial protection of the poor not to become poorer as a 
result of using health care, and equity of access according to need rather than ability to pay  
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psychosocial and life course. There is a consensus that ethnic inequalities in health are 
largely a consequence of socioeconomic differentials (lower family income and 
education) and of living in deprived areas. Equity in access to health care could be 
measured through availability, utilization as well as outcome of services. Deprived areas 
have the least available health services although they are most needed (inverse care 
law). Equitable delivery of health services does not guarantee equality of uptake. 
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Overarching conceptual framework 
 
The “right to health” framework helped to identify the potential factors that influence 
access to HPV vaccine. The framework that focused on quality of care helped to 
identify equity as an important concept in the evaluation of access to health care. I 
developed an overarching framework, which I used to understand the context of factors 
that influenced access to HPV vaccine. The approach was through two studies. The first 
study was a quantitative research related to access
13
 to information about HPV vaccine 
of all secondary schools in the UK by geographic and school factors. The second study 
was a mixed methods research including a quantitative component that investigated 
access
14
 to HPV vaccine of girls in the secondary schools in a city of study by area 
deprivation, ethnicity and religion as well as a qualitative component that explored the 
mechanisms, strategies and practices that influenced delivery and uptake of HPV 
vaccine. This second study was an exploratory parallel study in terms of mixed method 
design (Creswell and Plano Clark, 2011), which will be discussed in Chapter 5. 
In the next chapter, I present health promotion and models, a scoping literature review 
related to awareness and knowledge about HPV vaccine and a national study based on a 
mass campaign distributing teaching materials about HPV vaccine in the UK. 
 
                                                          
13
 Measured by uptake of informative materials 
14
 Measured by uptake of HPV vaccine 
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DIAGRAM - OVERARCHING CONCEPTUAL FRAMEWORK 
“Right to health” framework (access to health care) and framework of evaluation of quality of care  
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108 
  
CHAPTER 4: NATIONAL STUDY – UPTAKE 
OF INFORMATIVE MATERIALS ON HPV 
VACCINE IN SECONDARY SCHOOLS IN 
THE UK 
 
This chapter presents three sections, including health promotion theories and models, a 
scoping literature review related to awareness and knowledge about HPV vaccine and a 
national study based on a mass campaign distributing teaching materials about HPV 
vaccine to secondary schools in the UK. 
 
4. 1. Health promotion theories and models 
This section introduces the concept of health promotion, approaches to health promotion 
and three categories of models related to individual, interpersonal and community health 
behavior. 
 
Definition of health promotion 
The Ottawa Charter defined the key concepts of health promotion in 1986 (Donev et al., 
2007). Health promotion represent actions taken (Morton et al., 2012) at individual and 
community level (Sharma and Romas, 2012) to enable people to increase control over 
health and its determinants to improve their health and to prevent diseases (Davies and 
Macdowall, 2006). The increase in health or wellbeing could be measured for example 
by improvement in life expectancy, reduction in years of life lost or quality of life 
(Rootman et al., 2001). Health promotion involves a broad range of stakeholders such as 
governments, health and other social and economic sectors, nongovernmental and 
voluntary organizations, local authorities, industry and the media. Key actions to 
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promote health and to attain equity in health include efforts to influence the broader 
social context of health behavior (Glanz et al., 2008). The actions are directed towards 
building healthy public policy for safer and healthier goods and public services and 
cleaner environments, generating safe and enjoyable living and working conditions, 
strengthening community actions, developing personal skills and reorienting health 
services. Health promotion strategies also aim to empower communities increasing 
people’s access to information, providing learning opportunities and education for 
health in different educational, professional and voluntary institutions as well as funding 
support to control their own health (Donev et al., 2007). Empowerment is facilitated 
through client-centred approaches (e.g. advocacy, counselling) aimed at increasing 
people’s control over their health (Naidoo and Wills, 2000) and through community-
based interventions that create supportive environments for people to make healthy 
choices about their behaviors (Baum, 2003). A healthy choice requires change in cost, 
availability and accessibility (Naidoo and Wills, 2000). There is evidence that behaviour 
change programmes aimed to persuade individuals in disadvantaged communties were 
not successful (Baum, 2003). Health promotion strategies and programmes should be 
adapted to the community needs according to socio economic context. Advocacy is one 
of the key strategies for the achievement of health promotion and aims to make 
political, economic, social, cultural, environmental, behavioral and biological factors 
favorable for health.  
The second international conference on health promotion held in Adelaide in 1988 
focused on building healthy public policy (Donev et al., 2007). The third international 
conference was in Sundsvall in 1991 and stressed the importance of sustainable 
development of communities to create supportive environments for health (Donev et al., 
2007). The fourth international conference, which took place in Jakarta in 1997, put 
emphasis on promoting social responsibility for health, increasing community capacity 
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and empowering the individual, expanding and consolidating partnerships for health, 
increasing investment for health development, and securing an infrastructure for health 
promotion (Donev et al., 2007).  
 
Approaches to health promotion 
I looked at three main approaches to health promotion. One is medical approach that 
focuses on medical interventions derived from epidemiological evidence for prevention 
of disease and premature death, such as immunization and screening (Naidoo and Wills, 
2000). Another one is the behavioral change approach that addresses behavioral risk 
factors (e.g. smoking, alcohol abuse, poor diet, lack of physical exercises) at individual 
and group level (Baum, 2003) through provision of information to encourage 
individuals to adopt healthy behaviors (Naidoo and Wills, 2000). The third is the socio-
environmental approach that puts emphasis on communities at risk of poverty, living 
and working in unsafe and stressful conditions and who lack social support to decrease 
inequities between population groups (Baum, 2003).  
 
Health promotion interventions developed on the basis of theoretical models appear to 
be more effective than those which do not use a theory-based approach (Davies and 
Macdowall, 2006; Glanz et al., 2008; Whitehead, 2001; Agency, 2004). The reason is 
that theoretical models offer the guidelines for planning and delivery of a health 
promotion intervention. Health promotion theories or models which target individual 
and wider environment are more effective (Davies and Macdowall, 2006). Behavior 
both influences and is influenced by the socio-economic environment (Glanz et al., 
2008). Environment includes social norms, policy, economic factors, programmes, 
practices, social influences (Morton et al., 2012). Health promotion strategies are based 
on social psychology theories (Naidoo and Wills, 2000; Baum, 2003). Health promotion 
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theories or models are individually oriented and do not include in their design socio-
economic factors (Davies and Macdowall, 2006). The theories and models identify the 
determinants of behavior change. The purpose of the majority of models is to establish 
the relationships between people’s knowledge, attitudes, beliefs, values and their 
behavior (Whitehead, 2001) to understand how people make decisions about their health 
(Naidoo and Wills, 2000).  
 
There are three categories of models of health behavior mentioned in the literature: 
models of individual health behavior, models of interpersonal health behavior and 
community and group models of health behavior change (Glanz et al., 2008). Some 
examples of models in each of these categories are given below. 
 
4. 1. 1. Models of individual health behavior  
4. 1. 1. 1. Health belief model 
The health belief model (HBM) is a theoretical model that stresses the role of beliefs in 
decision making. It has been used to predict uptake of preventive services such as 
immunization (Davies and Macdowall, 2006; Naidoo and Wills, 2000) and screening, as 
well as compliance with medical advice (Naidoo and Wills, 2000) and HIV-protective 
behaviors (Glanz et al., 2008). It is a behavior change model. An individual changes the 
behavior taking into consideration the benefits and the barriers of a recommended health 
action. The constructs of the model include the individual's assessment of the 
susceptibility to, the severity of and the threat of disease, as well as the barrier to 
undertaking recommended behavior (Glanz et al., 2008), the efficacy and the benefits of 
action (likelihood to be protected from disease) and self-efficacy (individual’s ability to 
carry out the intended behavior) (Naidoo and Wills, 2000; Davies and Macdowall, 
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2006). The individual’s assessment of the risk of disease is the main component of the 
model. Some factors influence people’s perception and their assessment of risk such as 
demography (age, gender, and ethnicity), socio-psychological characteristics 
(personality, social class, and peer pressure) and cues to action (Naidoo and Wills, 
2000; Glanz et al., 2008). The relation between individual's perception and decision is 
mediated by cues to action including mass media campaigns, advice from others, 
reminder from health professionals, personal experiences of illness, information 
provided in newspapers or magazines (Naidoo and Wills, 2000).  
The advantage of the HBM is that it supports the development of messages delivered by 
mass media to improve knowledge (Davies and Macdowall, 2006), to change 
perceptions and reduce barriers (e.g. to screening and immunization) (Davies and 
Macdowall, 2006; Glanz et al., 2008). It also guided interventions delivered through 
printed materials and telephone calls to reduce perceived barriers and to enhance 
perceived benefits (e.g. mammography screening) (Glanz et al., 2008). The HBM has 
several limitations. It does not specify how constructs of the model interact with one 
another (Glanz et al., 2008) and it does not account for other factors that influence 
health behaviors (Janz and Becker, 1984). Cues to action are often difficult to assess 
(Glanz et al., 2008). Environmental factors outside one’s control may prevent an 
individual changing their behaviors (Janz and Becker, 1984). 
 
4. 1. 1. 2. Theory of reasoned action 
The theory of reasoned action, developed by Azjen and Fishbein, predicts a person’s 
behavior by own intentions. Intention depends on own attitudes (perceived 
consequences) and subjective norms (perception of the attitudes of others towards that 
behavior). A person’s behavior is influenced by three factors: the strength of a belief 
about the consequences of the behavior as well as by personal motivation to comply 
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with social norms according to family’s or peer group’s expectations (peer pressure) and 
ability (behavioral control). People’s perceptions of the attitudes of others towards their 
behavior make the theory of reasoned action differ from the health belief model (Naidoo 
and Wills, 2000) which will be described later. Two factors have a direct effect on 
behavior: the person’s intention and their perception of control over behavior. Intention 
is not enough for behavioral performance because a person needs knowledge and skill 
to carry out that behavior. Depending on the context, in one population behavior could 
be determined by people’s own attitudes while in another population it could be 
influenced more by the expectations of significant others (Glanz et al., 2008). 
 
4. 1. 1. 3. Stages of change (transtheoretical) model 
Prochaska and DiClemente developed the stages of change model on the premise that 
people change their behavior going through several stages including precontemplation 
(when there is low awareness of potential risky behavior), contemplation (when there is 
need for information to help decision making), preparing to change (when there is some 
extra support), making the change and maintenance of that change or behavior. This 
model differs from the other models through the fact that it shows how people change 
their behavior (Naidoo and Wills, 2000). One of the limitations of the model is that it 
does not apply very well to children and young people who have not used tobacco, 
alcohol or drugs (i.e. it is more about reducing existing unhealthy behaviours than 
choosing not to undertake them in the first place) (Glanz et al., 2008).  
 
4. 1. 2. Models of interpersonal health behavior 
4. 1. 2. 1. Social cognitive theory 
Social cognitive theory is a self-regulatory model proposed by Bandura and is 
operationalized as self-efficacy (a person’s belief in their own ability to successfully 
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perform a behavior) (Glanz et al., 2008), (Davies and Macdowall, 2006). The model 
examines the predictors of health-related behavior and an individual’s cognitive process 
which results in taking or not taking actions when there is a risk of disease (Whitehead, 
2001). Self-efficacy is proposed as the most important determinant for behavior change 
(Davies and Macdowall, 2006). For example, getting a flu vaccine or not getting it 
because of barriers are experiences which are interpreted differently according to an 
individual’s character and cognition (Morton et al., 2012). 
According to the theory, there is an interaction between an individual, their environment 
(Davies and Macdowall, 2006; Donev et al., 2007) and their behavior (Davies and 
Macdowall, 2006). The model is based on observational learning, which means that 
people learn from observing the behaviors of others to develop their knowledge and to 
model their behaviors, especially when the others are similar to them. For example, they 
could enact those behaviors when they anticipate positive outcomes or avoid them if 
they expect negative results (Glanz et al., 2008). Learning may be from direct 
observation or through mass media (Rogers, 2003) (e.g. celebrities used as role models) 
(Naidoo and Wills, 2000; Davies and Macdowall, 2006) and interpersonal channels 
(Rogers, 2003).  
 
4. 1. 3. Community and group models of health behavior 
change 
 
4. 1. 3. 1. Caplan and Holland’s model 
Caplan and Holland’s model refers to four paradigms of health promotion. Two of them 
are medical and behavior change approaches that were described earlier. The other two 
components of the model are the educational approach, based on the provision of 
knowledge to change individuals’ attitudes to choose a healthy lifestyle, and 
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empowerment to increase people’s control over their own lives (Naidoo and Wills, 
2000). 
 
4. 1. 3. 2. Health action model 
Tones developed a health action model based on healthy public policy and health 
education (Naidoo and Wills, 2000). Health promotion is different from health 
education that represents learning experiences to improve knowledge and skills aimed at 
enhancing health in individuals and communities (Sharma and Romas, 2012). Health 
education ignores the role of social and economic factors on behavior. It does not 
modify the environment but empowers the community to create public pressure for a 
healthy public policy. Empowerment is the main aim of this model. Policy creates a 
healthy social and physical environment that enables individuals and communities to 
take control over their personal lives. The health action model differs from the health 
belief model and the theory of reasoned action through emphasis on self-esteem. There 
is an assumption that self-esteem (i.e., social and life skills and personal efficacy) is part 
of an individual’s motivation system that influences health behavior (Naidoo and Wills, 
2000).  
 
4. 1. 3. 3. French and Adams model  
French and Adams developed a model with a hierarchical structure, having at the 
bottom a behavior change model, in the middle a self-empowerment model and on top 
of it a collective action model. The emphasis put on health promotion as a collective 
action makes this model different from the other models. Changing environmental and 
social factors is the most important part of the model because health is seen as a social 
issue (Naidoo and Wills, 2000). 
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4. 1. 3. 4. Diffusions of innovations theory  
Diffusion represents a type of communication using certain channels to transmit an 
innovation within a social structure. “An innovation is an idea, practice, or object that is 
perceived as new by an individual” (Rogers, 2003, p.12). Diffusions of innovations 
theory is related to the adoption of innovation in communities (Davies and Macdowall, 
2006). The decision to adopt or to reject an innovation involves a process of information 
seeking and understanding of advantages and disadvantages of that particular thing. The 
process occurs over time in five steps: getting knowledge about an innovation, 
developing favorable or unfavorable attitudes towards an innovation (is or is not 
persuaded), making the decision either to adopt or to reject an innovation, uptake of an 
innovation and confirmation of decision to uptake or to reject an innovation when there 
are conflicting messages about it. At the persuasion and decision stages, an individual 
seeks the opinion of peers to strengthen their own attitude towards an innovation. A 
discrepancy could exist between the attitude in the persuasion stage and the behavior 
(adoption of an innovation). This discrepancy could be diminished by a cue-to-action 
(Rogers, 2003) which could be a model or a change agency (Davies and Macdowall, 
2006).  
People adopt new ideas at different times. This is because people need time from getting 
knowledge of an innovation until they adopt it. According to this criterion, people were 
categorized in five groups: innovators, early adopters, early majority, later majority and 
laggards. How early some people adopt new ideas in comparison with others could be 
explained by people’s socio-economic status, personality, values and communication 
behavior. Diffusion research showed that early adopters have more years of education 
and a higher social status than late adopters (Rogers, 2003) and have personal skills, as 
well as social and financial resources to uptake the innovation (Davies and Macdowall, 
2006; Rogers, 2003). It could also be the consequence of the fact that those who 
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promote innovations usually target the segment of population with high socio-economic 
status (Rogers, 2003). The late adopters are those who initially are resistant to the 
innovation even if it is provided at no cost but who take it up later when are convinced 
of its benefits (Davies and Macdowall, 2006). 
The rate of adoption represents the speed with which people adopt an innovation and is 
expressed as the number of people who adopt an innovation within a specified period of 
time (Rogers, 2003). The rate of adoption depends on the attributes of innovations, the 
communication channels, the nature of the social structure and the effort of health 
promoters to diffuse innovations. Innovation characteristics are represented by the 
relative advantage in comparison with existing practice, the compatibility with people’s 
needs, the socio-economic and cultural values as well as the norms in the social 
structure, the simplicity to understand and use it, and observing successful results got by 
those who adopted it (Davies and Macdowall, 2006; Rogers, 2003). The relative 
advantage of an innovation is related to getting an immediate reward. The rate of 
adoption of preventive innovations is slower than for non-preventive innovations. The 
reason is on one hand that innovations are adopted now and the benefit occurs at some 
time in the future and on the other hand that people could have difficulty in 
understanding the event that could happen if they do not uptake those innovations. 
Diffusion of innovation theory and social learning theory have in common the idea that 
verbal and nonverbal interpersonal communication within networks could help the 
diffusion of innovation and behavior change. Interpersonal channels could slow the rate 
of adoption. The smaller the number of people involved in making a decision about 
innovation, the faster its uptake (Rogers, 2003).  
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4. 1. 3. 5. Communication-behavior change model 
The communication-behavior change model developed by McGuire has a few 
components including a message coming from a source and transmitted through a 
channel to a target audience. The source influences the credibility of the message. The 
content and form of a message influence receiver’s response. Diverse sources, messages 
and channels are necessary to reach different segments of the audience due to their 
social and cultural differences (Davies and Macdowall, 2006). People may respond to 
some health messages and may ignore other health messages according to their health-
related values (Whitehead, 2001). The channel is chosen according to the complexity of 
the message. There are different channels such as mass media, interpersonal channels, 
and electronic communications. In general, mass media messages do not provide an 
individual with the specific information to help deal with uncertainty of innovation 
(Rogers, 2003). In contrast, interventions delivered by health professionals take longer 
time but are more effective in persuading an individual (Davies and Macdowall, 2006; 
Rogers, 2003). Mass media include television, radio and printed materials such as 
newspapers, pamphlets, posters. Other media include Internet and mobile phone 
messages (Davies and Macdowall, 2006). Mass media campaigns have generally aimed 
primarily to change awareness, knowledge and attitudes, with the purpose to change 
behavior. Mass media is appropriate to be used when wide exposure is desired and 
when it is intended to stimulate simple behavior changes such as immunisation or 
cholesterol testing (Agency, 2004). Mass media campaigns could reach a large 
proportion of people and could increase their awareness quickly and effectively (e.g 
“England’s No Smoking Day” or “Don’t fool yourself, speed kills” that targeted road 
safety in Australia) (Davies and Macdowall, 2006; Agency, 2004; Rogers, 2003; Baum, 
2003). 
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4. 1. 3. 6. Social marketing 
Social marketing applies techniques of marketing to social psychology theories to 
determine population-wide behavior change. One of the techniques is mass media 
campaign that promotes products and messages to a well-defined target audience in 
terms of demographics, behavior, psychology and media preferences. One of the 
limitations of social marketing is that it ignores the complexity of factors that affect 
health behavior as well as social structures that reduce people’s ability to change their 
lifestyle. In addition, it could result in ethical problems because advertising could 
manipulate people’s behavior by appealing to particular images (Baum, 2003).    
 
4. 1. 4. Critique of behavior-based health promotion 
There are some criticisms to all the above mentioned theories and models of behavior 
change because they focus on individual factors and may ignore the role of societal 
influences affecting someone’s behavior (Baum, 2003). It has been argued that behavior 
is not the most important determinant of health (Naidoo and Wills, 2000). Different 
models of individual behavior change conceptualize behavior change as a rational 
choice. People choose their behavior according to what they believe is good for their 
health. The models assume that people will change behaviors if they are given 
information. Then individuals are made responsible for their own health disregarding 
the social and economic context where they live (“victim–blaming”). However, 
knowledge and understanding of health is different in the general population and among 
health professionals (Baum, 2003). 
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4. 2. Scoping literature review 
The scoping literature review aimed to identify the evidence available related to health 
promotion campaigns to prevent HPV infection through HPV vaccination. The literature 
search was carried out in OVID Medline and PubMed looking for articles (any type of 
evidence) about health information, awareness, knowledge, attitudes about HPV vaccine 
as well as health promotion of the HPV vaccine and factors influencing variation in 
outcomes of health promotion in general. I identified 58 articles published between 
2006 and 2008 all over the world. Out of these, 21 articles were related to awareness, 
knowledge and attitudes about HPV, HPV vaccine and cervical cancer. Two studies 
were reviews and the others had different study designs. The study population included 
young women in different age groups (14-24 years old) (five studies), women attending 
gynecologic clinics (16-61 years old) (seven studies), parents of daughters 8-12 years 
old (four studies) and health professionals such as obstetrician/gynaecologists, family 
physicians and/or paediatricians (three studies). Studies were conducted in different 
European countries (the UK, Italy, Belgium, Finland, and Slovenia) as well as in 
Canada, Australia, Brazil and Kentucky counties. 
Prior to the commencement of the vaccination campaign, the general public in the UK 
knew little about HPV (Marlow et al., 2007; Walsh et al., 2008). Adequate education 
was required, however, to support the take-up of the new vaccine, by helping young 
people and their parents to understand that cervical cancer is a genuine risk and that the 
vaccine is an effective preventive measure (Marlow et al., 2007). Most of the women 
who heard of HPV reported media as the main source (Pitts et al., 2007). Unfortunately, 
it was found that the available information from health agencies, pharmaceutical 
companies, and special interest groups, as well as through the news in media and on the 
internet, was conflicting, inaccurate, outdated, biased, incomplete, or written at 
inappropriately high literacy levels for general audiences (Friedman and Shepeard, 
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2007). In Western Europe and North America, the pharmaceutical industry provided a 
range of information related to HPV vaccine (particularly targeted at the upper- and 
middle-income markets) (Sherris et al., 2006), but people did not feel that they could 
trust it (Friedman and Shepeard, 2007). Given these circumstance of unreliable 
information from untrusted sources, there was a clear gap. Young people’s knowledge 
of HPV was poor (Di Giuseppe et al., 2008; Donders et al., 2008; Moreira et al., 2006) 
and inadequate (Kollar and Kahn, 2008; McClelland and Liamputtong, 2006). This 
scoping review did not find evidence about health promotion of HPV vaccine in 
schools. A high percentage of parents did not hear of HPV and were not aware of the 
role of HPV in cervical cancer (Paul-Ebhohimhen et al., 2010; Noakes et al., 2006; 
Brabin et al., 2006) even among women with the history of cervical cancer (Stark et al., 
2008). The WHO recommended that family planning clinics should provide health 
education to young people aged 10–13 years, especially to adolescents who did not 
attend school, as well as to women older than 26 years to prevent STIs including HPV 
infection and to understand the need for HPV immunization (World Health 
Organization, 2006). Some evidence suggested that knowledge about HPV infection and 
cervical cancer, as well as the need to vaccinate against oncogenic HPV infection, was 
lacking among physicians (Herzog et al., 2008; Esposito et al., 2007). One of the 
clinicians’ concerns was that the adolescents might practice riskier sexual behaviors 
after vaccination and on this ground they were reluctant to recommend the vaccine to 
them and their parents (Kollar and Kahn, 2008). In this context, young people, parents 
and the health professionals who advise them needed accurate and appropriately 
targeted information about HPV and the HPV vaccine (Kollar and Kahn, 2008; 
Woodhall et al., 2007) through awareness campaigns (Walsh et al., 2008; Herzog et al., 
2008; Vrscaj et al., 2008).  
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In addition, literature searching included identification of evidence about factors 
influencing variation in outcomes of health promotion. It was found an area level social 
gradient in the impact of health promotion efforts, whereby the impact of health 
promotion tends to be less in more deprived areas. For instance, people living in more 
deprived areas tend to have lower rates of smoking cessation (Giskes et al., 2006), lower 
rates of childhood vaccination (Middleton and Baker, 2003), and lower uptake rates of 
screening services (Middleton and Baker, 2003; Maheswaran et al., 2006). Explaining 
the relationship between area deprivation and the impact of health promotion activities 
has been the focus of far less research. Broadly, however, two kinds of explanation 
present themselves. The first kind of explanation relates to the receptiveness of people 
living in more deprived areas to health promotion messages. People in more deprived 
areas may “choose” to ignore the health promotion messages more than those in less 
deprived areas (Lynch et al., 1997). A second kind of explanation is that people living in 
more deprived areas are just as receptive to health promotion messages, but they are less 
likely to be exposed to health promotion messages than their counterparts in less 
deprived areas. It is this latter kind of explanation that is explored in the next section, 
where I present a national study based on an evaluation of a mass campaign using 
printed materials for use in formal education in the secondary schools. 
 
4. 3. Quantitative research – National study  
In this section, I describe the methods and results for research question 1. First, I 
describe the HPV education programme, then I present the evaluation approach to this 
programme, followed by the methodology of the study including data sources and the 
techniques I used for data analysis. Second, I present the results of the study including 
descriptive and inferential statistics. 
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4. 3. 1. Methods 
HPV education programme by RSPH 
At the beginning of 2007, the Royal Society for Public Health (RSPH)
15
, a major public 
health charity, and Sanofi Pasteur MSD, the manufacturer in the UK of the quadrivalent 
HPV vaccine, jointly identified the need for an information and education programme 
on HPV and cervical cancer. The programme targeted professionals (head teachers, 
teachers, the personal, social and health education (PSHE) leads, and healthy school 
coordinators) and healthcare professionals (school nurses, practice nurses, GPs with 
special interest, pharmacists, genitourinary medicine (GUM) staff, immunization 
coordinators, and directors of children services), to encourage a joined up approach in 
supporting the take-up of the HPV vaccination programme. The RSPH education 
programme was two-pronged. First, it aimed at providing teachers and school nurses 
with a means of supporting the messages about HPV and HPV vaccination within 
schools to help ensure timely take-up of the three doses of the vaccine. Second, it aimed 
to provide those health professionals outside schools who were likely to receive 
questions from parents about the HPV vaccine with appropriate information. 
The first stage of the RSPH programme was an awareness raising campaign through the 
distribution and availability of an information leaflet. The second stage was a school-
based campaign associated with the development of a curriculum linked to teaching and 
learning resources. The resources were designed to support teachers and school nurses 
in introducing and raising awareness and understanding of HPV and cervical cancer and 
the HPV vaccination programme. 
                                                          
15
 At the time it was the Royal Society of Health (RSH), but it has since merged with the Royal Institute 
of Public Health (RIPH) to form the Royal Society for Public Health (RSPH). For simplicity, only the 
new name is used.  
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The RSPH programme was designed independently and in parallel with the work of the 
Department of Health (DH) (Salisbury, 2008) and NHS Health Scotland (Woods, 2007), 
and was intended to complement and support those awareness raising/information 
campaigns. From the discussion with the members of the Steering Group of the RSPH 
programme I found out that the DH aimed at raising awareness about the HPV vaccine 
focusing on cervical cancer through its communication and information programme 
(posters, stickers, leaflets, question and answer booklets, series of workshops/seminars 
and slides for health professionals, advertising programme, a new chapter of the “Green 
Book” (Department of Health, 2008c)). The RSPH sought to increase knowledge about 
the role of the HPV vaccine in the prevention of cervical cancer within an education 
programme through curriculum linked teaching materials, while supporting that effort 
with the distribution of information leaflets. 
Phoenix Consultancy, an independent educational consultancy organization, designed 
the teaching and learning resources for the RSPH education programme. These 
resources consisted of three types of materials such as a lesson plan for students to take 
responsibility for their own health, another lesson plan related to benefits and risks of 
health and lifestyle choices, and a lesson plan about vaccination and immunisation. 
The objectives of the lessons were to empower teenagers to make safe and appropriate 
decisions in relation to their physical, emotional and sexual health, to have an 
understanding of the importance of vaccination in the prevention of cervical cancer and 
to provide parents indirectly with an understanding of the need for vaccination and an 
awareness of the vaccination availability. The content of ‘Taking responsibility for your 
own health lesson plan’ aimed to enhance pupils’ understanding about taking 
responsibility for their own health and to increase their ability to take actions at their 
age of 12-14 years that will have an impact on their health in later life. Another learning 
objective was to increase pupils’ understanding of the importance of vaccination in the 
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prevention of cervical cancer and their knowledge that most cases of cervical cancer are 
preventable through a three-dose vaccination delivered to girls through schools. It also 
aimed to increase pupils’ knowledge that cervical cancer is caused by HPV and that 
genital warts are caused by other types of this virus. This lesson intended to give them 
the opportunity to understand the concept of cause, detection and prevention of disease 
(Royal Society of Public Health, 2008a). The learning objectives of ‘Benefits and risks 
of health and lifestyle choices lesson plan’ aimed to establish how much the students 
knew about factors influencing their own health and to give them the opportunity to 
learn that cervical cancer is caused by some HPV types and that other types of this virus 
cause genital warts. It also aimed to increase students’ knowledge that most cases of 
cervical cancer are preventable through a three-dose vaccination delivered to girls in 
their school or via a GP. Another objective of the lesson was to make the students aware 
that practicing safer sex is essential in the prevention of the spread of STIs (Royal 
Society of Public Health, 2008b). The content of ‘Vaccination and immunisation lesson 
plan’ included information about the impact of smallpox and the important role that 
vaccination and immunisation programmes have played in reducing the impact of 
diseases. It aimed to teach the pupils about the HPV vaccination and to make them 
understand why vaccination is still important nowadays. Another objective of the lesson 
was to teach them about the positive impact of vaccination and immunisation on public 
health (Royal Society of Public Health, 2008c). 
Lesson plans were designed to be inclusive and to encourage engagement with both 
boys and girls. They were created for teachers and/or school nurses or other healthcare 
professionals, for PSHE educators and healthy schools coordinators to use them as a 
means of introducing the distribution and collection process for consent forms and as a 
follow up to vaccination sessions. The lessons were expected to be taught in the context 
of PSHE, Sex and Relationships Education, and Science Sessions in schools especially 
126 
  
in tutor groups. The lesson plans were linked specifically to each of the four UK country 
curricula. The teaching package included an evaluation form for student feedback and 
the Basics leaflet “the Royal Society of Health HPV and Cervical Cancer”. 
 
Delivery of the HPV education programme 
In the first stage of the education programme the RSPH mailed out a letter and an 
information leaflet to UK schools, Primary Care Trusts, General Practices, Pharmacies, 
Genitourinary Medicine clinics, and City Councils. Recipients were invited to request 
additional leaflets and/or the teaching pack that had been developed. It was anticipated 
that all recipients might be interested in receiving additional leaflets, but only schools 
and off-site school nurses would be interested in receiving the teaching pack. Initial 
letters were sent out in March 2008, with the intention of delivering the additional 
resources in time to support the first round of school-based vaccination in September 
2008. During the meetings of the Steering Group of the RSPH programme I found out 
that Phoenix Consultancy identified the schools which should be sent the letters (i.e., 
who should be targeted in the mail out) although it was not clear on what basis the 
schools were selected. There were 5,715 schools identified for the initial mail out in the 
UK. All the schools that were sent letters had children in the target age group for the 
HPV vaccine. However, although some of the schools (male, single sex schools) would 
not be a part of the government vaccination campaign. It was, nonetheless, felt by the 
RSPH that it was important for all schools to be included in the broader information 
campaign because HPV affects directly or indirectly both sexes, and as a sexually 
transmitted virus, is of public health relevance to both sexes. 
An in-house mailing list was used as the basis for the mail out to the other 
organisations/professions. 
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At the same time that the leaflet and teaching pack were being prepared, an evaluation 
of the education programme was also planned. I designed and I did the evaluation based 
on the analysis of secondary data. I received these data, which included all schools that 
did and did not request teaching and learning resources, from Phoenix Consultancy.  
 
Research question 1 
What is the association between the uptake of educational materials about HPV vaccine 
by secondary schools and area level, social deprivation in England?  
 
Aim 
The aim of this part of the evaluation was to assess the extent to which the HPV 
education resources developed by RSPH reached schools. By extension, the evaluation 
would also provide insight into the strengths and weaknesses of this kind of approach to 
health promotion, and inform future work. It was never the intention of the evaluation to 
assess the extent to which the RSPH education programme changed knowledge, 
attitude, or behaviour. This was excluded from the aims because of the inherent 
difficulty of disentangling the RSPH contribution to those changes from the DH 
contribution concurrently made through its own independent education programme. 
 
4. 3. 2. Evaluation approach 
Programme implementation includes a combination of reach (who participated), dose 
(amount of intended units delivered), dose received (the extent to which participants use 
materials) (Baumana et al., 2006; Steckler and Linnan, 2002) and fidelity (quality of 
intervention delivered) (Steckler and Linnan, 2002; Brandt et al., 2005). Implementation 
assessment is a process evaluation (Baumana et al., 2006) (post-dissemination research 
and part of summative evaluation) (Flay, 1987). Process evaluation can be used to 
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assess the process of delivering a health promotion programme ( Rural and Regional 
Health and Aged Care Services Division, 2003). This type of evaluation focuses on 
what the programme does and for whom (Public Health Agency of Canada, 2007). 
Process evaluation measures the activities of the programme (Rural and Regional 
Health and Aged Care Services Division, 2003; Steckler and Linnan, 2002). By 
matching activities with associated objectives and indicators of success, it provides a 
useful blueprint or template for evaluation design (Baumana et al., 2006) (Rural and 
Regional Health and Aged Care Services Division, 2003). It addresses the question of 
how well the programme was implemented and who it reached (is the programme 
operating as planned?) (Corrigan, 2006). Process evaluation assures that planned 
interventions are carried out equally at all sites (Steckler and Linnan, 2002).  
The evaluation applied to this study was what is known as an “objective-based” 
approach (Christie and Alkin, 2004). This approach has been particularly popular in 
educational evaluation and examines the match between the intended objectives of a 
programme and the actual achievement. Although the approach has been criticised for 
its simplicity, it is well suited to the current situation, where there is a clear operational 
objective in terms of maximising the “reach” or market penetration of the leaflets and 
teaching packs. “Reach” is one of five dimensions of RE-AIM (reach, efficacy, 
adoption, implementation and maintenance) framework used to evaluate the public 
health impact of health promotion interventions. The RE-AIM evaluation model can be 
used to evaluate studies with different designs. The evaluation based on the “reach” 
dimension refers to the proportion of the target population that receives or participates 
in an intervention. Calculation of participation rates is based on information about 
programme participants (the numerator) and the whole sample for a defined population 
(the denominator), such as all members in a given clinic, health maintenance 
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organization, or worksite. “Reach” requires information about the characteristics of 
participants and non-participants (Glasgow et al., 1999). 
 
The focus of the evaluation was on the number of requests received for the teaching 
packs; and the analysis could be further disaggregated by the nature and type of school 
making the request, and its location. In this way, the extent to which responses were 
geographically localised or UK-wide could also be assessed. 
The evaluation relied on information provided by Phoenix Consultancy about the 
schools targeted for the teaching packs, and records from RSPH of those schools which 
requested the additional resources. 
The study took place at the Centre for Public Health Research at Brunel University 
between October 2007 and June 2009. Ethical approval was obtained from Brunel 
University.  
 
Study design 
This empirical work was a cross-sectional study. 
 
4. 3. 3. Data source 
A database was created of all schools that did and did not request additional information 
following the initial RSPH letter. There were 5,715 schools around the UK included in 
the initial mail-out in March. There were 36 schools in the database from the UK Isles, 
and these were excluded from the evaluation, leaving a school sample of 5,679 schools. 
The Isle of Man launched the HPV vaccination programme in 2010 (Isle of Man 
Government, 2014). Comparing responding and non-responding schools, it is possible 
to see if some types of school were more likely to request additional information than 
others, and the characteristics of those schools. The information provided by Phoenix 
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Consultancy included the size of the school, the type of school, and the age range of the 
students. Using the postcode of the school it was also possible to determine the location 
of the school and the level of deprivation of the area in which it was located 
(Department for Communities and Local Government, 2008). 
 
4. 3. 4. Results  
The countries in which the schools were located is shown in Table 14. The majority of 
the schools are located in England (83.6%), fewer in Scotland (7.6%), Wales (4.5%), or 
Northern Ireland (4.2%). 
 
Table 14. Distribution of the schools across the UK 
 
 
Some of the descriptive statistics are not available in a disaggregated form for all 
countries. The number of leaflets and teaching packs distributed is described, as well as 
the proportion of schools requesting teaching packs. These data are further 
disaggregated by the location and type of school. Logistic regression, an analytic 
technique, was used to investigate the relationship between requests for additional 
information and region, level of area deprivation, school type, and school size. 
All statistical analysis was performed using STATA/SE 10.0 
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Descriptive statistics 
Overall, around 30% of schools across the UK requested materials (28.9%), the 
majority of those requested teaching packs (i.e., n=1,632). A very small number of 
schools requested leaflets only (n=7). Most schools requesting a teaching pack only 
requested one. A total of 1,872 teaching packs were distributed across the 1,632 
schools. It should also be noted that all teaching packs included at least one leaflet. 
Approximately 19,000 leaflets were distributed to schools specifically requesting 
leaflets. The median number of leaflets distributed to a requesting school was 250. 
 
Geographic location 
The location of schools, and whether they requested teaching packs was mapped using 
map-resources from the US Centers for Disease Control and Prevention (CDC) site 
(Figure 2) (Centers for Disease Control and Prevention, 2009). The location of the 
schools was estimated on the basis of their postcodes (GeoConvert, 2009); 
unfortunately, location based on postcode could not be readily identified for Northern 
Ireland, so the map is for England, Scotland and Wales only. 
 
Figure 2. Distribution of schools in England, Wales and Scotland included in the 
mail-out 
 
 
(Orange points represent schools that requested teaching packs, green points represent schools not 
requesting teaching packs) 
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Figure 2 shows the logically anticipated preponderance of requests from urban areas. In 
England, the requests came mainly from schools in London, cities in the Midlands, and 
North West. In Wales, the requests came mainly from schools in the South between 
Cardiff and Swansea. In Scotland, the requests came mainly from schools in and around 
Glasgow and Edinburgh. From the map, it is difficult to get a sense of regional 
differences in the levels of requests, but what is provided is a sense of the general 
distribution of both requests and non-requests for teaching packs. 
 
Schools by Country 
Of the schools in each country that were sent the initial letter, it was possible to 
calculate the proportion that requested the teaching packs, in each country (Table 15). 
 
Table 15. Distribution of the schools which requested and did not request teaching 
packs – variation by country 
 
 
There was a substantial (>10%) disparity in the requests for teaching packs between the 
countries. A little over thirty eight percent (38.5%) of schools in Scotland requested 
teaching packs. A few percent less in Wales requested teaching packs (35.2%). In 
England, around 28% of school requested teaching packs (27.9%). Northern Ireland, 
133 
  
however, had a substantially lower take-up of teaching packs (20.1%), almost 20% less 
than Scotland. 
 
Schools in urban/rural areas 
A similar analysis can be conducted with respect to the distribution teaching packs and 
the level of geographical isolation. England and Wales share a method for classifying 
regions as urban, town, village or hamlet in sparsely or less sparsely populated areas 
(according to 2001 Census data) (Bibby and Shephard). Scotland and Northern Ireland 
have each adopted different systems which are not entirely comparable with the 
England/Wales system – or indeed, each other. Given that, by a substantial margin, 
most of the schools and most of the requests for teaching packs came from England and 
Wales, the effect of geographic isolation was only examined in the context of those two 
countries. Four categories of school were created (Table 16): 
· Schools in urban or town areas in less sparsely populated areas (Urban Less Sparse); 
· Schools in urban or town areas in sparsely populated areas (Urban Sparse); 
· Schools in villages and hamlets in less sparsely populated areas (Rural Less Sparse); 
· Schools in villages and hamlets in sparsely populated areas (Rural Sparse). 
 
Table 16. The proportion of the schools in urban/rural areas in England and Wales 
requesting teaching packs 
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There is some variation in the take-up of the teaching pack with 23% of schools in 
villages and hamlets from sparsely populated areas requesting teaching packs. The 
number of schools, however, is few in all areas except the less spares urban areas, which 
includes the major cities, that no robust pattern could be discerned from the data. This 
is, however, returned to later. 
 
Government Office Region 
The “Government Office Regions” (GOR) divide England into nine distinct local 
government administrative regions. Using the GOR for England and whole country for 
Wales and Scotland it is possible to obtain a clearer sense of regional variation in the 
take-up of the HPV teaching packs (Figure 3). 
 
Figure 3. Percentage of schools requesting teaching packs in Scotland, Wales, and 
the separate Government Office Regions of England 
 
 
London and the North East of England stand out as having the lowest take-up rates of 
teaching packs (20% and 21% respectively). The West Midlands and South East 
England have both 27% take-up rates, which are almost the same as the take-up rates for 
England (28%). The remaining GORs in England have take-up rates varying between 
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30% (e.g, North West and Yorkshire and the Humber Side) and 34% (East of England). 
Wales (35%) and Scotland (38%), however, had the best take-up rates. 
 
Deprivation of local area 
Having examined the take-up of the teaching packs by country, level of geographic 
isolation, and region, it would be appropriate to end the consideration of geography as a 
factor affecting take-up, by considering the relationship between local area deprivation 
and take-up of teaching packs. 
 
The Index of Multiple Deprivation (IMD) 2007 combines 37 indicators related to a 
range of economic, social and housing issues, into a single deprivation score for each 
Local Super Output Area (LSOA) – small area in England with an average population 
of 1500 people (Department for Communities and Local Government, 2008). 
Accordingly, each LSOA is ranked relative to one another by their level of deprivation 
(Department for Communities and Local Government, 2008). The most-deprived areas 
have lowest ranks and highest scores. The IMD score of a postcode could be estimated 
on the basis of the LSOAs sharing the postcode. 
 
Unfortunately, the deprivation scores derived for one country in the UK cannot be 
compared with those from the deprivation indexes of other UK countries and the IMD 
2007 was available only for England. In England, the greatest percentages of LSOAs in 
the most deprived 20% were located in the north (North East, North West, Yorkshire & 
the Humber) and London (Department for Communities and Local Government, 2008), 
which may explain the regional variation in take-up of teaching packs. 
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The IMD scores were available for all but one of the schools in England (i.e., n=4,749). 
The score would reflect the level of deprivation of the local area in which the school 
was located. It would not necessarily reflect the level of deprivation of the areas in 
which the students attending the school lived. Nonetheless, for many students, the level 
of deprivation of the area in which the school was located would stand as a fair proxy of 
the level of deprivation associated with the areas in which they lived. 
 
The IMD scores were divided into quintiles representing the schools located in the most 
deprived 20% of postcodes through to the schools located in the least deprived 20% of 
postcodes. Table 17 shows the relationship quintile of deprivation and take-up of 
teaching packs. 
Table 17 shows a steady gradient of decreasing take-up of teaching packs with 
increasing levels of deprivation in schools in England. That is, schools located in more 
deprived areas appear to be less likely to take-up teaching packs than schools in less 
deprived areas. This theme is revisited. 
 
Table 17. Distribution of the schools which requested teaching packs by quintile of 
deprivation 
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School type 
Eighteen distinct types of school were identified in the original mail-out database. Most 
of these types, however, could be reduced either to forms of independent school (i.e., 
schools that are not reliant on state funding) or to forms of maintained school (i.e., 
schools reliant on funding by the state at the level of local government, or higher). In the 
database, approximately 79% of the schools were maintained and 21% of the schools 
were independent across the UK. 
 
Table 18 shows the breakdown of requests for teaching packs by independent and 
maintained schools. 
 
Table 18. Request for teaching packs by the type of school 
 
 
 
Independent schools requested less teaching packs than maintained schools. The 
explanation for this may lie in the particular religious or moral values maintained by 
independent schools, and this will be discussed later. 
 
School size 
The relationship between requests for the teaching packs and the size of the student 
body in a school was investigated because it seemed possible that smaller schools would 
have less capacity to take-up new teaching materials than larger schools. Around 230 of 
the schools had a student body of fewer than 100 students. Schools were first divided 
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into quintiles according to the size of the student body. Table 19 shows the take-up of 
teaching materials across the schools of different sizes. 
 
Table 19. Distribution of the schools which requested teaching packs by quintile of 
the student body 
 
 
 
The results suggest that the smallest schools had the lowest take-up rate of teaching 
materials (18.5%). Once a school exceeds the smallest quintile of schools in size, 
however, it appears that further increases are not associated with further increases in the 
take-up rate. 
 
Analytic statistics - logistic regression 
The descriptive analysis of the geographical data and the school specific data provides 
an appropriate entrée to a more complex analysis of the interrelationship between school 
and geographic factors and the take-up of the teaching packs. (An article specifically 
examining whether local area deprivation is an independent predictor of the take-up of 
teaching packs is appended.) 
The analysis used logistic regression because of the binary nature of the outcome 
(request coded “0 = no” and “1= yes”). The aim of logistic regression was to examine 
the bivariate relationship between the geographic or school factors and whether a school 
did or did not request a teaching pack. A progressive modelling approach was used, in 
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which each geographic and school factor and its relationship to requests for teaching 
packs was examined in isolation. This provided crude odds ratios representing the 
strength of the association between the factors and the request for teaching packs. A 
multiple logistic regression model was then developed in which the statistically 
significant factors were simultaneously included in the logistic regression. Pooling the 
statistically significant school and geographic factors produced adjusted odds ratios. 
Adjusted odds ratios can be interpreted as the independent effect of one factor on 
schools' decisions to request teaching packs, after the effect of the other factors have 
been taken into account. 
Table 19a shows the results of the series of bivariate logistic regression models. In the 
presentation of the results one category is the base category. For example, in the 
analysis of difference between the level of take-up by country, one country (England) is 
the base category, and the take-up level in the other countries are all compared to that 
one. 
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Table 19a: The relationship between geographic factors and the take-up of 
teaching packs: unadjusted odds-ratios, 95% confidence intervals, and p-values 
 
 
Table 19b. The relationship between school factors and the take-up of teaching 
packs: unadjusted odds-ratios, 95% confidence intervals, and p-values 
 
 
 
Schools in Scotland and Wales were significantly more likely to request teaching packs 
than schools in England or Northern Ireland. One can see in Table 19a that the highest 
take-up rates were Scotland, with odds of requesting the teaching pack 1.6 times greater 
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than England. Northern Ireland, in contrast, was 0.65 times as likely to request a 
teaching pack as England. Schools in the least deprived areas had odds 1.38 times 
higher rate of requesting teaching packs than schools in the most deprived areas. There 
was, furthermore, a significant trend in the relationship between decreasing deprivation 
and increasing take-up of teaching packs (z=-3.99, p<.001). This trend was maintained 
even when the most deprived quintile of schools was removed from the analysis (z=-
2.81, p<.005). Within England, schools in seven of the nine “Government Office 
Regions” were significantly more likely to take-up teaching packs than schools in 
London. The exception was the North East, where schools were not significantly more 
likely to take-up teaching packs than schools in London. Schools in the East and South 
West of England and in the East Midlands, were about twice as likely to take-up 
teaching packs as schools in London. Schools in the South East and in the West 
Midlands were about 1.5 times as likely to take-up teaching packs as schools in London. 
 
Government maintained schools had odds about 1.5 times higher of requesting teaching 
packs than independent schools. School size was also significantly associated requests 
for teaching packs with smaller schools significantly less likely to take-up teaching 
packs than larger schools. The largest schools had odds of requesting teaching packs 
twice those of the smallest schools. There was, furthermore, a significant trend in the 
relationship between increasing school size and the take-up of teaching packs (z=7.59, 
p<.001). This trend was maintained even when the smallest quintile of schools was 
removed from the analysis (z=2.09, p<.05) (Table 19b). 
 
Individually examining the relationships between each geographic or school factor and 
the take-up of teaching packs can mask dependencies in the data. For example, smaller 
schools were identified as less likely to request teaching pack, and some countries were 
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also identified as less likely to request teaching packs than others. If smaller schools, 
however, occur exclusively in those countries that are less likely to request teaching 
packs then it becomes impossible to disentangle a school size effect from a country 
effect. The relationships were further analysed using multivariate logistic regression. In 
this way, it is possible to identify the effect of a particular school or geographic factor 
after taking account of the effects of all the other school and geographic factors. Table 
20a shows the multivariate analysis for all schools of the UK. The factors examined 
were country, school type (independent or maintained), and school size. 
 
Independent of school size and country, there is no longer any association between the 
type of school and the take-up of teaching pack. After adjusting for school type and 
school size, however, there remained a significant association between the country and 
the take-up of teaching packs. Schools in Scotland remained significantly more likely to 
request teaching packs than those in England (OR=1.6, p<.001) as were schools in 
Wales (OR=1.3, p<.05). Schools in Northern Ireland remained significantly less likely 
to request teaching packs (OR=0.7, p<.05). After adjusting for school type and country, 
there remained a significant association between the school size and the take-up of 
teaching packs, with larger schools associated with greater odds of requesting teaching 
packs than smaller schools. Indeed, schools larger than the smallest quintile of schools 
were roughly twice as likely to request teaching packs (p<.001). 
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Table 20a. The relationship between school and geographic factors in the United 
Kingdom and the take-up of teaching packs: adjusted odds ratios, 95% confidence 
intervals, and p-values 
 
 
 
Table 20b shows the multivariate analysis for England only, which includes area 
deprivation and Government Office Region, but necessarily excludes country. An 
examination of the odds ratios for quintiles of area deprivation shows a steady increase 
in the take-up rate of teaching packs by schools as the level of deprivation decreases. 
This holds even after taking account of school size, school type, and the Government 
Office Region of England. Those schools located in the least deprived areas had odd 1.3 
times greater of requesting teaching packs than schools in the most deprived quintiles 
(OR=1.31, p<.015). The Government Office Region also showed an independent 
association with the request for teaching packs. Those associations identified in the 
univariate analysis largely held in the multivariate analysis. 
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Table 20b. The relationship between school and geographic factors in England and 
the take-up of teaching packs: adjusted odds ratios, 95% confidence intervals, and 
p-values 
 
 
 
Schools in the South West and the East of England were around 1.9 times more likely to 
request teaching packs than schools in London (p<.001). The schools in the remaining 
regions, with the exception of schools in Yorkshire and the Humber were about 1.5 
times more likely than schools in London to request teaching packs (p<.01). There was 
no significant difference in the take-up rate of schools in London and schools in 
Yorkshire and the Humber. Although univariate analysis showed that the schools in the 
North East were not significantly more likely to take-up teaching packs than schools in 
London, the multivariate analysis indicated that the requests in the schools in the North 
East were significantly different to the requests in the schools in London. This is 
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because the multivariate analysis shows how well each independent variable predicts 
the dependent variable, controlling for each of the other independent variables. The p-
value for each independent variable indicates if a particular independent variable is a 
significant predictor of the dependent variable, over the other independent variables. For 
example, an independent variable that is a significant predictor of a dependent variable 
in simple linear regression may not be significant in multiple regression. Apart from the 
individual influence of each independent variable on the dependent variable while 
controlling for the other independent variables, the multivariate analysis shows the 
combined influence of all independent variables on the dependent variable. In this 
respect, the multivariate analysis is more accurate than simple regressions for each 
independent variable (Tabachnick and Fidell, 1989). 
After controlling for school size, area deprivation, and the Government Office Region, 
there was no significant association between the type of school (maintained or 
independent) and the take-up of teaching packs. 
 
Size of school continued to show a significant association with the take-up rate of 
teaching packs, even after controlling for the other school and geographic factors. 
Schools in the second quintile of size were around twice (OR=1.99, p<.001) as likely as 
the smallest schools to request teaching packs, and this rose to around 2.4 times in the 
fifth quintile of school size (OR=2.42, p<.001). 
 
4. 4. Summary  
Using a database of all schools in the UK, I investigated the relationship between 
requests for information materials and school and geographic factors. This chapter 
showed that around 30% of schools across the UK requested teaching packs. By 
country, the take-up of teaching packs ranged from 38.5% of schools in Scotland to 
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20.1% in Northern Ireland. In England, East of England had the best take-up rates 
(34%) and London (20%) had the fewest requests.  
A multivariate logistic regression model showed that those schools located in the least 
deprived areas in England had higher odds of requesting teaching packs than schools in 
the most deprived quintiles when the other factors, the GOR, school type and school 
size, were held constant. After controlling for other school and geographic factors 
(school type, area deprivation, and the GOR), the largest schools had the highest odds of 
requesting teaching packs compared to the smallest schools. Independent of the effect of 
area deprivation, school type and school size, the schools in seven GORs, with the 
exception of schools in Yorkshire and the Humber, were more likely than schools in 
London to request teaching packs.  
 
The findings of work relating to the national study suggested the lowest uptake of 
teaching packs in the most deprived areas. In addition, statistics related to cervical 
cancer age-standardized rates between 2005 and 2009 showed that the West Midlands 
was one of the regions with higher rates (9.6%) than the national average (8.7% in 
England). Therefore, it was a need for further research which constituted the case study 
in a city in the West Midlands which I will go on to describe and explain in more detail 
in the next chapters of this thesis.  
 
In the next chapter, I describe the city of the study and the methodology of the study 
based on mixed methods research. 
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CHAPTER 5: SETTING AND METHODS OF 
THE STUDY IN THE WEST MIDLANDS 
 
This chapter includes two sections, one that describes the city of the study and another 
one that provides details about the methodology of the study.  
 
The first section, which presents the health profile of the city of study, is structured in 
three parts. Part one contains statistical data about the population including aspects of 
demography, ethnicity and employment. Part two gives information about area 
deprivation and part three presents health programmes provided since 2008 with special 
emphasis on sexual health services. 
 
5. 1. Setting – a city in the West Midlands 
5. 1. 1. Population 
5. 1. 1. 1. Demography 
According to the Office for National Statistics, the resident population in the city of 
study in June 2009 was 312,800 persons. Half of the population (53%) was of working 
age (20-59 years) in 2001 (Table 21).  
 
Table 21. Age structure in the city of study in 2001 
 
Age (years) Percentage 
 0-9 12.87 
10-19 14.33 
20-29 15.01 
30-44 21.34 
45-59 16.58 
60-74 12.45 
75-89 6.89 
90 and over 0.53 
Source:(Office for National Statistics, 2004a) 
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5. 1. 1. 2. Ethnicity 
The estimates by ethnic group showed that 79.2% were White and the majority (74.1%) 
were White British. 12.3% were Asian. Out of these, 7.7% were Indian and 2.9% were 
Pakistani. 3.1% were Black, mainly Black African (1.6%) and Black Caribbean (1.3%). 
Chinese or other ethnic groups represented 3% (Office for National Statistics, 2011). 
Data on people's religion in the city of study from the 2001 Census showed that 76.9% 
of people had a religion. Out of these, 65.3% were Christians, 4.6% were Sikhs, 3.9% 
were Muslims and 2.6% were Hindus. The people with no religion represented 15.1% 
(Office for National Statistics, 2004b). 
 
5. 1. 1. 3. Employment  
The ONS annual population survey in 2013 reported that in the city of study, the 
employment rate was 66.9% and the unemployment rate was 8.3%. By gender, the 
employment rate was 76.5% for men and 56.9% for women. The unemployment rate 
was higher for women than for men (8.3% vs. 7.2%). The employment by occupation 
groups (Office for National Statistics, 2000) 
16
 was high in professional (17.8%), 
associate professional and technical (12.9%), administrative and secretarial (11.1%) and 
elementary (14.9%) occupations (Office for National Statistics, 2014).  
 
5. 1. 2. Deprivation  
The city of study was ranked 50
th
 out of 265 Local Authorities (LAs) for average IMD 
2010 scores
17
. This rank placed the city of study in the 16% most deprived LAs. It was 
more deprived in comparison to other parts of England. Almost a third of the total 
                                                          
16
 Standard Occupation Classification 2000 is applicable to all paid jobs performed by economically 
active persons in the UK. Jobs are recognized by the associated job title. They are classified into groups 
according to the concept of “skill level” and “skill specialisation” 
17
 The IMD score is allocated at Lower Super Output Area (LSOA) 
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population (31%) lived in “most deprived” neighborhoods, compared to 20% in 
England.  Life expectancy was 11.5 years lower for men and 7.7 years lower for women 
in the most deprived areas than in the least deprived areas in the city (NHS Coventry 
and Coventry City Council, 2011). 
 
5. 1. 3. Health programmes 
The Health Improvement Programme in the city of study commenced in 2009/10 and 
finished in 2011/12. The programme represented a partnership between the NHS and 
the City Council and it was designed to promote the health and well-being of the 
population in the city of study, using a combination of evidence-based programmes and 
innovative approaches in prevention and early intervention. Priorities included tackling 
smoking, obesity in children and sexual health of young people. The nine projects areas 
within Health Improvement Programme were alcohol, health at work, health checks, 
healthy weight, infant mortality, parenting, sexual health, smoking and well-being. The 
evaluation of the projects was outcome-based in relation to improving health and 
reducing health inequalities (NHS Coventry and Coventry City Council, 2011). 
 
5. 1. 3. 1. Sexual health services  
In 2008, the Board in the NHS in the city of study approved a Sexual Health Needs 
Assessment and adopted a sexual health and HIV Strategy. One of the objectives of the 
local policy was to reduce the rates of STIs, especially infections with Chlamydia, 
genital warts and gonorrhea. Sexual health services (i.e., advice, health promotion, 
screening, contraception, hepatitis B immunization, STI testing) for those aged less than 
25 years were provided in different settings such as Genito-Urinary Medicine clinics 
based at the hospital in the city of study and GP practices. Sexual health services were 
also provided in schools where nurses offered sexual health advice and made 
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recommendations for appropriate services. In addition, school nursing service supported 
the delivery of Relationship and Sex Education in schools. In contrast with local 
schools, the two universities in the city of study provided fewer sexual health services 
(NHS Coventry, 2009).   
  
5. 1. 3. 1. 1. Cervical screening 
The incidence of cervical cancer was higher in the city of study (17.1 per 100,000 
women) than the incidence in the West Midlands overall (14.9 per 100,000 women). 
The NHS in the city of study has run a cervical screening programme, providing call 
and re-call services (i.e., text reminders, flagging patient records and personalized 
letters) to patients. An audit of access to cervical screening was carried out in 2009/10 
and found a downward trend in cervical screening coverage, especially in the oldest (60-
64) and youngest (25-29) age groups (Tennant, 2010). Cervical screening coverage was 
lower in the city of study (71.3%) compared to the West Midlands overall (73.9%) and 
England (74%) (NHS Coventry and Coventry City Council, 2011). The main 
conclusions of the audit were that deprivation was negatively correlated with coverage 
for cervical screening. Coverage was 81% for women in the least deprived areas of in 
the city of study compared to 71% among women in the most deprived areas. Coverage 
was particularly low in Muslim, non-Gujarati Hindu and Sikh women (significantly 
below the average for non-Asian women). There was no data about the use of cervical 
screening among non-Asian ethnic subgroups, nor among lesbian women. Some 
educational campaigns were made to advertise cervical screening in hair dressing salons 
and by radio, aiming at reaching young women, especially in deprived parts of the city 
(Tennant, 2010). 
  
151 
  
5. 1. 3. 1. 2. HPV immunization policy 
The DH and the Scottish Government began the implementation of a routine HPV 
immunization school based programme with the bivalent vaccine (Department of 
Health, 2008b, Salisbury, 2008; Kmietowicz, 2008; Woods, 2007) for girls aged 12-13 
years in September 2008 (Department of Health, 2008a; Woods, 2007) along with a 
catch up campaign for girls aged up to 18 years (Woods, 2007; Sheridan and White, 
2011). The national accelerated catch-up programme for HPV vaccine finished in 
August 2011 and since that time only year 8 girls have received the vaccine in line with 
the national programme (NHS Coventry and Coventry City Council, 2011). On advice 
from the Joint Committee on Vaccination and Immunisation (JCVI) it was decided that 
the vaccination programme was to be delivered through schools (Joint Committee on 
Vaccination and Immunisation, 2008a; NHS Coventry and Coventry City Council, 
2011) as the majority of the target age group was in schools (Sheridan and White, 2011) 
and because school based programme might close racial, ethnic and socioeconomic gaps 
in immunization rates (Woods, 2007). In some instances the HPV immunisation 
programme was delivered by local general practitioners (GPs) for some of the girls in 
catch up cohorts (13 to 18 year old girls) (Sheridan and White, 2011). 
The DH moved to a routine HPV immunization with the quadrivalent vaccine in 
September 2012 (Salisbury, 2011) in the context of NHS reform announced by the new 
Health and Social Care Bill (Department of Health, 2012). 
 
5. 1. 4. Summary 
The population in the city was mainly White British. Asians (mostly Indian) were 
another ethnic group living in the city. 76.9% of all residents were religious such as 
Christians, Sikhs, Muslims or Hindus. Almost a third of the total population lived in 
“most deprived” neighborhoods, compared to England. 
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The incidence of cervical cancer was higher in the city than in the West Midlands 
overall. Cervical screening coverage was lower in the city compared to the West 
Midlands and England overall. Coverage was particularly low in Muslim, non-Gujarati 
Hindu and Sikh women. 
An HPV vaccination programme has been delivered through schools since 2008. In the 
first two years, the programme covered routine and catch up cohorts and after 2010, it 
has targeted only year 8 girls.  
 
5. 2. Methodology – Mixed methods research 
This section contains two parts. In part one, I present the research design and the 
justification for doing a case study, and I also mention the philosophical position of the 
researcher. In part two, I discuss the methodology based on mixed methods research, 
providing details about its rationale, purpose, design and mixing strategies.  
 
5. 2. 1. Research design - case study  
Case study design  
Yin defined a case study as an empirical inquiry that explores a contemporary social 
phenomenon thoroughly and within a real-life context (O'Cathain et al., 2007; Yin, 
2009). A case study is chosen when the researcher has little control over events and 
when the boundaries between the phenomenon and the context are not clear. As any 
other research method, the purpose of a case study is descriptive, exploratory, or 
explanatory. A descriptive study depicts an intervention and the real-life context in 
which it occurred. An exploratory study aims at developing hypotheses for further 
inquiry. An explanatory study explains the presumed causal links in real-life 
interventions. The unit of analysis in a case study is selected in accordance with the 
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research question, and could be an individual or a group of people or organization(s). 
The case study’s strength is its use of a full variety of evidence. This gives the 
opportunity to address a broader range of issues, to establish converging lines of inquiry 
and to enhance data credibility. Triangulation of data from multiple sources is the 
strategy to corroborate the same phenomenon viewed and explored from different 
perspectives (Yin, 2009). In this respect, a case study design is appropriate for mixed 
methods research because of its epistemological, ontological and methodological 
flexibility (Tashakkori and Teddlie, 2010). The disadvantage of a case study is that it is 
generalizable only to theoretical propositions and not to populations (Yin, 2009). 
In this research, the case is a group of schools in a city in the West Midlands and it has 
an exploratory purpose to expand understanding about factors influencing uptake of the 
HPV vaccine delivered through a school-based programme. The proposition, which 
comes from the literature, states that different ethnic groups have faced various barriers 
to uptake of immunizations. 
 
5. 2. 1. 1. The philosophical position of researcher 
Paradigms are perspectives of looking at reality (Hennink et al., 2011). A paradigm is 
defined as a model or framework that contains the philosophical issues of ontology, 
epistemology, methodology, and axiology. Ontology refers to assumptions and beliefs 
about the world (Tashakkori and Teddlie, 2010), how the world is viewed and what 
reality is thought to look like (Hennink et al., 2011). It is important what kind of 
ontological assumptions are brought to research because they determine the knowledge 
that is produced. Epistemology is the branch of philosophy that studies knowledge 
(Tashakkori and Teddlie, 2010). Methodology refers to the way in which knowledge 
about the world is generated (Tashakkori and Teddlie, 2010) and the way in which data 
collection is justified (Hennink et al., 2011). Axiology is the philosophical study of 
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value in social inquiry (Tashakkori and Teddlie, 2010). Values influence the choice of 
research, the observations in the field and the interpretation of observations (Johnson 
and Onwuegbuzie, 2004). 
Different paradigms are described in the literature as examples of research models 
(Morgan, 2007). The positivist paradigm is the model for experimental approach and 
quantitative studies in social sciences, focusing on facts. The approach to quantitative 
research is based on deductive reasoning. The theoretical framework developed with 
information from existing literature guides data collection. The interpretative paradigm 
is the model for qualitative studies, seeking to understand the “meaning of social actions 
within the context where people live” (Hennink et al., 2011, p. 14). The approach to 
qualitative research is based on inductive reasoning. Concepts and theories emerge from 
information provided by participants (Hennink et al., 2011). Mixed methods research is 
considered the third research paradigm and is philosophically associated with 
pragmatism (Johnson and Onwuegbuzie, 2004). 
 
5. 2. 1. 2. Pragmatism  
Pragmatism is a philosophical belief which was developed from the writings of Charles 
Sanders Peirce, William James and John Dewey. Pragmatism is viewed as a 
philosophical thinking focused on problem solving and outcomes. Pragmatism allows 
researchers to select any method based on its appropriateness (Tashakkori and Teddlie, 
2010) and to mix the research approaches in ways (Johnson and Onwuegbuzie, 2004) 
that will best answer the research problem (Tashakkori and Teddlie, 2010). The strength 
of the pragmatic approach is given both by the epistemological interest in the nature of 
knowledge that is produced and by the technical interest in the methods used to produce 
that knowledge (Morgan, 2007). The pragmatic stance is the philosophical keystone for 
using mixed methods to generate information for answering research question 
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(Tashakkori and Teddlie, 2010). The pragmatic approach relies on abductive reasoning. 
It means to make a logical connection between theory and data and to “move back and 
forth between induction and deduction” (Feilzer, 2010, p. 10). Inductive results from a 
qualitative approach can serve as a basis for the deductive goals of a quantitative 
approach, and vice versa (Morgan, 2007). 
Dewey’s pragmatism emphasizes the fact that there is a relationship between science 
(knowledge) and practice (action) and their results. In his view, knowledge is gained 
through the experience of actions in the world (Morgan, 2007) combined with reflection 
(Tashakkori and Teddlie, 2010). Knowledge is a human construction (Tashakkori and 
Teddlie, 2010) based on reality of the world people live in (Johnson and Onwuegbuzie, 
2004). Dewey introduces the concept of intersubjectivity as a pragmatic emphasis on 
collaborative knowledge construction through social interactions (Morgan, 2007) and 
activity like observation, experience, and experiments (Johnson and Onwuegbuzie, 
2004). Pragmatism allows researchers to use a value-oriented approach derived from 
cultural values (Johnson and Onwuegbuzie, 2004). The findings of research with a 
pragmatic stance are used to inform potential solutions to problems. In addition, the 
results of pragmatic inquiry are the basis for warranted evidence that can be used in 
other settings. This is known as the transferability of research results (Tashakkori and 
Teddlie, 2010). However, a major drawback of pragmatism is that it could not specify 
“for whom a pragmatic solution is useful” (Johnson and Onwuegbuzie, 2004, p. 19). 
Current philosophers criticize pragmatism because it has not proved to be a solution to 
many philosophical dualisms (Johnson and Onwuegbuzie, 2004). 
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5. 2. 2. Mixed method research  
5. 2. 2. 1. Rationale of mixed methods research  
The study employed a mixed method approach as the optimum way to address the 
research questions 2 and 3 (Tashakkori and Teddlie, 2010; Johnson and Onwuegbuzie, 
2004). 
Mixed methods research has frequently been used in health service research. The main 
justification for using a mixed methods approach has been comprehensiveness, and the 
need for a range of methodologies to understand the complexity of health care 
(O'Cathain et al., 2007). Several characteristics of mixed methods research justify its 
use in this study. First, it is valuable to combine quantitative and qualitative methods in 
one study without disregarding the philosophical principles of each one of them 
(Morgan, 2007). These different methods can be combined in such a way to 
complement their strengths and minimize their weaknesses. In order to mix research 
methods effectively, the strengths and weaknesses of quantitative and qualitative 
research should be considered (Johnson and Onwuegbuzie, 2004). Quantitative research 
has several strengths. It is useful to study a large number of people, to make predictions 
and to assess cause-and-effect relationships (Hennink et al., 2011; Johnson and 
Onwuegbuzie, 2004). The focus is on deduction, confirmation and theory/hypothesis 
testing. One of the disadvantages is that the knowledge produced cannot necessarily be 
applied directly to specific contexts or individuals (Johnson and Onwuegbuzie, 2004). 
The purpose of qualitative research is to understand and to explore how and why 
phenomena occur in local contexts. The focus is on induction, discovery, exploration 
and theory/hypothesis generation. The drawbacks are that the knowledge produced 
cannot necessarily be generalized to other people or settings and that data analysis is 
time-consuming (Johnson and Onwuegbuzie, 2004).  
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Second, mixed methods research with its methodological pluralism (Johnson and 
Onwuegbuzie, 2004) can address a variety of explanatory and exploratory questions at 
the same time, in comparison to single approach designs which focus on one type of 
inquiry (Tashakkori and Teddlie, 2010; Johnson and Onwuegbuzie, 2004). The roles of 
different methods within a mixed method study have been to address the range of 
research questions, to design the study (i.e., to determine the sample, to design study 
instruments), to combine data for further understanding, to interpret the findings and to 
determine generalisability (O'Cathain et al., 2007). 
Third, mixed methods research is useful to obtain rich information because of the 
emergent themes derived from qualitative data collection and analysis (Tashakkori and 
Teddlie, 2010). Some of the disadvantages of mixed research are that it is time-
consuming and it is difficult to interpret conflicting results (Johnson and Onwuegbuzie, 
2004).  
 
5. 2. 2. 2. Purpose of mixed methods research 
Greene, Caracelli and Graham (1989) identified five purposes of mixed methods 
studies: triangulation, complementarity, initiation, development, and expansion (Greene 
et al., 1989). Mixed methods research could have one or more purposes (Onwuegbuzie 
and Leech, 2006). Triangulation is a methodological approach that represents the use of 
different and multiple research methods (O’Cathain et al., 2010) that study the same 
phenomenon (Onwuegbuzie and Leech, 2006; Johnson and Onwuegbuzie, 2004) (e.g., 
interviews and focus group discussion), sources (e.g., professionals and lay), theories 
(e.g., stages of behavior change and health belief model) or researchers (Farmer et al., 
2006) to conduct a study, to have a broader understanding of the research findings 
(O’Cathain et al., 2010). The rationale of triangulation is to provide a stronger evidence 
for a conclusion (Johnson and Onwuegbuzie, 2004), overcoming any biases of the 
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different methods used (Greene et al., 1989). Thus, methodological triangulation 
increases the validity of research results (Farmer et al., 2006). Also, triangulation 
provides credibility to the process of integration of results (O’Cathain et al., 2010). 
However, there are some concerns in using this method with the purpose of 
confirmation (O'Cathain et al., 2007) because the coverage and the nature of findings 
from two or more data sets may differ and it may be difficult to determine agreement on 
results (Farmer et al., 2006). 
Complementarity is used when different methods are applied to address different facets 
of a phenomenon (Greene et al., 1989) or different aspects of the research question 
(O'Cathain et al., 2007). This aspect differentiates complementarity from triangulation 
(Greene et al., 1989). Complementarity is used to elaborate, exemplify and clarify the 
results from one method with the findings from the other method (Johnson and 
Onwuegbuzie, 2004). The rationale of complementarity is to increase the 
interpretability, importance, and the validity of inquiry findings (Greene et al., 1989). 
Complementarity counteracts any biases of the different methods used and takes 
advantage of the strengths of different methods (Greene et al., 1989). 
Initiation is used to discover contradictions and paradoxes (Onwuegbuzie and Leech, 
2006). Disagreements between findings from different methods have been described as 
“inter-method discrepancy” (O’Cathain et al., 2010). Exploration of this discrepancy 
could result in a better understanding and reformulation of the research question 
(O’Cathain et al., 2010; Johnson and Onwuegbuzie, 2004). The rationale of initiation is 
to increase the depth of inquiry findings, interpreting them from different perspectives 
of different methods used and multiple paradigms (Greene et al., 1989).  
 
Development uses the results from one method to formulate the research question 
(Onwuegbuzie and Leech, 2006), or to select the sample, or to develop the instrument or 
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to inform the analysis of the other method (Greene et al., 1989). The rationale of 
development is to enhance the validity of inquiry findings, taking advantage of different 
methods strengths (Greene et al., 1989). Expansion is used to increase the variety of 
research by using the most appropriate methods for different inquiry aspects 
(Onwuegbuzie and Leech, 2006; Johnson and Onwuegbuzie, 2004).  
 
5. 2. 2. 3. Mixed methods research design 
The researcher can create a mixed-method design that effectively answers his/her 
research question (Johnson and Onwuegbuzie, 2004). There are six major mixed-
method designs: the convergent parallel design, the explanatory sequential design, the 
exploratory sequential design, the embedded design, the transformative design and the 
multiphase design (Creswell and Plano Clark, 2011). Two aspects should be taken into 
consideration to create a mixed-method design: paradigm status (priority) and timing 
(Johnson and Onwuegbuzie, 2004). Quantitative and qualitative components of a mixed 
study could have equal status or one method could be dominant in comparison to the 
other one. Quantitative and qualitative phases could occur sequentially or concurrently 
(Creswell et al., 2004).  
 The convergent parallel design occurs when quantitative and qualitative data 
collection and analyses are used at the same time with equal priority and the 
results are mixed during interpretation.  
 The explanatory sequential design starts with quantitative data collection and 
analysis and its results are used for subsequent qualitative data collection and 
analysis.  
 The exploratory sequential design starts with qualitative data collection and 
analysis followed by quantitative research method that tests or generalizes the 
initial findings. 
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 The embedded design is used when supporting data collection (i.e., qualitative) 
is added before, during or after the major data collection procedure (i.e., 
quantitative).  
 The transformative design occurs when the concurrent or sequential qualitative 
and quantitative data collection and analysis are outlined within a theoretical 
framework that guides the methodology of the whole study. 
 The multiphase design occurs when the concurrent or sequential qualitative and 
quantitative data collection is combined over multiple phases of a programme of 
study (Creswell and Plano Clark, 2011). 
Apart from concurrent, sequential, conversion and fully mixed design, parallel mixed 
design is mentioned in the literature. Although it is a debatable design, it is accepted as 
a mixed design and is different from the convergent parallel design. The parallel mixed 
design is similar to the concurrent design when the data are collected and analyzed 
separately. What distinguishes the parallel mixed design from the concurrent design is 
the matter of integration. While the results of both data sets are integrated in concurrent 
design, the findings from the separate quantitative and qualitative data are not integrated 
in parallel mixed designs (Onwuegbuzie and Johnson, 2006) .  
 
5. 2. 2. 4. Mixing strategies in mixed methods research 
Mixing could occur in the design level (programme objectives, theory), methods of data 
collection, data analysis and data interpretation (Johnson and Onwuegbuzie, 2004; 
Onwuegbuzie and Johnson, 2006; Creswell and Plano Clark, 2011). The more methods 
are integrated into each of these procedures, the stronger the mix of the methods (Yin, 
2006). The purpose of doing so is to keep, to analyze and to interpret mixed methods as 
a single study (Yin, 2006). Instruments of methods used (i.e., for quantitative and 
qualitative data collection) should include similar variables or items with the intention 
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to overlap or complement each other. In other words, designing quantitative and 
qualitative studies that address the same concepts facilitates merging the data sets. 
Mixing could be done through (1) merging the results of the two data sets, (2) 
connecting from the results of one type of data to the collection of the other, (3) 
embedding the two types of data within a larger design, (4) within a theoretical 
framework, or (5) within a programme objective framework (Creswell and Plano Clark, 
2011). O’Cathain described three techniques for integrating qualitative and quantitative 
data in mixed methods studies: triangulation protocol, following a thread and mixed 
methods matrix. While triangulation protocol takes place at the interpretation stage of 
the research process, the other two techniques occur at the analysis stage of a mixed 
methods study. There are some strategies for mixing the two data sets of results (from 
quantitative and qualitative analyses) using triangulation protocol at the interpretation 
stage. One strategy is to summarize the findings, identifying the key concepts/themes in 
each data set (Creswell and Plano Clark, 2011), to list them on the same page 
(O’Cathain et al., 2010) and after that to compare or synthesize them (Creswell and 
Plano Clark, 2011). Another strategy is to look for differences within a data set of 
results based on the concepts/themes within the other data set of results. A third strategy 
is to transform the results from one data set (i.e., themes in qualitative research) into 
results specific to the other data set (i.e., numeric data in quantitative research). The 
interpretation of the merged results represents a discussion of how the two data sets of 
results converge, diverge or relate to each other (Creswell and Plano Clark, 2011) and 
offer complementary information on the same issue. Triangulation could also include 
“silence” which means that a finding arises from one data set and not another 
(O’Cathain et al., 2010). 
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5. 3. Summary 
In this research, quantitative data was used to define the context of the study, to describe 
and to explain the variation in HPV vaccine uptake across secondary schools by area 
deprivation, ethnicity and religion. The qualitative data supplemented the statistical 
results from the quantitative methods, and the statistical interpretation of relationships 
(O'Cathain et al., 2007) by adding meaning and context to them. The qualitative data 
provided material on the participants’ experiences and views concerning the facilitators 
and the barriers to HPV vaccination uptake.  
Quantitative and qualitative researches occurred concurrently. An equal priority and 
emphasis was given to collection and analysis of quantitative and qualitative data that 
occurred almost simultaneously. The design of this mixed methods research was a 
parallel design, which had two purposes: triangulation and complementarity. I collected 
and analyzed data separately and I produced two sets of findings that I present 
separately in the next two chapters. 
 
In the next chapter, I describe the methods and the results of quantitative component of 
the mixed methods research. 
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CHAPTER 6 QUANTITATIVE RESEARCH – 
REPEATED CROSS SECTIONAL STUDY 
 
In this chapter, I describe the methods and results for research question 2. First, I 
describe my methods including data sources and the techniques I used to prepare the 
data for analysis; second, I describe methods of analysis including descriptive and 
inferential statistics and lastly I present the results of the study. 
 
Research question 2  
Is there an association between uptake of HPV vaccine in secondary schools in a city in 
the West Midlands and area deprivation, ethnicity or religion?  
 
6.1. Methods  
Study Design 
In order to answer this question I undertook a repeated cross-sectional study including 
all secondary schools in the city. 
 
Sampling frame 
The city under study had twenty-nine secondary schools catering for girls in the relevant 
age groups. 
 
Sample size  
I describe calculations to estimate the required sample size for my study, comparing two 
groups of secondary schools that had a continuous outcome variable (Campbell et al., 
1995). I stratified the secondary schools in the city of study into two groups based on 
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deprivation of SCA (higher and lower than the median 27.50 of IMD score for SCA). 
The advantage of stratified sampling is that a separate and independent sample is 
selected within each stratum. In addition, creating strata increases the probability that 
key subgroups have sufficient sample size (Frankel, 2010). Random or probability 
sampling allows each school in the population (of all secondary schools in the city of 
study) to have a known nonzero probability of being selected in the sample. In addition, 
it allows generalization of the results (Frankel, 2010). 
 
Quantitative studies aim to test a hypothesis. It is important to avoid errors known as 
type I and type II errors, which may lead to incorrect generalizations of the results (Fox 
et al., 2007). If the null hypothesis (i.e., there is no difference in uptake by area 
deprivation) is rejected when it is in fact true, then this error is called a Type I error The 
statistical significance of a statistical test (p-value) is known as alpha (α) and this is the 
probability of making a type I error (Fox et al., 2007). α is usually set to = 0.05, i.e. 
there is only a 5% chance of making a type I error. If the null hypothesis (i.e., there is 
no difference in uptake by area deprivation) is accepted, when it is in fact false, then this 
error is called a Type II error which means that an association which exists is missed 
(Bonita et al., 2006). This may be because of having a sample size which is too small to 
allow detection of that association by a statistical test at the established level of 
significance (i.e., if the p-value α is set to = 0.05). Beta (β) is the probability of making 
a type II error, and is related to the statistical power of the study:  power = 1-beta 
(Bonita et al., 2006). β is often set to 0.20 (i.e. a 20% chance of making a type II error) 
and then power of the study is 0.80 or 80%. A non-significant result could indicate 
inadequate power of the study to detect differences or associations at the established 
level of significance. Power is increased by increasing sample size. The sample size 
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calculation also takes into account the value set for α, such that a larger sample size will 
reduce  the likelihood of both type I and type II errors (Fox et al., 2007). 
 
Sample size calculations can be carried out with computer software (e.g., STATA, 
Excel) or with standard formulae (Bonita et al., 2006, Fox et al., 2007). In addition to 
the values of α (usually 0.05) and β (usually 0.20 for 80% power), the formulae require 
estimates of the minimum difference the study is trying to detect (d) and an estimate of 
the variance of the measurement in the population (the standard deviation [SD]). 
Usually the values of variance for the study population to use in the formulae are not 
available. Therefore, the value calculated for the sample size combines estimates for 
variance from previous studies in other populations, the size of the difference to be 
detected, the required statistical significance (α) and the required power (1-β) (Bonita et 
al., 2006). 
 
To calculate a sample size of secondary schools I used a formula from literature (in 
Appendix 2), including level of significance, power, difference in mean uptake between 
the two groups and standard deviation of HPV vaccine uptake in the general population. 
Comparing the means I tested the null hypothesis that the samples come from 
populations with the same mean (Peacock and Kerry, 2007; Campbell et al., 1995; 
Bland, 2000). To calculate the number of schools required in each group, I used a two-
sided significance level of 5% and a power of 80% to detect a difference (Bland, 2000; 
Peacock and Kerry, 2007) of 10% in the mean uptake between the two groups (schools 
in high and low deprived catchment areas). An estimate of the population standard 
deviation of uptake of two doses of HPV vaccine
18
 of 8.3 was taken from the literature 
also (Kumar and Whynes, 2011). The sample size required per group was 11 and the 
                                                          
18
  HPV vaccine uptake of two doses in routine groups in 152 PCTs in England  
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total sample size was 22 secondary schools. However, the sample size could be different 
if the standard deviation of uptake of HPV vaccine for three doses has a different value 
than for two doses. 
As mentioned earlier, the city under study had twenty-nine secondary schools. Based on 
the above calculations, I included all the eligible schools in my study [20 schools
19
 were 
eligible. Nine were excluded because were special (Coventry City Council, [2013]) 
20
 
secondary schools (covering a total of approximately 114 eligible girls)]. I excluded 
them because of the small numbers of girls vaccinated in each school and because of 
inconsistent recording of uptake in each year.   
 
6. 1. 1. Data sources and data preparation   
In order to undertake this study I needed to obtain data for each school on HPV uptake, 
including both numerators and denominators of eligible populations. For each school I 
also needed measures of ethnicity, religious affiliation and deprivation.   
 
HPV uptake  
The community health Trust
21
 provided data on year 8 girls aged 12-13 years eligible 
for HPV vaccine in all secondary schools between 2008 and 2012. These data were 
extracted from the McKesson
22
 child health system (Child and Maternal Health 
Intelligence Network, 2013) 
23
 and included school roll, immunization dates for each 
                                                          
19
 School characteristics are presented in Table 1 in Appendix 3  
20
 Special schools are part of the UK school education focusing on students primarily with learning, 
behavioral and emotional difficulties and/or disability  
21
 Former PCT in the city of study 
22
 Brand name software company 
23
 Child health system is a patient administration system that provides a clinical record for individual 
children to support individual children’s health for all children in a given local population through 
different services such as immunisations and childhood screening as well as support for children with 
Special Educational Needs  
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dose of the HPV vaccine and number of girls vaccinated
24
 with first, second and third 
doses in each academic year (2008/9, 2009/10, 2010/11 and 2011/12). The Department 
for Children, Schools and Families defined school roll as the number of pupils at the 
school including both the attendance and the admissions register ( Department for 
Children, Schools and Families, 2008). In this research, school roll represents the 
number of year 8 girls who were admitted and attended a school included in the study. 
Data obtained from the Trust were requested and released under the Freedom of 
Information Act 2000.  
 
Measures of deprivation, ethnicity and religious affiliation  
The Index of Multiple Deprivation (IMD) 2010 is a relative measure of multiple 
deprivation at Lower layer Super Output Area (LSOA) level which can be used to 
identify local variation and heterogeneity in an area. Thus, the area can be characterised 
as deprived, relative to other areas, in a particular dimension of deprivation depending 
on the proportion of people in the area experiencing a type of deprivation. LSOAs are 
defined as homogenous small areas of about 1,500 people. The higher the IMD 2010 
score, the more deprived the LSOA. The IMD allows a community to compare its area 
with similar, or nearby, areas on different measures (Department for Communities and 
Local Government, 2012). 
The Index of Multiple Deprivation (IMD) 2010 combines 38 indicators which relate to 
seven domains and are an update of indicators in the IMD 2007. The IMD 2010 was 
constructed by combining seven transformed domain scores: income deprivation, 
employment deprivation, health deprivation and disability, education skills and training 
deprivation, barriers to housing and services, living environment deprivation, and crime 
                                                          
24
 Year 8 Girls vaccinated in school and in mop-up clinic combined   
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(Department for Communities and Local Government, 2012). Ethnicity is not included 
in the definition of IMD 2010 score. 
I determined deprivation of the schools at two levels. One was Index of Multiple 
Deprivation (IMD 2010) for the school address postcode (SAP) to reflect area level 
deprivation of the school location and the other was IMD for the school catchment area 
(SCA) to reflect deprivation in the areas where the children attending the school live. 
Using the full postcode of the schools taken from the local council website (Coventry 
City Council, [2013]) it was possible to determine the location of the school (LSOA) 
through GeoConvert (Support, 2013) and the level of deprivation of the area in which it 
was located based on IMD 2010. 
 These data were linked to each school’s postcode, Lower Super Output Area (LSOA), 
and IMD 2010, as well as to the proportion of people from each ethnic group in each 
LSOA in the city under study. Data on the  LSOA and IMD 2010 score were obtained 
from the Department for Communities and Local Government (Department for 
Communities and Local Government, 2012). 
 
In order to obtain IMD for SCA, I obtained data on attendance at each school by LSOA. 
I then calculated the population weighted average of the combined scores for all the 
LSOA in each school’s catchment area. (Each LSOA Index of Multiple Deprivation 
score was multiplied by the proportion of the catchment area’s population (girls) which 
fell into that LSOA and these were summed to make the catchment area score)  
(Department for Communities and Local Government, 2012). 
 
Data about ethnicity by LSOA in England were obtained from the 2011 Census through 
Census Customer Services from the Office for National Statistics. Data on ethnicity 
included the number of people from each ethnic group aggregated by age and gender. I 
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summed the number of people by ethnic group by LSOA in the city of my study and 
created 6 ethnic groups (level 1), each of them including sub-ethnic groups (level 2) 
according to the Office for National Statistic’s classification (Office for National 
Statistics, [2013]). I determined the proportion of people from each sub-ethnic group by 
LSOA. In Table 1 in Appendix 4 I present five ethnic groups and their subgroups. One 
ethnic group representing “Other” was not included in the Table 1 in Appendix 4 
because of low percentages in the population (0-2%). One subgroup (“Other mixed”) 
was omitted in the ethnic group “Mixed” because the percentages of the population 
were under 1%. Two subgroups [“Black/African/Caribbean/Black British Caribbean” 
(under 1.8%) and “Other Black” (under 1.5%)] were not shown because of much lower 
percentages in comparison with Black/African/Caribbean/Black British African people. 
A comparison between the groups in Table 1 in Appendix 4 shows that the predominant 
populations in the city of study were White British, Indian, Pakistani, and Black 
African. 
 
Using the proportion of ethnic groups by LSOA I determined the ethnicity profile for 
each SCA for the 18 secondary schools reporting catchment areas. (The two private 
secondary schools did not report information on their catchment areas.) Using the total 
number of girls in the catchment area of each secondary school and the total number of 
residents in each catchment area, I estimated the percentage of girls in each ethnic group 
in each SCA. The percentage of girls could be slightly underestimated because the DE 
suppressed pupil numbers in some LSOAs with small numbers of children in order to 
protect pupil confidentiality. I used the age composition of ethnic groups in the 
population under 15 in the 2011 Census to estimate the composition of the girls’ ethnic 
background for the eligible population for each school in my study. 
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The Department for Education (DE) provided me with the number of girls attending 
each secondary school in the city by LSOA of pupil residence. These data were related 
to 18 secondary schools (two private secondary schools were not included) and were 
collected through the School Census in January 2012. Data obtained from the DE were 
released under the Freedom of Information Act 2000. I linked LSOA of pupil residence 
with IMD 2010. Using the number of girls attending each secondary school by LSOA of 
pupil residence and IMD score by LSOA of pupil residence I calculated the weighted 
average of LSOA scores for the catchment area of each secondary school.  
 
Details about these calculations are presented below in the section Deprivation of local 
area. The results of these calculations are related to one academic year. The analysis 
related to uptake of HPV vaccine is related to four academic years.  
 
Data cleaning was performed in Microsoft Excel, for example to examine individual 
variables to detect unexpected values. Data analysis was carried out using descriptive 
and inferential statistics.  
 
6. 1. 2. Data Analysis 
 
Exploratory analysis  
Uptake is defined by coverage with all three doses. I used data for uptake of the third 
dose of HPV vaccine because the third dose is given only after the documented uptake 
of the first dose and the second dose. Uptake of the HPV vaccine (third dose) is a 
proportion which represents the number of year 8 girls who were vaccinated with the 
third dose out of the total number of year 8 girls eligible to be vaccinated with the HPV 
vaccine at a school. Appendix 5 Table 1 presents the percentages of uptake of HPV 
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vaccine by school and by each academic year as well as by all academic years 
combined. All years combined gave the whole picture of the HPV vaccination 
programme for the first four years of its implementation. I calculated the percentages of 
uptake of HPV vaccine for all academic years as follows. I obtained the numerator 
summing the number of year 8 girls vaccinated with the third dose at a school in all four 
academic years. I determined the denominator adding the number of year 8 girls eligible 
to be vaccinated at a school in all four academic years. Then, I divided the numerator by 
the denominator and I multiplied by 100.  
 
The first stage of descriptive statistics was to examine individual variables and to 
establish the relationship between variables. I used descriptive statistics to provide 
information about the uptake of HPV vaccine by school and to describe level of 
deprivation of school location and catchment area, and religious affiliation and ethnicity 
in catchment areas. Continuous variables were expressed using medians. In the 
exploratory analysis box plots, bar charts of means with error bars added and dot plots 
were produced to assess distribution of continuous variables (uptake of HPV vaccine) 
by academic year and by categorical variables (Fox, 1997; Field, 2013).  
 
I created a binary dummy variable for each of the independent variables according to 
values above and below the median. Dummy variables were produced for deprivation of 
SCA, deprivation of SAP, and ethnicity (which represents the proportion of White 
English/Welsh/Scottish/Northern Irish/British people in each SCA). Another categorical 
independent variable “religion” was created to reflect schools’ religious affiliation. 
Faith schools were coded “1 = yes” and all other schools were coded “0 = no”.  In 
addition, a categorical independent variable “academic year” was created and was coded 
“1 = 2008/09, 2 = 2009/10, 3 = 2010/11 and 4 = 2011/12”. 
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Scatter plot matrices were created to assess the linear relationship between continuous 
dependent and independent variables as a preliminary step before doing simple and 
multivariate linear regressions.  
 
Inferential statistics 
Mann Whitney test statistics were carried out to assess statistically significant difference 
in mean values of uptake of HPV vaccine within categorical variables (deprivation, 
ethnicity and religion). I used the Wilcoxon-Mann-Whitney test, which is a non-
parametric analog to the independent samples t-test, where the dependent variable was 
not normally distributed. Also, I used it for normally distributed dependent variables 
because of small sample size. 
The same binary dummy variables for deprivation, ethnicity and religion were used 
within the regression analysis. The association between uptake of HPV vaccine and 
continuous variables (deprivation of school location and catchment areas and ethnicity 
in catchment areas) were determined by Pearson's Product-moment Correlation 
coefficient and Spearman's correlation coefficient. Also, I established whether there 
were associations between independent variables. 
 
Analytic statistics included simple and multivariate linear regressions for all years 
combined.  
I performed linear regression because the dependent variable was continuous (Katz, 
2006; Peacock and Kerry, 2007). A univariate linear regression analysis was undertaken 
to investigate the association between uptake of the third dose of HPV vaccine and each 
of the independent variables deprivation of SCA, deprivation of SAP, ethnicity, school 
type (religious affiliation) and year.  
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The classical regression assumption requires that the outcome (dependent) variable is 
normally distributed. There were deviations from this assumption because the 
dependent variable did not follow a Normal distribution as shown in histogram in 
Figures 1-5 in Appendix 6 I used “ladder of power” in Stata which showed normality 
tests for various transformations. I selected the transformation with the lowest chi2 
statistic, which tested each distribution for normality. The lowest chi2 statistic indicated 
cubic transformation. Because of difficult interpretation of the coefficients of cubic 
transformation, I looked at the distribution of different transformations shown in 
histogram in Figures 12 below and 1-3 in Appendix 7 (Stata.com, 2013). None of the 
transformations normalized the total distribution of the dependent variable. However, I 
used it in linear regression analysis based on evidence of strong and statistically 
significant correlations with independent variables presented in section “Linear 
relationship between uptake and continuous variables”. I looked at the histogram by 
transformation and chose “identity”. I used an untransformed dependent variable in 
further analyses. Two methods could justify the use of a skewed variable in the 
analyses. One of the assumptions in linear regression is to normalize the distribution of 
the residuals (Torres-Reyna). I predicted the residuals and I looked at their distribution 
on a kernel plot (Torres-Reyna, Peacock and Kerry, 2007). The distribution was normal 
to some degree. Next, I did simple linear regression using Huber variances with 
vce(robust) in Stata to obtain robust standard errors for the parameter estimates to 
control for mild violation of underlying assumptions (UCLA, 2013c). The independent 
variables in all analyses are in their original metric. 
First, I built simple linear models between the outcome (dependent) variables and each 
of the independent variables (interval or categorical). I chose as reference category the 
first group (for school type (religious affiliation) and year). The reference category was 
not entered into analysis and the other categories were compared to that reference 
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category (Katz, 2006). Following the findings from the univariate linear regression 
analysis, multiple ordinary least-squares regression was undertaken to explore the 
relationship between uptake of the vaccine and area level of deprivation adjusting for 
ethnicity, religious affiliation of the schools and year. Multicollinearity between 
independent variables was considered for the interpretation of the results since in 
multiple regression analysis one explanatory variable should not be correlated with one 
or more of the other explanatory variables (Kaye and Freedman, 2000).  
Two multiple regression models were created because of multicollinearity between area 
level of deprivation in catchment areas and area level of deprivation of SAP. Model 1 
included area level of deprivation in catchment areas, ethnicity (White British 
population), 
religious affiliation of the schools and year. Model 2 included area level of deprivation 
of SAP, ethnicity religious affiliation of the schools and year.  
All statistical analyses were performed using STATA/SE 11.1.  
 
In the previous section, I described my methods of data analysis. In this section, I will 
present the main findings of the study in line with the study aim. The findings will 
include both descriptive and inferential results. 
6.2. Results  
Exploratory Analysis  
Descriptive statistics 
7276 girls were eligible for HPV vaccination in all years combined which included 
1857 in 2008/09, 1857 in 2009/10, 1785 in 2010/11 and 1777 in 2011/12 (Table 1 in 
Appendix 5). Third dose uptake by school varied between 65% and 100% with overall 
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median uptake in each year of 90% in 2008/09, 75% in 2009/10, 86.50% in 2010/11, 
and 89.50% in 2011/12 and 86.5% in all years. 
 
I checked uptake by school for normality (Peacock and Kerry, 2007; Kaye and 
Freedman, 2000) and identified uptake of the third dose in 2008/09, in 2009/10, in 
2010/11, and in all years as having a non-Normal distribution) (Figures 1-3 and 5 in 
Appendix 6). Uptake for the third dose in 2011/12 had a normal distribution.   
 
IMD scores for SAP ranged from 9.71 to 66.63 with a median of 27.90.and had a non-
Normal distribution. Similar figures for IMD scores for SCA ranged from 8.65 to 42.62 
with a median value of 27.50.  
The median proportion of the population who fell into the ‘White’ group was 65.50% 
overall for schools with a range of 35% to 79%.  
IMD scores for SCA were normally distributed whereas IMD scores for SAP and 
ethnicity were non normal distributed (Figures 1-3 in Appendix 8).  
 
Pattern of uptake of the HPV vaccine 
In this section uptake of the third dose of the HPV vaccine is described. Figure 4 shows 
that in 2008/09, overall uptake across the 20 schools ranged from 69% in school 16 to 
94% in schools 6, 8 and 19. In 2009/10, uptake ranged between 65% in school 20 and 
90% in school 15 (Figure 5). In 2010/11, uptake ranged between 72% in school 2 and 
97% in school 8 (Figure 6). In 2011/12, the lowest uptake was 81% in school 16 and the 
highest level of uptake was 100% in school 14 (Figure 7). In all years combined, 
schools 16 had the lowest uptake (76%) while school 13 had the highest uptake (89%) 
(Figure 8). Overall, school 16 had the lowest uptake in two academic years (2008/09 
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and 2011/12) and in all years combined. There was also a pattern of low uptake in 
school 2 in three academic years from 2008/09 to 2010/11 as well as in all years 
combined. In conclusion, there are inconsistent coverage patterns across the years. 
 
Figure 4. Distribution of uptake of 3
rd
 dose by schools in year 08-09 
 
 
 
Figure 5. Distribution of uptake of 3
rd
 dose by schools in year 09-10 
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Figure 6. Distribution of uptake of 3
rd
 dose by schools in year 10-11 
 
 
 
Figure 7. Distribution of uptake of 3
rd
 dose by schools in year 11-12 
 
 
 
Figure 8. Distribution of uptake of 3
rd
 dose by schools in all academic years 
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I compared the rates of coverage with the third dose of HPV vaccine between the city of 
study and England by academic year, which are represented graphically in Figure 9. 
There was a larger difference in vaccination rates in the city of study than at national 
level in 2008/9 (difference = 8% (Sheridan and White, 2011; Health Protection Agency, 
2012) 
25
), and a smaller difference in vaccination coverage in 2010/11 (difference = 
2.2%) and in 2011/12 (difference =3.2%). There was no difference in the mean of 
uptake in the second year of the programme (2009/10) which could suggest that the 
incident in October 2009 affected the schools in the whole country.
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Figure 9. Distribution of uptake of 3
rd
 dose in the city of study and in England by 
academic year 
 
 
 
Because the distribution of uptake of the HPV vaccine was skewed and the mean could 
have been affected by very large or very small values, I also used descriptive statistics 
[median (min and max)] which are robust to an outlying value (Thabane and Akhtar-
                                                          
25
 Confidence intervals cannot be calculated because of limited access to data for England. Uptake in 
England by academic year was based on a sample of about 300000 girls in year 8 in total in 151 PCTs in 
each academic year and this data was obtained from the reports available on the website of the 
Department of Health  
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Danesh, 2008; Andersen and Skovgaard, 2010; Fox, 1997; Kaye and Freedman, 2000). 
Table 22 shows that there was a substantial disparity (>25%) in median uptake of the 
third dose between schools in the first three academic years 2008/09, 2009/10 and 
2010/11. The difference in median vaccination rates between the schools reduced from 
25% to 19% in the academic year 11-12. The figures for all academic years combined 
showed that there was inequality in the uptake of vaccine between schools (difference = 
13%).  
 
Table 22. Summary statistics of uptake of HPV vaccine by academic year and in all 
years combined  
 
Uptake N Quantiles 
Min .25 
(Q1) 
Median 
(Q2) 
.75 
(Q3) 
Max 
2008/09 20 69.00 83.50 90.00 93.00 94.00 
2009/10 20 65.00 71.00 75.00 80.00 90.00 
2010/11 20 72.00 83.00 86.50 89.50 97.00 
2011/12 20 81.00 87.00 89.50 94.00 100.00 
all years 20 76.00 83.50 86.50 88.00 89.00 
N = number of schools 
 
Box plot in Figure 10 shows the characteristics of the distributions of uptake such as 
center (median), spread, skewness and outliers (Thabane and Akhtar-Danesh, 2008; 
Fox, 1997; Field, 2013). Asymmetrical distribution of uptake in 2008/09, 2009/10, 
2010/11 and in all years confirmed that the uptake of the third dose was skewed. Also, it 
appeared that the middle 50% of observations in 2008/09 were more spread in 
comparison with the other academic years  
  
180 
  
Figure 10. Distribution of uptake of the third dose in each academic year and in all 
academic years   
 
 
 
An outlier is defined as any observation greater than the upper quartile plus one and a 
half times the length of the interquartile range as well as any score smaller than the 
lower quartile plus one and a half times the length of the interquartile range (Field, 
2013; Peacock and Kerry, 2007; Thabane and Akhtar-Danesh, 2008).  
 
Delivery of the HPV immunization programme 
Three-dose completion rate of HPV vaccination programme and the intervals between 
administrations of the first dose and the second dose as well as between the first dose 
and the third dose are presented in Appendices 8, 9 and 10. The rationale to calculate 
these rates and these intervals was based on the results of qualitative data analysis in 
Chapter 7. 
 
School Factors 
School type 
Four of the 20 schools were religious. Of these, three schools were Catholic and one 
was a Church of England faith school.  
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Table 23 shows uptake of the third dose of HPV vaccine by school type in all academic 
years. There was no statistically significant difference in mean uptake between the faith 
schools and those without a religious character.   
 
Table 23. Distribution of average uptake of HPV vaccine by schools’ religious 
affiliation 
 
 
Uptake 
per year 
 
N 
Mean uptake  
non-religious 
schools 
 
N 
Mean uptake 
religious 
schools 
                      
     Test Mann Whitney  
all years 16 84.81 4 86 z = -0.14, p value = 0.88 
N = number of schools 
 
A graph displaying the distribution of average uptake by religious affiliation in all 
academic years is presented in Figure 1 in Appendix 13.  
 
Geographic Factors 
Deprivation of local area 
Table 24 presents summary statistics for the independent variable (deprivation of SCA) 
in terms of means and standard deviations. Because the distribution of the independent 
variable (deprivation of SAP) was skewed I used descriptive statistics median (min and 
max) (Thabane and Akhtar-Danesh, 2008). It appeared that the mean of deprivation of 
scores was slightly higher (greater deprivation) for the areas where the schools were 
located (postcode) than for SCAs. Deprivation values for SAP were spread over a larger 
range of values than deprivation of SCAs. Details about the distribution of the 
deprivation of catchment area as well as for SAP by school are shown in the Table 1 in 
Appendix 12. 
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Table 24. Summary statistics of deprivation of school address postcode and 
deprivation of school catchment area 
 
Deprivation   N Mean S.D. Quantiles 
Min .25 
(Q1) 
Median 
(Q2) 
.75 
(Q3) 
Max 
deprivation of 
SAP 
20 28.59 15.68 9.71 15.87 27.90 33.73 66.63 
deprivation of 
SCA 
 
18 
 
25.58 
 
9.44 
 
8.65 
 
15.75 
 
27.50 
 
33.02 
 
42.62 
 
Definition of deprivation levels 
IMD scores for all 197 LSOAs in the city of the study ranged from 3.72 to 78.43. Table 
24 shows that the range of IMD scores for SAPs as well as the range of the average 
weighted IMD scores for SCAs were narrower. This was because only 20 out of 29 
schools in the city were included in the study. 
There is no cut-off for deprivation level mentioned in literature. I used median of IMD 
scores for SAPs (27.90) as cut-off point to define two deprivation levels of SAPs. Thus, 
my definition of a low level of deprivation of SAPs included IMD scores lower than and 
equal to 27.90 while my definition of a high level of deprivation of SAPs included IMD 
scores equal to and higher than 27.91. Similarly, I used median of IMD scores for SCAs 
(27.50) as the cut-off point to define two deprivation levels of SCAs. Low level of 
deprivation of SCAs was defined by IMD scores lower than and equal to 27.50 and high 
level of deprivation of SCAs was defined by IMD scores equal to and higher than 27.50. 
 
Deprivation of school address postcode by academic years 
Table 25 shows differences in mean uptake between the two categories of deprivation of 
SAP in each academic year and in all years combined. The difference between the low 
and high level of deprivation of indicated that the mean uptake in more deprived areas 
was lower than in less deprived areas of school location (postcode). The figures for 
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these differences were 3.1% in 2008/09, 5.4% in 2009/10, 3.8% in 2010/2011, 4% in 
2011/12 and 4.3% in all years combined. The difference between the mean uptake in 
high and low deprivation areas in the academic year 2009/10 and all years combined 
was statistically significant. 
 
Table 25. Distribution of average uptake by deprivation of school address postcode 
by academic year                       
 
 
Uptake 
per year 
 
N 
Mean uptake in 
areas with low 
deprivation 
(≤27.90) 
 
N 
Mean uptake in 
areas with high 
deprivation 
(≥27.91) 
                  
             Mann-Whitney 
Test  
2008/09 10 89.7  10 86.6 z = 1.14, p value = 0.25           
2009/10 10 78.8  10 73.4 z = 2.01, p value = 0.04 
2010/11 10 88.3 10 84.5 z = 1.06, p value = 0.28          
2011/12 10 92 10 88 z = 1.71, p value = 0.08 
all years 10 87.2 10 82.9 z = 2.80, p value = 0.005 
N = number of schools 
 
Graphs displaying deprivation of school address postcode in 2008/09, 2009/10, 
2010/11, 2011/12 and all years are presented in Appendix 14. 
 
Deprivation of school catchment area by academic year 
Table 26 shows distribution of average uptake by deprivation of SCA and by academic 
year. A consistent observation was that the schools in more deprived areas were more 
likely to have a lower mean uptake than the schools in less deprived areas of school 
catchment in each academic year and all years combined. The difference in average 
uptake between the areas with low and high level of deprivation of SCA varied across 
the years. The biggest difference was in 2008/09 (8.66%%), and there was no difference 
in 2009/10. A statistically significant difference in the mean uptake was found in the 
academic year 2008/09 (p value = 0.001) but no overall difference was found between 
school with low and high levels of deprivation of SCA when all years were investigated. 
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Table 26. Distribution of average uptake by deprivation of school catchment area 
and by academic year      
 
 
Uptake 
per year 
 
N 
Mean uptake in 
areas with low 
deprivation   
(≤ 27.50) 
 
N 
Mean uptake in 
areas with high 
deprivation  
(≥ 27.51) 
                  
     Mann-Whitney Test  
2008/09 9 92.66 9 84 z = 3.28, p value = 0.001 
2009/10 9 75.88 9 75.55 z = 0.53, p value = 0.59 
2010/11 9 87.33 9 84.77 z = 0.35, p value = 0.72 
2011/12 9 90.77 9 89.44 z = 0.44, p value = 0.65 
all years 9 86.55 9 83.33 z = 1.53, p value = 0.12 
N = number of schools 
 
Graphs displaying deprivation of school catchment area in 2008/09, 2009/10, 2010/11, 
2011/12 and all years are presented in Appendix 15. 
 
Ethnicity in school catchment areas  
In Table 27 descriptive statistics median (min and max) are presented because the 
distribution of the independent variable was skewed (Thabane and Akhtar-Danesh, 
2008). Table 27 shows that the variable “ethnicity” (the percentage of people in the 
white ethnic group) ranged from 35% to 79%. 
 
Table 27. Summary statistics for the independent variable ethnicity 
 
 N Quantiles 
Min .25 
(Q1) 
Median 
(Q2) 
.75 
(Q3) 
Max 
Ethnicity  18 35.00 53.00 65.50 70.00 79.0 
 
Ethnicity varied across schools. Figure 11 shows that White British was the commonest 
ethnic group in all schools except School 16.   
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Figure 11. Percentage of population from different ethnic groups by schools 
 
 
These ethnic groups refer to total population including all age groups 
 
Table 28 presents differences in mean uptake by ethnicity in each academic year and in 
all years combined. In general the areas with more white British girls had a higher mean 
uptake than the areas with a smaller proportion, although differences were small (1.4%) 
and non-significant when all years were put together.  
However, in the academic year 2009/10, there was a large and significant difference 
between the areas (72.55% vs. 78.88%) (difference = 6.33%, p value = 0.03) showing 
that uptake was lower in areas with higher proportions of white British people compared 
to areas with a smaller proportion of white residents. This pattern was reversed in the 
following year when there was a large and significant difference in uptake between the 
two groups. Thus, in 2010/11, schools with a higher proportion of white residents in 
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SCA had an increased uptake (difference = 6.11%, p value = 0.02) compared to schools 
with a lower proportion of white British people in SCA. 
Table 28. Distribution of average uptake by ethnicity in school catchment area by 
academic year 
 
 
 
 
Uptake 
per year 
 
 
 
N 
Mean uptake in  
areas with low 
% of white 
pop. in school 
catchment area  
(≤ 65.50) 
 
 
 
N 
Mean uptake  
areas with high 
% of white  pop. 
in school 
catchment area  
(≥ 65.51) 
Difference in 
mean uptake 
between areas 
with high % 
and low % of 
white 
population 
               
 
 
   Mann-
Whitney Test  
2008/09 9 86.11 9 90.55 4.44 z = -0.88, 
 p value = 0.37 
2009/10 9 78.88 9 72.55 -6.33 z = 2.12,  
p value = 0.03 
2010/11 9 83 9 89.11 6.11 z = -2.21,  
p value = 0.02 
2011/12 9 89.55 9 90.66 1.11 z = -0.48,  
p value = 0.62 
all years 9 84.22 9 85.66 1.44 z = -0.67,  
p value = 0.49 
N = number of schools 
 
Graphs displaying average uptake by ethnicity in school catchment area in 2008/09, 
2009/10, 2010/11, 2011/12 and all years are presented in Appendix 16. 
 
I used the median of ethnicity (the percentage of people in the white ethnic group) in 
SCA (65.50%) as cut-off point to define two ethnic groups: white and non-white. Thus, 
in the “non-white” group the percentage of people in the white ethnic group was lower 
than or equal to 65.50%. The “white group” included a percentage of people in the 
white ethnic group equal to or higher than 65.50%. 
 
The majority of the total population (all age groups) in the SCAs was White British 
(Figure 11). I calculated the number of the under 15s out of the total population in each 
ethnic group based on the age composition of ethnic groups in 2011 Census in Figure 1 
in Appendix 17. Then I calculated the percentage of the under 15s by ethnic group out 
187 
  
of the total population of the under 15s which I presented in Table 1 in Appendix 17. 
Table 1 in Appendix 17 shows that in the teenage population at national level (England) 
there is as high a percentage of teenagers who are White British (74.45%). Based on 
these data I derived from the Census the children in the schools in the city of my study, 
who are not White British, came from a variety of backgrounds including Pakistani, 
African and Indian groups. 
 
Linear relationship between uptake of HPV vaccine and continuous variables 
The strength of relationship between uptake of the third dose, deprivation of SCA, 
deprivation of SAP, and ethnicity were determined by the Pearson's Product-moment 
Correlation coefficient or the Spearman correlation coefficient (rho) (Peacock and 
Kerry, 2007).  The Pearson's Product-moment correlation coefficient was carried out to 
estimate the linear association between continuous variables in which at least one of the 
variable followed a Normal distribution (Field, 2013). The correlation coefficient can be 
distorted by outliers (Kaye and Freedman, 2000). The Spearman correlation coefficient 
is a non-parametric statistic which was carried out when none of the variables were 
Normally distributed (Peacock and Kerry, 2007) and because the sample size was small 
(Field, 2013). A weak correlation is defined as the value between 0.1-0.3, a moderate 
correlation between 0.4-0.6 and a stronger correlation between 0.7-1 (Peacock and 
Kerry, 2007). I calculated the coefficient of determination R
2 
as squared Pearson's 
correlation coefficient to show the amount of variation in the outcome variable (uptake 
of the third dose) that was explained by the independent variable (Fox, 1997; Field, 
2013). I calculated Rs
2 
as squared Spearman’s correlation coefficient representing the 
proportion of variance in the ranks that two variables share (Field, 2013). Correlation 
coefficients between uptake and continuous variables, p values and CI 95% for each 
academic year and all years are shown in Table 29.  
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Table 29 shows that in 2008/09, there was a strong, negative and statistically significant 
correlation between uptake of the third dose and deprivation of SCA, and a moderate, 
positive and statistically significant correlation between uptake of the third dose and 
ethnicity. The Spearman’s correlation coefficient between uptake of the third dose and 
deprivation of SAP showed a weak, negative and not statistically significant correlation.   
In contrast in 2009/10, there was no significant relationship between uptake of the third 
dose and deprivation of SCA, deprivation of SAP and ethnicity. All coefficients 
indicated weak, negative and not statistically significant correlations.  
In 2010/11 uptake of the third dose was significantly related to deprivation of SAP and 
ethnicity. The relationship observed between uptake of the third dose and deprivation of 
SAP was moderate and negative while the correlation between uptake of the third dose 
and ethnicity was moderate and positive. There was no significant relationship between 
uptake of the third dose and deprivation of SCA.  
In 2011/12, uptake of the third dose was not significantly related to deprivation of SCA, 
deprivation of SAP and ethnicity.  
In all years combined, there was a moderate, negative and statistically significant 
correlation with deprivation of SCA and a negative and statistically significant 
correlation with deprivation of SAP. Ethnicity was not significantly related to uptake of 
the third dose. 
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Table 29. Correlations between dependent and independent variables by academic 
year  
 
r= Pearson's product-moment correlation coefficient 
rho = Spearman's correlation coefficient 
*p value p <0.05 
**coefficient of determination 
N = 18 (deprivation of SCA), N = 20 (deprivation of SAP) 
 
Tables 30 and 31show correlations between independent variables. There was a 
statistically positive, moderate and statistically significant correlation observed between 
deprivation of SCA and deprivation of SAP as well as a moderate, negative and 
statistically significant correlation observed between deprivation of SCA and ethnicity.  
 
Table 30. Correlations between independent variables  
 
Independent variables Deprivation of SAP Ethnicity 
Deprivation of SCA r = 0.6021 (0.0082) * r= -0.4902 (0.0389)* 
r= Pearson's product-moment correlation coefficient 
*p value <0.05 
N = 18 (deprivation of SCA), N = 20 (deprivation of SAP) 
Independent variables Uptake 3
rd
 dose 2008/09 95% CI R
2 
/Rs
2 ** 
Deprivation of  SCA  r=  -0.7202 (0.0007)* -0.888 to -0.382 0.5186 
Deprivation of   SAP rho = -0.3244 (0.1629)*  -0.671 to 0.138 0.1052 
Ethnicity rho = 0.4797 (0.0439)* 0.017 to 0.773 0.2301 
 Uptake 3
rd
 dose 2009/10   
Deprivation  of  SCA  r= -0.0610 (0.8100)*  -0.513 to 0.418 0.0037 
Deprivation  of SAP rho = -0.3834 (0.0952)* -0.706 to 0.071 0.1469 
Ethnicity rho= -0.3053 (0.2179)* -0.676 to 0.188 0.0932 
 Uptake 3
rd
 dose 2010/11   
Deprivation of SCA  r= -0.3928 (0.1069)*  -0.726 to 0.091 0.1542 
Deprivation of SAP rho = -0.5226 (0.0181) * -0.784 to -0.104 0.2731 
Ethnicity rho = 0.4946 (0.0369)* 0.036 to 0.781 0.2446 
 Uptake 3
rd
 dose 2011/12   
Deprivation of SCA  r= -0.1683 (0.5045)*  -0.589 to 0.324 0.0283 
Deprivation of SAP r = -0.3438 (0.1377)*  -0.683 to 0.116 0.1181 
Ethnicity r = 0.2031 (0.4188)* -0.291 to 0.612 0.0412 
 Uptake 3
rd
 dose all 
years 
  
Deprivation of SCA  r= -0.5545 (0.0169) * -0.811 to -0.118 0.3074 
Deprivation of SAP rho = -0.7383 (0.0002) * -0.890 to -0.439 0.5450 
Ethnicity rho = 0.2865 (0.2491)* -0.208 to 0.664 0.0820 
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Table 31. Correlations between independent variables  
 
Independent variables Ethnicity 
Deprivation of SAP rho= -0.4060 (0.0946)* 
rho = Spearman's correlation coefficient 
*p value <0.05 
N = 18 (deprivation of SCA), N = 20 (deprivation of SAP) 
 
Assessment of correlations between dependent and independent continuous 
variables and between independent continuous variables 
 
Figures 1-5 in Appendix18 show scatter plot matrices to reveal the relationships 
between all combinations of raw variable pairs such as the dependent variable (uptake 
of the third dose) and any of the independent variables (deprivation of SCA, deprivation 
of SAP and ethnicity) in each academic year and all years. Figure 3 shows that the 
relationship between uptake of HPV vaccine and ethnicity (White British population) 
was linear in 2010/11. There was some degree of nonlinearity [i.e., a curved band or a 
big wave-shaped curve (Field, 2013; UCLA, 2013a; UCLA, 2013b)] for the 
relationships between the dependent variable and all independent variables in 2008/09, 
2009/10, 2011/12 and in all years combined. 
Dot plots in Figure 1 in Appendix 19 show the relationship between continuous variable 
(uptake of the third dose) and categorical variable (school type) for each academic year 
and all academic years. The spread and the values of the dots indicate the level of 
uptake. A consistent observation was that the spread of the dots representing religious 
schools was little in comparison to the schools without religious affiliation. This could 
suggest a similar pattern of uptake in faith schools.  
 
Analytic Statistics 
Simple and multiple linear regression analyses for each academic year are in Appendix 
7. 
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Simple and multiple linear regression analysis in all academic years  
Table 32 presents the results of simple and multiple linear regression models with 
coefficients, standard errors, p-values in all years. The size of the coefficient for each 
independent variable gives the size of the effect that variable has on the dependent 
variable, and the sign of the coefficient (positive or negative) gives the direction of the 
effect (increase or decrease of the dependent variable).  
 
Figure 12 shows that the distribution of the dependent variable (uptake of the third dose) 
by transformation remained skewed. Therefore, the outcome variable was entered in the 
models untransformed.  
 
Figure 12. Transformations of the dependent variable in all academic years  
 
 
 
Table 32 shows the unadjusted and adjusted results of the association between uptake 
and the study area characteristics. The unadjusted results indicate that there was a 
negative statistically significant association between deprivation of SCA and uptake, as 
well as the deprivation of SAP and the academic year 2009/10. For a one-unit increase 
in deprivation of SCA, there was 0.22% decrease in uptake which was statistically 
significant (p value = 0.04). For a one-unit increase in deprivation of SAP, there was 
0.15% reduction of uptake which was statistically significant (p value = 0.009). For a 
02
.0
e
-0
6
4
.0
e
-0
6
6
.0
e
-0
6
8
.0
e
-0
6
4500005 00005500006 00006500007 0000
cubic
02
.0
e
-0
4
4
.0
e
-0
4
6
.0
e
-0
4
8
.0
e
-0
4
.0
0
1
5500 6000 6500 7000 7500 8000
square
0
.0
5
.1
.1
5
.2
75 80 85 90
identity
0
1
2
3
8.8 9 9.2 9.4
sqrt
0
5
1
0
1
5
4.3 4.35 4.4 4.45 4.5
log
0
5
01
0
01
5
02
0
02
5
0
-.114 -.112 -.11 -.108 -.106
1/sqrt
0
5
0
0
1
0
0
01
5
0
0
-.013 -.0125 -.012 -.0115 -.011
inverse
01
.0
e
+
0
4
2
.0
e
+
0
4
3
.0
e
+
0
4
4
.0
e
+
0
4
5
.0
e
+
0
4
-.00017-.00016-.00015-.00014-.00013
1/square
0
1
.0
e
+
0
6
2
.0
e
+
0
6
3
.0
e
+
0
6
-2.20e-06-2.00e-06-1.80e-06-1. 0e-06-1.40e-06
1/cubic
D
e
n
s
it
y
Uptake 3rd dose all years
Histograms by transformation
192 
  
one-unit increase in percentage of White British population, there was 0.16% increase in 
uptake but this was not statistically significant.  
Differences in mean uptake were observed in the categories of two independent 
variables. There was small difference in mean uptake between faith schools and the 
schools with no religious affiliation (difference = 1.43%) which was not statistically 
significant. The difference in mean uptake between academic years 2008/09 and 
2009/10 indicated that the mean uptake in the second year of the programme was 
12.05% lower than in the first year of the programme which was statistically significant. 
There was a small difference (not statistically significant) in mean uptake between 
2008/09 and 2010/11 as well as between 2008/09 and 2011/12. 
Multiple regression model 1 including deprivation in SCA, ethnicity, school type 
(religious affiliation) and year did not show any statistically significant effect of 
deprivation in SCA on uptake after taking account of the effects of all the other 
independent variables. There was a large and significant reduction in mean uptake 
adjusted in year 2009/10 compared with 2008/09 (12.05%) after controlling for the 
other school and geographic factors (p value = 0.00). Also, adjusting for deprivation in 
SCA, school type (religious affiliation) and year, there was no statistically significant 
association between uptake and ethnicity. There was a small and not statistically 
significant increase in mean uptake adjusted in religious schools compared with schools 
without religious affiliation when the other variables were held constant.   
When deprivation of SAP, ethnicity, school type (religious affiliation) and year were 
modeled together in multiple regression model 2, there remained a small but significant 
association between uptake and deprivation of SAP after controlling for the other 
variables. There was a large and significant reduction in mean uptake adjusted in year 
2009/10 compared with 2008/09 (12.61%) after controlling for deprivation of SAP, 
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ethnicity and school type (p value = 0.00). Adjusting for school and geographic factors, 
there was no statistically significant association between uptake and ethnicity. In 
addition, there was no statistically significant increase in mean uptake adjusted in 
religious schools compared with schools without religious affiliation when the other 
variables were held constant.   
The independent variables included in the regression analysis model 1 explained 56% of 
the variation in uptake and those modeled together in the regression analysis model 2 
explained 58% of the variation in uptake. 
 
Table 32. The relationship between uptake and variables related to geographic 
factors and school factors in all years 
 
 Unadjusted Adjusted  
  MODEL 1  MODEL 2  
Uptake  Coeff SE p value Coeff SE p value Coeff SE p value 
deprivation SCA* -0.22 0.10 0.04 -0.15 0.07 0.054    
deprivation SAP ** -0.15 0.05 0.009    -0.13 0.05 0.008 
ethnicity**  0.16 0.08 0.053 0.10 0.07 0.15 0.07 0.06 0.28 
school type **          
No (reference) 0   0   0   
Yes  1.43 2.11 0.5 0.68 1.2 0.57 2.21 1.18 0.06 
2008/09 (reference) 0   0   0   
2009/10 -12.05 2.00 <0.001 -12.61 2.02 <0.001 -12.61 1.96 <0.001 
2010/11 -1.75 1.96 0.37 -2.27 1.68 0.18 -2.27 1.67 0.17 
2011/12 1.85 1.85 0.32 1.77 1.73 0.30 1.77 1.70 0.30 
*N = 18 observations 
** N = 20 observations 
School type = religious 
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6. 3. Summary  
The quantitative study of the mixed methods research showed that the third dose uptake 
by school varied between 65% and 100% with an overall median uptake in each year of 
90% in 2008/09, 75% in 2009/10, 86.5% in 2010/11, 89.5% in 2011/12 and 86.5% in all 
years. Every year median uptake rates were higher than the goal set by the WHO (70%) 
(World Health Organization, 2008). 19 schools out of 20 in the first two years and all 20 
schools in the last two years of the HPV vaccination programme had uptake rates of 
70% or above. Thus, I concluded that the programme was successfully implemented 
across the years. In this context, I looked at variation in uptake between schools located 
in high and low deprived areas (of SAP and SCA). I found that uptake rates were 
consistently over 80% in both high and low deprived areas (of SAP and SCA) across 
years, except the second academic year when uptake was over 70% meaning that even 
in the context of a dramatic event following the HPV vaccination, the goals of the 
programme were met. 
While the lowest uptake was found in school 16 and school 2 repeatedly, the highest 
uptake was achieved by different schools across the years and in all years combined. It 
was noted that the percentage of non-white residents in SCA of school 16 was 65%, 
which was the highest among all the secondary schools included in the study. A similar 
high percentage (54%) of non-white residents was found in the SCA of school 2. 
The unadjusted results indicate that there was a negative statistically significant 
association between deprivation of SCA and uptake, as well as the deprivation of SAP 
and the academic year 2009/10 (the last was possibly associated with the negative event 
in 2009/10 described in detail in Theme 3 of Chapter 7). In the two multiple regression 
models (i.e. after multiple adjustments for other factors), deprivation of SAP remained 
statistically significantly associated with uptake after controlling for ethnicity, school 
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type and academic year. Similarly, the academic year 2009/10 remained statistically 
significantly associated with uptake after adjusting for geographic and school factors. 
Deprivation of SCA was no longer statistically significant associated with uptake when 
the other variables were held constant and the same was true for the association between 
ethnicity (proportion of white residents) and uptake.  
In conclusion, I found that uptake was only significantly associated with deprivation of 
SAP and no association was found between uptake and other geographic factors 
(deprivation of SCA and ethnicity) or school factors (religious affiliation). 
In the next chapter, I present fieldwork approach, data collection, the methods and the 
techniques of thematic analysis and the results of the qualitative study. 
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CHAPTER 7: QUALITATIVE RESEARCH 
STUDY 
In this chapter, I describe how I obtained ethical approval for the qualitative component 
of the mixed methods research in schools which addressed research question 3. Then, I 
describe my methods of data collection: individual face-to-face interviews and non-
participant observation. Next, I present how I collected data, including the recruitment 
of the participants, the conduct of the interviews, the transcription of the interviews, 
reflexivity and the procedures to minimize possible researcher effect and researcher bias 
and thematic analysis and in the end, I present the results. 
 
7. 1. Ethics  
 Permission to conduct this research was sought from the NHS Research Ethics 
Committee (NHS REC) Black Country. I received ethical approval from the NHS REC 
and a research passport at the University of Warwick in October 2012. A Disclosure 
from the Criminal Records Bureau was obtained April 2012. The West Midlands 
(South) Comprehensive Local Research Network granted NHS permission to conduct 
my study at an NHS site and the R&D approval allowed me to interview nurses and to 
observe them during vaccination sessions. I obtained secondary data from NHS through 
the Freedom of Information Act 2000. 
 
I gained access to conduct interviews in the schools from the Head teachers although 
this was not straightforward and took some time. Gatekeepers increase barriers to 
children’s participation in research to protect them from harm (Powell, 2011) although 
children’s involvement in research is based on their right to express their views (Powell, 
2011). 
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Principles of ethics in research include autonomy, beneficence and non-maleficence, 
and justice (Powell, 2011). Freely given informed consent is required when social 
research involves human subjects (Social Research Association, 2003; National 
Research Ethics Service, 2011). This is because before a subject decides whether or not 
to take part, it is important for him/her to understand (Powell, 2011) why the research is 
being done, and if there are benefits or risks for him/her in the study (Social Research 
Association, 2003). An acceptable risk for a child participating in research varies from 
study to study (National Research Ethics Service, 2011). Risk is minimal when research 
involves questioning or observing children (National Research Ethics Service, 2011).  
 
The amount of information provided to participants to ensure that they are sufficiently 
informed about research (Powell, 2011) could be decided according to standard 
protocols (Social Research Association, 2003) or comments of service users or members 
of the public after they have read the information sheet (National Research Ethics 
Service, 2011). Evidence suggests that discussion between the researcher and the 
participants on different aspects of the written information sheet is a means to seek their 
“informed” consent (National Research Ethics Service, 2011). Consent is an ongoing 
process (National Research Ethics Service, 2011) so that the participants have the right 
to withdraw at any time without giving any reason (Powell, 2011; Social Research 
Association, 2003).  
 
Participant information sheets and consent forms were developed according to 
guidelines of the National Research Ethics Service (National Research Ethics Service, 
2011) and of the Social Research Association (Social Research Association, 2003) and 
approved by the NHS NREC (See Appendix 21). Consent involves verbal or written 
agreement (Powell, 2011). Informed consent in writing was gained from all people who 
198 
  
were part of the qualitative study. Those who participated were ensured that privacy - 
anonymity and confidentiality of their information was protected at all times. There are 
three types of confidentiality: public confidentiality (anonymity), social network 
confidentiality (i.e., family members, friends) and third party breach of privacy (Powell, 
2011). Privacy considerations include a private physical location to conduct the research 
(Powell, 2011). The individual interviews with the nurses, the teachers and the girls 
took place in meeting rooms in the schools to secure confidentiality of discussions 
during individual interviews.   
 
Anonymisation can prevent breach of confidentiality (Social Research Association, 
2003) to maintain participants’ trust (National Research Ethics Service, 2011). I planned 
anonymisation at the time of transcribing the interviews before data analysis. 
Participants were told in the participant information sheet that all identifiable 
information (i.e., name, place, profession) collected during interviews and non-
participant observations would be removed from the interview transcripts or quotations.  
A person's name and a school's name was replaced with a number (e.g. nurse 1, school 
1). Participants were told that the research information would be analyzed and reported 
anonymously so that no individual could be identified from the documents. They were 
told also that anonymised results of the research study would be used to write my PhD 
thesis in Public Health at the University of Warwick and that I and my supervisors 
would write articles in scientific journals and present the anonymised results at 
conferences. In addition, I mentioned to them in the information sheet that the data will 
be stored in the University of Warwick and accessed by me and my supervisors in 
accordance with the Data Protection Act 1998. In order to respect social network 
privacy, participants were told that the information about them that was collected from 
the study will be put away and no-one but the research team will be able to see it.  
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Research with children and young people raises ethical concerns and research practice is 
guided by different types of rights of the child to protection, choice and participation 
(Powell, 2011). In order to protect girls against potentially harmful effects of 
participating (Social Research Association, 2003), I made sure that the school 
counsellor was on site before the individual interviews. Also, I informed the girl that if 
she was distressed she could contact her school counsellor, or if she preferred she could 
call ChildLine by phone or contact Get Connected by phone or use WebHelp. 
 
The participant information sheets for girls as well as the letters of invitation, the 
participant information sheets and the consent forms for Head teachers set out the limits 
to confidentiality and stated that this may need to be breached if there is a risk of harm 
to the child or someone else (Powell, 2011, p. 26). Disclosure would have occurred after 
I had talked to the girl about the best thing to do. In the UK it is considered a good 
practice to report disclosed information (Powell, 2011). In case of need, information 
disclosed by the participant would have been discussed by me (the researcher) with my 
supervisors (Professor Clarke and Professor Hundt) at the University of Warwick and if 
necessary with the Head teacher or the safeguarding governor or the chair of governors 
in the school. 
 
As all the girls were under 16 years, I wrote to parents/carers about the study with the 
information sheet. Participant information sheets had my contact details so that all 
participants were welcome to contact me, if they had any questions or concerns. If the 
girls wished to participate to the study, they were asked to sign the informed consent 
form. At the same time informed consent was sought from girls' parents even if the girls 
had the capacity to give consent for themselves. Consent depends on the capacity to 
provide it (National Research Ethics Service, 2011). In the UK, Gillick competence is 
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applied because there is no law to decide definitive ages when a child can give informed 
consent and when the researcher should seek consent from a parent (National Research 
Ethics Service, 2011). Gillick competence refers to the capability of children under 16 
years old to give valid consent (Powell, 2011) if they understand information presented 
to them (National Research Ethics Service, 2011).  
 
I asked the head teachers’ permission for the parent/guardian information sheets and 
opt-out forms to be sent to parents by the school administration which enabled them to 
know that the school has given support for my study and for them to use the opt-out 
option if they wished to. There is evidence that the opt-in approach reduces numbers 
recruited (National Research Ethics Service, 2011). The use of the opt-out forms has 
been recommended in studies with low risk participants (National Research Ethics 
Service, 2011). I chose to use the opt-out forms because they were used in another study 
in the University of Warwick and it worked well. 
 
Guidelines of the National Research Ethics Service state that participants need at least 
24 hours to make a decision (National Research Ethics Service, 2011). The girls 
received the participant information sheet two weeks prior to the interviews and the 
Information sheet was made easy to read and understand by piloting it on two girls of 
the same age not included in the study.  
When interviewing, I carried an authenticated badge to show to respondents. The girls 
who agreed to participate to individual interviews and who had their parent’s consent to 
participate, received again a participant information sheet and I spent time going 
through it to explain to the girls the purpose of the study, what an interview involved, 
that an interview lasted 30-45 minutes, that participation was voluntary, that they had 
the right to withdraw at any time without giving any reason (National Research Ethics 
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Service, 2011), that there were no right or wrong answers to any of the questions 
(Punch, 2002), and I used age-appropriate and understandable language (National 
Research Ethics Service, 2011). Then, I invited them to ask any questions they might 
have had related to the research. The girls were asked to sign a consent form.  
 
7. 2. Methods 
I started the fieldwork after I received ethical approval, CRB and research passport in 
October 2012. The initial plan was to design the mixed methods research as a sequential 
exploratory study and first to conduct quantitative analysis to inform the sampling of 
data collection for qualitative analysis. In the end, it was a parallel design owing to the 
delays in getting access to both the quantitative and qualitative data. Negotiation of 
getting a secondary dataset and waiting for the staff in the Trust in the city of my study 
to extract the requested data took around six months from November 2012 to April 2013 
that was much more than the time frame of my research plan. I decided to start 
qualitative data collection because HPV vaccination was carried out in the schools at 
certain times throughout the academic year such as in September for the first dose, in 
November for the second dose and in March-April for the third dose. I carried out 
qualitative data collection until October 2013. In parallel, I conducted quantitative data 
collection and analysis over the period from December 2012 until December 2013.  
 
7. 2. 1. Fieldwork approach 
During the fieldwork, I collected two main types of data: 
 
1) Field notes from non-participant observation of vaccination sessions in the 
schools  
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2) Individual interviews with adults and children 
I discuss the rationale for the choice of these methods.  
 
7. 2. 1. 1. Interviews  
I conducted individual interviews with adults (nurses and teachers) and with preteenage 
girls. I interviewed 9 nurses and 4 teachers and 34 girls. The main advantage of doing 
an individual interview is that in-depth information is gained and sensitive issues can be 
discussed. It has some disadvantages. For example, it provides individual perceptions so 
that multiple interviews are needed to identify a range of issues. Also, sampling of 
participants depends on the achievement of data saturation (Hennink et al., 2011).  
Interviews are classified as structured, semi-structured or unstructured. I used semi-
structured individual interviews. I chose this technique because it was flexible so that 
the flow and sharing of views were more natural. It gives the opportunity to the 
researcher to probe to understand participants’ perspectives and experiences. In 
addition, the respondent could influence the topic, so unexpected issues/topics emerge 
(Hardon et al., 2004). I developed a topic guide according to literature which I pilot-
tested and refined during data collection (Hennink et al., 2011). Because the research 
questions of the study aimed to capture the young people’s perspectives and opinions 
about barriers and facilitators to HPV vaccine, all questions were flexible and open-
ended. 
 
7. 2. 1. 2. Non-participant observation 
I carried out non-participant observation in schools from November 2012 to April 2013 
and I did this on Mondays, Tuesdays and Wednesdays in 12 schools. The aim of the use 
of non-participant observation was to understand the context of the HPV vaccination 
provision in schools and to become more familiar with the study setting and population 
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(girls, teachers, and nurses). The advantage of non-participant observation is that it 
provides contextual information, identifying people’s actual behavior (Hennink et al., 
2011) and it informs about the influence of the physical environment on people and 
interactions (Mulhall, 2003). The disadvantage of non-participant observation is that 
interpretation of the researcher’s observation is subjective (Hennink et al., 2011).  The 
researcher could pay attention to some people or events more than to the others, either 
because they are different or because of researcher’s background knowledge 
(Wolfinger, 2002). In order to overcome this disadvantage I developed a guide what to 
look for when doing observation.  
 
During fieldwork, I observed vaccination sessions looking at the interactions between 
nurses, girls and teachers. I used a comprehensive strategy to record notes supplying 
enough detail about what happened in the field and documenting the events strictly 
chronologically (Wolfinger, 2002). I recorded the events in the fieldwork at the time 
when they happened, to capture detail. I wrote the field notes at the end of each day 
after the events were observed (Mulhall, 2003). I wrote subjective interpretation of 
some events in brackets in the field notes (Hennink et al., 2011) and I kept a field diary 
where I wrote down all my reflections based on the observations. This helped me to 
develop questions and to seek clarifications later during interviews. 
 
7. 2. 2. Data collection  
7. 2. 2. 1. Individual interviews with nurses 
I liaised with the lead nurse of immunization in the Trust in October 2012. She liaised 
with the general manager of the Children's Services in the Trust to negotiate my access 
in the Trust. I was invited to give a presentation about my research in a meeting with the 
heads and the team leaders from Children’s Services as well as members from 
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Corporate Services. The general manager granted the permission for my study in the 
Trust. Afterwards, I met with the lead nurse of immunization to explain to her my 
research in more detail. I was told that bank nurses carried out the vaccinations and they 
were not based in the offices in the Trust. Therefore, I could not meet personally with 
the nurses. I gave her a pack with the information sheets and consent forms to inform 
the bank nurses about my study that included observing vaccination sessions in the 
schools and individual interviews with them. The lead nurse selected the nurses. 
Sampling was purposive and the criterion was to include nurses with various nursing 
specialties and roles (as presented in Table 1 in Appendix 22) and presumably different 
views on the implementation of the HPV programme in the schools in the city.   
 
The lead nurse and I discussed how to organize the interviews with the bank nurses 
given that their workload was quite high and that they were employed only for two 
hours per school. The interview had to fit within those two hours. It was not feasible to 
conduct interviews with the bank nurses after the vaccination sessions because there 
was no place available to do it in the school or in the Trust. Sometimes the vaccinations 
were carried out in two schools on a day. The break between the vaccinations in the 
schools was enough to move from one school to another one. In addition, there was no 
financial incentive for the nurses to stay after the session had ended.  
 
I started qualitative data collection in November 2012 during the second round of HPV 
vaccination. The lead nurse of immunization gave me the dates of the vaccination 
sessions in each school and she suggested I go with the bank nurses into all 20 schools 
and that I take the opportunity to interview the nurses where it was possible to do that. 
The vaccinations were carried out four days per week from Monday to Thursday. In 
205 
  
some schools, I made only field observations and in other schools, I made observations 
and I organized interviews. 
  
The lead nurse introduced me to the nurse team at the time of vaccination session in the 
first school. Each day, only five-seven bank nurses participated in immunization 
activities depending on the school roll. Some of the bank nurses came every day while 
others came occasionally. Thus, the team changed slightly from one day to another.  
When the lead nurse was not present, another senior nurse introduced me to the bank 
nurses.  
 
Observation was a dynamic activity (Mulhall, 2003). During observations in some 
schools, I sat away from the tables where the nurses vaccinated the girls but could see 
what the nurses, the girls and the teachers were doing, how the girls interacted with the 
nurses, the teachers, and with each other. In other schools, I stayed at the table where a 
nurse gave the vaccination to capture what the people were talking about without 
interacting with anybody and without disrupting them in any way. Sometimes I moved 
around to see what the girls were doing, before they were invited to receive the injection 
and to hear the conversation between other nurses and girls.  
 
I interviewed one nurse per vaccination session (Table 1 in Appendix 22) and only in 
those schools where the time and the context allowed this. This was possible on those 
days when only one school was scheduled and towards the end of the vaccination 
session. The consent form was signed on the day of the interview.  
 
I interviewed four nurses in a sports hall away from the site of vaccinations to respect 
the confidentiality of the discussion and to avoid noise. In another three schools I 
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interviewed the nurses in a separate room because in those schools the vaccinations 
were carried out in classrooms or small meeting rooms. I organized the interviews with 
the lead nurse and the senior nurse in their office in the Trust during the lunch break. In 
total, I interviewed nine nurses until I obtained data saturation (Hennink et al., 2011).  
 
7. 2. 2. 2. Individual interviews with girls and teachers 
7. 2. 2. 2. 1. Getting access to schools  
I got a list of the secondary schools from the lead immunization nurse. There were 29 
secondary schools in the city of which: 19 were mixed schools, one was a girls’ school 
and nine schools were special
27
.  
 
The original research design had been to complete the quantitative data analysis of 
mixed methods research and then to select four schools according to two criteria to 
reflect variation in uptake: high and low HPV vaccine uptake and year 8 girls’ ethnicity. 
The sampling could not be carried out this way because qualitative data collection 
preceded secondary data analysis in quantitative study.  The initial access to schools 
was difficult and time-consuming and I adopted a mixture of strategies and pathways to 
find four schools. I contacted 17 mixed schools and one girls’ schools and I approached 
them in four stages. The first stage was in November 2012 when I sent a whole pack 
with invitation letters, information sheets and consent forms to the head teachers in 11 
schools by email and by Royal Mail Special Delivery. I received the confirmation that 
all 11 packs were delivered. My request to Head teachers was to observe Personal, 
Social, Health and Education (PSHE) classes to organize individual interview with 
PHSE teachers and individual interviews with years 8 girls from different ethnic groups.  
 
                                                          
27
 Special schools are part of the UK school education focusing on students primarily with learning, 
behavioral and emotional difficulties and/or disability. 
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One week later, I contacted the schools by email and phone and found that some of the 
head teachers had not read the pack of documents. Assuming that the Head teachers had 
a busy agenda, at the beginning of January 2013 when the schools reopened, I decided 
to send out only a personalized invitation letter by email to each head teacher. Each 
school was called a week after the receipt of the letter. The Head teacher of one school 
agreed to participate in the study, three did not reply and seven out of eleven schools 
declined to participate by email. Some of the head teachers who replied unfavorably 
informed me that HPV the vaccination was not the subject of any PSHE lessons and no 
teachers were involved in discussing the issues with the students, or delivering any kind 
of formally taught subject material. 
 
The third stage was in February 2013 when I sent out personalized invitation letters to 
the head teachers in the three schools, which did not reply, and to seven other secondary 
schools requesting permission to conduct only individual interviews with year 8 girls. 
Five schools declined participate and the other five schools did not reply.  
 
The fourth stage was in March 2013 when my supervisor introduced me to a public 
health professional, who would work with me to find alternative ways to access the 
schools. First, we revised the invitation letter to introduce my study to the schools and 
to ask permission to interview face-to-face year 8 girls. Second, she put me in contact 
with the Head of Personal & Social Development in the Learning & Young People's 
Directorate in City Council. She supported me to get access to the schools sending all 
my documentation with invitation letters, information sheets and consent forms to 
teachers in all 20 secondary schools in the city. Unfortunately, none of the schools 
replied either to her or to me. Therefore, I tried another two strategies. I went to two 
schools with the nurse team for the third round of vaccinations in April 2013. Once I 
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was in the schools, I went to Reception where I introduced myself and I mentioned that 
I had sent a pack of documentation to the head teacher and that he/she had received it. 
Further, on that day I explained to the Reception staff that the purpose of my visit in 
their school was to meet with the head teachers. I was told that the head teachers were 
busy at that time and without a prior appointment, I could not see them. I realized that 
this strategy was not going to work. The other attempt to get access to the schools was 
through snowball recruitment method, which is described later in this Section.  
 
In April 2013 I and the public health professional decided to send reminder emails only 
to those five schools which did not reply in February 2013 and to follow them up one 
week later. Three schools out of five accepted participation in the study. All four 
schools which accepted participation in the research were maintained schools. The 
characteristics of the schools in terms of HPV vaccine uptake and the level of 
deprivation of their location and their catchment area are presented in Table 1 in 
Appendix 23.  
 
I describe below how I organized the fieldwork in each school. 
 
The access to the religious school in January 2013 was gained through the Deputy Head 
teacher. To gain access it is important who the researcher contacts, but also how the 
project is explained to them (Crang and Cook, 2007). I met with the Deputy Head 
teacher at the end of January 2013 to discuss with her the research in more detail. I 
explained to her that I was interested in interviewing a mixed group of 10 year 8 girls in 
terms of ethnicity because I wanted to see both differences and similarities across the 
groups of students. I asked her to select year 8 girls from all ethnic groups and religions 
in that school including vaccinated and not vaccinated girls to reflect the demographic 
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profile of the school.  I asked her if any teacher in the school had talked to the girls 
about HPV vaccine at the beginning of the academic year. I found out that this was 
pastors’ responsibility and I obtained permission to interview one of them. I explained 
to her that before the interviews I needed to get parental consent because the girls were 
12-13 years old. We discussed the options to send the information sheets and the 
consent forms to the parents and we concluded that the best choice was to send them 
through the school. The reason was that the young participants may not have passed the 
information on to parents and as such they could have been taking part in the study 
without their parents’ knowledge. In addition, sending the forms via school was a way 
to reassure parents that the school had given support to my study. The information 
sheets contained my contact details so that the girls or the parents could contact me, if 
they had any questions or concerns. The Deputy Head teacher agreed to select the girls 
and to inform them as well as their parents about my research and she suggested I 
waited two weeks to collect the consent forms. The person who chased up the consent 
forms was the administrative assistant to the Deputy Head teacher. I contacted her once 
a week to ask about how many parents had consented for their daughters to take part in 
my study. At the end of February 2013, I found out that she had nine forms with 
parental consent. We agreed to arrange a schedule of interviews and to carry them out in 
March 2013.  
 
After I conducted all the interviews with the girls and the pastor, I met with the Deputy 
Head teacher to enquire if she could recommend one of her contacts in other schools in 
the city who might give support to my study. She gave me the name and the email 
address of the Assistant Principal in the school with the most ethnic groups in the city.  
Despite my efforts to get in touch with that Assistant Principal by email in which I 
included the name of the Deputy Head teacher from the religious school, I did not get 
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any reply. Then, I contacted the lead nurse of immunizations to enquire about her 
contact in this same school and I found out that the contact was the same person - the 
Assistant Principal. The lead nurse offered to help me and to write to the Assistant 
Principal to inform her that I worked very closely with the nurses for the first part of my 
research. The lead nurse tried to get her permission to let me come to the school. A 
month later, after I and my supervisor’s secretary had sent several reminder emails and 
made phone calls, the Assistant Principal contacted me and agreed to her school 
participating in my study. I met with her and advised her to give the information sheets 
and the consent forms to 25 girls and their parents as she could expect to get about half 
returned consent forms with parental permission, In May, she got 11 forms with 
parental consent and then she scheduled the interviews with the girls. She accepted to be 
interviewed as well because she was the teacher in charge of the organization of HPV 
vaccination in the school.   
 
In mid-April another two schools gave a positive response to my invitation, one being 
the smallest secondary school in the city and the other one being a girls’ school with the 
biggest cohort of year 8 girls. In the former school, I liaised with the Safeguarding & 
Social Inclusion Manager who put me in contact with the Office Manager of the School 
Reception. The Manager of Reception was the coordinator of HPV vaccination in that 
school. She supervised School Reception staff that distributed my documentation to the 
girls and chased up the consent forms. In addition, she welcomed the opportunity to take 
part in an interview for my research. Within a week, only three year 8 girls got parental 
consent to participate in my research study and the Manager of Reception arranged for 
me to conduct interviews with them.  
In the other school, the Assistant Head teacher answered my invitation announcing that 
her school gave support to my research. She introduced me to the head of year 8 who 
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handed out my information to the students at the time of the third round of HPV 
vaccination. After a month, the Assistant Head teacher informed me that the girls were 
keen but the parents did not agree to my request. However, I was able to interview the 
head of year 8 in June 2013.  
 
In total, I interviewed four school staff. This was because in each school one person was 
the coordinator of the organization of the HPV programme. 
 
I contacted these two schools again in September 2013 hoping that the parents of a new 
cohort of year 8 girls would consent for their daughters to be interviewed. I told my 
contacts that by that time I had interviewed successfully around 10 girls/school in 
another two schools in the city (giving the name of the schools) to encourage them to 
recruit. Then, I was able to interview seven more girls in one school (the smallest one) 
and four girls in the other school (girls’ school) in October 2013 after the first round of 
HPV vaccination.  
My contacts collected all the consent forms and kept them in the schools until the time I 
organized the interviews. 
 
As planned in the research design, these young girls came from a variety of different 
backgrounds. The girls were selected from different Houses in the school. The year 8 
girls sampled in each school are presented in Table 1 in Appendix 24. 
 
7. 2. 2. 2. 2. Interviews with 34 girls in schools 
I conducted interviews at different hours during the day when the girls were taken from 
classes. 
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All interviews in this research project were carried out within the school in a quiet 
meeting room. It may be argued that because the interviews took place within a school 
setting I perhaps would have had different data had I conducted the interviews in an out-
of school setting. In a school, the researcher has to pay particular attention to the setting 
of the interview to establish a comfortable space where children feel that they are 
welcome (Punch, 2002; Freeman and Mathison, 2009). I welcomed each girl offering 
biscuits at the beginning of interview. I tried to make the interview context informal and 
conversational with open-ended questions (Watt, 2007). Open ended questions are 
better to be used before the topic of researcher’s interest because the children become 
comfortable when they discuss what is familiar to them (Freeman and Mathison, 2009). 
 
I established the rapport gradually making initial conversation on non-threatening issues 
(Winter, 2011) and introducing myself as a student at the University of Warwick. I tried 
to get them to talk to me by asking easy to answer questions, such as "What lesson are 
you missing? Do you like literature? What are you learning about Shakespeare? Why 
are you interested in social care? Do you like Indian movies?” Also, I picked up on their 
watch/bag/earrings or something else to talk about. Children were used to a range of 
adults being in their school (e.g. bank nurses). My interaction with the girls was helped 
by the completed non-participant observations in November 2012. During the initial 
conversation, I advised them how to keep the audio recorder in their hand to get a clear 
recording and to help me monitor it if it was working properly. Additional items were 
included during the interview process with the girls guided by emergent findings such 
as own decision related to HPV vaccine, knowledge about cervical cancer and others’ 
influences in their own uptake of HPV vaccine.  
I built successful rapport with all 34 girls listening to them with non-verbal responses 
(Winter, 2011) mostly a smile (Kyronlampi-Kylmanen and Maatta, 2011).   
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At the beginning of each interview, the project was carefully explained to the students 
and I made sure that they had understood what it was about. The girls who agreed to 
participate to individual interviews and who had their parent’s consent to participate to 
individual interviews received a participant information sheet again on the day of 
interview when I went through it to explain to the girls the purpose of the study, what an 
interview involved, that their participation was voluntary, that they had the right to 
withdraw at any time, the principles of confidentiality and anonymity. I used age-
appropriate and understandable language for girls aged 12-13 years. I invited them to 
ask me any questions they might have had related to the research. 
 
Each interview lasted between 30 minutes – 1 hour. All girls were taken from lessons. 
An audio recorder was used to record all interviews with the nurses, the girls and the 
teachers. Before beginning the interview, the interviewees were furthermore asked 
whether they felt comfortable with me audio-recording the interview. All participants 
gave signed consent to the audiotaping.  
 
7. 2. 3. Reflexivity 
Qualitative research includes reflection on researcher’s subjectivity and positionality. 
Reflexivity is important in data analysis (Mauthner and Doucet, 2003) because it adds 
credibility to qualitative research (Dowling, 2006). This issue will be revisited in 
Chapter 8 in the section “Strengths of qualitative study”. Reflexivity is a process of 
conscious self-reflection on the influence of researcher’s role or title (positionality) and 
researcher’s characteristics (subjectivity) on data collection. I reflected on several 
issues. One aspect is how my decisions influenced data collection (i.e., the choice and 
implementation of study methods in research with children (Powell, 2011)). Also, I 
reflected on the influence of the social setting of the research (school), on the wider 
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social and political context of data collection (Hennink et al., 2011) as well as on ethnic 
difference between the participants (children) and me. 
 
As a novice qualitative researcher, I recognized that I was affected by being in the field 
(school environment) and that I could have had an effect on the subjects of study 
(Dowling, 2006). I am a public health specialist physician and I interviewed nurses, 
teachers and girls who may have reacted in a socially desirable way owing to my status 
as a doctor. Therefore, during interviews with nurses and teachers I took steps to 
primarily identify myself as a student and although a physician I emphasised that I was 
familiarising myself with the UK setting. During interviews with the girls, I introduced 
myself only as a student trying to give them the impression that I had a similar status as 
them with the only difference that I was a student at University. At the beginning of the 
interview, I explained to them that I wanted to learn from them about their experiences 
with HPV vaccination with the purpose to convince them that I was a student. If I had 
introduced myself as a doctor to the girls, it may be that they would have felt 
uncomfortable when we discussed medical issues like cervical cancer. I made clear to 
them the point that I was not a teacher and that our interview was not an exam to give 
them a mark for their answers. Although I was a visitor in the school and I could not 
arrange the place of interview, the discussions with the girls took place in meeting 
rooms available for use by staff, which were different from a classroom. I believe that 
the environment supported to some extent my message to the girls that the interview 
was not going to be an exam. There was an age difference between the girls whom I 
interviewed and me. Power is a major issue in undertaking research with children 
because it is considered that adults have more power than children (Powell, 2011). 
Reflexivity could redress power imbalances encouraging the researcher to consider 
personal assumptions and how these impact on the study and on participants (Powell, 
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2011). The researcher’s role as non-authoritarian adult could facilitate children’s 
participation in research (Powell, 2011). Therefore, I tried to make the interviews 
resemble an everyday conversation as much as possible (Kyronlampi-Kylmanen and 
Maatta, 2011). To make easier for the girls to engage in the discussion and to maintain 
their enjoyment throughout the interview I displayed each question from the topic guide 
on a separate laminated paper with famous cartoon characters. I was unknown to all the 
girls at the time of interviews. However, I developed a trustful relationship with each of 
them because the school staff (the coordinator of HPV vaccine programme in the 
school) introduced me to the girls on the day of each interview. In addition, being a 
female researcher could have made the girls feel more comfortable in contributing to the 
discussion (Hopkins, 2007). 
 
My country of birth and ethnicity were different from those of all participants. Some 
researchers consider that this aspect could be beneficial to the information gained in the 
interview. For example, it is likely that the participants could have described the 
discussion issues to me in greater detail than to a similar moderator of British 
background (Hopkins, 2007). Being an interviewer with differing characteristics to 
participants gave me the opportunity to ask for clarifications or explanations. 
 
7. 2. 4. Procedures to minimize possible researcher effect and 
researcher bias 
 
Semi-structured individual interviews were used to minimize the influence of my own 
views on the quality of information obtained during an interview. During the interview, 
I used a topic guide with probes to obtain an adequate answer to understand 
participants’ perspectives (See Appendix 21). It also helped me to give voice to the 
participants and not to talk much in the conversation. Recording the interviews helped 
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me to get feedback on my performance from my supervisor after the first interviews. In 
order to avoid bias from interviewer performance, I planned three pilot interviews 
before the fieldwork: two pilot interviews with year 8 girls and one interview with a 
nurse. In order to avoid bias from interviewer characteristics, I controlled behavior, 
mannerisms, my appearance and voice. I read literature on effective communication 
with children before the fieldwork (Winter, 2011, pp. 74-95). I used my interpersonal 
skills to enable children feel safe, without fear of rejection or judgement (Winter, 2011, 
pp. 25-36).  
 
7. 2. 5. Thematic analysis  
Research question 3 
What are the mechanisms, strategies and practices that influence uptake of HPV 
vaccine? 
 
7. 2. 5. 1. Data management 
I transcribed half of the interviews and the other half were transcribed by a professional 
transcriber since transcription takes a long time and English is not my mother tongue so 
that my transcriptions were incomplete. I used thematic analysis (Braun & Clarke 
thematic analysis model) because it is inductive allowing categories to emerge from 
data (Saldaña, 2009) and also for the reason that I was a novice researcher. The field 
notes and the interview transcripts were coded in relation to research question  reading 
and re-reading the material and asking myself questions about  the data (Coffey and 
Atkinson, 1996) to search for patterns of meaning through a semantic approach (Braun 
and Clarke, 2006). I started with very open codes doing line by line analysis which 
involved close examination of data phrase by phrase (Corbin and Strauss, 2008). I used 
an inductive approach by not engaging with literature at those early stages of the 
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analysis (Braun and Clarke, 2006). An individual extract of data (identifying a feature) 
was coded across the entire data set (Braun and Clarke, 2006). I attached only one code 
to a segment of data (Coffey and Atkinson, 1996). As a beginner qualitative researcher, 
I used descriptive coding summarizing in a word or short phrase the topic discussed in a 
segment of data. Also, I used in vivo coding referring to a term used by young 
interviewees (Corbin and Strauss, 2008) (Saldaña, 2009). The data was reorganized 
according to the ideas that were obtained throughout the process of coding. Further, all 
data extracts relevant to each code were then collated (Braun and Clarke, 2006). All 
interviews with nurses, teachers, and girls represented the whole dataset. I coded 
separately the interviews for each group of participants (nurses, teachers, and girls). The 
codes were entered into NVivo 10 as free nodes in three different folders. I got 79 codes 
from the interviews with nurses, teachers, and girls that I organized in 9 categories 
which I synthesized in three major themes (Saldaña, 2009) (Table 1in Appendix 25). 
The number of the categories reflected the nuances in the data (Powell and Renner, 
2003).  
 
To make sense of the data, I analyzed the content of each code and I considered 
differences, similarities and patterns in what the participants said and did using the 
OSOP technique (one sheet of paper). This method involved reading each code and 
writing down on a single sheet of paper the key ideas expressed within a code along 
with the relevant respondent IDs. In this way I obtained a summary of all the issues for 
each code (Bussche et al., 2010; Ziebland and McPherson, 2006). All categories were 
emergent categories which I defined after I worked with the data (Powell and Renner, 
2003). Then, I formed overarching themes which were based on ideas brought up by the 
people in the interviews and on concepts which I developed during data analysis 
(Saldaña, 2009). I discussed the identified themes with my supervisor. 
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I conducted an interpretative analysis for each theme (Braun and Clarke, 2006) based on 
these relationships (Coffey and Atkinson, 1996). To show which categories appeared 
more important within a theme I used a visual model (tree map) in NVivo. Overall, I did 
a rich thematic description of my entire data set (Braun and Clarke, 2006) (including 
field notes from observations as well as interviews) to explain the phenomenon under 
my study (Corbin and Strauss, 2008).  
 
7. 3. Results 
This section presents the analysis of the qualitative data comprising nine interviews with 
health professionals, four interviews with school staff and 34 interviews with girls 
attending the secondary schools in year 8. The first section addresses the research 
question related to the mechanisms and strategies that influence uptake of HPV vaccine 
on the way in which the delivery of the vaccination was organized in the schools. The 
second section is an analysis of factors facilitating uptake of the vaccine and the third 
section is an analysis of the barriers to uptake. These last two sections address the 
research question related to factors and practices affecting the uptake of HPV vaccine.  
 
7. 3. 1. Theme 1 - Analysis of delivery of HPV immunization 
in the schools to girls  
 
This first section of the findings chapter is an analysis of the school context for the 
implementation of the HPV vaccine programme in secondary schools in the city of 
study. It starts with an analysis of how the programme ran in the city of study according 
to the understandings of the health professionals involved, followed by an analysis of 
the reflections of secondary school staff who organized and delivered the HPV vaccine 
supplemented by fieldwork observations. Subsequently, the analysis focuses on the 
organization of delivery of HPV vaccination programme in the schools before and on 
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the day of vaccination. Also, it describes the way in which the HPV vaccine has been 
promoted in schools.  
 
A school-based HPV vaccination programme  
The HPV immunisation programme in the UK is part of the national adolescent 
vaccination schedule and it is mainly a school-based programme. In the city of study, a 
highly skilled and well trained team of bank nurses has provided HPV vaccinations to 
pre-adolescent and adolescent girls in secondary schools since 2008. When I asked the 
nurses if GPs have been involved in the HPV immunizations, an immunization nurse 
stated that the GP involvement was related to the fact that HPV immunization is a three-
dose vaccination schedule and that  
“When they [GPs] need to do it privately they send them [the girls] to us. They [GPs] 
need to really because is a three part immunization. They don’t know what the child 
already had.” [Nurse 8]  
 
According to the interviewees, the delivery of the HPV vaccination programme through 
a team of nurses was adopted for several reasons. One of the reasons was the issue of 
local data management. A few nurses said that the information from the consent forms 
is entered manually into the child health information system and then “that information 
is passed on to the GP” [Nurse 4].  However, it was felt that the information system is 
set up in such a way that the communication between the child health services and the 
GPs was difficult as described by one of the nurses in the following quote: 
“...the paper work going between practice and child health isn’t very robust…it takes 
long time, it takes a year. So they [GPs] will have that information to the end of August 
of all the girls who have been immunized. In the future when their information system 
links up that would be great because they will get the information automatically. So it’s 
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not going to be a problem. But until that happens, it’s an issue. So you can end up with 
kids that are over immunized and things. It needs to be controlled by one area really.” 
[Nurse 8]  
 
Another reason given by the same nurse was related to cost effectiveness of employing 
bank nurses by the hour.  
“It’s just a way the team was set up initially because that was going to be, like a couple 
of hours here and there and everywhere. It is more cost-effective just to employ nurses 
specifically, to target them at the time when you need them. That’s why it was set up 
that way.” [Nurse 8] 
 
It was thought that a mobile clinic strategy could increase the uptake of the HPV 
vaccine based on experiences with the provision of flu vaccine in hospitals: 
“Going into school and going to the girls is much better way of doing it. If you have a 
programme where people actually make the effort and go themselves...lots of them 
won’t do it…whereas if you take it to them, the uptake is going to be a lot…I mean, I 
found this with doing flu vaccines in the hospital …normally that’s what they do…well, 
is here...you come and get it if you want it and some people do, but  a lot don’t…in the 
year with swine flu we went to them…That uptake was a loads more just because you 
actually took it to them and is amazing what a difference it makes.” [Nurse 2] 
  
7. 3. 1. 1. School policy and HPV vaccine 
 I asked the nurses about school policy in relation to HPV vaccination as a school-based 
programme. The nurses felt that most of the schools have supported and helped the 
delivery of the HPV vaccine programme.  
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“The majority are really good….are very welcoming, very accommodating and 
friendly…The majority are really, really helpful and really want to try and do their 
utmost to help us because, you know, we realise as well that this is an extra added role 
for them, although obviously for us it’s our priority.” [Nurse 9] 
 
The staff involved in facilitating and organizing the HPV vaccination in their schools 
showed that acceptance of this programme was high and they “took it on board 
straightaway.” [School staff 36, School 9]   
For example, an administrative staff member in one school said that both the Head 
teacher and the staff supported the delivery of the HPV vaccination:  
“the Head would make that decision… The Head [thought that] they [the girls] have 
just got to have their injection, that's important. It doesn’t disrupt for long, it’s 
something that happens, it goes on, the children are fine, and just get on with it. As a 
staff, we all agree that it is a good thing for the girls to have, if it will prevent people 
dying of something like that.” [Support staff 20, School28 14] 
 
The faith based schools also delivered the HPV vaccination programme. A teacher in a 
Catholic school described the involvement of staff and governors in decision-making 
process about the HPV vaccine programme in the school since 2008.  
 
“Our policy is that we do we support it and we offer the vaccination here in school. As 
long as we’re doing it in accordance with the Catholic Church, then we carry on and 
we do it. Our Church leaders support it and they back the idea. Being a Catholic school 
we had to be very careful and very sensitive the very first time. Everybody had questions 
about it, not just the girls themselves; you know...the staff, the governors….. Once 
                                                          
28
 The number of the school in qualitative analysis is different than the number in quantitative analysis. 
The correspondence of the schools in the two studies is presented in Appendix 26 
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everybody understood what it was, then we hadn’t any problem at all. There were a lot 
of misconceptions at the very beginning. Once we found out these were misconceptions 
then it was fine.” [Teacher 19, School 6] 
 
I would seem that each school organizes the delivery separately as a support staff said: 
“We don't talk to anybody else about how they do it.  Everybody has got their own way 
of doing it.” [Support staff 20, School 14] 
 
The goal of school policy is “to have all the girls vaccinated. We try to drag as many 
people through it as possible.” [Teacher 33, School 7]. In order to achieve that goal, the 
schools encourage the parents and the girls to make a decision about the HPV vaccine 
but only the girls with parental consent are vaccinated as exemplified by the following 
quotation:   
  
“It is not in our policy that they have to have it done, that is up to their parents to 
decide. We just encourage it and support it really”. [School staff 36, School 9] 
 
“We can say that it’s part of Government policy, now it’s National Health Service 
policy and that we, as a school, are the vehicle really. We don’t decide who has it, we 
don’t decide what it is, it’s offered to year 8 girls, we don’t pay for it, we don’t do any 
of that.  It’s the Health Service administering in school as it is merely the easiest, most 
practical way of administering it to the girls of that age.” [Teacher 33, School 7] 
 
This quote clearly shows that the schools do not decide whether the girls receive the 
HPV vaccine. The schools represent a location where HPV vaccine programme is 
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delivered to the girls, but administratively handled by the NHS staff and the Local 
Authority.  
 
Although the majority of schools have been in favor of the HPV immunization, the 
attitude has varied across the schools with some being more helpful than others. “I feel 
that we go in there and this is a bit of a nuisance really and they’ve got to find staff to 
help on that session and they’ve got to find us a location. So there are a couple of 
schools that I do feel that we’re classed as a bit of a nuisance really.”  [Nurse 9]  
 
One of the nurses felt also that: 
“Some of them are really keen and really helpful and some of them you can tell they are 
not really. They think it is all a bit of a pain. They don’t really want to do it but because 
is Local Authority they do it, they have to.” [Nurse 2] 
 
 Another nurse suggested that factors that affect the approach within a school may be 
the time needed to organize the delivery of the HPV vaccination programme in an 
already crowded school curriculum.  
 
“I think generally they are quite good, but I think for the schools is very difficult 
because of their short of time and education is their priority so it can be quite 
difficult…for them to make time for us to come in because they have to fit it with what’s 
going on within their curriculum as well and sometimes I do feel that perhaps …we are 
educating the children as long as we are looking for their health but I think sometimes 
they think…it is a separate thing and we shouldn’t always necessarily be coming into 
schools to give the vaccinations…but most of the time we’ve been able to do it.” [Nurse 
3]  
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The view of the teacher below clearly shows that in her school the vaccination 
programme is seen as a medical service and that the confidentiality of girls’ 
immunization status is respected:  
 
“We don’t keep a record of who has and who hasn’t been vaccinated, because it’s a 
medical issue which is really private in terms of vaccination, it’s not anything that is 
likely to impact upon them in school.” [Teacher 33, School 7] 
 
In the city of study, there are five faith schools: three Catholic, one Church of England 
and one Muslim. The nurses expressed the view that sometimes it has been more 
difficult to go to some of the faith schools in comparison to others because, in some 
cases, the schools with religious affiliation “are a bit anxious to be vaccinating girls or 
not.” [Nurse 5]  
 
One of the nurses gave an example, saying that liaising with one of the Catholic schools 
has been difficult. This school has not provided them with the girls’ names and 
addresses for the reason that it “is not covered on the Data Protection.” [Nurse 8] The 
nurse said that this has affected their communication with the parents when they needed 
to send them a letter to offer a clinic appointment in case their daughters missed the 
vaccination in the school. The following quote illustrates her point: 
 
“That’s their [schools’] decision not to give out that information that’s fine, but then we 
need them [teachers] to be the ones to make the contact for us [nurses] then to the 
parents. If it is a case that the child hasn’t taken the form home, how are these parents 
ever going to know that this child should have had their vaccination and their form and 
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everything? And I don’t think our percentage at that school is particularly good.  No, 
it’s sort of, that school has got a 5% to 10% lower uptake than generally the others.” 
[Nurse 9]   
 
All nurses explained to me that only a small private Muslim school has entirely rejected 
the HPV vaccination and has not allowed them to enter that school since 2008. One of 
the nurses made clear that the school’s refusal could be due to the link between HPV 
vaccine and the prevention of a sexually transmitted disease: 
 
“From the discussion with our manager there is one school that’s the Muslim school 
and they [staff] are not happy for us to go in and as far as I am aware this is the only 
secondary school in the city where we hadn’t had access to those girls which I think is 
terrible personally to deny them choice. It’s not right. I am sure is sex thing. It’s 
because we’re protecting them against what essentially is a sexually transmitted 
infection.” [Nurse 5]   
  
Another nurse thought that the parental refusal for HPV vaccination influenced that 
school’s decision to restrict the nurses’ access to the school. “There it wasn’t the 
[Muslim] school, it was the parents. We have since been in this school giving leaver 
boosters so it’s not particularly vaccination that they are against, it’s this particular 
vaccine” [Nurse 4] “because the subject [HPV vaccine] is quite controversial.” [Nurse 
3] Another   nurse mentioned that, “They [school staff] always say ‘We’ve asked and 
nobody wanted the vaccination.’ ” [Nurse 8]  
 
The nurses have not known for sure if the Muslim school informed the parents about the 
HPV vaccine.  
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“We don’t really know. We just get their word that they sent out the forms. You can’t be 
really sure but you would imagine they did do. It’s a very small school with a small 
number of girls so you can only take it on trust that the forms did go out, but you 
haven’t a real proof.” [Nurse 4] 
 
7. 3. 1. 2. Organization of delivery of HPV vaccination programme 
7. 3. 1. 2. 1.  Liaising with the school 
There were variations in the delivery of the HPV vaccination programme across the 
schools. The nurses agreed that the HPV vaccination increased schools’ workload. 
Therefore, it appeared that “some [schools] are better in organization than others.” 
[Nurse 7]  
Before the beginning of an academic year, the nurse immunization coordinators liaised 
with the school sending a letter to the Head Teacher. Further, the nurse coordinators 
worked with a contact in each school who was organising the administration of the HPV 
vaccine in addition as part of their job in the school. 
This contact person “varies from school to school.  With some schools, it’s 
administration [school name] for example and some schools [name], it’s teachers.  A 
lot of schools usually allocate the year 8 manager, the year 8 head as the contact 
person because obviously, they know that whole year group hopefully, so yes, it varies.  
It’s based on whoever has been allocated to do it really.” [Nurse 9] 
 
The nurse coordinators liaised with the contacts in the schools before the 
commencement of the new school year to discuss the programme for the coming year, 
to arrange three dates for vaccination sessions and to ask for a suitable room to ensure 
the programme was accommodated within the school calendar year. This 
communication is illustrated by the following two quotes:  
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 “They [nurses] usually contact me early in the autumn term….. The nurses contact me 
and they say ‘we’d like to do your vaccinations between these dates’…They’ll give me a 
choice of dates…and then, we’ll agree the three dates for the year.” [Teacher 33, 
School 7] 
 
“When we first make contact we get three dates off them so that we can facilitate the 
rooms on one day, sort it out on the first day, so that those rooms are then free for 
future.” [School staff 36, School 9] 
 
A nurse described the process of communication with the contact person in each school 
to get information about the number of eligible girls so they can prepare an appropriate 
number of information packs per school to be given to the girls and their parents. The 
following quote highlights the importance of the return of consent forms to the schools 
whether the parents accept or refuse the vaccination. 
“Before the end of the academic year we’ll ask schools for their estimated coming roll 
for the next year…. then we’ll send that appropriate number of packs out to the school 
and that’s got a consent form in it, an information letter, which has been devised by us 
as a team and public health and an information leaflet. So then, I drop them to the 
school and I ask that every girl in year 8 receives that pack to take home for the parents 
to read all the information, make a decision, fill out the consent form and return it to the 
school. Whether their decision is a ‘yes’ or a ‘no’, a signed consent form is expected 
back for every girl in the school.” [Nurse 9] 
 
The information packs including NHS standardised materials (a leaflet and a consent 
form) are given to schools at the beginning of the academic year in September two or 
three weeks before the first HPV vaccination sessions. The nurse coordinators rely on 
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schools to distribute them to girls and their parents. The schools have used two ways to 
send the packs to the parents either via girls or by post. One of the nurses pointed to the 
disadvantages of one way compared to the other: 
“The senior members of our team decide that…they go on how it worked out previously, 
what the uptakes were liked …they do communicate with each other and with the school 
to work out the best way really…I’ve seen actually both ways…sometimes if you give it 
to the pupils it does not always get home ...sometimes if you send it directly to the home 
address …some families may have moved or it’s not always the right address.” [Nurse 
3]  
 
Most of the schools preferred to distribute the packs via girls because posting them cost 
money. The administrative staff stated that her school chose to “send them out by post” 
and she explained the reason why: 
“I mean I could give them to the girls but I always think they are not going to get there, 
you know, a lot of the girls won't give them to their parents if I give them it by hand.” 
[Support staff 20, School 14]  
 
The coordinators of HPV vaccination in the schools plan the time and the place of the 
sessions in such a way so as not to disrupt teachers’ classes, using previous experience 
with the organization of other vaccinations done in the school. “We used to do the TB 
ones before, so you sort of know what to do and you know what to expect…I will check 
the calendar and I will speak to staff or I will perhaps email. Science, maths and 
English don't like us to interrupt their classes because they are core subjects so I will 
try and avoid those classes - do it before break ...or before lunch…I just put a general 
email out to everybody ‘if you've got any objections let me know’”.  [Support staff 20, 
School 14]  
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In another school, a teacher explained how she decided on suitable vaccination dates, 
avoiding holidays and other days when important activities take place in the school: 
“We have to make sure it’s not a training day, that they’re [girls are] all going to be in 
school. For example, it’s not in a holiday obviously, there’s nothing major going on that 
day which is likely to prevent them from having the vaccination. We wouldn’t do a 
vaccination programme on a day when we’ve got something else of significance going 
on really, which is going to involve our use of space. We need to make sure that that a 
[room is] free at that time...” [Teacher 33, School 7] 
 
A nurse pointed out, as the teacher above, that one of the logistical challenges for the 
HPV vaccination administration in schools is to allocate a suitable room for sessions. 
Another teacher mentioned that, “getting the forms out is not a problem, it is trying to 
get a room. Obviously we have not got nursing rooms, we have to use classrooms. So it 
is making sure that timetables are sorted so that we have got rooms free.” [School staff 
36, School 9] 
My observations showed that schools used different spaces such as a canteen, the staff 
room, a meeting room, a classroom, the gym hall, the kitchen, the prayer room.   
 
The organization of the HPV vaccination required teamwork. A teacher stated that “It is 
an effort…It is not just me, I oversee it and I make the process happen, but other people 
are involved in it…” [Teacher 33, School 7]  
 
One of the coordinator’s tasks is to allocate staff to provide the girls and the parents 
with the information packs as well as to chase up consent forms that are not returned by 
a specified date. The tutors predominantly assumed the responsibility of disseminating 
the packs to the girls.  
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As one coordinating teacher said, “The timing of when you actually send the forms 
home is really important, because if you send it home too early, it will just be lost.  If 
you send it home quite late on, you don’t give yourself enough time to chase up. They 
[parents] don’t, they will take their time and they’ll wait to be nagged…It’s a bit like 
paying on the red reminder, isn’t it? You always wait until the last minute, they [school 
staff] do a lot of chasing, a lot of talking to parents…It is my job to make sure that they 
have a timeline and so forth which enables them to do that…” [Teacher 33, School 7]  
 
In one school, the teachers chased the parents for the forms and “asked to have them 
back at least a good two [weeks]” before the vaccination date to be able to “…chase 
any that are missing.” [School staff 36, School 9] Chasing up the forms meant 
sometimes calling the parents. One of the teachers described how resource intensive and 
time consuming this process was in her school. If “nurses will say ‘yes, we’ll accept 
verbal consent from the parent’… [then] the parents are phoned….We’ll keep doing it 
until, as I say, even on the day of the vaccination.” [Teacher 33, School 7] 
 
These quotes show that there were repeated attempts in different ways to obtain the 
signed consent forms and that different staff members took on this responsibility. The 
forms were sent out to the parents with an information pack, and then until the day of 
vaccination the parents were phoned by the teachers to remind them to sign. After that, 
on the day of the vaccination they were phoned again by the teachers or other school 
staff to obtain a verbal consent. The nurse coordinators explained that chasing up the 
forms is an essential strategy for a high HPV vaccine uptake. Their opinion is illustrated 
in the two quotes below. 
“…You do find some schools…allocate more help than other...ones that don’t allocate 
help or don’t want specific person responsible to help with the programme have a lower 
231 
  
uptake...that’s because they don’t have people that will chase the forms and make sure 
that they come back in.” [Nurse 8] 
 
“but by and large, the majority of schools are really good and really help, like chasing 
the forms and you can tell  the schools are really very proactive and are very 
encouraging with the vaccine because that’s when our uptake is really good, because 
they will chase the girls to get the forms back in. ” [Nurse 9] 
 
The “consent is obtained once for all three doses.” [Nurse 1] The organizers of the 
programme in the schools collect all the consent forms and they give them to the nurse 
coordinator at the first vaccination sessions. From that time on, the nurse coordinator 
administers the forms during and between the subsequent vaccination sessions to follow 
up the girls who did not return the forms and to identify those who are absent on the 
day.  
“We ask for a roll from the school; a list of all the girls on that roll, so when we then 
arrive at the school for the first HPV session the forms will have been collected back in 
the school.  We ask them to be put back into the folder in an alphabetical order, which 
we’ve always done and then from there, then we’ll mark off on the roll that we’ve been 
given.” [Nurse 9] 
 
The organizers of HPV vaccination showed that the schools have adopted different 
approaches related to the announcement of the date when the HPV vaccination takes 
place. One teacher said that in her school the staff members do not make known the day 
of the vaccination to the students to avoid their absenteeism.  
“We never tell the girls when the vaccination is going to be. Some of them might make 
an excuse and not come to school, they’ll ‘say ‘I’m not going to school, I don’t feel very 
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well today mum’. But also we don’t want parents keeping them off either, for whatever 
reason.” [Teacher 33, School 7]  
 
Another school had a contrasting approach to this issue. The school staff member stated 
that it was good “to tell them the day before so that they are not asking questions or 
they are not trying to skip school, to miss it.” [School staff 36, School 9] 
 
Before the vaccination day, the teachers need to overcome the challenges of providing 
explanations to motivate the girls to get the vaccine and to reassure them “that they had 
injections [before]… and [these three jabs are] no different.” [School staff 36, School 
9]  
The school staff plays an important role in making the girls understand the potential 
benefits of HPV vaccine. In one school, the teacher explained that the tutors initiated 
conversations with the girls to support them in understanding the HPV vaccine and to 
persuade them to return the consent forms. She said:  
 
“The tutor will give the forms out to the girls and will tell them that that’s what it is. 
And then when they’re asking for the forms to come back, if the girls bring them back 
automatically, fine, thank you very much. If they’re finding that girls aren’t bringing 
them back, then they would speak to them individually…about it [HPV vaccine] and 
answer questions that they might have or any concerns they might have…Those that 
they have to chase up to return the forms are the ones who tend to get most of the 
conversations...it’s reactive rather than proactive in terms of them having a 
conversation with them….So they might say, call them over and say ‘I need your form’, 
‘why haven’t you returned the form?’  And they might say ‘I don’t know whether I want 
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it or not’.  ‘Why don’t you want it?  Do you understand what it is?  Yes?’.” [Teacher 33, 
School 7] 
 
The same teacher described how the school staff made the girls aware of the importance 
of the vaccine if they have not brought back a signed form:  
 
“We’ll talk to the girl: ‘you’ve not got a form, you know this is a really important 
vaccination, it’s important for your health.  It doesn’t mean that you’re going to be 
sexually promiscuous, it doesn’t mean anything like that, it’s not a protection against 
pregnancy, it’s nothing like that, but it will protect you …Do you want it?’.” [Teacher 
33, School 7]  
These two quotes cited above clearly indicate that, apart from making the girls 
understand the benefits of the vaccination, the teachers tried to get the cooperation of 
the girls not telling them what day it will be on as well as persuading them to accept it. 
Persuasion in social science is defined as a type of influence with the purpose to create a 
positive result without threat or willingness to harm. It is a psychological process based 
on the transmission of a message that, according to these quotes, was verbal (Powers, 
2007). Persuasive conversations between a teacher and each individual girl who did not 
return the form might have increased the likelihood of persuasion because of face to 
face communication and the credibility and the trustworthiness (Powers, 2007) of 
school staff as illustrated in the following quote: 
 
 One teacher explained that the girls in her school are “…able to trust the people that 
are around them” because the teachers “…have a lot of contact with the students before 
they join [school name].” [Teacher 19, School 6] 
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The staff expressed the view that the schools have good communication with the 
parents. A teacher affirmed, “We stay with them [girls] from year seven right through to 
year eleven so we get to know the parents quite well or most of them.”[School staff 36, 
School 9] Another teacher explained, “We’re a school which does communicate a lot 
with parents and I think parents generally feel quite comfortable about approaching us 
as a school.” [Teacher 33, School 7]  
 
The teachers may exert influence in helping the parents to decide about the vaccination 
of their daughter.  
 
“It’s about talking to the mum, getting the mum on your side and then getting the mum 
to reassure the child…we are not saying ‘you have to, your daughter doesn’t have to 
have it’, we are just saying ‘it’s a good idea’” and usually they will say ‘Oh yes, go on, 
they [girls] will have it’.” [Support staff 20, School 14]  
When parents are unwilling for their daughters to have the vaccination, school staff 
seemed to respect this, but had additional strategies and suggestions which showed their 
commitment to obtaining consent from parents. 
 
Although “we have to respect their decision obviously” [Teacher 33, School 7],  
“We encourage them even after they said ‘no’…at least to speak to their nurses at their 
own surgeries to see if there is any way [to have it].” [Teacher 19, School 6] 
“If they are still adamant then I will have passed it back to the vaccination team.” 
[School staff 36, School 9] 
 
The school staff contacts the parents, especially the mothers, and take different 
approaches getting across how important it is for them to agree to their child having the 
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injection in the school or at the community clinic.  The following excerpt from an 
interview is an example of the way in which a teacher gives explanations to parents 
about the vaccination when they phone them up if they have not agreed on the consent. 
 
“I would say that many girls all over the country have it, it is considered to be very 
important, it is a protection, it is free of charge if you have it done at this age.  If you 
want it later on in life, it’s going to cost money.  You can have it at the clinic if not in 
school, but it’s much better if your daughter has it when everybody else is having it in 
school.  So I’d talk more about the practicalities of it.  
We just say that anybody can contract cancer of the cervix and it’s not to do with 
promiscuity, it is something which is particularly prevalent in younger women and if it 
is not treated and identified very early on, then it can be fatal and it usually is fatal if it 
is not treated very early on.   Like any cancer treatment, the treatment is not pleasant 
and it has its side effects and prevention is better than cure.  So if you can prevent it in 
the first place, then it’s much better to prevent it for the sake of a vaccination which is 
proven to have no side effects really.  That’s the line we take with them. We certainly, as 
a school, would encourage it as part of normal health care and healthy living.  And I 
say, one of my daughter’s has had it and I wish the other one had as well.  
Sometimes they [the parents] don’t appreciate how important it is and sometimes by 
talking to them the teacher can encourage them to have it, and sometimes they will say 
‘oh yes I didn’t realise, oh yes’, …. and then the form appears.  
I would not start talking about it actually preventing a sexually transmitted disease, 
sexually transmitted diseases do come in to the picture here.  Cervical cancer can be 
considered to be a sexually transmitted disease, but I wouldn’t go there because I don’t 
then want to be questioned further and further about it as something which I don’t know 
enough about.  I would not do that, because I’m not a scientist and I’m not a doctor and 
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I wouldn’t go on to say of course this vaccine does this and this vaccine does that and it 
has this effect on this and it has this effect on that.  I just wouldn’t go there. 
And also I’m not going to get involved in conversations which make any judgement at 
all on sexual activity.  When it comes to cultural issues, I obviously have my own 
thoughts and my own feelings personally, but professionally it is not my place to pass 
judgement on people’s religion. ” [Teacher 33, School 7] 
 
The quotations above suggest that on the ground of moral considerations the teachers 
used a persuasive strategy making persistent phone calls, as discussed earlier, and 
transmitting the message about the need of vaccination to parents to obtain their 
consent.  
 
7. 3. 1. 2. 2. The tasks on the day of the vaccination 
The organization of the vaccination on the day of the sessions involves effort, resources, 
and partnership working between the nurses and the school staff.  The nurse coordinator 
said, “It’s hard for all of us covering shifts…as long as we get a good number of bank 
staff we can usually fill that gap.” [Nurse 8] 
My observations showed that the vaccination team worked with a number of nurses 
which varied from six to ten influenced mostly by the size of the cohort of the eligible 
girls in a school as well as by the number of school staff allocated to support the 
delivery of the programme on the vaccination day. I noticed that the number of girls 
varied between 44 and 175 and that in general, two or three school staff helped the 
nurses.   
 
The HPV vaccination sessions increase the school’s workload on the day as well as the 
effort to manage them effectively. One teacher explained the workload:  “...you’ve got 
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to make sure that all the staff...their lessons aren’t being to be affected because of girls 
going out of the room to have the vaccination. But the effort put in is so important. It’s 
never ever seen as ‘Oh I don’t want to do this...it’s just annoying’. It’s important, it’s 
done and it’s done well. It’s a big effort and everybody is supportive of it. So for 
example, if one of my colleagues was free, she would happily take my lessons while I am 
supporting the girls. So everyone gets on board …we need staff there to support it. ” 
[Teacher 19, School 6]  
 
The senior nurse felt that allocation of different school staff every year can result in 
more work. She mentioned: “Once the staff know how the session works, it does go a lot 
more smoothly I find. But when you get different staff every time we go in to do a 
session and they don’t really know what they’re doing and they don’t know us and we 
don’t know them,that makes it a bit harder.”[Nurse 9] 
 
The school staff’s main responsibility on the day is to arrange the room and support the 
vaccination team as well as the girls. A teacher explained: “We make little private 
cubicles, we use quite tall boards to separate out six mini cubicles so they [the girls] 
have got the privacy that they need and each nurse has their own station and their table 
with their equipment on it….a chair for the girl, a chair for the nurse…you know there 
is a place to sit down afterwards and is all very controlled and comfortable.” 
[Teacher19, School 6]  
Another teacher added that it is required to “…have crash mats out ready and benches 
[for girls] to put their legs up on.” She also said, “We have got eight nurses…they are 
great on the day they come in…We get the tables ready for them, they set everything 
up.” [School staff 36, School 6] 
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The allocated staff on the day is different in each school and it could be Assistant Head 
Teachers, House Heads, Heads of year 8, support staff, and tutors. One teacher stated, 
“there is always [name] assistant head teacher, is always her secretary, is always one 
of us [House Heads] as well.  There is probably three teachers, but then you also have 
about four support staff, our teaching assistants as well.” [Teacher 19, School 6] 
At one school, only the support staff was involved in the process of coordination. “We 
are just there conveniently for the nurses to give the injections. We are there to support 
them, that's why we are called support staff and not administrative staff. We don't get 
involved, we are just doing as we are told basically. It won't be teachers, it is support 
staff so it will probably be three of us so maybe one in there and then there might be one 
that might need to make phone calls…there will be perhaps two [staff] monitoring the 
girls because they get louder.” [Support staff 20, School 14] Contacting the parents on 
the day of vaccination suggests staff’s persistent attempts to obtain verbal consent that 
could have limited parents’ right to freedom of vaccination choice. 
The school with the biggest cohort of year 8 girls allocated almost double number of 
staff. “We could have probably 16 different teachers in one day. If they are free… will 
come down and reassure them as well…because they know them, they see them every 
day. They are really good with them.” [Teacher 36, School 9] 
 
The schools accommodate the sessions in the morning during school hours. From my 
observations, it was clear that each session was planned to be two hours per school. One 
teacher explained how the time is managed: “They are split into seven or eight different 
classes in the day. So, we try and do four classes during period one which is an hour 
and then the other three or four classes, period two. We give them [teachers] probably 
about 15 minutes to get the small group done and then they start bringing the other 
classes down.  Eight girls are vaccinated at a time, so we get them done quite quickly so 
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then they go back to lessons. Sometimes it  runs over so it does mean that I have to look 
at their timetables, work out which classes they are in, let their teachers know, get their 
teachers to bring them down and take them back.”  [School staff 36, School 9]  
 
During the whole process, the coordinators of immunization have “to get them through 
as quick as we can and calmly as we can. It helps the nurses, everybody gets done much 
quicker then…We encourage them to go straight back to their lesson…so that we don't 
have like girls wandering around or not going to their lessons.” (Support staff 20, 
School 14] 
 
A nurse perceived that “some of them [schools] are better than others in the 
organization…sometimes is very quiet...just a few girls come in at a time...but in other 
schools they seem to bring the whole year down and it’s very noisy...and it’s not easy to 
concentrate or to get the child that you’re working with to concentrate because they are 
very interested in everybody watching them.” [Nurse 7] This quote indicates the 
importance to vaccinate in a quiet environment that facilitates the communication 
between the nurses and the girls.  
 
A school staff member explained the way the process is coordinated: “They [support 
staff] work in student reception so we get a list of the girls and they will organise the 
girls to come down in order so they might just choose class order or alphabetical 
order…The teachers know what is happening, they are all informed, so they are aware 
that the girls will be going out and coming back in. There is a student bulletin as well 
which we can put on messages for them and the staff will read that out in the morning.   
We are a small school, so there may only be 40/50 girls, we might get twenty down at a 
time and then they [nurses] usually do about five or six injections at a time. We just 
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have them queuing up waiting for their injection and it usually works quite well in the 
staff room because it is comfortable and it’s quiet and it’s cosy. There are sofas in there 
that they [girls] could rest on and we don't have so much panic in there. If they are 
really frightened we will try and get them in first so they haven't got so long to wait and 
worry.” [Support staff 20, School 14]  
 
The coordinators of the HPV vaccination in the school have a crucial role in 
“organising the practicalities of the vaccination” on the day. [Teacher 33, School 7] as 
well as managing the unexpected situations like “Panics about having it done…[which] 
delays things a little bit…The ones that are going to say ‘I don’t feel well and I want to 
go home’…we try to keep them in school as much as we can.” [School staff 36, School 
9]  
A school staff member said that “it’s not the actual cancer that they are worried about, 
it’s just the injection…There will always be somebody that over reacts and even just 
messing about will freak the others.” [Support staff 20, School 14]  
 
Another teacher described how fearful girls are if they are vaccinated before the others. 
“If they are really worried…we have got a certain amount of girls...we had about 15 
girls that were really scared about having their injections, so we get them first, we pull 
them down first so it is very quiet it is a very small group, so they have not everybody 
around, they have not got a whole class there.  And we just talk to them and just 
reassure them that it is in their best interests to have it done, that it is a little tiny needle 
it is not a great big needle,that it is over in a matter of seconds. So they are a lot better 
if we bring them down first.” [School staff 36, School 9] 
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The analysis showed that the school staff used different strategies to create a supportive 
environment and to encourage the girls to receive the injections. A school staff member 
indicated the type of emotional support which she used: “I will give them a cuddle, I 
will get them a drink of water if they are feeling sick, because I am first aid trained as 
well so I will keep an eye on the ones that are a little bit faint, so just again 
reassurance, being their mum for them.” [School staff 36, School 9]  
A nurse felt that the school staff adopted different ways to get the girls vaccinated. “The 
teacher will come up and say, ‘Look...’ you know, either being the nicey-nicey teacher 
and say, ‘Look, you can hold my hand,’ or be the firm teacher saying, ‘Come on, pull 
yourself together.’” [Nurse 9] 
 
One of the nurse coordinators emphasized that some girls “don’t want to have it in front 
of the friends because a lot of them might cry” [Nurse 8] which would affect the other 
girls.  
One of the nurses gave other two potential explanations for the barrier to vaccination in 
school. She said, “Probably the environment within the school could possibly be a bit 
awkward for some of the children because if they have medical problems they will not 
want to have their friends around them or the parents sometimes prefer to go to another 
place to have it done.” [Nurse 3]  
 
A teacher added another reason and she said that the girls who do not have parental 
consent cannot be vaccinated on the day. If such a thing occurs, “I won’t make that 
decision, the nurses have to make that decision obviously, because that’s a medical 
decision.” [Teacher 33, School 7] This quote shows once again that the teachers do not 
involve in decision making for vaccination of girls. 
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If the girls cannot be vaccinated in the school as well as “those who missed a scheduled 
immunization” [Nurse 8], the health professionals offer them another opportunity to be 
vaccinated and invite them to clinic. One of the nurses indicated that “we give them 
reminders…so we try and get a high consent…a high proportion of the forms back so 
we can vaccinate more pupils.” [Nurse 3] Her statement emphasizes the idea that 
reminders are used as a strategy to increase HPV vaccine uptake.  
 
Ethnicity may be a factor influencing uptake but this is speculation based on 
observations and nurses’ views. From observations and looking at the consent forms, I 
noticed that, apart from the girls with White ethnic background, Black and Indian girls 
were vaccinated also. I observed that there were girls with different religious beliefs 
such as Muslims, Sikh and Hindu who received the vaccine. For example, in one school 
almost half of the total vaccinated girls were Muslims (42 Muslim girls out of 97 girls). 
There could have been other girls with the same religions as those mentioned 
previously, whom I could not recognize because they were not dressed according to 
these traditions. There could have been girls with other religious beliefs (e.g. Jewish or 
Jehovah Witness) difficult to identify through observations. Similarly, there could have 
been girls with other ethnicities that remained unknown because they were not recorded 
in the consent forms. In addition, my data did not identify girls’ ethnic origin, except for 
a few of them whom I asked directly during interviews about their and their parents’ 
country of birth.  
 
The literature review indicated that there are several ethnic groups in the UK. Apart 
from “White” residents there are people from other ethnic groups who could be British, 
immigrants or could have mixed heritage. This idea was emphasized by a teacher who 
stated that in her school: “We are predominantly Catholic…we don’t tend to refuse 
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anyone on the religious basis… we have a lot of students from other countries, we have 
a lot of students from Poland, we do have some that come from India or from other 
countries, but we have some that are British and their parents were originally from 
those different countries.” [Teacher 19, School 6] This quote shows that, in the school, 
there are students born in the UK or in their parents’ countries. However, this poses the 
question if ethnicity influences uptake of the HPV vaccine as long as parents make the 
decision for vaccination as stated earlier in this section. 
 
When I asked a nurse to make a comparison between the HPV vaccine uptake in 
different schools, she said that “it changes to be honest…initially these schools [names] 
had the poorest uptake... [because] these have more vast ethnicity ranges.”[Nurse 8] 
This quotation indicates that uptake has changed over time across schools but ethnicity 
does not seem to explain this variation except for the first academic year. 
 
Likewise, my data does not make it possible to make a statement about language as a 
barrier to the HPV vaccine uptake. Based on the minimal information which I obtained 
from the school staff it appeared that the schools have different mechanisms in place to 
provide interpreters when it is necessary. One teacher said that the teachers “know their 
students and they know whether the parents can speak English or read English. They 
will say this child or this parent will not understand, then we’d arrange for them to 
make sure that they understood the information…We do have a Czech interpreter and 
we have a Romanian interpreter….if they would have language difficulties, then we get 
the interpreters obviously to contact the families directly…they do some home 
visits…they have built up quite strong relationships with the Roma families…Now we’ve 
got two of them working on a part time basis, where part of the time they are supporting 
in class and part of the time they are out working with parents and working with 
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students individually or small groups, but actually it’s going to be a lot easier for 
them…If we’ve got some African parents or Somali parents, for example, then, to be 
fair, the Somali community is quite strong and if we want to speak to them, they will 
usually bring somebody with them who does speak English.  If they know they don’t 
speak English, they will often bring a relative or a friend or a neighbour, somebody 
from the community who does speak English. And sometimes we have used the child 
themselves sometimes. We’ve said, for example, if it’s a situation where we haven’t had 
a form back and the child has said to us that they would like the vaccination, then we 
say ‘talk to your mum, talk to your dad on the phone, talk to them, tell them you’d like 
it’ and we can get verbal consent if they’ll give verbal consent.  And usually they’ve got 
enough English to be able to give consent.” [Teacher 33, School 7] This quote shows 
that the school uses different interpreters to facilitate communication with the parents 
such as professional interpreters for Czech, Romanian and Roma families as well as 
relatives for African families and the girls for other families. 
 
A teacher in another school mentioned that “…There is a Sahil project that have a lot of 
Asian speaking staff, as there are different languages there.  We do have some language 
teachers in school so they are French speaking or we have Japanese teachers, a teacher 
in school that speaks Urdu and we sometimes ask her to give parents a call and speak to 
them....” [School staff 36, School 9] 
 
This suggests that schools used other people as interpreters apart from trained 
interpreters: children, relatives, community members and teachers. This practice could 
perhaps affect the accuracy and completeness of interpretation because non-
professionals could alter or omit something that is stated.           
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7. 3. 1. 3. Information about HPV vaccine in the schools  
7. 3. 1. 3. 1. Information about the HPV vaccine in the curriculum 
I asked the coordinators of the HPV programme if the schools had talked to the girls 
about the HPV vaccine and sexually transmitted diseases in any of their classes. They 
said that they brought up issues related to barriers to the promotion of the HPV vaccine 
in the discussion about sex education in their school. Sex and Relationship Education 
(SRE) teaches about reproduction, sexuality and sexual health as well as relationships 
through compulsory science lessons and during PSHE lessons (Personal, Social and 
Health Education). SRE is a compulsory subject included in Key Stage 3 (Years 7 to 9) 
and Key Stage 4 (Years 10 and 11) of the National Curriculum. The parents cannot 
remove the child from statutory elements of SRE about reproduction taught in science 
(GOV.UK, 2013a).  
The interviews showed that sex education is a very sensitive optional topic with little 
emphasis on vaccines and sexually transmitted diseases. The schools had materials 
about sex education in different subjects and science seemed to be one of the places 
where sexual health was taught.  
 
One teacher said “Sexual health will come partly under PSHE, science and partly under 
citizenship, sex and relationship education...it’s mandatory….In science it will be 
spoken about more from a scientific point of view, whereas it’s spoken about more in 
terms of relationships within the citizenship programme.  
Health and social care would obviously talk about health. Pastoral programme talks 
about health and healthy eating and healthy lifestyles, but it doesn’t go in to detail 
about sexually transmitted diseases, because they are in vertical tutor groups. [The talk 
about sexually transmitted diseases] might come up to a certain extent in history when 
they’re talking about the history of medicine, which they do, the history of medicine is 
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one of their modules, so it might come up there, and obviously it could possibly be 
touched on in other areas of history, but I don’t think it’s, I wouldn’t have thought it’s 
gone in to anywhere else really…The sixth form programme [Year 12 and 13] may well 
deal more with that, but again, it’s a profile of our sixth form, it’s not an area that a lot 
of students are very comfortable with…I think culturally some of them find it difficult to 
talk about sexual activity full stop…we just have to handle these things quite 
sensitively.” [Teacher 33, School 7] This extract of interview shows that teaching about 
sexually transmitted diseases is more difficult than about sexual health because of 
cultural barriers. 
 
Another teacher in a different school stated, “We talk about sex and relationships in 
religious education anyway and another one obviously science teaches a little bit 
biology at that point.” [Teacher 19, School 6]  
 
Another teacher elaborated a bit on the way in which sex education is implemented in 
her school: “They [the students] will have sex education in some form in science and in 
tutorials about protecting themselves still…. and they will use a lesson plan and 
materials then but not necessarily linked to having the vaccination…They [the girls] are 
informed that they are going to be doing sex education and parents have the right to 
write in to us and explain that they don’t want to take part…But the year sevens will 
have a tutorial and they will have some form of sex education and then it gets more 
involved as they get older…STIs and pregnancy and teenage pregnancies and they do a 
lot of...that sort of starts in year nine.  And then they have a talk from the nurse in year 
ten and eleven a bit more in depth about sexually transmitted diseases.” [School staff 
36, School 9] This quotation indicates that sexually transmitted diseases are taught to 
older cohorts than those in year 8.  
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Time pressure is a constraint and the curriculum, especially the pastoral programme, is 
planned in advance before notification of the dates of the HPV vaccinations. 
 
“We probably haven’t done it [talk about HPV vaccine]…because literally the time is so 
packed with so many other things…The science department is very…, they’ve got their 
syllabus to follow, every minute of every lesson is important, but this is health…The 
pastoral programme is so tightly prescribed and every session is written down point by 
point in terms of what has to be done. When that pastoral programme is written we 
don’t know the dates for the HPV vaccines, so it doesn’t get built in to the pastoral 
programme. It might be that if we knew dates early before the pastoral system were put 
together, we could perhaps plan at least a session where perhaps the girls were 
withdrawn from tutor groups just for one session, just to be spoken to, that might be a 
possibility.” [Teacher 33, School 7] 
Another issue is whether this information is specific to girls and if they could be spoken 
to separately from the boys in their classes.  
 
“I’m not sure whether the girls have ever been spoken to as a group, to be honest.” On 
the other hand, the teacher added, “they [the girls] are in mixed tutor groups and it’s not 
the kind of thing that we talk about in a mixed tutor group, particularly in this school, 
with our particular profile. Tutor groups are mixed ages, so you’ll have four year 7’s, 
four year 8’s, four year 9’s, four year 10’s and four year 11’s in one tutor group.” 
[Teacher 33, School 7]  
  
One school talked to the girls “in tutorial …because it is year eight they have the 
vaccine that is the only time that is discussed, the HPV.” [School staff 36, School 9] 
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Nevertheless, in this school, a teacher thought that the tutors felt that they did not have 
the knowledge to counsel girls if asked to give them more information about the 
vaccine. “Tutors  struggle  talking about sex in general…Some tutors are a little bit 
nervous about saying things as well because we have got a couple of teachers that are 
obviously from a religious background as well.  So in those sort of cases we try to put a 
different tutor in so that they are quite open and they can have a frank discussion…”. 
[School staff 36, School 9] 
 
7. 3. 1. 3. 2. Talk about the HPV vaccine in assembly  
School nurses who work in the schools are generally not involved in giving information 
about HPV vaccine although some schools invite school nurses to give talks to the girls 
about it.  
One nurse said that “the school nurses [in the vaccination team] will do assemblies and 
things in [the school] and [the schools] let them discuss before we come in doing the 
jab...but that doesn’t happen very often any more.” [Nurse 8] 
 
The interviews with three staff members showed that their schools organized an 
assembly and it was planned a month before the first HPV vaccination to allow the 
parents to get in contact with the school and to ask more information about it.  
 
A teacher described how the assembly has been organized and what issues have been 
discussed with the students. “The school nurse came and spoke to myself and…the 
Assistant of Head teacher….and explained all about it [HPV vaccine] and then the 
three of us took the assembly…between half an hour and 40 minutes. There is a Power 
Point…[which was] given to us initially when HPV vaccination first started…by the 
NHS… what the HPV vaccination is, why is so important for them to have it and…what 
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the [consent] forms mean…what the vaccine is fighting against…the risks of not having 
the vaccination and leaving it so late…the importance of what might happen if they 
don’t fight against it now…In assembly will be very general practical questions….’will 
it hurt?’…we don’t go deeper than that…” [Teacher19, School 6]  
 
The interviews with the school staff suggested that the girls had the tendency to raise 
different questions when they were informed about the HPV vaccine and cervical cancer 
in their tutors groups or assemblies. One teacher reported on the types of discussion that 
occurs with tutors as illustrated in the following excerpt of interview. 
“…their tutors go through that form with them and answer any questions that they have 
got…They obviously have to explain that it is the three vaccinations, three injections.  
They are probably not aware of what is in the injection themselves, just that it covers 
them against cervical cancer in the future…I think it starts very quiet and then you will 
get one that is brave that will ask a question and then it will stem from there really. 
They [tutors] have been asked questions like ‘what do you mean sex?, what is 
that?’….’when are they going to have it?’, ‘does it hurt?’, ‘how long is it going to 
hurt?’  Other girls will then pipe up and the teacher will let the discussion happen and 
keep it under control… It is more those sort of questions than the sexual side of things, 
yes.  Whether that is because they are still only twelve…I think they are probably a little 
bit more open because there are not boys there…There are a few that are shy and are 
totally oblivious to what is going on and what could happen, and they are the ones that 
you tend to have to speak to a little bit more. But no I think the girls on the whole are 
really good and I think they are probably a little bit more open because there are not 
boys there, they will talk quite openly….We obviously discuss that as they get older they 
are going to become more sexually active. So to do it now is an age that we think is 
appropriate for them where they shouldn’t be having sexual intercourse but obviously 
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they are going to be starting, the sexual age I suppose is coming down and I think we 
need to explain that to them…and just that this is a good age to start getting that 
protection there…Some girls are quite worldly and will understand why they need it and 
how they could get the cancer.  But then you have got a lot of the Asian population that 
haven’t had that sort of discussion with parents and are totally unaware of what could 
happen and why they could get the cancer.  So, they are the sort of people that you then 
have to explain to them, they are the ones that are probably a bit more inquisitive and 
‘why do we need it?’…it depends on what the tutor group is like and how much they 
want to know.” [School staff 36, School 9] 
 
Another teacher indicated frequently asked questions about HPV vaccine during the 
assembly in her school: “They [the girls] have questions concerning what cervical 
cancer actually is because they’re still very young to be hearing about such adult 
diseases…We explain just by giving them the facts by trying to put it in as easy 
language as be possibly can for them…unprotected sex can lead to several different 
infections and left untreated they can lead onto more serious things…probably not 
during the assembly because they wouldn’t feel comfortable…If they got more sensitive 
questions… like ‘what does it actually mean?’…’how do you get that cancer?’...’what is 
cancer?’…our school nurse did a drop in-service….so that everyone could go and 
speak to her…cos they might not want to tell me and they might not want to tell another 
teacher…One of the questions that comes after the first one [vaccination] is because 
the nurse has to say to them ‘is there any chance that you might be pregnant?’...and our 
girls are quite horrified at that question…So a couple of questions come up then…’Miss 
why do they ask me if I may be pregnant?’...’why do they think that I would be?’…you 
know…so...I try to explain to them that we are living in a society where girls are 
sexually active a lot younger than they used to be years ago and because of the nature 
251 
  
of the vaccination they have to be 100% sure that you are well enough for it.” [Teacher 
19, School 6]  
 
This section showed that school based HPV vaccination programme was accepted by all 
the schools except for private Muslim school in the city of study and was delivered by a 
mobile clinic aiming to vaccinate all eligible girls. It described the organization of 
delivery of HPV vaccination programme before and on the day of vaccination through a 
partnership between the nurses and the school staff including setting up dates and places 
of vaccination as well as getting the informed consent. Gaining parental consent was the 
most important factor that affected uptake of the vaccine. The manner in which the 
school staff sought parents’ and girls’ written and verbal consent was often persuasive 
with repeated different approaches. Finally, there was limited discussion of the HPV 
vaccine in the school curriculum using a range of different lessons. 
 
7. 3. 2. Theme 2 - Facilitators to uptake of HPV vaccine  
This section addresses the research question related to factors and practices affecting the 
uptake of HPV vaccine. It is an analysis of the facilitators to the vaccination. It starts 
with an analysis of the way the consent was obtained from the parents and from the 
girls, followed by an analysis of the role of girls’ social interaction within and outside 
the family on the decision for HPV vaccine uptake. The second part of this chapter 
explores the different influences related to girls’ personal characteristics as well as to 
their parents’ reported views. 
The analysis in the previous chapter about the delivery of HPV immunization in the 
schools to girls showed that the school setting facilitates dealing with large numbers of 
girls at a time in a routinized way within the school day, and that the process of 
informing them about the vaccine is done by the teachers and that the school seeks 
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informed consent from the parents/carers of the girls. Aside from the school setting 
there are other factors that facilitate the uptake of the vaccine. One of these factors is 
obtaining consent from the girls themselves by nurses. 
 
7. 3. 2. 1. Consent for HPV vaccine 
 Consent for the HPV vaccine from the parents is obtained generally before the day of 
the vaccination and has been discussed in the previous chapter. When the nurses come 
into the school informed consent is requested from the girls themselves. One of them 
said“…We discuss it [HPV vaccine] with them [the girls] and make sure they 
understand the implications and then they sign the form”. [Nurse 5] A teacher pointed 
out that the girls might not be informed about HPV vaccine and in her view they sign 
the form because they are easily influenced by others: “There are [girls] that don’t read 
[the consent form or leaflet] and just sign because they think it’s just a part of this 
course ‘We have it done’ [and] mum says ‘We have it done’…”. [Teacher 19, School 6] 
   
 One nurse thought  that “It’s usually mum that’s signed the form…mums are the ones I 
think with the deciding factors and I think a lot of the dads will go along and they 
probably do support each other and they do it as a family decision”. [Nurse 9]  
Which parent signed the form was considered to vary across ethnic groups. For 
example, a nurse affirmed that “In (White) British groups is usually the mother that 
signs because…probably is easier to the mother to explain to a daughter what is all 
about, it may be embarrassing coming from the father…” [Nurse 4] Another nurse 
mentioned that “Often we find with the Muslims girls [that] the fathers give the consent 
or not because is usually the fathers who speak better English than mothers.” [Nurse 7] 
When “…the child is not in contact with the parents or some children weren’t in 
schools, especially extended schools, or they’ve been excluded from schools, first the 
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parent or usually social services have ultimate responsibility for their health and well-
being…so you have to go through layers before you get to the consent, but we usually 
do get it in the end.”  [Nurse 4] 
 Parental consent plays a crucial role in the process of HPV vaccination. Sometimes the 
nurses needed to contact the parent in order to make sure that the parent’s signature was 
real. For example, “If something was standing out to us that...’oh the writing was the 
same like the child’s signature’ [then] obviously we raise alarm bells about that...but I 
suppose in a way we have to trust that the form is brought back and signed by the 
parents.” [Nurse 6]  
 
If there is no signed parental consent, then the nurses will try to contact the 
parents/carers on the day of the vaccination, “keep contacting until we actually speak to 
the parents on telephone” [Nurse 7] “upon the day when we are actually in the school” 
[Nurse 8] to get verbal consent. During the conversations, the nurses addressed different 
perceived parental misconceptions with reassurance and communicating effectively 
about HPV vaccine. One of the most prevalent misconceptions was related to the safety 
of HPV vaccine. 
 
“We will have a chat with them on the phone first of all…I think the key is 
communication really...is having the time to chase your non responders and your 
refusers…If they want to come to the clinic we will arrange for them  to come to the 
clinic and make sure we have enough time to put aside to spend more time with them at 
the clinic…We just go through all the evidence with them…we go through all the side 
effects if that’s what they’re worried about…and tell them how long it [HPV vaccine] 
has actually been around because a lot of them had been around for a couple of 
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years…we direct them to the Department of Health website information...to see the 
reports on the safety side of it …”.  [Nurse 8] 
 
Nurses felt that another perceived parental misconception would be premature sexual 
activity after the girls receive HPV vaccine. Nurses explained how they talked with 
parents about their daughters’ need for this vaccine. 
 
“When we talk to people the language we use is important … and also to ensure that 
they know that is for prevention for the future…It’s not that we expect to begin now and 
having sex at earlier age...it’s just that the vaccination can actually work and protect 
them for the future when no doubt they will be sexually active as adults…possibly 
teenagers...parents don’t want to talk about that.” [Nurse 6]  
 
Although the parents were from different ethnic backgrounds, the way in which the 
nurses talked to them was similar. “It’s fairly similar in all of the groups. It’s just 
explaining a little bit more about the virus and how it’s quite common. It’s a more 
common virus than a lot of people think and trying to explain that it can be passed from 
person to person, not just via full sexual intercourse.” [Nurse 9] 
 
One of the nurses expressed the view that sometimes there is a language barrier in the 
communication with the parents and one nurse said that a good strategy would be to talk 
with the parents in their own language. “I feel that would be a very important thing if we 
can have people who actually go to speak to parents...we need somebody who has the 
medical knowledge but also can speak a language as well”. [Nurse 7] 
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The success of the discussion with the parents depends on their attitudes towards the 
vaccine as illustrated by the following quote:  
“Sometimes speaking to them, they will understand more than actually reading the 
information…sometimes they are grateful and quite pleased that you’ve done that…you 
can speak to some of them and persuade them and change their mind…sometimes they 
are clearly quite abrupt. If it is somebody who got a very strong feeling about it...you 
have to go with how it feels on the day I think.” [Nurse 2] 
 
The views of the participants below suggest that some parents did not sign the consent 
form if their daughters were scared of injection.  
 
A Muslim girl pointed out that “Maybe the parents weren’t educated a lot about that 
vaccination so they wouldn’t think that it is as important as it is and they just wanted to 
make their kids happy. They don’t want them to go through the pain of the vaccination”. 
[African girl 26, School 7] 
 
One of the nurses made a similar point when she stated that “Their daughter says, ‘I’m 
not having it.  It will hurt,’ and they’ll [parents] say, ‘OK, they don’t have to have it’.  
I’ve found that quite a lot…we explain to the parents, ‘Well, let’s talk to them, let us see 
how we get on, a lot of girls are scared of the vaccine, but you know, they’re worried 
about the injection, but just let her [the nurse] speak to them and then with the 
reassurance that they [the nurses] obviously won’t traumatise them [the girls] or 
anything’ and parents are quite happy for us to do that.” [Nurse 9]  The nurses felt that 
with parental permission they could try to convince the girls to get the HPV injection. 
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 When the parent does not consent for the HPV vaccination, the nurses could choose to 
apply Gillick competence which a nurse defined as “Through the interview you decide 
what you think they [the girls] know exactly what is for, what are they doing…it’s your 
impression that you get really [after that]…we put on the form that we assessed them 
[the girls] and in their opinion they are competent to consent for themselves.” [Nurse 2]  
 
Applying Gillick competence to assess children’s 12–13 year old capacity to consent to 
vaccination is a challenging task. The nurses acknowledged a child's right to be 
vaccinated if the child was considered competent to self-consent. Vaccinating a child in 
these conditions would require no breach of a child's right to confidentiality. However, 
one of the nurses mentioned that parents’ decisions should be respected on the grounds 
of their right to refuse the vaccination: “If mum has said ‘no’, [but] we’ve deemed these 
girls competent to consent for themselves and we’ve vaccinated them, [but] parents 
have not been made aware of it at the time, because obviously we need to respect the 
child’s privacy when they’ve [girls have] made that decision that they want it, but we 
never really want to go against parents’ wishes.” [Nurse 9]  
 
Nurses said that they would hesitate to give vaccination based on this assessment to so 
young and most often immature girls because of legal implications: “We don’t very 
often do with 12-13 year old girls because probably some of them are a bit young … it 
could cause problems … we  could be up in court for assault.” [Nurse 7]   
“Although we do get them [the girls] to consent, it is only a kind of paper copy and in 
the eyes of the law it will not stand necessary up in court.” [Nurse 3]  
 One of the nurses said how she assessed girls’ maturity. For example, “If you explain to 
them [the girls] and they still don’t seem to understand, then you will deem them not 
competent.”  [Nurse 4]  
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 When the nurses concluded that the girls did not have the ability to consent for 
themselves, they were willing to contact the parents. “If it is a child who has some 
learning difficulties or I am not happy that she understands and is not able to give 
consent and the parents haven’t given consent, I wouldn’t vaccinate…so we can phone 
the parents … [and] invite them to the clinic.” [Nurse 5] 
 
Nurses’ actions like checking for the validity of parental signature and caution in 
applying the Gillick test, as previously mentioned, indicate that one of the main 
facilitators to HPV vaccination is parental consent which, if it is not obtained via the 
school, is actively sought by the nurses. The nurses facilitate the process of vaccination 
chasing up the parents and increasing the delivery of information to help them to decide 
on the day of vaccination and after. This was illustrated by one of the nurses’ following 
remark: “…We [nurses] can only advice, we can’t force the family to have it. We can 
only give information to the family to make their own decision”. [Nurse 3] 
There would seem to be a range of practices concerning whether to apply the Gillick 
approach and override parental lack of consent. The high uptake of HPV vaccine is thus 
achieved partly through the school staff actively seeking parental consent and 
subsequently the nurses seeking consent from non-responders or refusers or overriding 
parental wishes. 
 
7. 3. 2. 2. Parental involvement in decision-making on HPV vaccine 
Social interaction and discussion between the girls and their parents played a significant 
role in the process of making a decision about the vaccine as well as helping the 
students to understand why it was important to have it done.  
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The nurses and the teachers assumed that the parents talked to their daughters about the 
value of the vaccine at the time when they received the consent form and signed it as 
showed in the following two quotations: 
“You would hope that if you are signing a form like that for your child, that you would 
have some discussion with your child to say this is what it’s about and this is why I 
think you should have.” [Support staff 20, School 14] 
 ”The consent form that we use the parents actually have to sign to say [that]…the child 
got no severe allergies and has no major health problems...so they must at least discuss 
that because will tick those boxes and sign that form...so I assume that by doing that 
they actually sat down with the child and read the information and discussed it 
together”. [Nurse 5] 
 
The analysis indicated that some girls talked to various family members about the 
vaccine.  
“I’ve asked all of my family would they have it done.” [White British girl 37, School 9] 
For example, “I told my mum, I told my aunty, I told my sister.” [British Asian girl 39, 
School 9]  
“My mum and my dad said it’s a good idea, my two sisters had it. Therefore it is a good 
idea for me to have it because if nothing happened to them then nothing will happen to 
me.” [Polish girl 12, School 6] 
In girls’ views, the parents’ decision was based on trust in the vaccine and protecting 
their daughters from disease.  
“…They [the parents] might think that any chance they get to protect their children they 
might just take it and just trust it” [White British girl 18, School 6] because they “want 
the best for their kids…they care about them…so they won’t become ill.” [Polish girl 15, 
School 6] 
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A number of interviews showed that some of the girls felt that they could not make the 
decision for themselves.  
 For example, a Muslim girl, said “You’re still really young at this age…sometimes you 
don’t know what you’re saying... you’re not fully grown up, that you can take your own 
decisions.… You still live in your parents’ house and you still have to abide by their 
rules… It’s best to leave it up to the parents, because they’re older than you, they’re 
mature and they know what they’re doing.”  [Mixed British girl 28, School 7] 
 Similarly, another girl pointed out that “I decided with my mum because I knew that 
obviously she needs to choose what is right for me.” [Slovakian girl 40, School 9]  
 Another girl mentioned, “If we think we shouldn’t have it and our mums think we 
should, then you have got to kind of realise that you might actually need it.” [White 
British girl 21, School 14] 
  
 Several girls described the conversations with their mothers as well as with their fathers 
who tried to convince them to get the injection explaining to them the importance of the 
vaccine for their future life. A Muslim girl said her mother told her “You should really 
take it [HPV vaccine] because it will help you later on in life if you do get it [cervical 
cancer], then it’ll probably lessen the chances of getting it.  So they [the parents] said 
that…it will be good for you. That’s how they sort of influenced me, sort of talked me 
into it”. [British Asian girl 27, School 7] Another girl gave a similar example when she 
stated that “She [mum] was saying ‘Oh, you might not think that is important now but 
when you get older you could be just like...oh, I wish I had had it now’ .“ [White British 
girl 18, School 6] Also, a Hindu girl talked about her Dad who” told me the benefits of 
getting this and what would it do to you and what cervical cancer is. She [mum] was 
just saying that how we’re really lucky to get this injection because in her days they 
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didn’t get a chance to have this injection done, so not everyone gets a chance to have an 
injection like this to cure an infection.” [British Asian girl 32, School 7]  
  
Some girls felt that their parents did not put pressure on them to get the vaccine. They 
perceived the discussion with their parents as support in making their own choice about 
the vaccine or as joint decision-making. 
 “My mum made the decision with me, but she wanted to know how I felt about it as 
well” [White British girl 37, School 9]   
 “…She [mother] said it’s my choice if I want to get it. I’m glad that she said ‘you don’t 
need to do it but I think it would be good if you did but is really up to you’ “. [White 
British girl 16, School 6] 
 
 A Muslim girl said about her parents that “They give you the basic information about it 
[HPV vaccine] and then they say ‘it’s your decision and you have to decide.  You are 
old enough, you are in year eight and you should be able to decide what is good for you 
and what’s not’” [British Arab girl 35, School 7] 
 
Some girls preferred to talk to their mothers about the vaccine. Two girls said that they 
trusted their mothers more than they trusted their friends. 
 A Muslim girl mentioned that “If you’ve got girl problems we would tell, like, our mum 
or our sister or someone. I think it’s better to share it with your family, because, your 
mum she’s given birth to you and she knows you so well.” [British Asian girl 39, School 
9] 
 Another girl explained her reason, saying “My mum is a nurse so I can talk to her about 
it…I read the letter as well just saying that we were going to have an HPV jab…I just 
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wanted to be clear with my mum just what it is…...All my questions were pretty much ‘is 
it going to hurt?’ and the pain and size of needles”. [White British girl 21, School 14] 
 
The data show that some girls considered and welcomed parental advice. Some of the 
girls saw family as an important source of socio-emotional support and confidence 
building. They pointed out to the way in which their parents prepared them 
psychologically before having the injection and supported them to overcome their fear 
of it. A Muslim girl stated that “My parents also wanted that I don’t get cancer in my 
life and my life doesn’t get ruined, so that’s how they supported me, to take the 
vaccination and be brave and face my fear”. [Mixed British girl 28, School 7] Another 
girl said “Sometimes you don’t understand what half of the words say, so my mum 
explained it in a simpler way for me…you were going to have injections into your arm, 
and I got a bit worried at that point, I was like, ‘hang on’.  She was like, ‘it’s not like a 
blood test’ that I’ve had done in the past. ‘It’s just a little pin prick, you won’t feel it….” 
[White British girl 37, School 9]  Parents and especially mothers had a strong influence 
on their daughters’ decisions, as demonstrated by the fact that some girls conformed to 
their families’ views rather than their own after some discussion. 
 
“I said that ‘I don’t wanna take it’ and she said ‘You have to’ and I said ‘What if I am 
like allergic to something inside it’ and she said ‘You could be allergic to 
anything’…she just said ‘Go outside, you cross the road and anything will kill you... 
just take it, what’s the worst that could happen because it’s for a good cause anyway’.” 
(African girl 14, School 6] 
Some mothers encouraged their daughters to get the vaccine because of family history 
of cancer especially breast cancer. 
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In a teacher’s opinion “…A lot of parents take it [decision] into their own hands to say 
that the girls are having it done…[because] ‘cancer has been in our family’. So, it is 
protecting them, it is giving them the safeguarding.”  [School staff 36, School 9] 
 
A girl made a similar point when she talked about her mother’s argument in favor of 
vaccine “…She [mother] explained to me about all the cancer part, about my grandma 
and she was really supportive…‘Don’t make a mistake about this, because if you don’t 
have this done then look at grandma’... breast cancer…it’s to do with my grandma, my 
mum’s side and obviously my dad doesn’t know much about it because no one on his 
side ever had cancer.” [White British girl 37, School 9] 
 Another girl added “Her mum’s mum had breast cancer, and my mum’s just found out 
she might have breast cancer, so she said it might not stop it because it runs in her 
family…but it just prevents it being that bad in a short space of time.” [White British 
girl 43, School 14] 
  
 The girls reported that some of their mothers tried to make them understand that 
cervical cancer is connected to sexual relations.  
 “She was just like ‘when you have sexual intercourse with a boy, they can give you 
something called cervical cancer, which can affect you massively. It can harm you in a 
way and the cervical cancer goes around the…. ” [White British girl 44, School 14] 
 “She [mother] said ‘if you have a sexual relationship with someone when you are older, 
the sperm and everything that goes inside you, it might like have a disease and the 
injection will stop you from getting it’ [cervical cancer]”. [White British girl 30, School 
7] 
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Other parents seemed to give limited information about HPV vaccination to their 
daughters and did not explain to them why they needed to have it done but the girls 
trusted their views.  
 A Muslim girl said “I asked her [mother], why do people have it, then she said, ‘Well, I 
don’t really know that question, but, the question in my head can only be that to be 
protected from it’…. I leave everything up to my mum to tell me. So, if my mum thought 
it was right for me to tell the whole information she would...She just told me just about 
the injection…that it’s more safer to have it.” [British Asian girl 39, School 9] 
 
Some mothers could not read the documents in English related to HPV vaccination, 
which they received from school. This was the experience of a girl who said that she 
“…needed to tell what is this paragraph about, what is this paragraph about and what 
is this paragraph about. So I needed to be very formal and say what is it about so she 
understood the whole thing”. [Slovakian girl 40, School 9] 
Due to the barriers of language experienced by some of mothers, other actors within the 
family, particularly fathers, may be important in communication with the mother about 
the vaccination. A Hindu girl mentioned “My dad speaks English very fluently, so me 
and my dad discussed it and then he had told my mum about what this is about and 
what it’s for, so that’s why she [mother], at first she was concerned she didn’t know 
anything about it, so after my dad told her about it she was positive about me getting 
it.” [British Asian girl 32, School 7] 
 
 Other girls had family members who opposed the vaccination. Some girls felt 
confidence in their ability to decide: “It should be our decision whether we want to have 
it or not.” [White British girl 11, School 6] One of the girls made the following point 
“you can have a look at why the parents didn’t want you to have it and why you want to 
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have it, and which argument is better, take that on.” [Mixed British girl 28, School 7] 
Another girl described how she negotiated with her mother. “I would make her [mother] 
understand why I should get it and what are the pros and cons of getting this 
vaccination done…and I’d also prove my point by going onto the internet, telling her 
about it, showing her the leaflet and getting some more information from everyone 
else.” [British Asian girl 32, School 7] Another girl was keen to listen to health 
professionals. 
 “Take a person that’s qualified in this vaccination, as they know more about it. Like the 
nurses, they know more about the vaccinations, so if the parents don’t agree, then you 
should listen to them [nurses]. That would be a second choice in my opinion”. [Mixed 
British girl 28, School 7]  
 
 This section showed that the family had a major role in decision-making providing the 
girls with emotional support to overcome any fears of the injection as well as discussing 
the information. The decision-making was often jointly done or by helping them to 
make their own choice in most cases. 
 
7. 3. 2. 3. Girls’ views about the HPV vaccine 
Girls are given some information about the HPV vaccine at school as set out in the 
previous chapters and they have a range of views about it. Clearly if they think 
positively about it then this facilitates high uptake. 
One of the teachers who said “My feeling is that most of them feel that it is actually 
important to have it, even if they don’t like needles, even if they don’t like injections, 
they appreciate that it’s important.” [Teacher 33, School 7] 
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The girls who were interviewed expressed views about a number of different benefits to 
having it done. First, in some girls’ opinion, getting vaccinated had a lot to do with 
saving their life due to the perceived severity of having cervical cancer as showed in the 
following quotes:    
 “It is just good for us to have the vaccine so that we don’t get cancer at our age because 
we don’t really know much about cancer”. [White British girl 21, School 14]  
“Cancer it’s quite dangerous cos it can kill you maybe. So, I just thought that it would 
help my body and keep me alive just a bit longer”. [White British girl 16, School 6] 
 
 “I am young and I still want to live so it is good to have it and be safe but it is just that I 
don’t want to die really, so that made it more important”. [Slovakian girl 40, School 9] 
 “I thought there were more advantages [to have HPV vaccine].  I wasn’t really sure 
about the risks, I knew there was one risk of cervical cancer, I didn’t know any other 
risks, so instead of getting cancer, which could kill me, I had to take the vaccination…I 
already have an experience of cancer before this vaccination.  My mum had cancer I 
think it was….” [Mixed British girl 28, School 7]  
  
 Second, the desire for protection was a stronger motive for having the vaccination. One 
of the girls said that 
 “It is a good medicine cos it protects your body and makes your body stronger. It’s 
better to be safe than sorry”.  [African girl 14, School 6] and “it can buy you time in 
life”.  [White British girl 43, School 14] Some of the girls thought that the benefits of 
the vaccine outweighed its side effects. 
 
One of the students felt that “it doesn’t affect anything in your life and …it’s good for 
everything.” [Polish girl 12, School 6] 
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“It might be a low chance that it can be a side effect in the future and side effects might 
not even kill you.” [White British girl 18, School 6] 
 
Third, the girls expressed the views about the advantage of receiving the vaccine at 
school.  
“It’s good that they do it in school because it’s given to everyone instead of having to do 
on your own… it’s good that they do it in groups” [White British girl 10, School 6], 
“It’s in school time and you don’t need to go out of the school…The school pays for it 
cos otherwise would be quite expensive if you just have to get it done privately”. [White 
British girl 18, School 6] 
 
7. 3. 2. 4. Communication with friends about HPV vaccine 
The analysis showed that the girls talked not only with their family before the 
vaccination but also to their peers. A teacher pointed out: “I think they have older 
sisters. I think they see other year groups of girls having it and girls talk and read 
magazines, read the pamphlets and look at the media. They just know now that it is 
something out there that girls have.  And I think the longer it has gone on just as 
everybody knows that you have MMR or you have DTP they just know it is one of those 
vaccinations which girls have.” [Teacher 33, School 7] 
  
Peers can be an important resource of information and social influence. “…When all the 
girls are talking, they don’t know everything about the HPV jab…some understood it 
more than others, so the one that understood it more was explaining it to the ones that 
really didn’t.” [White British girl 21, Student, School 14] 
Having the vaccination as a group together facilitated the decision to have it. “I was 
kind of interested if someone else is having it because I don’t want to be the only one 
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who is having it.  So I wanted someone else to come with me and actually have it.” 
[Slovakian girl 40, School 9] “  
 
 “I was encouraged by friends and I'm sure everybody else was because their friend was 
taking it and other friends were taking it and their friends already took it and then it just 
goes on…it’s mostly the students, they motivated me, not the teachers really…They 
[students] were just saying that they are going to take it because their parents told them 
to take it and their teachers told them to take it, so they were going to take it and 
everybody else came to take it so I was going to take it.” [British Arab girl 35, School 7] 
The administration of the vaccine to the group clearly supported uptake positively. 
 
The girls described how social support from peers was important to them. A Hindu girl 
said “We just talked about how it’s important to get this done…how it would affect you 
in a good way...they know that as they’ve got this injection they know that they’re not 
going to catch it [cervical cancer], so that’s why they feel it’s important”. [British 
Asian girl 32, School 7] 
 
 Another girl added “One of my friends said, ‘Yes I am going to have it because it is 
really important’...two of my friends said, ‘Yes I am going to have it, I still feel more 
pushed onto the good side than onto the bad side’…One of my friends was saying, “I 
am going to have this because I saw that you can’t have it at your doctor, so it is good 
that there is a chance for you to have it here [in school]’ .”  [Slovakian girl 40, School 
9] 
 
One of the most recurrent topics they reported discussing was whether the injection 
would be painful or not. A girl mentioned that “We just talked about the pain really”. 
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[White British girl 22, School 14] Similarly, a Muslim girl said “…It was just there was 
a pain that I really had it in on my mind, but I don’t think we talked about it other than 
that.” [British Asian girl 25, School 7]  
When looking at girls’ accounts of social interactions with their peers there was a 
tendency to consult not only friends in the same year, but older girls who had had the 
vaccination. A Muslim girl emphasized the idea that she trusted her close friends. “I 
trusted my friends because the people who said it hurt weren’t really as close to me as 
my friends so I trusted my friends more”. [African girl 26, School 7] A Muslim girl said 
“…I have some friends that are above this year and asked them whether they did take 
the injection or not…we mostly just discussed whether it would hurt or not... they said 
that it wouldn’t be as much painful as it sort of seemed to be… we were just debating 
whether we should take it or not.” [British Asian girl 27, School 7] These quotes 
highlight the importance of peer group interaction and support on decision-making 
concerning the uptake of the vaccination. This peer group support was also relevant 
during the administration of the vaccine. 
 
The girls described communicative factors as influencing their attitudes towards 
vaccination. One of the girls affirmed that “I did explain to my friends, they explained to 
me, and we just, we kind of made it each of us feel a little bit better towards ourselves.  
We were all like in a group and we just explained it to each other and we felt a bit 
better when we all understood that we had the same feeling about it.” [White British 
girl 37, School 9]  
Girls explained that friends provided important emotional support on the day of 
vaccination to overcome the fear of injection. “We just told each other that we'd be 
there for each other [White British girl 42, School 14] “… Go with your friend so you 
are not on your own” [White British girl 18, School 6] “...an injection can't kill you”  
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[White British girl 42, School 14] “ Just look at their [girls’] faces not the needle and 
just think if their face is not showing any fear then your face shouldn’t.” [White British 
girl 21, School 14] 
 
This section demonstrated that discussion with friends and peer group support 
constituted a major role in decision-making by the girls through information and 
emotional support and in dealing with the injection itself. 
 
7. 3. 2. 5. Communication with nurses  
The girls’ social interaction with the nurses was very short and it occurred mainly on the 
day of vaccination. There were a few occasions when the girls met with the nurses 
before the day of vaccination, particularly when the nurses came to the schools to talk to 
them about the vaccine during assemblies. 
 
 “The nurses came in and told us about it, what it was going to be like. We’d seen like a 
PowerPoint thing…what it would benefit, when you have it and telling you like the pain 
and not to worry about it and all that…They just said you can get cancer and I think 
because we all kind of know what cancer is and it’s bad that, yeah, they didn’t really 
need to say that much.” [White British girl 22, School 14] 
Compared to how much the students talked about their parents and their social 
interaction with peers, relatively little attention was given to nurses. However, the girls’ 
accounts showed that the students had positive attitudes about nurses:  
 
 “They [nurses] are just helping people get over their fear…” [White British girl 21, 
School 14]. For example, “the first time I was scared what are they going to do but the 
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second and the third time I really trusted them because they were really nice….” [Asian 
girl 34, School 7]  
  
 The talks between the students and the nurses related mainly to whether the injection 
would be painful or not. One of the girls said “I asked the question to the woman, I said, 
‘Does it hurt?’ because I thought, because everyone else was saying it hurt, and I said, 
‘Does it hurt?’ and she went, ‘Well let’s say this, I’m not going to lie, it will hurt a little 
bit, you’ll feel a little pin prick, but it won’t hurt as much as if you did get cancer’ ”.  
[White British girl 37, School 9] 
  
 Building trust was an important thing for nurses in their relationship with the girls. One 
of the nurses said “you should try and tell them that what will happen is normal and will 
go off because I don’t want to say something that’s not right because they will not trust 
you again….” [Nurse 2] Another nurse gave an example of such a conversation with the 
girls: “‘it’s going to be more painful if you hold yourself very tense, if you calm down 
and relax it’s much easier to get the vaccine and will be less painful’…we play like dolls 
when we get them to have their arm flippy floppy if you can get them to do that.” [Nurse 
7] 
  
Another important component of nurse-girl communication that facilitated a positive 
relationship was listening to girls’ worries to know how to addresses their concerns. 
One of the nurses made the remark: “We often say ‘come and have a chat with us and 
tell us why you are worried about it…the reasons why you don’t want it…and a lot of 
the time it’s just reassurance, that’s what they want” [Nurse 3] “A bit of encouragement 
and that is enough.” [Nurse 2]  
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Sometimes, the nurses’ attempts to convince the girls to be vaccinated in the school 
were not successful. Nevertheless, the nurses took a flexible approach and offered them 
the opportunity for vaccination at a later point in time:  “…we’re not going to force 
anybody to do anything … you can only advise and reassure them and promote the 
vaccine…”. “…There is provision made for them to have it a later day if they are not 
sure or want more time.” [Nurse 6] “…If they are really anxious about it [injection] 
then we can say ‘well, you can contact your parent if you want to, if it makes you feel 
better or your parent can bring you down to the clinic and  you can come down with 
your mum’, or ‘we can always catch you when we come back and do the next vaccine’, 
so that’s another way around it, there are options we can take…at the end of the day 
it’s their decision... .” [Nurse 3] A nurse expressed the idea that one of the most 
successful options was to offer a mop-up clinic: “we give them the option of clinic 
because some people would rather be with their mum when they have the vaccine 
because they’re worried, they’re scared and they don’t want to be worried and scared 
in school, but if they’re with their mum in clinic it’s all right.  That’s a couple of the 
ways that we get over it.” [Nurse 9] A few girls explained that in their opinion some 
girls wanted to be vaccinated in the clinic because “She [the girl] wanted her mum to be 
with her to comfort her” [White British girl 18, School 6] “to talk to [her], to get [her] 
mind off” [White British girl 41, School 14], “making [her] feel better about it 
[injection].” [White British girl 37, School 9] These views indicate that for some girls, 
not the majority, being with their mother was the preferred option. 
 
This section indicated that the nurses played a significant role in girls’ reassurance 
during the vaccination session as well as in catching up the girls at the clinic when they 
postponed the vaccination for whatever reason. 
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In summary, the analysis showed that the main facilitators to HPV vaccination were 
parental consent as Gillick competence was difficult to be applied for year 8 girls. The 
role of the families was reported as important by the girls in overcoming their fears of 
injections as well as the opportunity to discuss the information with them. Other 
important facilitators were their peer groups of friends which provided information and 
emotional support in dealing with the injection on the day of vaccination. Nurses also 
played a significant role reassuring the girls during the vaccination session in the school 
and catching up with other girls at the clinic. 
 
7. 3. 3. Theme 3 - Barriers to HPV vaccination 
This section of the findings is an analysis of the barriers to uptake of the vaccine from 
the interviews with staff, health professionals and the girls. 
 
7. 3. 3. 1. Fear of injections 
The girls had different experiences of uptake of vaccination. One of the themes that was 
common to many of the interviews with the girls was the expressed feelings of anxiety 
about needles. Two school staff expressed their opinions that “It’s the needle that they 
are frightened of, not the fact that it is a HPV injection” [Support staff 20, School 14] 
and “…It’s a little bit of panic on their part that they are going to have this needle and 
they are going to have it in school and their mum is not going to be there to hold their 
hand.” [Teacher 19, School 6] 
One of the nurses said “You get the ones that sit down and they can be a bit stroppy and 
a bit bolshie like, ‘I’m not having it, I’m not having it’, and you say, ‘Why are you not 
having it?’ and, nine times out of ten it will be, ‘Because it hurts’ .“[Nurse 9]  
A girl explained “It is like the fear of you thinking about the pain will bring more pain 
to you … [I] didn’t know how to react with it….” [White British girl 21, School 14] 
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A Muslim girl said, “I can’t have an injection because I’m afraid of blood coming out of 
me, I don’t like anything to do with taking out my blood, because I get really afraid.” 
[British Asian girl 39, School 9]  
Another girl added, “I just forgot all of the stuff really like the important things like you 
don’t want to die from it [cervical cancer]. I just forgot that and my mind went blank. 
So I was like, ‘I don’t want to have this anymore’.” [Slovakian girl 40, School 9]  
The nurses were clear that they did not vaccinate girls against their wishes. 
Therefore, “even if the parents want to give it to them [the girls], kicking and 
screaming, they’re not going to have it, then we [the nurses] are not going to force them 
to have it.”  [Nurse 8] 
One of the nurses described how these reactions could affect the process of vaccination. 
As she said and as I observed at the schools, the nurses had the tendency to become 
authoritative in some cases to overcome these obstacles.  
“Sometimes it takes ages before we get [the girls vaccinated] although they signed the 
form, the parents have consented and the very last minute just when you want to put the 
needle into their arm they move and they don’t want it which is quite dangerous to the 
nurse and to the person you inject if they move, so we have to coerce them by saying 
that ‘You signed the form, go back to the class then or come to clinic’ and then they will 
very often will say ‘All right do it’….” [Nurse 4]  
The fear of the needle of some young people affected not only the nurses’ work but the 
attitudes of the other girls waiting to be vaccinated also. A nurse said that “…the only 
thing is it [girls’ fear] will very often set off the rest of the group.” [Nurse 4] For 
example, the account of one of the girls illustrated a change of her feelings created by 
mass vaccination setting: 
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“When I was standing there, I saw some of the girls screaming that made me feel much 
more scared about maybe something is going to really hurt and maybe I’ll start 
screaming and crying just like other girls sitting there.” [Polish girl 12, School 6] 
In addition, the rumours spread by peers made the girls feel scared as highlighted in the 
following quotes: “They [the girls] hear rumours that it is going to really hurt and 
‘your arm is going to fall off’ and silly things…and I think that’s what puts them off, so 
they get quite nervous.” [Nurse 9]  Social interactions with peers affected young 
people’s attitudes and decision-making about the vaccine. One of the students made the 
comment “They [the girls] might ask people’s opinions and what if they give bad points 
about it [vaccination] and not good.  So they might think ‘okay, that is not good so I am 
going to tell my mum and dad I am not going to take it’.” [Asian girl 34, School 7]  
The girls and nurses were clear that there was talk amongst themselves about the 
vaccination that sometimes scared them. “Girls joke around a lot and you don’t really 
know when they are going to be kidding or telling the truth.” [White British girl 21, 
School 14] “People will tell them horrible stories about vaccinations especially the boys 
and probably older girls as well who were very frightened and pass on to the younger 
sisters.” [Nurse 7]  
“Some people just try to worry people on purpose…because they want you to worry 
more than they worried about it [injection]. They want you to feel as scared as they 
did.” [White British girl 38, School 9] There were also some concerns about the health 
professionals, which demonstrated a lack of trust. A Muslim girl stated that “if the nurse 
puts the injection in, then if it goes in the wrong bit they’ll have to put it in again or it 
will come out. It was really scary when people say stuff like that. She [the girl] was 
asking, ‘Is it going to be qualified nurses?’ And the teacher was like, ‘No, we’re just 
going to go and pick someone from the street and say put the injection in.’ Then 
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everyone started laughing because some people think that the nurses won’t be trained.” 
[British Asian girl 39, School 9] 
For instance, a Hindu girl expressed her view that “They [the nurses] may have identity 
but…it’s fake identity that they could have just made fake badges. If they were in fact 
fake nurses, they [the girls] don’t know what’s going into their body.” [British Asian 
girl 32, School 7] 
Another issue was the possible side effects of the vaccine. A girl, who was not 
vaccinated, said “My mum and my friends in the school told me about different after 
effects [that] you might get a little bit of a cold and you might get another kind of 
cancer from getting the vaccine.” [British African girl 17, School 6] The perception of a 
Muslim girl was that parents influenced their friends’ beliefs “…Maybe they've [the 
friends have] had this idea from their parents or they had it from other friends which 
they had from their parents.” [British Arab girl 35, School 7] Another girl confirmed 
the point mentioned above that her parents  shaped her negative attitude “…They  heard 
something from other people like they had it [HPV vaccine] or someone from their 
family had it and something happened so they don’t want [me] to have it. If you haven’t 
read anything on the Internet you don’t really know what the results might be cos some 
people became disabled after vaccination but a higher amount of people ended up 
dead”.  [Poland girl 15, School 6]  
This section demonstrated that peers and family influenced their feelings about having 
the injection and its possible consequences.   
 
7. 3. 3. 2. Attitudes about the effectiveness of HPV vaccine 
In the interviews, several of the girls brought up issues related to the perceived 
ineffectiveness of vaccines.  
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A Hindu girl explained, “That all vaccines can’t be positive, it doesn’t have much of a 
chance, there may be like, I don’t know, 10% of a chance that you still get cervical 
cancer even if you’re vaccinated.” [British Asian girl 32, School 7] 
A girl discussed the vaccine with her family and made the remark that she could not 
trust it  ‘How do you know that it [HPV vaccine] stops cancer because I am not sure if 
they’ve tested it…cos say ‘someone has cancer and they give the vaccine, I am not sure 
the cancer is gonna go away, I don’t think that there is any way really to know how it 
actually works.” [African girl 14, School 6] 
Another girl expressed this view about unreliable information: “Some companies might 
be fake. They just want to make the vaccine for the money [and] it won’t work...some 
companies [produce] the actual vaccine and it will work [but] probably they didn’t test 
it on children at all, they probably tested it on, I don’t know what, like hamsters, not 
actual girls… If the people that make the vaccines say a better one [HPV vaccine] is 
coming then I don’t think that’s much use of giving the present one to the daughters and 
if they say the present vaccine is good, then [they should] give us more information 
about it how it can help us.” [African girl 17, Student, School 6]  
In addition, there was an idea expressed that other countries have a different HPV 
vaccine or policies than that provided in the UK. For example, “They [countries] have 
different health care, maybe they [providers] might put a different solution in the 
vaccine so it might not work as the one here although the one here might not work as 
well. They [countries] might have different sciences that make it, different people and 
they might have different views about it.” [White British girl 18, School 6] 
These excerpts from the interviews with the girls at the schools demonstrate that in 
addition to fearing injections, for some there was a lack of trust in the nurses and a lack 
of belief that the vaccine was effective or safe. 
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7. 3. 3. 3. Girls’ knowledge about HPV vaccine and cervical cancer 
The analysis showed the girls had several sources of information about HPV vaccine 
and cervical cancer such as the school, family and friends. The findings presented in the 
other two sections above, related to the delivery of HPV immunization in the schools as 
well as to facilitators to HPV vaccine uptake, indicated that the information from these 
sources differed. The girls in some schools found out during tutorials, which focused on 
the vaccine rather than cervical cancer.   
‘It was just really about the injection, it wasn’t really about where it [cancer] is.  I think 
I would have liked to find out a bit more about that.” [White British girl 37, School 9]  
“They don't really tell us much but they basically just made it basic for us. They said 
that you are going to have a jab for HPV, something to do with cervical cancer, and 
they said that it’s, yes, that's all they said.  It wasn't very in-depth. They didn’t give us a 
lot of information.” [British Arab girl 35, School 7]  
A few girls tried to explain the little information provided in the school. One girl made 
the remark that “None of the teachers actually talked to us about it [vaccine]…..they 
might not know much about it.” [White British 18, School 6] “…The doctors could be 
reliable because they know more about it.” [British Asian girl 27, School 7] Other girls’ 
discussions highlighted that limited information in a mixed school was related to this 
vaccine being for girls only. One girl said “She [the Head of House] was talking about 
it [HPV vaccine] in that lesson [assembly] because there are all girls…so it would be 
weird to hear about…going to the boys...because the boys don’t have it done because 
it’s just for the girls.” [White British girl 10, School 6]  
“… I think it would affect the boys because you know boys like to know what happened, 
how it happened, did it hurt and that.”  [British Asian girl 25, School 7]  
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Another girl thought that learning about HPV vaccine in tutor groups was a barrier to 
asking questions. She said, “…because it isn't just like me and the tutor, she had to sort 
out the rest of the [class].” [White British girl 42, School 14] However, a tutor 
encouraged the students to find information themselves “If you want to look for more 
information, it [letter] would give you some websites to visit.” [British Asian girl 32, 
School 7] The girls reported there was limited time and limited information in the face-
to-face sessions at the schools but more information in the letters. When I asked the 
girls if they had read the materials about HPV vaccine received from the school, many 
of them reported that they had not read the letter which was sent to parents.  
 “I didn’t read all the letter…” [White British girl 16, School 6]  
“…just the important parts...” [British Asian girl 32, School 7]   
“…my mum read it…I didn’t read”. [British African girl 17, School 6]  
Some girls gave different reasons. A Muslim girl said that, in her case, the teachers 
influenced her “Because I thought it was for parents.  They [tutors] said to give it 
[letter] to your parents.” [Asian girl 29, School 7] Another Muslim girl explained that 
she felt negatively towards the vaccine which affected her intake of information. “At the 
time when I got the leaflet, I was adamant that I didn’t want to get it, that’s why I briefly 
read through it, I didn’t really read through it properly because I did not want to have 
the vaccination.” [British Asian girl 27, School 7]  
The girls’ knowledge about cervical cancer was limited. The girls’ views on the location 
of cervical cancer: “I think it was breast cancer, I am not sure” [Polish girl 12, School 
6], “It’s like when we have a baby” [British Asian girl 13, School 6], “It is somewhere 
like your ovaries or something near there” [Asian girl 23, School 14] and “It’s like 
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something that you could pick up from someone else that you could get from sexual 
contact.” [African girl 14, School 6] 
When discussing why the HPV vaccine is given to girls aged 12-13 years old, the girls 
expressed contrasting views.  
“I’m not actually sure why we are vaccinated at this age, but I think because it might 
give us a bit more protection because we’re younger.” [White British 18, School 6]  
“It [HPV vaccine] can just stay in your body and if anything happens when you start to 
change your body, when you get older, it can protect you.” [White British girl 16, 
School 6]   
“…This is like a mature age when people are actually starting to grow up. Young 
people might just take it as a joke” [White British girl 21, School 14]   
“…We’re like starting our periods at this age and that’s when you can get pregnant”.  
[White British girl 22, School 14]  
Despite having been vaccinated, the students were unaware of the relation between 
sexual behaviour and HPV. Some of them did not make the connection between the 
vaccination and relationships while others were very clear about this link. Some of the 
girls’ comments reflected that they thought it would not change their behaviour. 
“A vaccination wouldn’t have anything to do with a relationship. If you ought to be out 
somewhere, you wouldn’t really behave differently because of the vaccination.” [White 
British girl 16, School 6]  
“Because it [HPV vaccine] wouldn’t disturb you and all it will do is just protect you 
and you will just lead your normal life.” [British Asian girl 32, School 7]   
“People don’t tend to remember the past or what injections they had, so I don’t think it 
[HPV vaccine] will affect their relationships.” [Mixed British girl 28, School 7]  
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In contrast, some other girls mentioned that despite of the fact that they felt safer after 
vaccination, they would “think twice for doing anything.” [African girl 14, School 6] 
For example, a girl said “I think I would always be careful. Once I’ve had the injection, 
I’d probably be a bit more like, ‘Oh, it’s okay though,’ but I’d still be very 
cautious…like when you want sexual intercourse with them [boys], just be very aware 
of what could happen or what it could cause…they could have something and they 
could pass it on to you.” [White British girl 44, School 14] 
Another girl made a similar point “In a relationship between boyfriend and girlfriend, 
like when they’re older, I think the girls might be a bit protective, because they’ve had 
jabs and they don’t want to ruin the chance of the jabs, so they might ask their 
boyfriend to get tested…sometimes it [HPV vaccine] might not work, then [if] he’s got 
something that she could catch, then she could…get really ill, and it’ll be his fault, sort 
of, but he wouldn’t even know that he’s got anything if he doesn’t get tested.” [White 
British girl 38, School 9] 
These expressed views showed that the majority of girls had a poor understanding of the 
role of HPV vaccine as well as of the link between the vaccine and sexual behaviour. 
 
7. 3. 3. 4. Parental refusal of HPV vaccine 
7. 3. 3. 4. 1. Parents’ understanding of HPV vaccine 
No parents were interviewed but teachers and students and nurses had views about 
parental attitudes based on their contact concerning consenting to the vaccine being 
given to their daughters. The data is therefore based on what was reported second hand. 
Teachers thought some parents’ decisions not to vaccinate their daughters were 
influenced by their views about the HPV vaccine. A teacher explained that “They have 
been spoken to on the phone…parents, but usually they have made up their mind quite 
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categorically that they don’t want them [girls] to have the vaccination…and that’s 
it…and obviously we have to respect that decision”. [Teacher 33, School 7] 
In the opinion of the participants, some parents did not want to justify their decisions to 
others and the teachers felt that sometimes cultural factors were relevant for some 
parents from ethnic minority groups. One of the teachers gave the following example: 
“The only barriers that we have occasionally, we have parents who refuse that the girls 
to have the vaccination. They don’t feel that it’s something that they want and they do 
not always tend to give you a reason, they don’t feel that they have to justify their 
reasons to us… The very first year we did have a parent that refused the vaccination 
and he actually had twin daughters. I think that he very much felt there was the risk of 
the girls becoming sexually active sooner than they should. I mean the culture that they 
came from was very protective, very innocent … I know that the language was Tamil, 
but I can’t remember the country...the father just didn’t want the girls to have it. From 
what I gathered, it was a cultural thing, but he didn’t really give me anything specific.” 
[Teacher 19, School 6] One of the nurses expressed the view that “The ethnic groups do 
not tend to put the reasons for refusal… we do put a space saying ‘why do you refuse?’ 
but they don’t comment...they just leave that part blank.” [Nurse 8] This quote could 
suggest that either the parents wanted to keep secret their reasons or that they had 
language difficulties in understanding the form.   
Some girls felt that the reasons for refusal were private. “Some people like to keep their 
reasons away from other people…and it’s private.” [Mixed British girl 28, School 7] 
For example, “one of my friends said that her mum wouldn’t let her have it. But, she 
didn’t give the reason... She just said ‘My mum wouldn’t let me’.  I think she knew why 
her mum wouldn’t let her, but I think it was just personal and she just wanted to keep it 
282 
  
to herself. She wouldn’t even tell her best friends and they’re really close together.” 
[White British girl 38, School 9] 
However, the data from interviews indicated that participants had various opinions 
about the factors that might have affected parental decisions regarding HPV 
vaccination. One of the nurses mentioned that a potential factor was lack of 
understanding of the information about HPV vaccine that the parents received from the 
school. “I think that there are people across all ethnicities that will say ‘no’ often for a 
reason, the fact that they really don’t understand about it [HPV vaccine], maybe they 
don’t take on board what the leaflet says”.  [Nurse 7] A Muslim girl said “Parents 
would just think it’s useless [vaccine] because...they [parents] don’t know anyone who 
has died or got the disease or been affected by the disease”. [African girl 26, School 7] 
Another Muslim girl gave a view about parents being influenced by experiences from 
their country of origin. “Some of my friends’ parents didn’t let them have it [HPV 
vaccine] because they thought it was a waste of time to have it…my friends said that 
their parents said ‘It doesn't normally work’ and they never said why they said it. I think 
that they think that the other injections that people have got, but they have still got 
cancer. My friend is from Afghanistan. She said that some people from her mum’s 
country had it [injection] and it never worked and their country has a lot more diseases 
than they should have and it got worse”. [Asian girl 29, School 7] 
In their discussions, several of the participants brought up issues related to some 
influences affecting parents’ understanding. Two interviewees felt that the parents did 
not make time to read the information about HPV vaccine.  A teacher said “There are 
really some parents that we have got, that have no interest in whether their child has an 
injection or not...] ‘it is another letter, another form, can't be bothered’…it is maybe 
just that, not anything against the injection”. [Support staff 20, School 14].  
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Similarly, a nurse explained “A lot of parents don’t have time to read 
materials…because sometimes the questions they asked [us]… it’s obvious that they did 
not read it [letter] properly and they made a presumption …We had some parents 
[who] believed that it is MMR that we are offering”. [Nurse 8]  
Parents’ lack of English was felt to be a factor affecting their understanding of the 
materials related to HPV vaccination: The problem is that we don’t know what language 
the parents speak beforehand so they have just got something in English and unless 
somebody comes back to us and say if we have any information in a different language, 
which has never happened, we don’t know how much they understand…We haven’t the 
time or capacity to look at how big it [the problem] is...this is just something that I 
suspect from a lot of foreign names for the refusals”. [Nurse 8] Another nurse 
confirmed that   sources of help for these people with language barriers were limited “A 
lot of the time it’s very unlikely as well [for them] to maybe try and source somebody 
who could help them out with that”. [Nurse 9] 
Based on the minimal information which I obtained from the school staff it appeared 
that “in the last three years only…a handful [of parents] at the most” [Teacher 33, 
School 7] needed interpreters. 
A  Hindu girl expressed her belief that the parents did not have enough knowledge 
about the HPV vaccine because of their limited access to information: “A lot of people 
may not trust what’s in the vaccine and people’s parents might not consider to get this 
because they don’t know a lot about this vaccination and some people may not have a 
computer at home that they can do more research on so that’s where they would have 
second thoughts on getting this done”. [British Asian girl 32, School 7] 
A nurse mentioned parents’ level of education as another factor that could have 
influenced their understanding of the information about HPV vaccine: “Level of 
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education comes with everything and people’s understanding and their interpretation of 
what the programme is about must have a major effect on what they are going to agree 
or their child to have the vaccine”. [Nurse 6] 
 
This section showed that parents’ understanding of information about HPV vaccine 
played an important role in decision-making for uptake of the vaccine. The factors that 
influenced parental levels of understanding were their level of English reading, 
education, and experiences in other countries of origin. In addition, parental views were 
reported as diverse concerning the desirability of the vaccination. A nurse said that 
parents were more likely to have a negative perception of the vaccine if they found 
information that it was for the prevention of a sexually transmitted disease: “You get the 
very intelligent persons...They’ll have done their own research, they’ll have heard 
something about the vaccine that they’re not happy with...I think that has something to 
do with the fact that it’s got this negative image, that it’s for a sexually transmitted 
disease ...and instead of maybe actually talking to one of us, or phoning us up, because 
the information that they get given has got our number if they want to phone us and ask 
us any information, they don’t do that.  That doesn’t happen.  I don’t get a parent 
phoning me up and saying, “I’ve read this, this and this.  Can you tell me if that’s 
true?” [Nurse 9] 
The participants’ discussions about factors influencing negative perception of the 
vaccine in relation to sexually transmitted diseases centred around three issues. Some 
parents were reported to think that their daughters were not at risk of getting a sexually 
transmitted disease so this was a barrier to vaccination: “They [parents] don’t believe 
their child is at risk with HPV, so it’s not necessary.  It comes down to the importance I 
suppose, doesn’t it?  Do they see it as a vaccine that’s needed, important? and they say 
‘no’.” [Nurse 9] 
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Some nurses thought that parents might feel that the vaccine would promote sexual 
activity. “People think it is a sexual vaccine” [Nurse 7]   
“The main barrier I think is people’s attitudes towards vaccinating young girls against 
a sexually transmitted infection which is essentially what HPV is...A lot of parents don’t 
want their child vaccinated because they think that’s leading children into having sex, 
sexualizing children, and people say ‘oh, sex! No! Can’t be vaccinated because is to do 
with sex, she might have sex if she has this vaccination because she thinks she is 
safe’…they didn’t want to promote them having sex until they are 16. ‘Why should they 
have it in year 8 at such a young age?’ because they didn’t feel that their child will need 
it.” [Nurse 5] One teacher expressed her opinion about the possible impact of parental 
views on adolescent sexual behaviour in some cultures. She said,  
“I think some cultures as far as women are concerned they have to be very monogamous 
in terms of their sexual relationships and it all has to happen under certain conditions 
and at certain times.  And any thought of any kind of promiscuity or even different 
sexual partners at all is just something which is not supported in any way.  I think the 
idea of this vaccine with sexual activity is one of the reasons why people who have those 
strong feelings feel that it is not appropriate for their daughters…But that is only a 
hypothesis…From just a couple of conversations with girls, and that is all I can base it 
on, nothing else, I don’t have any hard evidence other than what the girls have said, is 
that their dads feel that it would encourage them to be sexually promiscuous or sexually 
active even...I just think from what they see, from what they hear, from what other 
people say to them, from what they just think and believe themselves, I think they 
consider it to be connected with sexual activity.” [Teacher 33, School 7] 
Some participants made a clearer distinction between culture and the religion. A student 
felt that religious faith was a reason for which the parents declined the vaccine: 
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“Religions have rules they need to follow. And if it says, like for example the girls with 
the headscarf, ‘You are not allowed to take your headscarf off, only when you are 
asleep or something’, they would obviously follow that.  And if it said something like 
‘You can’t have this vaccine’ then they would obviously follow that”. [Slovakian girl 40, 
School 9] 
A teacher highlighted the importance of religion in refusal of the vaccine because of 
parental beliefs in their daughter’s sexual abstinence until marriage. In her view, the 
parents felt that their daughter did not need the vaccine because she was supposed to 
have only one partner in her life: “they [parents] think they don’t need it because their 
religion is that they will have one partner and that you can’t get cancer through having 
the one partner….A lot more of the Asian families, religious families… didn’t want to 
have it [HPV vaccine] done…it is just this ‘my daughter is not going to have sex until 
she is married, so it is not going to affect her, she won’t get it’. “  [School staff 36, 
School 9]  
A Muslim girl affirmed that premarital sexual intercourse is against some societal norms 
“…in Islam they say that you shouldn’t do that action that causes the cancer, like you 
are only supposed to do it after you are married, not before…then there’s no point in 
taking the injection because some religions don’t believe in doing that [action].” 
[British Indian girl 27, School 7] A nurse mentioned that “in my experience it seems to 
be the Muslims and particularly Pakistani families...I think is a cultural thing that the 
girls remain virgins until they marry…” [Nurse 5] Another nurse noted that “a lot of 
Catholic parents will put on the refusals for the consent form ‘we believe in monogamy 
and my daughter will only have sex with her husband’.” [Nurse 8] These quotes 
illustrate the existence of socio-cultural differences in sexual attitudes and behaviour 
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and parental views of their daughters’ low susceptibility to HPV infection because of 
future monogamous relationships.  
In comparison with these views, other opinions expressed by the participants were 
related to young men. A nurse explained that the younger generation of men does not 
conform to religious rules and this increases their susceptibility to HPV infection.  
“‘If you can guarantee that your child, your daughter’s partner has never had any other 
partners then they don’t need, they aren’t susceptible to HPV, they won’t need the 
vaccine, but unless you can guarantee that, there’s still a risk’….and I think a lot of 
parents, regardless of quite a few, regardless of religion and culture will realise they 
can’t make that guarantee…in my belief and what I’ve heard from other people, there 
are plenty of male Muslims who do have lots of sexual partners before they marry.  
They’re not inclined to just have no one and like Catholics, you don’t have any sexual 
partners before marriage, it’s the one and only partner you should have and I think 
whereas a lot of Catholics are realistic in this day and age, that doesn’t happen .” 
“if you just explain to the parents that you only need one partner and if that partner 
carries HPV, it only has to be one person to pass it to you for you to then carry it and it 
lay dormant in your body… I have had one parent and sort of on the grounds that she 
said, ‘Well my daughter is not going to sleep around, my daughter is not going to have 
sex before she’s married,’ and she was quite adamant she didn’t need it, but when I 
then explained a bit more about the virus and the vaccine and said a bit more, that 
condoms won’t necessarily protect you, she was quite shocked at that….” [Nurse 9] 
Several girls talked about people’s reliance on divine power of protection as an 
alternative to vaccination. “They [parents] probably believe in just God helping” 
[African girl 26, School 7] and “God is protecting my child.” [White British girl 38, 
School 9]  
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“When they [parents] pray to God probably they think that everything is going to be 
fine, nothing is going to happen to us…they don’t believe in nurses and doctors.” 
[Asian girl 34, School 7]   
A nurse expressed the view that some parents’ thought that the vaccine could have 
adverse effects on fertility: “You won’t be able to have children if you have the vaccine, 
a myth…that I did hear from a young girl from an Asian family.  I’m not sure what their 
religious background was, but it was an Asian background and she had been told by her 
elders, a member of her family, an aunty, that now she’s had the vaccine she won’t be 
able to have children.  Now, if the rumours and myths like that go round in families then 
that’s going to put people off”. [Nurse 9]  
A nurse felt that people did not trust HPV vaccine because they did not trust the 
vaccines in general: “A very, very few [parents] don’t believe in vaccination at all.  
They’ve never had their child vaccinated with any of the childhood vaccines.  I don’t 
think you’ll ever convince that parent that it’s [HPV vaccine is] good to have.” [Nurse 
9]  
This section showed that interviewees thought that the parental reasons for vaccine 
refusal were religious beliefs in risky sexual behavior after vaccination, beliefs in 
daughters not being sexually active before marriage and distrust of vaccines. 
  
7. 3. 3. 4. 2. Concerns about the safety of HPV vaccine in the aftermath of the 
death of a girl 
 
Another expressed view was that some parents thought vaccination is unsafe. The 
reason for refusing that their daughter to participate in the vaccination programme was 
fear of adverse events about which they found out in different media sources. A girl said 
“I think that British parents might not trust it [HPV vaccine] because…maybe things 
that they’ve got on the news they might be worried about so they might not want to have 
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it done.” [White British girl 18, School 6] A girl who was not vaccinated described how 
information on Internet affected her parents attitudes towards the vaccine and their 
reasons to decline it: “They [parents] went on the Internet to read more about it [HPV 
vaccine] after they got the letter and then they found out everything about it and told me 
like it’s better for me not to have it because of what they read that high amount of 
children that actually got the vaccination and they actually died or became very very ill. 
My mum said to me that with the vaccination or not the results will be still the same like 
I might have it [cervical cancer] or I might not.” [Polish girl 15, School 6] 
 
Other girls talked about their parents’ opposition to HPV vaccine because of mistrust of 
a medical intervention provided in school environment. An unvaccinated girl  
mentioned that “They [parents] might feel a bit anxious about their daughter getting it 
because…it’s happening in the school and not like in a professional hospital and people 
might not be sure about what they actually get … My mum said ‘no’ because she 
doesn’t want her child to get sick...yeah, until she is fully grown”. [African girl 17, 
School 6] All nurses talked about an incident in the city when a girl died that was a 
significant barrier that influenced parents’ decision concerning the uptake of the HPV 
vaccine. “We’ve experienced  one  major barrier...a child fell ill on the day of 
vaccination and that was a massive barrier  because everyone associated the girl’s 
illness with the vaccine which was proved not to be the case...So I think that was a big 
hurdle to get over because it did affect the uptake of the vaccine and people’s attitudes 
towards the vaccine…Some people said that they don’t want to have it and wanted to 
wait and some of them had it a year later when everything settled down.” [Nurse 6] 
Several nurses discussed the relation between the incident and uptake of the vaccine: 
“Everything stopped I think all around the country, I would imagine, until they looked 
into what had been the cause….” [Nurse 2]  
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“I think the first year we had over 90% [uptake], we were the highest in the country for 
all three vaccinations and I think in the end it dropped down to 40-50% that year.” 
[Nurse 4]  
“Because obviously everyone, girls included, were very unsure of the [HPV] vaccine.  
That was still on a lot of the girls’ minds, especially in 2010, 2011 ...We lost a lot of 
confidence with it [HPV vaccine] then.  There were lots of questions about the safety of 
the vaccine… a lot of girls would ask ‘What about that girl that died?’, so even though 
their mum had said, ‘Yes you can have it’, they still had that doubt in their mind.” 
[Nurse 9] 
Intensive vaccine promotion through various channels followed after the incident to 
remove people’s doubts and to clarify  that the incident was not a side effect of the 
vaccine: “We had a member of the Health Protection Agency, a gentleman, a head of 
health protection in [name place] who went along with us to every single vaccination 
session sitting there waiting for the girls to ask for any questions, waiting for the 
parents to ask for any questions, staff to ask for any questions who were there...and that 
person helped and the media, the newspapers, the journalists, TV, everything helped us 
and particularly the family...” [Nurse 4]  
In summary, the barriers to uptake therefore were fear of injections, concerns about 
safety, the impact of the death of a girl several years ago.  
 
7. 4. Summary 
The above analysis has identified a number of issues affecting the implementation of 
HPV programme in secondary schools. It has shown that the school based HPV 
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vaccination programme was accepted by all the schools but one
29
 in the city of study. 
The schools were used as a setting for the delivery of the programme for group 
vaccination by a mobile clinic aiming to vaccinate all eligible girls. The analysis has 
indicated that the organization of a school-based HPV programme was resource 
intensive in terms of staff, time and space. It appeared that the school staff had a part in 
the successful delivery of the HPV vaccines in their schools. Although their role in 
distributing and collecting the consent forms to obtain informed consent from the 
parents of the girls was one of the most challenging activities in the HPV vaccination 
administration, it was essential for a high HPV vaccine uptake. Despite the fact that 
HPV vaccination programme is not compulsory in the UK, the school and nursing staff 
faced the challenges of routinizing the delivery of this programme within the schools. 
The manner in which the school staff sought parents’ and girls’ consent was often 
persuasive through repeated phone calls to reach the parents, keeping secret the date of 
vaccination from parents and girls and having individual discussions with the girls; but, 
they believed this was the most effective strategy for gaining parental and girls’ 
cooperation. Also, the analysis pointed to the fact that the HPV vaccine was promoted 
in a limited way in school environment owing to time pressure in the curriculum for 
compulsory subjects. 
   
The analysis has identified a number of important facilitators affecting uptake of the 
HPV vaccine. It has shown that parental decision was the most important facilitator for 
getting the girls vaccinated. This was because applying Gillick competence, overriding 
parental lack of consent, was a challenging task and nurses hesitated to put it in practice 
for year 8 girls. Health care providers played a crucial role in the delivery of persistent 
messages about HPV vaccine to parents across all ethnic groups to bridge their 
                                                          
29
 a private Muslim school 
292 
  
information gaps, to help them in the decision making process and to obtain their 
consent. The analysis has shown that a number of different influences such as parents, 
friends and nurses affected girls’ choices. The girls had different levels of social 
interaction with all these people. Family played the most important role for daughters’ 
emotional support as well as the provision of information to help them understand and 
make their own decision about the vaccine. The interactions with friends and nurses 
were beneficial for students’ confidence and feelings on the day of vaccination to get 
the injection. The girls’ discussions about factors influencing their own choice centered 
around two main things: pain of injection and uptake of the vaccine by peers. 
Also, the analysis has pointed to several barriers affecting uptake of the HPV vaccine. It 
showed that girls’ fears of injection, caused by their fear of pain and also their limited 
knowledge, rumors spread by peers and parental negative attitudes about the HPV 
vaccine, were major obstacles to uptake before and on the day of vaccination. The 
students’ discussions about HPV vaccine, cervical cancer and future relationships 
highlighted their gaps of knowledge about the link between HPV and sexual behavior. 
Parents represented a significant factor in declining the vaccine because of inadequate 
information obtained from other sources than health professionals, their concerns about 
the safety of the vaccine and their religious beliefs related to their daughter’s future 
sexual activity.  
In the next chapter, I present the main findings from each section of the thesis, the 
strengths and limitations, comparison with other studies and recommendations for 
policy, practice and future research. 
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CHAPTER 8: DISCUSSION 
 
In this chapter, I summarise the main findings from each section of the thesis in relation 
to the original research questions, highlight the strengths and limitations of the present 
study, discuss the relationship between the findings and the results of previous research, 
discuss the implications for policy, practice and future research, and end with a broad 
conclusion. 
 
8. 1. Principal findings 
I have described my study area, including epidemiology of HPV infection, HPV 
vaccine, and implementation of HPV immunization programme in Europe (in Chapter 
2), as well as access to health services measured by utilization of health services and 
equity as a sub-component of access and as one of the main dimensions of quality of 
care (in Chapter 3).  
I have done two pieces of empirical work. The first piece was a cross sectional study 
related to a national health promotion intervention about HPV vaccine targeting 
secondary schools in the UK (in Chapter 4) and the second piece was a mixed methods 
research related to the delivery of HPV vaccination programme in secondary schools in 
a city in the West Midlands (in Chapter 6 and 7). I have discussed the methodological 
issues including the study design, data collection tools and data analysis for each study 
(in Chapter 4 for the national study and in Chapter 5 and 7 for the West Midlands study) 
which I chose following the review of literature and discussions with my supervisors 
and statisticians. I selected the variables in the quantitative studies (in Chapter 4 and 6) 
that were available and I considered most relevant to my research questions based on 
the published literature. The findings related to each study are summarized in the next 
three sections. 
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8. 1. 1. Results of the national study 
A scoping literature review showed that the available information from health agencies, 
pharmaceutical companies, and special interest groups, as well as through the news in 
media and on the internet was unreliable. No evidence was found about health 
promotion of HPV vaccine in schools. Young people, parents, and the health 
professionals who advise them needed accurate and appropriately targeted information 
about HPV and the HPV vaccine through awareness campaigns. The impact of health 
promotion tends to be less in more deprived areas. This was the rationale for study 1, 
which addressed the research question related to the association between uptake of 
educational materials about HPV vaccine by secondary schools and area level, social 
deprivation in England. 
This study reported in Chapter 4 showed that around 30% of schools across the UK 
requested teaching packs. By country, the take-up of teaching packs ranged from 38.5% 
of schools in Scotland to 20.1% in Northern Ireland. In England, East of England had 
the best take-up rates (34%) and London (20%) and in the North East of England (21%) 
had the fewest requests.  
Modelling showed that those schools located in the least deprived areas in England had 
higher odds of requesting teaching packs than schools in the most deprived quintiles 
when the other factors (the GOR, school type and school size) were held constant. After 
controlling for other school and geographic factors (school type, area deprivation, and 
the GOR), the largest schools had the highest odds of requesting teaching packs 
compared to the smallest schools.  
 
The findings of this work showed that the West Midlands had poorer take-up rates 
compared to the national level. My data did not allow me to make a statement about the 
proportion of schools in each city in England requesting informative materials. 
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Therefore, it was a need for further research that led to the case study in a city in the 
West Midlands to understand if uptake or non-uptake of educational materials, among 
other factors, had any influence on subsequent uptake of the HPV vaccine. This aim was 
addressed in a mixed methods research including two studies, one quantitative and the 
other one qualitative. Quantitative data was used to define the context of the study, to 
describe and to explain the variation in HPV vaccine uptake across secondary schools in 
a city in the West Midlands. The qualitative data supplemented the statistical results 
from the quantitative methods, and the statistical interpretation of relationships by 
adding meaning and context to them.   
 
8. 1. 2. Results of quantitative component of mixed methods 
research 
 
A literature review that addressed common determinants of the HPV vaccine uptake 
showed that there was a gap in relation to the influence of ethnicity and girls’ age on 
HPV vaccine uptake due to inconclusive evidence. Also, it identified that ethnic 
inequalities in health are largely a consequence of socioeconomic differentials (lower 
income and education) and of living in deprived areas. Deprived areas have the least 
available health services although they are most needed. Even if the delivery of health 
services is equitable, it does not mean always equality of uptake. This was the rationale 
for the quantitative part of study 2, which addressed the research question related to the 
association between uptake of the HPV vaccine by secondary schools in a city in the 
West Midlands and area deprivation, ethnicity or religion. 
 
The results showed that the third dose uptake by school varied between 65% and 100% 
with overall median uptake in each year of 90% in 2008/09, 75% in 2009/10, 86.50% in 
2010/11, 89.50% in 2011/12 and 86.5% in all years. Every year median uptake rates 
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were higher than the goal set by the WHO (70%). 19 schools out of 20 in the first two 
years and all 20 schools in the last two years of the HPV vaccination programme had 
uptake rates 70% or above 70%. Thus, I concluded that the programme was successfully 
implemented across the years. In this context, I looked at variation in uptake between 
schools located in high and low deprived areas (of SAP and SCA). I found that uptake 
rates were consistently over 80% in both high and low deprived areas (of SAP and 
SCA) across years, except the second academic year when uptake was over 70%, 
meaning that even in the context with a dramatic event following the HPV vaccination, 
the goals of the programme were met. 
While the lowest uptake was found in school 16 and school 2 repeatedly, the highest 
uptake was achieved by different schools across the years and in all years combined. It 
was noted that the percentage of non-white residents in SCA of school 16 was 65% that 
was the highest among all the other secondary schools included in the study. A similar 
high percentage of non-white residents was found in SCA of school 2 (54%). 
The unadjusted results indicate that there was a negative statistically significant 
association between deprivation of SCA and uptake as well as the deprivation of SAP 
and the academic year 2009/10 (the last was possibly associated with the negative event 
in 2009/10 described in detail in Theme 3 of Chapter 7). In the two multiple regression 
models (i.e. after multiple adjustments of other factors), deprivation of SAP remained 
statistically significantly associated with uptake after controlling for ethnicity, school 
type and academic year. Similarly, the academic year 2009/10 remained statistically 
significantly associated with uptake after adjusting for geographic and school factors. 
Deprivation of SCA was no longer statistically significantly associated with uptake 
when the other variables were held constant and the same was true for the association 
between ethnicity (proportion of white residents) and uptake.  
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In conclusion, I found that uptake was only significantly associated with deprivation of 
SAP and no association was found between uptake and other geographic factors 
(deprivation of SCA and ethnicity) or school factors (religious affiliation). 
 
8. 1. 3. Results of qualitative component of mixed methods 
research 
 
The exploratory nature of the interviews led to broad findings. Firstly, the analysis 
showed that school based HPV vaccination programme was accepted by all the schools 
but one
30
 in the city of study and was delivered by a mobile clinic aiming to vaccinate 
all eligible girls. It appeared that the school staff had a part in the successful delivery of 
the HPV vaccines in their schools. Although their role in distributing and collecting the 
consent forms to obtain informed consent from the parents of the girls was one of the 
most challenging activities in the HPV vaccination administration, it is essential for a 
high HPV vaccine uptake. Despite the fact that the HPV vaccination programme is not 
compulsory in the UK, the school and nursing staff faced the challenges of routinizing 
the delivery of this programme within the schools. The manner in which the school staff 
sought parents’ and girls’ consent was often persuasive through repeated phone calls to 
reach the parents, keeping secret the date of vaccination from parents and girls and 
having individual discussions with the girls (especially tutors). It could be that the 
school staff relied on their credibility and the trustworthiness to increase the likelihood 
of persuasion. Similarly, health care providers played a crucial role in the delivery of 
persistent messages about HPV vaccine to parents across all ethnic groups to bridge 
their information gaps, to help them in the decision making process and to obtain their 
consent. Applying Gillick competence and overriding parental lack of consent was a 
challenging task and nurses hesitated to put it in practice for year 8 girls. Because of no 
                                                          
30
 a private Muslim school 
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legal requirement for written consent (Department of Health, 2012), the school staff and 
the nurses believed that persistence for obtaining a verbal consent from parents was the 
most effective strategy to gain both the cooperation of girls and parents for a favorable 
decision for vaccination and thus leading to  a high uptake of HPV vaccine rates. As 
chasing up the consent forms to have them returned was the main activity that occurred 
two-three weeks before the vaccination day, on the day and after the vaccination, it 
could be argued that the organization of a school-based HPV programme was resource 
intensive in terms of time and staff (health providers and school  staff). It seemed that 
some parents had concerns about the HPV vaccination. School and nursing staff’s 
persuasive discussions with the parents were sometimes successful. This raises the 
difficult issue of balancing the public health viewpoint of it being in the public interest 
to have high coverage of the population to promote the health of all, against the 
individual right to informed consent. Vaccination choice is about ethics, human rights 
and individual autonomy. The parents did not have unrestrained freedom of choice and 
ability to choose (Powers, 2007) because verbal consent was sought over the phone with 
time pressure. However, nurses did not vaccinate the girls against their wishes or their 
parents’ decision.  
Secondly, the analysis showed that there were several facilitators to uptake of the 
vaccine. The HPV vaccine was promoted in a limited way in school environment owing 
to time pressure in the curriculum for compulsory subjects. Some attempts were made to 
talk to the girls about the vaccine in assemblies and in tutor groups in some schools. 
However, a number of different influences such as parents, friends and nurses affected 
girls’ choices. The girls had different levels of social interaction with all these people. 
Discussion with parents, particularly mothers or older sisters, were reported as 
important source of information to help them understand and make their own decision 
about the vaccine. Vaccination in year groups facilitated the interactions with nurses as 
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well as with friends in the same year and older that were beneficial for students’ 
confidence and feelings on the day of vaccination. 
 
Thirdly, the analysis showed a number of important barriers affecting uptake of the 
HPV vaccine. Girls’ fears of injection were a major obstacle to uptake before and on the 
day of vaccination. It was caused partly by their fear of pain and also their limited 
knowledge about the HPV vaccine, cervical cancer and the link between HPV and 
sexual behaviour. Parents represented another significant factor in declining the vaccine 
because of lack of understanding of the information about HPV vaccine received from 
the school, inadequate information obtained from other sources than health 
professionals, their misconceptions about the safety of the vaccine especially after a 
vaccinated girl’s death and their religious beliefs related to daughter’s sexual activity in 
the future. 
 
The conclusion for the results of the national study and mixed methods research is that 
both quantitative studies found low exposure to health promotion campaign about HPV 
and HPV vaccine followed by low uptake of HPV vaccine in high deprived areas of 
SAP. It is not known if the same schools had low exposure to health promotion 
campaign and low uptake of the vaccine. The qualitative study conducted in four 
schools, three located in mid deprived areas
31
 and one situated in a very highly deprived 
area
32
, enhanced the understanding of some school factors that influenced uptake of the 
vaccine in a school-based programme. The programme was successfully implemented, 
reaching uptake rates above the goal of the WHO (70%) even in the context of little 
information about the role of the HPV vaccine in the prevention of cervical cancer 
                                                          
31
 Both SAP and SCA  
32
 Both SAP and SCA 
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among the year 8 girls and their parents. The findings of this research highlighted that 
the key school factor that contributed to the achievement of high uptake rates was the 
organization and the delivery of the HPV vaccination programme, especially getting the 
parental consent. Parental decision and consent was essential as applying Gillick 
competence was a challenging task in the context of vaccination of year 8 girls aged 12-
13 years. The barriers found in this research, like girls’ fear of injections and parents’ 
misconceptions, suggest indirectly low exposure to professional information about the 
HPV vaccine.   
 
Before making a comparison with other studies, I discuss the strengths and limitations 
of the two quantitative studies and the qualitative study in this research. 
 
8. 2. Strengths and limitations  
8. 2. 1. Strengths of quantitative studies  
The results of the national study are based on a large sample including all secondary 
schools in England.  
The quantitative component of the mixed methods research had two strengths. One of 
them was the approach to analysis year by year from the beginning of programme 
implementation and I was able to determine variation in uptake rates of HPV vaccine 
within one academic year as well as across the four academic years. Variation in uptake 
within an academic year permitted understanding of diversity in HPV vaccination 
programme implementation, providing some clues that the programme in some schools 
was more effective than in others. The programme started successfully in 2008/09 with 
a median uptake of 90%, which dropped significantly in 2009/10 because of a girl’s 
death shortly after receiving an HPV vaccination at her school in October 2009, 
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followed by an increase of median uptakes in the subsequent two years. It appeared that 
implementation of the HPV vaccination programme across the years was a dynamic 
process to increase uptake after 2009/10 and to achieve the initial high rate in 2008/09. 
The other strength was the use of the population weighted average of the combined 
IMD scores corresponding to all LSOAs to estimate the deprivation of each SCA. To 
the best of my knowledge, other studies used IMD scores that reflect the area 
deprivation linked to a postcode or a LSOA. This theme will be revisited later in the 
discussion. 
 
8. 2. 2. Strengths of the qualitative study 
The qualitative component of the West Midlands study gave strength to the mixed 
methods research because it complemented the quantitative element, offering a more 
complete picture of the issue under study and thus increased my level of understanding 
of the uptake of HPV vaccine. The interview findings pointed to school factors affecting 
uptake of the vaccine that were not analysed in the quantitative research.  
 
To validate my study I used the framework of Creswell et. al combining two 
perspectives, the lens of the researcher and researcher’s paradigm assumptions. Validity 
was defined by Creswell et. al as how accurately the story represents participants’ social 
realities of the phenomena under study (Creswell and Miller, 2000). The lens, which I 
used, was based on my views conducting the study and on the views of people who read 
and reviewed it. The validity procedures used from the perspective of  the lens of the 
researcher were triangulation and researcher reflexivity (Creswell and Miller, 2000). 
Triangulation of data sources (nurses, teachers, girls) as well as triangulation of 
methods (non-participant observation and individual interviews) increased the validity 
of conclusions because they provided more detailed and multi-layered information 
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(Meijer et al., 2002; Creswell and Plano Clark, 2011). The story is valid because I relied 
on three forms of evidence rather than a single incident or data point in the study 
(Creswell and Miller, 2000). I described early in the research process my double 
position in the study (as a doctor and student) creating a separate section in Chapter 7 
called “Reflexivity” (Creswell and Miller, 2000). I used my position as a student during 
interviews with the girls because I wanted to see and to hear only from their viewpoint 
without the influence of my medical training. I used my position as a doctor during 
observations and interviews with nurses and school staff looking for practical 
implications of what I found out in the fieldwork.  
I used two validity procedures from the perspective of lens of people external to the 
study: the lens of readers (thick, rich description) and peer review or debriefing 
(Creswell and Miller, 2000). Thick, rich description of the themes (Creswell and Miller, 
2000; Johnson and Onwuegbuzie, 2004) provided as much detail as possible about the 
HPV immunizations in the schools, bringing alive the relationships between nurses, 
school staff and girls especially before and on the day of the vaccination sessions. This 
procedure enables readers to make decisions about the applicability of the findings to 
other settings or similar contexts. My peer reviewer was my supervisor with a 
background in social sciences who reviewed the data and research process, provided me 
with written feedback, challenging my assumptions as a public health professional, and 
asked me questions about my interpretations (Creswell and Miller, 2000). 
 
The paradigm assumption was constructivist with its criteria of trustworthiness: 
(Creswell and Miller, 2000) credibility, dependability, transferability, and 
confirmability (Creswell and Miller, 2000; Ryan et al., 2007). The trustworthiness or 
rigour of a study shows the plausibility, credibility and integrity of the qualitative 
research process (Ryan et al., 2007). Credibility, one of the criteria used to appraise 
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qualitative studies for their trustworthiness, was given by the richness of the data 
(D’Auria, 2007) obtained from 47 interviews. The type of sampling (purposive 
sampling of girls in each school to cover their diversity in terms of ethnicity and 
religion) also ensured richness in the data. Credibility was also demonstrated by 
prolonged non-participant observations (each lasting two hours) in 12 schools during 
the delivery of the second and the third dose of the HPV vaccine (Ryan et al., 2007). To 
enhance the credibility of the research I kept a field journal with my personal thoughts 
about the research process in relation to the contact with the participants, especially with 
the girls, during interviews that helped me in data collection. For example, I used 
various probes and I encouraged the girls to elaborate on what they said rather than just 
to give me simple answers to my questions. This strategy helped me to develop 
interview skills to talk less and to let the interviewees to talk more to express their views 
(Krefting, 1991). I also added credibility to my study seeking my supervisor’s feedback 
as a peer debriefer (Creswell and Miller, 2000). 
 I described each stage of the qualitative research process (data collection and analysis) 
in the sections Methods and Data management in Chapter 7 to show the dependability 
of my study. This provides the reader with evidence of the decisions and choices which 
I made regarding methodological issues throughout the study (Ryan et al., 2007; 
Krefting, 1991). Several documents related to data collection demonstrate dependability 
(Ryan et al., 2007): (1) invitation letters sent to the Head teachers (showing the initial 
plan for sampling girls and teachers), (2) the topic guide for interviews (showing that I 
questioned the same areas for all the participants (Graneheim and Lundman, 2004)), (3) 
the Table 1 in Appendix 24 with the characteristics of the girls (showing the decision to 
interview all the girls recruited by school even if their ethnicity was not as diverse as 
expected), (4) the Table 1 in Appendix 25 with thematic analysis (showing the decision 
of triangulation). During the analysis, I used a code-recode procedure on data to 
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increase the dependability of the study (Krefting, 1991). First I coded all interviews on 
printed transcripts and after that I coded them again in NVivo. Apart from the 
description of selection and characteristics of participants, data collection and process of 
analysis in Chapter 7, I used a rich presentation of the findings with quotations to 
enhance transferability (Graneheim and Lundman, 2004) to enable the reader to 
appraise whether the findings can be applied to similar contexts with 
routinization of immunization. Confirmability was based on previous criteria 
(credibility, transferability and dependability). Goodness was demonstrated by 
explanations related to the whole study including context, data collection and 
management and the interpretation (Ryan et al., 2007). 
 
Another strength of qualitative study was the opportunity to interview those delivering 
and implementing the programme in schools such as school staff and nurses. 
I was trained in qualitative research methods in the University of Warwick prior to the 
commencement of qualitative data collection. A professional transcriber was used for 
half of interviews and I checked the transcripts for accuracy. NVivo was used to 
facilitate the process of coding and the subsequent analysis. 
 
8. 2. 3. Limitations of quantitative studies  
The deprivation scores derived for one country in the UK could not be compared with 
those from the deprivation indexes of other UK countries and because the IMD 2007 
was available only for England the national study was limited to England. 
The use of IMD postcode as a predictor of uptake of informative materials did not 
reflect an individual’s exposure to the health promotion materials. It may be that schools 
that did not request the materials from the RSPH but obtained the materials through a 
secondary source (i.e., the DH). It is not known if the schools which requested the 
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materials integrated them into the curriculum which could be constrained by 
competition with other topics (Buston et al., 2002), school policy or local culture 
(Schaalma et al., 2004). A range of unmeasured (and unknown) possible confounders 
makes any inference about a causal relationship between request of informative 
materials and school and geographic factors impossible. 
 
Different limitations in the quantitative component of mixed methods research warrant 
consideration. I did not find a statistically significant association between uptake and 
deprivation of SCA as well as between uptake and ethnicity in multiple regression 
models. Therefore, the results of multiple regression models should be interpreted with 
caution. It is important to critique the study methodologies to consider whether the lack 
of associations were the result of chance or small sample size. The analyses of the 
associations including the two independent variables (deprivation of SCA and ethnicity) 
were based on a sample size of 18 schools, which is lower than 22 schools based on 
theoretical calculations. I assume that theoretical sample size could have been different 
and even bigger than 22 schools if I had access to standard deviation in population for 
uptake of HPV vaccine three doses.  
The school’s religion was a proxy for pupils’ religion assuming that the pupils attending 
a faith school would have that particular faith also. However, this may not be true for all 
religious schools in the city as the findings of qualitative analysis suggest presented in 
theme 1 of Chapter 7. It might have been possible to ask the schools for a breakdown of 
their pupils’ religions to test this assumption although they might have been unwilling 
to give out this information from the point of view of confidentiality. 
My original null hypothesis was that there was no association between uptake of the 
third dose of vaccine and ethnicity. I did not find an association between ethnicity and 
uptake. I found a moderate collinearity between independent variables (IMD for SCA 
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and ethnicity) which could suggest an interaction effect between area deprivation and 
ethnicity. Ethnicity is not routinely collected by the participating Trust in this study. 
Thus, it was not possible to determine uptake of the HPV vaccine in more detail by each 
ethnic group in SCA. 
This study utilized routinely collected data in the Trust related to 5672 year 8 girls aged 
12-13 years. An issue, common to all routinely collected data, is that there are data input 
errors and the dataset could not be used as it was intended. The limits to confidentiality 
did not make it possible to have access to the full postcode addresses of year 8 girls’ 
households to analyse HPV vaccine uptake at individual level. Therefore, I used the 
aggregated data at school level with a small sample size. The best way to reduce 
sampling error is to increase the sample size to have sufficient statistical power to detect 
statistically significant results (Bonita et al., 2006) and to detect the anticipated 
difference between groups of comparison (Machin et al., 2009). Statistical power is a 
function of three variables: sample size, the chosen level of statistical significance 
(alpha) and effect size (Fox et al., 2007).  
Because I did not have access to individual-level measures of socioeconomic status, I 
relied on area-based measures of deprivation which could have potential limitations. 
There are a number of deprivation indices including the Carstairs index, the Townsend 
index and the Index of Multiple Deprivation. Carstairs scores represent a combination 
of four 2001 Census variables: male unemployment, overcrowded households, car 
ownership and low social class (Social Class IV and V). The Townsend Index 
comprises four variables based on 2001 Census Data: unemployment as a percentage of 
those aged 16 and over who are economically active, household overcrowding, non-car 
ownership and non-home ownership (Burr et al., 1997). In this analysis, I used the IMD 
2010 based on the results of my previous study (quantitative study at the national level) 
and on previous publications. The IMDs are not the same because in one study IMD 
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2007 was used while in the other study IMD 2010 was used. Although IMD 2007 and 
IMD 2010 are comparable in terms of geographical scale, domains, indicators and 
methodology, some changes in the level of deprivation between the IMD 2007 and IMD 
2010 took place due to small changes to indicators and methodology for IMD 2010 
(Department for Communities and Local Government, 2012). The overall IMD 2010 is 
based on rankings and not real measures of deprivation.  
The reason for using IMD scores for SCA from one academic year to make estimates of 
the uptake of HPV vaccine in four academic years was based on the assumption that the 
population in catchment areas was relatively stable. A school’s catchment area is a 
geographical boundary from within which children have historically attended a school. 
It is used as a criterion in case of oversubscription in the admissions process (i.e., 
children who live in the catchment area served by the school or children who live in the 
catchment area served by the school, who have a brother or sister attending that school 
the following year or children living closest to the school) (Coventry City Council, 
2013). IMD for SAP would not necessarily reflect the level of deprivation of the areas 
in which the students attending the school lived. Also, the population of a school does 
not necessarily reflect its catchment area, because local pupils may choose to go 
elsewhere to school (e.g. religious school).  The IMD score for the environs of the 
school does not provide much information about deprivation at school level. A more 
precise measure of deprivation (e.g. the proportion of pupils eligible for free school 
meals (FSM)
33
) might lead to different results. Low income is a central component of 
the definition of multiple deprivation for the IMD 2010. The lack of association 
between uptake and deprivation of SCA could be because deprivation of SCA was a 
proxy for the deprivation of the places where the girls live. It could be a good proxy 
socioeconomic measure for access to services and improvement of health but it might 
                                                          
33
 A definition of free school meals is presented in Appendix 27 
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not be a good measure for uptake of HPV vaccine which was delivered free of charge. 
The results might reflect the fact that other socioeconomic factors such as education 
may contribute more to uptake of the HPV vaccine.  
The schools in this study were located in urban areas. Other school-level characteristics 
arising from factors internal to the school (e.g. teachers’ attitudes towards the HPV 
vaccine) could affect uptake of the HPV vaccine to a greater extent. 
Uptake of the HPV vaccine in the city is overestimated because nine special schools, 
which were excluded, had poorer performances and lower uptake.  
 
The cross-sectional design of the two quantitative studies, when exposures and outcome 
are assessed at a single point in time, does not allow for establishment of a cause and 
effect relationship among the variables because it is not known whether the exposure 
precedes or follows the effect (Bonita et al., 2006). For example, a longitudinal study 
would be required in the future to establish satisfactorily such a relationship between 
measures of variables of interest (geographic and school factors) and uptake of the 
vaccine. 
 
The findings of both quantitative studies may be subject to ecological fallacy because 
the association observed between the outcome (HPV vaccine uptake) and independent 
variables at the group level does not necessarily represent the association that exists at 
an individual level (Bonita et al., 2006). A multilevel analysis would have been 
appropriate to investigate results at individual and group levels to avoid ecological 
fallacy. I intend to do a multilevel analysis in the future if more data becomes available. 
For example, to do an analysis at individual level I would need at least a denominator 
for the population of all year 8 girls in all secondary schools in the city of study (Table 1 
in Appendix 20). Types of models, assumptions, sample size, variance, multilevel 
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regression model 1 - intra class correlation, multilevel regression model 2 with 
individual variables, multilevel regression model 3 with individual and cluster variables, 
multilevel regression model with individual variables and random slopes are detailed in 
Appendix 20. 
 
8. 2. 4. Limitations of qualitative study 
The main weakness of the interview method was the sampling of the girls. Despite 
using purposive sampling and continuing recruitment until saturation, I was not directly 
involved in the selection of the girls and because the teachers recruited the girls, it may 
be that the participant girls were volunteers. Mainly vaccinated girls were included in 
the study except two girls who were unvaccinated so that data from girls who refused 
the vaccination is scant. No information was collected about girls who did not 
participate in the study. It cannot be determined whether there was any difference 
between the girls who participated and those who refused to participate, that is, whether 
there might have been selection bias. It is likely that the girls who did not participate 
may have had particular views about their experience of HPV vaccination. Another 
related factor is that the girls described their past experience, but the majority of them 
were interviewed at five - seven months after the initial dose when they or they together 
with their parents had made a decision for HPV vaccine. Therefore, their accounts may 
be subject to recall bias.  
The qualitative analysis was subjective in nature, meaning that researcher bias could 
have affected the interpretation (Johnson and Onwuegbuzie, 2004; Ryan et al., 2007). 
Another limitation of qualitative study is that generalisations cannot be made to a wider 
context than the one studied (Johnson and Onwuegbuzie, 2004) because of two reasons. 
One reason was that the selection of schools was based on convenience sampling and 
the recruitment of participants within the schools (girls and staff) was based on 
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purposive sampling but both of them are non-random samplings. Convenience sampling 
of the schools was the result of difficulty getting access to the schools reflected by the 
response of only four schools to the invitations to participate in my study. It could be 
also a response bias of schools. To maximize the response rate, I sent invitation letters 
to all secondary schools in the city followed by several reminders. A covering letter, 
attached to the invitation letter to explain the importance of the research, was 
postmarked from the University. Low response rate could be because of different 
factors: (1) high uptake rates of HPV vaccine in most of the schools, (2) need of school 
staff and time to chase consent forms sent to parents to get permission for their 
daughters’ participation in my research, (3) Head teachers’ lack of time to read the 
documentation related to my study including invitation letter, information sheets and 
consent forms, and (3) lack of talk about the HPV vaccine in PSHE class which I 
intended to observe. Purposive sampling of the girls was used in each school to cover 
the diversity of girls from all ethnic groups and religions to reflect the demographic 
profile of the school. Another reason for which the results cannot be generalized was 
that data represented people’s views, which could be prone to misinterpretation. A way 
to reduce the risk of misinterpretation would have been member check (Creswell and 
Miller, 2000) to validate my interpretation of the data.  
A limitation of the study could be small sample of school staff. I conducted interviews 
only with four school staff and it might be possible that I could not obtain data 
saturation despite purposive sampling and diverse responsibilities, which they had in 
their schools. This was because in each school one person was the coordinator of the 
organization of the HPV programme.  
One limitation of the study design was that there were no interviews with parents of the 
girls. All the data on parental attitudes is reported data by the girls, teachers or the 
nurses. Therefore, I am aware of their possible misinterpretation biases. If I were to 
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conduct the study again in order to avoid this problem I would hold a presentation 
evening for the parents to present my findings, followed by a discussion session 
afterwards for people to come forward with their views which might be similar or 
different from those found in my interviews with the girls.  
Because the qualitative data collection was delayed owing to difficulties in accessing 
the schools, the mixed methods research design was changed from sequential 
exploratory to parallel design.  
 
The results are now discussed in relation to previous work in this area. 
 
8. 3. Comparison with previous studies 
My research focused on the HPV vaccination programme being implemented in 
secondary schools. It included analysis of uptake of information materials about HPV 
vaccine by schools during a national education campaign launched by the RSPH and 
uptake of the third dose of HPV vaccine in a routine cohort (year 8 girls) in a city in the 
West Midlands. 
My study showed that the school based programme was successfully implemented 
across four years (2008-2012), achieving uptake rates of 70% or above 70% in almost 
all schools in each year. Overall median uptake in all years combined was 86.5%. The 
school based HPV programme has been successful both in developed countries (Rondy 
et al., 2010) (e.g., Portugal, 81% and UK, 80% (Dorleans et al., 2010) and developing 
countries (e.g., Peru, Uganda, Vietnam and India (over 80%)). Some countries in 
Europe (e.g., the Netherlands, Italy, France, and Belgium), Australia and the United 
States had low uptake rates (around 50%) using settings other than schools to deliver the 
programme (Fregnani et al., 2013). School based HPV programmes have several 
advantages. They have resulted in faster uptake (Cooper Robbins et al., 2011), have had 
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better completion rates for three doses (Smith et al., 2012), have been offered during 
school hours (Ogilvie et al., 2010), have been sustained over time (Sinka et al., 2014) 
and have overcome several obstacles including the cost of and access to both the 
vaccine and a health care provider (Cooper Robbins et al., 2011). Because the vaccine is 
available in school, parents do not need to leave work or children miss classes to travel 
to the health provider (Cooper Robbins et al., 2011; Ogilvie et al., 2010). Some parents 
perceived the school as a more convenient place for vaccination than sexual health 
clinics (Brabin et al., 2007).  
 
Although the school-based strategy has achieved high uptake rates in different settings, 
variations in uptake have occurred as a result of various factors. I found that uptake 
varied by school between 76% and 89% for all years combined in the city of my study. 
Uptake was significantly associated with deprivation of SAP. However, deprivation of 
SCA, which was a proxy measure of the socioeconomic area where the girls live, was 
not associated with uptake. Uptake rates were consistently over 80% in both high and 
low deprived areas (of SAP and SCA) across years, except the second academic year 
when uptake was over 70%, meaning that even in the context of a dramatic event 
following the HPV vaccination, the goals of the programme were met. High HPV 
vaccination uptake (80%) was also noticed in areas of high deprivation in Scotland and 
in Wales (Boyce and Holmes, 2012) but there has not been any clear analysis in the 
literature of this. 
Different measures of deprivation were used in other studies at individual, school and 
area level. A national study in Scotland showed that there was a significant association 
between individual level deprivation of the pupil population and a lower uptake of the 
second and the third dose of the vaccine (in a routine cohort) adjusting for programme 
year and other organisational factors (school denomination and vaccination setting). 
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Also, deprivation at the school level measured through the percentage of pupils eligible 
for FSM showed a significantly lower uptake of three doses in the highest FSM quintile 
than those in the lowest FSM quintile in the routine programme (Sinka et al., 2014).  
A study conducted in England including 151 PCTs assessed coverage for routine and 
catch-up cohorts from 2008 to 2011 by area deprivation, which represented the 
population weighted average of the combined IMD scores for all the small areas in the 
PCT.  PCT-level coverage with three doses of HPV vaccine showed that for the routine 
cohorts there was no significant correlation between HPV immunization coverage and 
deprivation. Also, no significant correlation was found between HPV immunization and 
IMD at the area-level for the catch-up cohorts including the girls under 16s in 
compulsory full time education. A significant correlation was found between coverage 
with HPV vaccine at age over 16 (catch-up groups) with area deprivation (Hughes et al., 
2013). A study of three PCTs in South West England indicated that there was no 
significant association of uptake of three doses in a routine cohort by deprivation based 
on IMD scores of LSOAs linked to postcodes from individual records. Similarly, 
multivariable analysis of HPV vaccination initiation showed that there was no evidence 
of an association of HPV vaccination initiation and deprivation (Fisher et al., 2013). 
Spencer et al. found that the most deprived quintile of area deprivation, based on IMD 
2010 scores linked to LSOAs derived from the address postcode in the North West of 
England, was significantly associated with incompletion of the programme with three 
doses of vaccine in the catch-up group. Deprivation was not associated with routine 
(12–13-year-olds) vaccination initiation. In this study, the researchers linked girls’ HPV 
vaccination records by address to cervical screening records for their mothers and found 
that mother – daughter pair living in the most deprived areas did not take up either 
cervical screening or the HPV vaccine (Spencer et al., 2014). In Scotland, a widening 
gap was found between starting and completing a three dose series with HPV vaccine 
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by deprivation. The uptake of the first dose had a high and even level across deprivation 
quintiles and across years. Completion of the programme was increasingly lower in the 
most deprived compared with the least deprived areas by year between 2008 and 2011. 
Thus, the gap between starting and completing a course of HPV vaccination by 
deprivation became bigger over time (Sinka et al., 2014).  
In a study on uptake of the first two doses, Kumar and Whynes used a measure of 
deprivation at an aggregate level (PCT) in the first year of the programme. They found a 
significant association between deprivation and catch-up girls who were mostly 
vaccinated in community clinics or general practice. There was no significant 
association for uptake in the routine cohort and deprivation. The limitations of this study 
were that the analysis was related to the first two doses and because it was done at 
aggregate level did not show the variation in uptake across schools in a PCT (Kumar 
and Whynes, 2011).  
These studies indicate that lower uptake seemed to be associated with area deprivation 
in catch up groups who were more likely not to complete the programme. In my study, I 
found that uptake of three doses was related to deprivation of school postcode address 
and this is an original contribution to this debate. I conclude that it is likely that the 
schools in less deprived areas had a higher uptake than the schools in more deprived 
areas because of better organization and lower absenteeism rates. There were studies 
that reported a relationship between school attendance and completion of the 
programme (Brotherton et al., 2013). 
Ethnicity is another important factor that may affect uptake, both because of the way it 
may operate through deprivation and because of the way it may influence religious and 
cultural attitudes to HPV vaccination. Ethnicity has been analysed in quantitative 
studies to assess the association with uptake. In my study, I did not find an association 
between ethnicity, representing the proportion of the population who are White 
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residents in SCA and uptake of the third dose. Similarly, Fisher et al. found weak 
evidence for variation in uptake of three doses in routine cohort by ethnic composition 
at PCT level. However, there was evidence for an overall association of HPV 
vaccination initiation by ethnicity. In that study, researchers found that Asian, Black, 
Chinese or other groups were less likely to initiate HPV vaccination (to receive the first 
dose) in comparison with White groups (Fisher et al., 2013). Findings related to HPV 
vaccination completion in Black and other ethnic (Chinese) groups in both routine and 
catch-up vaccination cohorts were reported in a study conducted by Spencer et al. There 
were no ethnic differences in completion rates in the routine group, but they were 
present in the catch-up group. This study found that mixed and other ethnic groups had 
reduced completion rates in the catch-up group (Spencer et al., 2014).  
Other studies using correlation and multivariate analyses reported a significant 
association between ethnicity (measured by UK Census or country of birth) and low 
HPV vaccine uptake (1 or 2 doses) in routine and catch-up cohorts (Rondy et al., 2010; 
Roberts et al., 2011; Widgren et al., 2011; Kumar and Whynes, 2011). In the context of 
contradictory results and inconsistent classification of ethnicity across studies because 
of insufficient data (not recorded in health system (Spencer et al., 2014)) or different 
definitions across countries (Rondy et al., 2010; Roberts et al., 2011; Widgren et al., 
2011) it is difficult to draw a conclusion for the effect of ethnicity on uptake. Certainly, 
in my study I found that ethnicity, based on UK Census classification, was not 
associated with uptake of three doses of the HPV vaccine. One explanation could be 
that the majority of schools (18 schools) had more than 50% White population in their 
catchment areas (as shown in Figure 11 in Chapter 6). Another explanation could be 
that if the girls were from other ethnic groups than White group they could be the first 
generation of migrants (e.g., UK born having at least one parent non UK born) or the 
second generation of migrants (e.g., UK born having both parents UK born) or 
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immigrants (e.g., non UK born having both parents non UK born) (Marlow et al., 2009). 
Marlow et al. used this classificantion of generational status that reflected acculturation 
in a UK study on ethnic differences in HPV vaccine acceptability and did not find any 
statistical significant association with acceptability in multivariate analyses. The authors 
concluded that acculturation might not be a mediator in the relationship between HPV 
vaccine acceptability and ethnicity (Marlow et al., 2009). 
 
Other studies have attempted to explain variation in uptake in relation to organizational 
factors in schools. Although there is little research on the delivery of the HPV 
immunisation programme in the UK, one study conducted in Scotland (Boyce and 
Holmes, 2012) indicated the success of a school-based programme, which achieved 
uptake rates over 90% for all three doses of the vaccine in the first two years. The 
success was the consequence of a project management approach to the implementation 
of the programme with a focus on school-based delivery, logistics and tailored 
communications directed at adolescent girls (Potts et al., 2013).  
The qualitative part of my research conducted in four schools explored in more detail 
the promotion and organization of the HPV programme and brought understanding how 
these contributed to high uptake rates in the city. It showed that a mobile clinic, 
comprised of a team of bank nurses, delivered the vaccinations in all the schools. 
Although a school nurse was part of the team, it seemed that she was not attached to a 
school, as she was accompanying the team in some schools in the city. I found that no 
school nurse attached to a school was involved either in the promotion or in the delivery 
of the programme.  
There is no evidence about implementation of the programme at school level in other 
areas. Studies conducted in the UK showed that the programme was organized and 
delivered in different ways at PCT level (Brabin et al., 2011; Boyce and Holmes, 2012) 
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mainly in schools (Potts et al., 2013) involving school nurses (Boyce and Holmes, 
2012) as they were the main deliverers of childhood and adolescent vaccinations (e.g., 
in Scotland (Boyce and Holmes, 2013)) and more interested in teaching sex education to 
pupils (McFadyen, 2004). In contrast, the team in my study was set up to include bank 
nurses because it was cheaper. They were employed by the NHS Trust in the city. 
School nurses were also employed by PCTs (in England) or Local Health Boards (in 
Scotland, Wales, and Northern Ireland) before NHS reform in April 2013. In Wales, 
each school has its own school nurse. In Northern Ireland and Scotland, a school nurse 
could cover more schools (Boyce and Holmes, 2012) but this could increase her 
workload. A study in Greater Manchester described the performance of two different 
nurse teams. A PCT used four teams of school nurses to vaccinate the eligible girls in 
all secondary schools. Another PCT set up a vaccine team, comprising three school 
nurses, to deliver the vaccination sessions asking the school nurse attached to a 
particular school to help the team on the day. It seemed that this team was more 
successful than the other one because of the relationship between the school and school 
nurse which was affected by the school nurse’s workload, and school’s help with 
consents (Brabin et al., 2011). This study interviewed only 15 school nurses. A rapid 
evidence assessment based on interviews with 80 health professionals from across the 
UK, including 36 school nurses and 26 coordinators showed that school nurses 
addressed health inequalities in the HPV immunization programme targeting girls who 
did not attend the school or missed doses. These girls were more likely to live in areas 
and communities of high deprivation or to belong to vulnerable groups (e.g., travellers, 
looked after children). The strategy, which they adopted to increase uptake in these 
groups, was to follow up the girls persistently (Boyce and Holmes, 2012). Similarly, 
high uptake at a school in an area in England with high deprivation, mixed ethnicity and 
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high teenage pregnancy was due to a nurse chasing up the forms (Boyce and Holmes, 
2013). 
In my study, the school staff chased up the forms persistently before and on the day and 
the nurses sometimes called the parents on the day and after the session if consent was 
missing. The health care providers played a crucial role in the delivery of persistent 
messages about HPV vaccine to parents across all ethnic groups to bridge their 
information gaps, to help them in the decision making process and to obtain their verbal 
consent. The school staff and the nurses believed that persistence for obtaining a verbal 
consent from parents was the most effective strategy to gain both the cooperation of 
girls and parents for a favorable decision for vaccination, leading to a high uptake of 
HPV vaccine rates.  
Focusing on the parents’ side it could be claimed that vaccination choice is about ethics, 
human rights and individual autonomy. Routinization of vaccination is a process 
through which people are expected to adhere to a social norm (Habakus and Holland, 
2013) because of the benefit of herd immunity (Habakus and Holland, 2013; Caplan and 
Schwartz, 2013). Some parents did not adhere unreflectively to a social norm for uptake 
of HPV vaccination (Fairhead and Leach, 2012). They seemed to be convinced with 
difficulty to make a decision pro-vaccination for their child in the context of debates 
about the safety and value of vaccinations (Caplan and Schwartz, 2013) especially after 
conflicting information about MMR (Fairhead and Leach, 2012). Vaccines could protect 
some people but could harm others also. Therefore, individuals have the right to free 
and informed consent to make their own decisions (Habakus and Holland, 2013). I 
would argue that teachers’ messages were persuasive because the school staff did not 
inform parents about the existence of exemptions from vaccination (Habakus and 
Holland, 2013) (e.g. religious, philosophical, medical). A powerful tool in persuading 
the parents could have been related to fear produced by their messages (Colgrove, 2004) 
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suggesting the parents to choose between the prevention through vaccination and 
available cancer treatment (Powers, 2007). Although the teachers presented to parents 
other vaccination choices, such as vaccination later in life, their persuasive discussions 
with the parents, which sometimes were successful, were perhaps not entirely ethically 
justified. It is not known whether all parents understood teachers’ arguments. On the 
other hand, it might be that the parents did not have unrestrained freedom of choice and 
ability to choose (Powers, 2007) because informed verbal consent was sought over the 
phone with time pressure.  
Based on the evidence in literature, I argue that teachers’ actions were more persuasive 
than coercive. Coercion is also a type of influence but the distinction between a coercive 
and a persuasive action is not very clear in the literature. It has been said that a situation 
is evaluated as coercive or persuasive according to the context and on moral grounds. 
Usually coercion is exerted within a legal framework such as public health law 
requiring vaccination of children (Powers, 2007). This did not apply here because the 
HPV vaccination programme is not compulsory in the UK.  
A study in Victoria (Australia) highlighted that difficulties in returning consent forms to 
schools with a high proportion of indigenous students resulted in significant lower 
vaccine uptake. The process of following-up non-returned consent forms could also be 
impeded by restrictions in the provision of student lists by schools (Brotherton et al., 
2013).  
The literature indicated that the consent form return rate could be increased through 
incentives, for example reminding and encouraging the girls to complete the course with 
three doses (Smith et al., 2012). It appeared that classroom peer incentives (Cooper 
Robbins et al., 2011) were more effective than individual incentives for immunization 
against Hepatitis B (Rose et al., 2011). In Western Australia, sending a second consent 
form was more effective than a letter, phone call or school incentives for improving 
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return rates (Brotherton et al., 2013).The school staff in an area of New Zealand, with 
previous experience in school-based immunization programmes, such as Hepatitis B 
and MMR vaccines, suggested sending multiple notices home to parents than to phone 
them or to send forms to parents by texting, use of e-mail and Web sites (Rose et al., 
2011). 
 
Another successful tactic used by the nurses in my study with girls who missed doses 
was to invite and vaccinate them at a mop-up clinic on Tuesday in the evening between 
4pm and 6pm. This is in line with the findings of another study which showed the 
benefits of mop-up clinics at flexible times which were convenient to girls rather than 
the school nurses (e.g., late Saturday morning, evenings and weekends, Christmas 
holidays, and home visit). Apart from mop-up clinics, this study indicated the 
importance of obtaining informed consent by teachers and nurses, of reminding the girls 
to complete the HPV vaccination schedule, of persistently chasing consent forms and 
addressing parents’ concerns. Persistence in chasing up those who missed vaccination 
occurred because there was no recommendation how many attempts should be made to 
follow them up (Boyce and Holmes, 2013).  
Fisher et al. found that funding an additional member of staff to encourage young 
women to receive missed scheduled doses in community health clinics increased uptake 
at the PCT/local authority level (Fisher et al., 2013). A successful reminder method to 
attend a community catch-up clinic for school-based vaccinations as found to be 
telephone call in addition to a postal reminder letter compared to a reminder letter only 
(Cooper Robbins et al., 2011). An evaluation of the programme in New Zealand showed 
that opportunistic drop into schools was a successful tactic when the vaccinator was in 
the area (Smith et al., 2012). In British Columbia, children who are absent on the day 
could receive vaccines either in local public health units or in schools when the school 
321 
  
nurses returned for other vaccinations (Ogilvie et al., 2010). My study confirmed the 
findings in New Zealand and British Columbia and revealed that teachers and nurses 
increase uptake rates by being persistently persuasive. Whilst high take up is in the 
public interest, one could argue that there may be an issue here of protection of the 
rights of the individual versus the NHS/state’s desire to increase vaccination rate. 
 
Applying Gillick competence and overriding parental lack of consent was a challenging 
task and the nurses in my study hesitated to put it in practice for year 8 girls (aged 12-
13) especially because of the legal implications. They used it for catch up groups in the 
first two years of the programme. It seemed that they did not follow a structured 
approach to assess girls’ competency because the assessment was subjective based on 
their impression of girls’ understanding of the HPV vaccine which they would gather in 
a very short time at the beginning of the sessions. However, the nurses and the school 
staff did not force any girl to be vaccinated against her parents’ wishes. These findings 
were consistent with the results of a feasibility study conducted in 2007–2008 in the 
northwest of England. Even if the child was considered to be Gillick competent, the 
nurses, who knew how to assess this competency, would not have given HPV 
vaccination if the parents refused or they would have sought parents’ permission when 
the consent form had not been returned. However, contacting the parents in these 
circumstances might be considered as raising the concern of breaching a child's 
confidentiality (Stretch et al., 2009). Similar practices were shown by school nurses in 
Wales. Likewise, school staff would not override parental refusal in order not to damage 
the relationship between the family and the school (Wood et al., 2011). A semi-
qualitative study showed that parents’ ethnicity was significantly associated with views 
on this type of consent. Both White and Black Caribbean parents agreed that a child 
could request vaccination at a sexual health clinic without parental consent if the child 
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had ability to understand and process information. The limitation of the study was that 
data was obtained from surveys and the response rate was relatively low (Brabin et al., 
2007). 
 
In order to understand information about HPV vaccine and to consent for it, the girls 
needed to have access to information, which was limited in the school environment in 
my study. Tutors attempted to talk to the girls about the vaccine in tutor groups but 
some were reluctant to talk about sensitive issues (e.g., that HPV was related to an STI). 
I found in my study that some tutors were teaching religion. One explanation for their 
reluctance could be that teachers do not have the knowledge to counsel parents or girls 
if asked and that they need to be given more information about the vaccine (Ling et al., 
2012). My quantitative study did not find an association between uptake and a school’s 
religious affiliation (the sample included affiliated church schools both Catholic and 
Church of England, and non-religious schools). Other researchers have noted similar 
findings. In Scotland, there was no influence on uptake by type of school 
(nondenominational/ denominational) (Sinka et al., 2014). However, my qualitative 
research showed that a private Muslim school had rejected the HPV programme since 
2008. Another qualitative study based on interviews with school nurses indicated that 
smaller religious schools, such as Christian schools, a Church of Wales school and 
ultra-Orthodox Jewish schools rejected the HPV immunisation programme also (Boyce 
and Holmes, 2013). The ultra-orthodox Jewish community had a low uptake of other 
childhood vaccinations (Sekwalor, 2012). In contrast, schools with high percentages of 
Muslim or Catholic students had good uptake (Boyce and Holmes, 2013). 
As the HPV vaccine prevents an STI it was expected that the girls would be taught in 
Sex and Relationship Education classes. However, none of the schools in my study were 
able to find a place for the HPV vaccine in the SRE curriculum. 
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It was reported that head teachers do not have a direct influence on the sex education 
programmes, but they have a broad influence on the timetabling of PSHE (Buston et al., 
2001). School policy and cultural aspects could constrain sex education. Past sexual 
health promotion in schools in Scotland showed that despite apparently successful 
training, some teachers remained reluctant to deliver sex education (Schaalma et al., 
2004).  
Schools in other settings have been shown to be involved in the promotion of the HPV 
vaccine. For example, in British Columbia, the HPV vaccine programme was widely 
promoted through schools using different resources including a web site, information 
packages and DVDs targeted at parents and girls, pamphlets, brochures and information 
sessions held locally by public health nurses for parents and providers (Ogilvie et al., 
2010). In Australian states and territories, the programme was also promoted in schools 
using methods used for other adolescent vaccines (Brotherton et al., 2013). In the 
Netherlands, the organization of meetings with pupils at schools in order to inform them 
about the vaccination was associated with higher uptake (Rondy et al., 2010). Similarly, 
the success of the HPV vaccination programme in Brazil was due to the integration 
between the public health and schools. The schools had a significant role in the 
dissemination of information, which increased vaccine uptake in children 10–16 years 
old exceeding 85% for each individual dose (Fregnani et al., 2013). 
In contrast, the findings based on a systematic review indicated that an educational 
package for students delivered in classroom prior to vaccination did not increase uptake 
of Hepatitis B vaccine. Information increased students’ knowledge, attitudes, and 
awareness of Hepatitis B vaccine and possibly supported them to make an informed 
consent and to reduce anxiety (Cooper Robbins et al., 2011). There is evidence that the 
most effective interventions for health promotion (e.g., to reduce smoking or increase 
physical activity and/or healthy eating) include provision of information combined with 
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professional advice because it could improve knowledge and recall. In addition, 
information could change behaviour only when it is combined with behavioural 
strategies such as teaching self-management techniques (Michie et al., 2009). 
These studies show contradictory results about the influence of information on uptake of 
the vaccine. Based on this evidence it is difficult to assess the effectiveness of each 
resource. It might be that direct communication is more successful than printed 
materials, which could be read, or not. However, none of these studies indicated that 
information about the HPV vaccine was included in the curriculum to be taught in a 
formal class.  
In the context of limited information provided by the schools in my study, the girls were 
dependent on information from other sources especially mothers or older sisters. In 
some cases, it was reported that parents lacked understanding of the information about 
the HPV vaccine received from the school or had inadequate information obtained from 
sources other than health professionals and for that reason, may have declined the 
vaccine. My data did not indicate parents’ level of education. A study reported that 
parents with higher levels of education were less likely to consent to their daughters 
receiving HPV vaccination in a school-based vaccination programme (Cooper Robbins 
et al., 2011). Having more education was associated with a decreased likelihood of 
having a daughter receive the HPV vaccine presumably because of more access to the 
Internet and other forms of media compared with less-educated parents in British 
Columbia (Ogilvie et al., 2010). Thus, inaccurate information about the HPV vaccine 
could impair decision-making and could result in lower uptake. 
The qualitative part of my study showed that some parents (especially Asians) did not 
talk to their daughters about the vaccine regarding the link between HPV and an STI. 
Therefore, school plays a major role in teenagers’ education about sex and relationship 
and self worth. Schools provide students with knowledge and skills and opportunities 
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for personal and social development created by the school organization, curriculum and 
pedagogic practice. The students and their families have social norms and values related 
to their social class and culture. School’s influence on students’ lives was compared 
with influences of social class and the communities where the students live through a 
measure called school-level meaningfulness. Students attending low school-level 
meaningfulness are less likely to adopt valued school identities and as a result they 
could be negatively influenced by social peer pressures (e.g., adopting substance use) 
(Markham, 2014). 
 
Original contribution 
My original contribution to knowledge is empirical, methodological and conceptual.  
I made an empirical contribution including two pieces of research in this thesis. One 
piece of research was a national study about uptake of informative materials by all 
secondary schools in the UK and the other one was a mixed methods research about 
uptake of the HPV vaccine by secondary schools in the West Midlands. The aim was to 
understand to what extent the results of the first study about information related to the 
HPV vaccine informed the second study about uptake of the vaccine. The assumption 
was that increased knowledge would play a role in increasing uptake of the vaccine. My 
first study aimed to evaluate the process of distributing teaching materials to teachers in 
the secondary schools to assist in the teaching of year 8 girls about HPV, HPV vaccine 
and cervical cancer in a formal class in order to help them to make safe and appropriate 
decisions in relation to their physical, emotional and sexual health and to develop an 
understanding of the importance of vaccination in the prevention of cervical cancer. To 
my knowledge, awareness and knowledge about the vaccine and uptake of the vaccine 
have been addressed separately in other studies. 
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To my knowledge, there is no evidence about the implementation of the programme at 
school level in a Local Authority area/PCT. The qualitative section of my research 
investigated the organization of the programme in schools in city through interviews 
with teaching staff and nurses and observation of HPV delivery. 
 
 The original methodological component of this study was the use of the population 
weighted average of the combined IMD scores for all the LSOA in each school’s 
catchment area to reflect deprivation in the areas where the children attending the 
school live. This was different to other studies which have used deprivation at 
individual, school and PCT level.  
The purpose of analyzing uptake by deprivation in SCA was to distinguish factors 
related to girls’ personal characteristics (ethnicity and living area) from school factors. 
Area deprivation is an indicator of socio economic circumstances of persons and the 
places where they live. Contextual factors in the catchment area could be interpreted in 
terms of socio-cultural characteristics and contextual factors of school location could be 
interpreted in terms of material infrastructure (Macintyre et al., 2002). 
 
Another original conceptual contribution made by this thesis is related to the debate 
concerning vaccines and the ethics of informed consent. To my knowledge previous 
studies have focused on strategies of delivery of the programme and the return of 
consent forms to increase uptake of the vaccine. Routinization of vaccination is a 
process through which people are expected to adhere to a social norm (Habakus and 
Holland, 2013) because of benefit of herd immunity (Habakus and Holland, 2013; 
Caplan and Schwartz, 2013). Delivery of the programme is a public health issue but 
obtaining informed consent is an ethical issue. School and nursing staff’s persuasive 
discussions with the parents were sometimes successful but this raises the difficult issue 
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of balancing the public health viewpoint ( being in the public interest to have high 
uptake and coverage of the population to promote the health of all), against the 
individual right to free and informed consent for individuals to make their own 
decisions (Habakus and Holland, 2013). Vaccination choice is about ethics, human 
rights and individual autonomy. The parents did not have unrestrained freedom of 
choice and ability to choose (Powers, 2007) because informed verbal consent was 
sought over the phone with time pressure.  
 
8. 4. Implications for policy 
There were neither direct financial nor organizational barriers to the receipt of the HPV 
vaccine in this programme as it was offered for no cost to the participants. Eligible year 
8 girls had two routes via which to access the vaccine in the city: at school or at the 
community clinic. Integration of school-based and primary care delivery was important 
to ensure high vaccine uptake, particularly as some girls missed doses or were delaying 
uptake for different reasons. Mop-up clinics were organized after each dose, targeting 
girls who missed the previous dose, either at the community clinic or in the school when 
the next vaccine was delivered. Also, there were vaccination opportunities in the next 
school-year for those who had missed doses (especially in the second year of the 
programme with the negative event) and this had an important effect on the equity of 
vaccine coverage. 
School-based programmes have achieved the equity uptake goal to some extent because 
it has been delivered to year 8 girls from all ethnic groups without discrimination. 
However, my data does not allow me to make any statement about vaccination of year 8 
girls in hard to reach and vulnerable groups. In addition, there is evidence that girls who 
are educated in non mainstream educational settings are less likely to initiate the HPV 
vaccination and even if they initiate it they are less likely to complete the course with 
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three doses (Fisher et al., 2013). The implication for policy would be to target also these 
groups to assure equitable delivery of the programme to all eligible girls. 
School-based programmes have exceeded the desired uptake goal, which was 70% of 
the eligible population. However, the delivery of the programme varied across schools 
as reflected in the variation of vaccine uptake by 13% in all years combined. It means 
that the programme did not run equally across all schools in the city. This has an 
implication for policy to assure that HPV vaccination sessions are carried out equally at 
all schools. Lower uptake in areas with lower socioeconomic status needs attention 
since participation in cervical screening is also lower in these areas (Spencer et al., 
2014). To reduce inequalities in affected schools with low uptake it is necessary to 
allocate more resources including school staff, vaccination nurses and schools nurses 
and to invest more time in meeting with parents directly.  
As I have already mentioned the NHS Trust in the city of my study used a team of bank 
nurses for the reason of being cost-effective. Although the team had good relationships 
with all secondary schools, the nurses were health visitors in each school. Therefore, 
they relied on schools’ efforts in the delivery of the HPV vaccination including 
distribution of consent forms, chasing them up, informing the girls and the parents about 
the HPV vaccine. The schools used teachers or administrative staff but not school 
nurses to organize and deliver the HPV vaccination. Variation in schools’ allocation of 
school staff as well as in NHS allocation of bank nurses resulted in overall inequity in 
the allocation of resources involved in the delivery of the HPV vaccination. The equity–
efficiency trade-off has been used as a framework for the consideration of equity in the 
allocation of healthcare resources (Sassi et al., 2001a). Theoretically, efficiency 
represents the ratio between benefit and costs. But the resources should be distributed 
efficiently to particular subgroups in the population according to principles of need and 
equity (Campbell et al., 2000). 
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The national immunisation team in the Health Protection Directorate of Public Health 
England has the responsibility for planning and implementation of national 
immunisation programmes. NHS England, through its area teams at local level, is 
responsible for the commissioning of all national immunisation and screening 
programmes (Public Health England, 2013). Immunisations are part of the Healthy Child 
Programme (5-19). School nursing services are a key component of the Healthy Child 
Programme (5-19) including development reviews, screening tests, immunisations, 
health promotion guidance. Since April 2013, Local Authorities have been responsible 
for commissioning public health services for school-aged children (5-19) which 
encompass the Healthy Child Programme (5-19). However, the Local Authorities need 
to work with area teams of NHS England and provider services (e.g. school nursing 
services or health visitors) to ensure high uptake (PHD-PHN/32420, 2014), to reduce 
health inequalities and to ensure that disadvantaged groups can access immunisation 
programmes (Public Health England, 2013). 
School nursing services, commissioned by Local Authorities (Public Health England, 
2013), have been delivered differently across England. It may be because school nursing 
services are funded from the public health grant (PHD-PHN/32420, 2014). Public health 
services have been and will continue to be funded by NHS England (NHS England, 
2014b). On the other hand, the school nursing workforce is relatively small and cannot 
deliver the Healthy Child Programme alone. It has been proposed that they to work 
across a range of organisations including education services, general practice, secondary 
care and children’s services. School nursing teams need to work with other partners 
including health and social care teams, teachers and youth workers to deliver public 
health interventions in schools (PHD-PHN/32420, 2014). For example, NICE guidance 
related to immunisation for children and young people is that school nurses should work 
with the director of public health and local public health services to advise young people 
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and their parents about the vaccinations recommended at secondary school age to 
reduce differences in the uptake of immunisations. NICE has made also 
recommendations on the extended school role referring to head teachers, school 
governors, managers of children's services and Sure Start children's centres and primary 
care immunisation coordinators that they should work with parents to support schools to 
become settings for vaccinating local children (National Institute for Health and Care 
Excellence, 2014).  
Policies regarding the process to obtain parental informed consent to respect individual 
right should be implemented. Guidelines to assess Gillick competence within a school 
setting are needed. A standard framework to assess Gillick competence and to establish 
adolescents’ consent to vaccination is necessary to be developed and used by all 
vaccinators irrespective of their nursing specialty. In addition, managerial and legal 
support structures should be in place in the event of parental complaints (Stretch et al., 
2009) and head teachers would also need to be familiar with these guidelines to face 
parental objections (Wood et al., 2011).  
 
8. 5. Implications for practice 
I conducted my study in a city in the West Midlands corresponding to a PCT where I 
discovered a model of delivery where none of the school nurses attached to a school 
was involved. The implication for future practice would be to compare different 
delivery strategies based on a bigger sample of schools from more PCTs/Local 
Authorities in the West Midlands to recommend the best practice aiming to achieve 
high uptake.  
 
Some school nurses promoted the HPV vaccine in assemblies in schools in the first 
years of the programme but not in the following years. School nurses have the 
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responsibility to educate pupils about health. The implication for practice would be to re 
organize school assemblies, which would provide an appropriate forum for 
dissemination of information about the vaccine including boys also, creating a 
“supportive environment.., that ensures the opportunity to acquire appropriate 
information and to participate in decisions affecting their health” as stipulated in 
Paragraph 23 of the UN General Comment No.14 (United Nations.Economic and Social 
Council, 2000, p. 6). Assemblies could include talks about STIs, which currently are 
taught in older years (10 and 11).  
 
Teaching materials, including lesson plans distributed by the RSPH, would be useful 
resources for PSHE, science or tutor classes because they were designed to be inclusive 
and to encourage engagement with both boys and girls. The advantage to provide 
information both to girls and boys would be that the inclusion of HPV vaccine for boys 
in vaccination programmes is currently debated (Eurosurveillance editorial team, 2012). 
It has been introduced in Australia (Brotherton et al., 2013) and it could be adopted in 
the UK also. If this occurs, the implication for practice would be a different way of 
delivery of the programme as well as of organizing the process to obtain consent. 
 
All information materials including leaflet, letters and consent forms given by the 
nurses to the girls and their parents were in English. NHS Choices is a website that has 
been set out to help patients to understand what services are available and where these 
services can be accessed (Department of Health, 2009) including the HPV vaccine. It 
could be accessed in English as well as in other languages but it remained unknown in 
my study whether parents have accessed it or not. In maintaining equity of uptake, 
consideration is needed on how to effectively address the information needs of those 
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with language barriers. Schools and health providers need to be aware that some parents 
especially mothers might not speak English. 
 
Parents from different ethnic groups might want to delay their daughter’s vaccination 
until an older age. To obtain information related to this issue they have to actively seek 
nurses’ advice. Nurses would direct them to their GP if the girl is under 18. My 
recommendation for practice would be to involve school staff and health professionals 
in the promotion of the HPV vaccine targeting both parents and the girls through direct 
communication in assemblies or other meetings held in schools. Also, GPs should be 
involved in the process of follow up of these girls until the age 18. 
 
Without the school roll data to check consents, vaccinators cannot ascertain whether or 
not any eligible girls have missed out on the opportunity of the free vaccine (i.e. has a 
girl declined or simply lost their consent form?). The implication for practice would be 
to inform head teachers to cooperate in handing over the school roll to the nurses.   
 
Practices regarding the process to obtain parental informed consent respecting 
individual rights should be implemented. The best reminder methods for follow up of 
consent forms should be chosen based on evidence to increase the return rates and clear 
guidelines and training given.  
 
8. 6. Implications for research  
 Further research could include a multilevel analysis of these data and could also include 
data about ethnicity and religion at individual level. A further analysis of the 
geographical location of professionals visiting the HPV vaccine web-pages on the 
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RSPH website (using the log of IP-addresses), could elucidate some of the reasons for 
schools’ lack of requests. 
There is a lack of research on the views of parents and if conducted this could extend 
understandings of barriers to consent for the HPV vaccine for their year 8 daughters. 
Not all factors in the conceptual framework were used in the analyses of this research 
because of unavailable data but they could be a valuable topic for further research for 
optimal vaccine delivery strategies to routinely reach girls with 3 doses in ways which 
are acceptable, affordable, ethical and sustainable and which achieve high and equitable 
coverage in vaccination. 
Further qualitative research could be conducted within the context of routine school-
based programmes on the process of obtaining informed consent from the perspective of 
all participants. 
If the HPV vaccination is extended to boys in the near future, further research on the 
implications for delivery could be done.  
 
8.7. Conclusions 
The delivery of the HPV vaccine to teenagers is an important area of public health and 
the use of school setting with further mop up clinics for this seems to ensure high 
uptake. There is a need to balance in the future the public health interest and the 
individual rights to informed consent. Despite the differences, I found in uptake by 
deprivation and my concerns with ethics and truly informed consent, uptake of the HPV 
vaccine remains very high and well above target levels. I have found interesting areas 
for further research and I have made recommendations for changes in practice which 
might be beneficial in terms of uptake and informed consent and which could be 
implemented relatively rapidly. 
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APPENDICES 
Appendix 1. The PRISMA
34
 Flow Diagram – literature review related to HPV 
vaccine uptake 
  
                                                          
34
 PRISMA = Preferred reporting items for systematic reviews and meta-analyses 
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Appendix 1. Table 1 Searches in OVID MEDLINE 
 
  
Search terms and combination of search terms Results 
 
1 papillomavirus vaccines.mp. or exp Papillomavirus Vaccines/ 3221  
 
2 human papilloma virus vaccines.mp. 15  
 
3 human papilloma virus.mp. 2953  
 
4 hpv.mp. 20856  
 
5 exp Vaccination/ or exp Mass Vaccination/ or vaccination.mp. 101250  
 
6 exp Immunization/ or immunisation.mp. or exp Immunization Programs/ 133763  
 
7 immunization.mp. 115738  
 
8 vaccin*.mp. 235979  
 
9 3 or 4 21883  
 
10 5 or 6 or 7 or 8 309292  
 
11 9 and 10 4309  
 
12 1 or 2 or 11 5073  
 
13 great britain.mp. or exp Great Britain/ 284294  
 
14 exp Europe/ or europe.mp. 1058074  
 
15 13 or 14 1061871  
 
16 12 and 15 637  
 
17 exp "Patient Acceptance of Health Care"/ or patient acceptance.mp. 149227  
 
18 health attitude.mp. or exp Attitude to Health/ 264897  
 
19 exp Health Knowledge, Attitudes, Practice/ 63467  
 
20 consumer health information.mp. or exp Consumer Health Information/ 2448  
 
21 health promotion.mp. or exp Health Promotion/ 54482  
 
22 uptake.mp. 242875  
 
23 health inequalities.mp. 1679  
 
24 17 or 18 or 19 or 20 or 21 or 22 or 23 553902  
 
25 16 and 24 138  
 
26 limit 25 to yr="2007-Current" * 136  
 
27 16 and 22 and 26 35  
* “Current” = 2012 
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Appendix 1. Table 2 Searches in OVID EMBASE 
  
  
Search terms and combination of search terms Results 
 
 
1 papillomavirus vaccines.mp. or exp Papillomavirus Vaccines/ 5748  
 
 
2 human papilloma virus vaccines.mp. 24  
 
 
3 human papilloma virus.mp. 4508  
 
 
4 hpv.mp. 28545  
 
 
5 exp Vaccination/ or exp Mass Vaccination/ or vaccination.mp. 164722  
 
 
6 exp Immunization/ or immunisation.mp. or exp Immunization Programs/ 243685  
 
 
7 immunization.mp. 152194  
 
 
8 vaccin*.mp. 364365  
 
 
9 3 or 4 30007  
 
 
10 5 or 6 or 7 or 8 461607  
 
 
11 9 and 10 6678  
 
 
12 1 or 2 or 11 8995  
 
 
13 great britain.mp. or exp Great Britain/ 321781  
 
 
14 exp Europe/ or europe.mp. 1223389  
 
 
15 13 or 14 1231278  
 
 
16 12 and 15 1060  
 
 
17 exp "Patient Acceptance of Health Care"/ or patient acceptance.mp. 225842  
 
 
18 health attitude.mp. or exp Attitude to Health/ 74227  
 
 
19 exp Health Knowledge, Attitudes, Practice/ 74173  
 
 
20 consumer health information.mp. or exp Consumer Health Information/ 2011  
 
 
21 health promotion.mp. or exp Health Promotion/ 70164  
 
 
22 uptake.mp. 357609  
 
 
23 health inequalities.mp. 2452  
 
 
24 17 or 18 or 19 or 20 or 21 or 22 or 23 711692  
 
 
25 16 and 24 122  
 
 
26 limit 25 to yr="2007-Current" 116  
 
 
27 16 and 22 and 26 37  
 
* “Current” = 2012 
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Appendix 1. Table 3 Searches in CINAHL 
 
Searc
h ID#  
Search Terms  Search Options  Actions  
S10 S7 AND S8  Limiters - 
Published Date 
from: 20070101-
20121231 
Search modes - 
Find all my search 
terms 
View Results  (155)  
View Details 
Edit 
 
S9 S7 AND S8  Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
S8 accept* or uptake  Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
S7 S3 AND S6  Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
S6 S4 OR S5  Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
S5 vaccin* or immuni*  Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
S4 "vaccination" OR (MH 
"Immunization")  
Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
S3 S1 OR S2  Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
S2 hpv or hpv vaccine  Search modes - 
Find all my search 
Rerun  
View Details 
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terms Edit 
 
S1 (MH "Papillomaviruses") OR 
"Human papillomaviruses" OR 
(MH "Papillomavirus Vaccine")  
Search modes - 
Find all my search 
terms 
Rerun  
View Details 
Edit 
 
 
 
Appendix 1. Searches in WEB OF KNOWLEDGE/ WEB OF SCIENCE 
 
Topic = ("papillomavirus vaccin*" or "human papillomavirus" or hpv or "human papilloma virus*")  
AND  
Topic = (vaccin* or immunis* or immuniz*)  
AND 
Topic = (uptake) 
Refined by: Countries/Territories = (England OR France OR Greece OR Switzerland OR Netherlands 
OR Hungary OR UK OR Ireland OR Italy OR Sweden OR Belgium OR Scotland OR Spain OR North 
Ireland OR Norway OR Germany OR Denmark OR Wales)* 
Doc Type = All document types;  
Language = All languages; 
Time span = 2007-2012 
Results: 59 records  
*It was no option to select UK or Great Britain. I had to choose available individual European countries.  
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Appendix 2. Sample size calculations - Comparing means from two groups  
 
n = 2 k SD
2
/d
2
 
n = number in each group 
k = multiplier for conventional values (significance level and power). Assuming 5% 
significance level and 80% power k = 7.8 (tabulated)  
SD = standard deviation 
d = difference to be detected 
 
Source: (Bland, 2000; Peacock and Kerry, 2007) 
 
 
 
 
 
 
 
 
Appendix 3. Table 1. School characteristics 
 
N/20 schools School characteristics N/20 schools School characteristics 
2/20 Private 18/20 Public  
4/20 Religious 16/20 Non religious  
11/20 Academies 9/20 Secondary  
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Appendix 4. Table 1. Ethnic groups (including all age groups) in school catchment areas 
 
 
 
* out of all ethnic groups in secondary school in academic year 2011/12 
Secondary 
school 
% 
Girls 
year 
8 
* 
 
% 
White: 
English/
Welsh/ 
Scottish/
Northern 
Irish/ 
British 
 
% 
White
: Irish 
 
% 
White: 
Polish 
 
% 
Other 
white 
 
% 
Mixed/ 
multiple 
ethnic 
group: 
White and 
Black 
Caribbean 
 
% 
Mixed/ 
multiple 
ethnic 
group: 
White and 
Asian 
 
% 
Black/ 
African 
/Caribbean/ 
Black 
British: 
African 
 
 
% 
Asian/ 
Asian 
British: 
Indian or 
British 
Indian 
 
% 
Asian/ 
Asian 
British: 
Pakistani 
or British 
Pakistani 
 
% 
Asian/ 
Asian 
British: 
Banglades
hi, British 
Banglades
hi 
 
% 
Asian/ 
Asian 
British: 
Chinese 
 
% 
Other 
Asian 
 
% 
Other 
ethnic 
group: 
Arab 
2 0.12 45.84 2.3 2.81 3.89 1.45 1.07 7.07 12.12 9.91 2.43 0.78 3.9 1.11 
3 0.13 66.92 2.17 1.47 3.02 1.04 0.74 4.76 8 2.67 1.99 1.2 2.09 0.77 
4 0.12 52.43 1.95 1.55 2.4 0.82 0.58 4.06 10.19 2.78 0.99 0.82 2.54 0.63 
5 0.33 72.6 2.29 1.51 2.04 0.97 0.68 2.89 9.4 1.23 0.33 0.49 2.56 0.34 
6 0.14 65.03 3.01 2.2 2.61 1.28 0.79 2.8 9.53 4.48 0.53 0.63 3.03 0.46 
7 0.13 66.46 2.33 2.35 2.8 1.52 0.69 5.87 8.18 1.86 0.5 0.41 2.52 0.49 
8 0.26 78.36 3.55 1.39 1.87 1.04 0.64 1.32 5.33 2.04 0.14 0.38 1.47 0.29 
9 0.19 73.17 2.18 2.48 2.75 1.06 0.59 6.82 5.72 0.43 0.24 0.29 1.38 0.22 
10 0.28 70.35 1.95 0.73 3.07 0.62 0.77 1.26 11.37 1.59 0.72 2.01 2.39 0.6 
11 0.3 49 1.71 2.29 2.72 1.98 0.75 5.35 12.59 10.97 1.31 0.32 4.39 0.79 
12 0.25 69.21 2.27 2.11 2.04 2.02 0.56 6.82 6.36 1.27 0.34 0.32 2.29 0.31 
14 0.08 54.16 2.08 2.78 3.07 1.76 0.8 7.39 10.75 5.89 1.76 0.34 3.24 0.76 
15 0.19 52.67 2.15 2.8 2.93 1.41 0.92 4.69 12.9 8.5 1 0.45 4.19 0.68 
16 0.19 35.35 1.61 3.05 4.4 1.36 1.14 8.87 14.62 11.99 4.09 0.82 4.69 1.51 
17 0.17 57.83 2.32 2.98 3.89 1.13 0.85 5.88 11.63 3.12 1.93 0.78 2.73 0.82 
18 0.12 78.57 2.7 1.14 3.11 0.88 0.71 2.62 3.12 1.36 0.18 2.01 1.22 0.34 
19 0.2 64.01 2.36 1.96 2.94 1.02 0.76 3.98 8.52 4.93 1.5 1.03 2.78 0.71 
20 0.21 67.54 2.25 2.38 3.4 1.08 0.64 6.69 7.88 1.08 0.5 1.06 1.82 0.64 
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Appendix 5. Table 1. Distribution of HPV vaccine uptake (third dose) by school in 
each academic year and in all academic years  
 
School 
 
Uptake 3
rd
 dose  
2008/09 
Uptake 3
rd
 dose 
 2009/10 
Uptake 3
rd
 dose  
2010/11 
Uptake 3
rd
 dose  
2011/12 
Uptake 3
rd
 dose  
all years 
n N % n N % n N % n N % n N % 
School 1 50 55 90 50 67 74 50 59 84 52 61 85 202 242 83 
School 2 51 65 78 48 68 70 44 61 72 57 63 90 200 257 77 
School 3 55 59 93 62 82 75 72 80 90 84 87 96 273 308 88 
School 4 92 100 92 84 111 75 78 95 82 105 118 88 359 424 84 
School 5 129 138 93 89 109 81 97 116 83 121 128 94 436 491 88 
School 6 108 114 94 89 109 81 93 110 84 94 105 89 384 438 87 
School 7 113 125 90 89 125 71 94 106 88 100 107 93 396 463 85 
School 8 124 131 94 88 122 72 125 128 97 121 136 88 458 517 88 
School 9 77 83 92 46 64 71 47 54 87 47 48 97 217 249 87 
School 10 108 116 93 72 102 70 119 126 94 103 109 94 402 453 88 
School 11 73 81 90 74 88 84 75 84 89 70 77 90 292 330 88 
School 12 43 48 89 44 57 77 65 76 85 69 82 84 221 263 84 
School 13 45 54 83 47 55 85 60 63 95 30 32 93 182 204 89 
School 14 50 60 83 45 57 78 35 42 83 43 43 100 173 202 85 
School 15 100 118 84 98 108 90 80 89 89 77 87 88 355 402 88 
School 16 62 89 69 68 91 74 71 90 78 73 90 81 274 360 76 
School 17 71 78 91 70 88 79 74 89 83 88 93 94 303 348 87 
School 18 37 41 90 33 46 71 44 51 86 38 43 88 152 181 83 
School 19 221 233 94 187 236 79 173 198 87 159 184 86 740 851 86 
School 20 56 69 81 47 72 65 63 68 92 69 84 82 235 293 80 
n = number of girls vaccinated with the third dose 
N = total number of year 8 girls eligible to be vaccinated 
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Appendix 6. Histogram of the dependent variable in 2008/09, 2009/10, 2010/11, 
2011/12 and all years  
 
Appendix 6. Figure 1.                              Appendix 6. Figure 2.     
Uptake 3
rd
 dose in 2008/09                        Uptake 3
rd
 dose in 2009/10 
 
 
Appendix 6. Figure 3.                                      Appendix 6. Figure 4. 
Uptake 3
rd
 dose in 2010/11                           Uptake 3
rd
 dose in 2011/12 
 
 
Appendix 6. Figure 5. Uptake 3
rd
 dose in all years 
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Appendix 7. Linear regression analyses in 2008/09, 2009/10, 2010/11 and 2011/12 
 
Linear regression analysis in the academic year 2008/09 
Figure 1 shows that the distribution of the dependent variable (uptake of the third dose 
2008/09) by transformation remained skewed. Therefore, the outcome variable was 
entered in the models untransformed.  
Appendix 7. Figure 1. Transformations of the dependent variable in the academic 
year 2008/09 
 
 
 
Table 1 shows the unadjusted and adjusted results of the association between uptake and 
the study area characteristics. The unadjusted results indicate that there was a negative 
statistically significant association between deprivation of SCA and uptake (i.e. a unit 
increase in deprivation was associated with a reduction of uptake). There was a positive 
statistically significant association between uptake and ethnicity as well as religious 
schools. In multiple regression model 1, deprivation of SCA remained statistically 
significantly associated with uptake after controlling for ethnicity and school type. In 
multiple regression model 2 (i.e. after multiple adjustments of other factors), deprivation 
of SAP became statistically significantly associated with uptake. In the two multiple 
regression models, ethnicity remained statistically significantly associated with uptake 
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when the other variables were held constant and the same was true for the association 
between religious schools and uptake. 
 
Appendix 7. Table 1. The relationship between uptake and variables related to 
geographic factors and school factors in 2008/09 
 
 Unadjusted  MODEL 1  MODEL 2  
Uptake  Coeff SE p value Coeff SE p value Coeff SE p value 
deprivation SCA* -0.51 0.16 0.006 -0.30 0.11 0.01    
deprivationSAP ** -0.18 0.12 0.15    -0.16 0.06 0.02 
ethnicity**  0.40 0.12 0.006 0.28 0.10 0.02 0.29 0.09 0.006 
school type **          
No (reference) 0   0   0   
Yes  5.12 1.93 0.01 3.11 1.17 0.01 5.65 2.07 0.01 
*N = 18 observations 
** N = 20 observations 
School type = religious 
 
The independent variables included in the regression analysis model 1 explained 71% of 
the variation in uptake and those modeled together in the regression analysis model 2 
explained 68% of the variation in uptake. 
In conclusion, I found that uptake was significantly associated with geographic factors 
(deprivation of SCA, deprivation of SAP and ethnicity) and school factors (religious 
affiliation). 
 
Linear regression analysis in the academic year 2009/10 
Figure 2 shows that the distribution of the dependent variable (uptake of the third dose 
2009/10) became Normal after 1/square root transformations. However, log 
transformation showed that the outcome variable had a distribution near to Normality. 
For an easy interpretation of the results of regression analyses, the dependent variable 
was entered in the models log transformed.  
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Appendix 7. Figure 2. Transformations of the dependent variable in the academic 
year 2009/10 
 
 
 
Table 2 shows the unadjusted and adjusted results of the association between uptake and 
the study area characteristics. The unadjusted results indicate that there was a negative 
statistically significant association between uptake and deprivation of SCA as well as 
deprivation of SAP (i.e. a unit increase in deprivation was associated with a reduction of 
uptake). There was a positive statistically significant association between uptake and 
ethnicity as well as religious schools. In multiple regression model 1, deprivation of 
SCA remained statistically significantly associated with uptake after controlling for 
ethnicity and school type. In multiple regression model 2 (i.e. after multiple adjustments 
of other factors), deprivation of SAP remained statistically significantly associated with 
uptake. In the two multiple regression models, ethnicity remained statistically 
significantly associated with uptake when the other variables were held constant.  
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Appendix 7. Table 2. The relationship between uptake and variables related to 
geographic factors and school factors in 2009/10 
 
 Unadjusted  MODEL 1  MODEL 2  
Uptake  Coef
f 
SE p value Coeff SE p value Coeff SE p 
value 
deprivation SCA* 1.16 0.01 <0.001 1.05 0.01 <0.001    
deprivationSAP ** 1.12 0.01 <0.001    1.03 0.007 0.001 
ethnicity**  1.06 0.002 <0.001 1.04 0.004 <0.001 1.05 0.003 <0.001 
school type **          
No (reference)*** 0   0   0   
Yes  75.4 1.81 <0.001 1.42 0.49 0.32 0.93 0.34 0.85 
*N = 18 observations 
** N = 20 observations 
***geometric mean = 75.98 
School type = religious 
 
The independent variables included in the regression analysis model 1 explained 98% of 
the variation in uptake and those modeled together in the regression analysis model 2 
explained 98% of the variation in uptake. 
In conclusion, I found that uptake was significantly associated with geographic factors 
(deprivation of SAP, deprivation of SCA and ethnicity) and no association was found 
between uptake and school factors (religious affiliation). 
 
Linear regression analysis in the academic year 2010/11 
Figure 3 shows that the distribution of the dependent variable (uptake of the third dose 
2010/11) became Normal after cubic and square transformations. Without 
transformation, the outcome variable had a distribution near to Normality (shown by 
histogram corresponding to “Identity”). For an easy interpretation of the results of 
regression analyses, the dependent variable was entered in the models untransformed.  
  
347 
  
Appendix 7. Figure 3. Transformations of the dependent variable in the academic 
year 2010/11 
 
 
 
Table 3 shows the unadjusted and adjusted results of the association between uptake and 
the study area characteristics. The unadjusted results indicate that there was a negative 
statistically significant association between deprivation of SAP and uptake (i.e. a unit 
increase in deprivation was associated with a reduction of uptake). There was a positive 
statistically significant association between ethnicity and uptake (i.e. a unit increase in 
percentage of white residents was associated with an increase of uptake). In multiple 
regression model 1, ethnicity remained statistically significantly associated with uptake 
after controlling for deprivation of SCA and school type. In multiple regression model 2 
(i.e. after multiple adjustments of other factors), no association was found between 
uptake and geographic factors (deprivation of SAP and ethnicity) or school factors 
(religious affiliation). 
  
0
1
.0
e
-0
6
2
.0
e
-0
6
3
.0
e
-0
6
4000005 00006 00007 00008 00009 0000
cubic
01
.0
e
-0
4
2
.0
e
-0
4
3
.0
e
-0
4
4
.0
e
-0
4
5000 6000 7000 8000 9000
square
0
.0
2
.0
4
.0
6
.0
8
70 80 90 100
identity
0
.5
1
1
.5
8.5 9 9.5 10
sqrt
0
2
4
6
8
4.3 4.4 4.5 4.6
log
0
5
0
1
0
0
-.12 -.115 -.11 -.105 -.1
1/sqrt
0
2
0
0
4
0
0
6
0
0
8
0
0
-.014 -.013 -.012 -.011 -.01
inverse
05
0
0
0
1
.0
e
+
0
4
1
.5
e
+
0
4
2
.0
e
+
0
4
2
.5
e
+
0
4
-.0002-.00018-.00016-.00014-.00012-.0001
1/square
0
5
.0
e
+
0
5
1
.0
e
+
0
6
1
.5
e
+
0
6
-3.00e-06-2.50e-06-2.00e-06-1.50e-06-1.00e-06
1/cubic
D
e
n
s
it
y
Uptake 3rd dose 10-11
Histograms by transformation
348 
  
Appendix 7. Table 3. The relationship between uptake and variables related to 
geographic factors and school factors in 2010/11 
 
 Unadjusted  MODEL 1  MODEL 2  
Uptake  Coeff SE p value Coeff SE p value Coeff SE p value 
deprivation SCA* -0.24 0.13 0.10 -0.08 0 .11 0.48    
deprivation SAP ** -0.19 0.07 0.01    -0.08 0.06 0.22 
ethnicity**  0 .30 0.10 0.01 0.26 0 .11 0.03 0.24 0.12 0.07 
school type**          
No (reference) 0   0      
Yes  -0.5 2.32 0.83 -0.67 2.17 0.76 0.24 1.88 0.90 
*N = 18 observations 
** N = 20 observations 
School type = religious 
 
The independent variables included in the regression analysis model 1 explained 39% of 
the variation in uptake and those modeled together in the regression analysis model 2 
explained 41% of the variation in uptake. 
In conclusion, I found that uptake was only significantly associated with ethnicity and 
no association was found between uptake and other geographic factors (deprivation of 
SAP and deprivation of SCA) or school factors (religious affiliation). 
 
Linear regression analysis in the academic year 2011/12 
The outcome variable uptake of the third dose 2011/12 was Normally distributed.  
Table 4 shows the unadjusted and adjusted results of the association between uptake and 
the study area characteristics. The unadjusted results indicate that there was no 
statistically significant association between uptake and geographic factors (deprivation 
of SCA, deprivation of SAP and ethnicity) or school factors (religious affiliation). In the 
two multiple regression models (i.e. after multiple adjustments of other factors), no 
association was found between uptake and geographic factors (deprivation and 
ethnicity) or school factors (religious affiliation). 
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Appendix 7. Table 4. The relationship between uptake and variables related to 
geographic factors and school factors in 2011/12 
 
 Unadjusted  MODEL 1  MODEL 2  
Uptake  Coeff SE p value Coeff SE p value Coeff SE p value 
deprivation SCA* -0.09 0.14 0.54 -0.02 0.16 0.88    
deprivation SAP** -0.11 0.07 0.15    -0.08 0.09 0.36 
ethnicity**  0.08 0.10 0.42 0.07 0.13 0.56 0.02 0.12 0.81 
school type **          
No (reference) 0   0   0   
Yes  1.87 2.17 0.40 1.60 2.07 0.45 2.19 2.35 0.36 
*N = 18 observations 
** N = 20 observations 
School type = religious 
 
The independent variables included in the regression analysis model 1 explained 6% of 
the variation in uptake and those modeled together in the regression analysis model 2 
explained 11% of the variation in uptake. 
In conclusion, no association was found between uptake and geographic factors 
(deprivation and ethnicity) or school factors (religious affiliation). 
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Appendix 8. Histogram of the independent variables: deprivation of school address 
postcode, deprivation of school catchment area and ethnicity 
 
Appendix 8. Figure 1. IMD of SAP             Appendix 8. Figure 2. IMD of SCA 
 
 
Appendix 8. Figure 3. Ethnicity 
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Appendix 9. Three-dose completion rate of HPV vaccination programme 
 
The statistics for the three-dose completion rate by academic year were calculated 
according to the following definition: the relative proportion of girls who completed 
vaccination to the total number of girls who only received the first dose. Table 1 gives 
details about the completion rates by school and by academic year. The number of 
schools which vaccinated all year 8 girls was one in 2008/09, nine in 2009/10, four in 
2010/11 and six in 2011/12.  
 
Appendix 9. Table 1. Completion rate of HPV vaccination programme by school 
and by academic year 
 
School  
Completion 
Rate 2008/09 
Completion 
Rate  2009/10 
Completion 
Rate 2010/11 
Completion 
Rate  2011/12 
1 98 100 98 98 
2 94 91 85 98 
3 96 100 97 99 
4 100 85 101 100 
5 97 103 100 98 
6 98 101 99 98 
7 98 96 98 100 
8 98 100 100 97 
9 95 82 94 98 
10 99 94 99 99 
11 92 109 99 99 
12 98 88 96 93 
13 98 102 98 100 
14 88 90 95 100 
15 97 101 96 97 
16 97 97 99 100 
17 99 97 96 97 
18 95 106 100 100 
19 98 97 99 96 
20 98 92 95 95 
 
The percentage of year 8 girls who completed the programme in each academic year 
was very high - on average 97-98%. The completion rate of the programme varied more 
widely across the schools in 2009/10 (from 82% to 109%) in comparison with the other 
academic years when the rates ranged from 88% to 100% in 2008/09, from 85% to 
101% in 2010/11 and from 93% to 100% in 2011/12. (It should be noted that the 
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percentages of year 8 girls vaccinated in the academic year 2009/10 and 2010/11 
exceeded 100%). In all years combined, uptake of the first dose was 88% and uptake of 
the third dose was 85%. In all 97% of year 8 girls completed the programme from 
2008/09 to 2011/12. Table 2 presents summary statistics (mean, standard deviation and 
median) for the completion rate of the programme by academic year. 
 
Appendix 9. Table 2. Summary statistics for the completion rate of HPV 
vaccination programme (percentage of girls receiving the first vaccine who 
received the second and final dose) by academic year 
 
Completion 
rate  
N Mean Std. Dev. Min Max 
2008/09 20 96.72 2.78 87.71 100 
2009/10 20 96.56 7.00 82.14 108.82 
2010/11 20 97.22 3.56 84.61 101.29 
2011/12 20 98.03 1.91 93.24 100 
N = number of schools 
 
Appendix 10. Delivery of the HPV immunization programme - Interval between 
administrations of doses
35
 
 
Interval between administration of the first dose and the second dose 
According to the schedule of HPV immunization, the vaccine should be administered at 
0, 1 month and 6 months. I calculated the interval between administration of the first 
and the second dose. Table 1 shows the interval (expressed in days) for each academic 
year. I considered one month being on average 30 days.  
The second dose of the vaccine was administered 27-35 days after the first dose in the 
majority of schools in the academic year 2008/09 (18 schools) and in the academic year 
2010/11 (14 schools). Similarly over half of the schools (12 schools) gave the second 
dose after 28-35 days in the following academic year 2011/12. In contrast, in 2009/10 
the girls were vaccinated with the second dose after a longer interval (36-95 days) in 
more than half of the schools (12 schools).  
Figures 1 and 2 present the variation of the interval between administration of the first 
two doses by bar charts with error bars by school in the academic years 2009/10, 
2010/11 and 2011/12. Figure 1 shows that in the academic year 2009/10, four schools 
(3, 10, 15 and 18) administered HPV vaccine two three months later than the schedule. 
                                                          
35
 Based on the results of qualitative data analysis in Chapter – Theme 1 and theme 2 
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Figure 2 indicates that three schools (1, 6 and 9) vaccinated the girls with the second 
dose at one and a half months after the first dose in 2010/11 and Figure 3 shows that 
this occurred in five schools (2, 3, 4, 5 and 16) in 2011/12. This interval could reflect 
the way in which the HPV immunisation programme was offered by the vaccination 
team. Usually one-two schools were visited per day four days per week so that all the 
schools were covered in about two-three weeks. 
 
Appendix 10. Table 1. Interval between the administration of the first dose and the 
second dose by academic year 
 
 
Academic 
year 
2
nd
 dose given within 1 month 
after the 1
st
 dose 
2
nd
 dose given > 1 month 
after the 1
st
 dose 
Interval 1
st
  – 2nd dose * N schools 
18 
8 
14 
12 
Interval 1
st
  – 2nd dose  N schools 
2 
12 
5 
8 
2008/09 35   38  
2009/10 27-35  36-95  
2010/11 28-35  36-49  
2011/12 28-35  36-49  
  *days 
 
Appendix 10. Figure 1. Interval between the first dose and the second dose in year 
2009/10 
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Appendix 10. Figure 2. Interval between the first dose and the second dose in year 
2010/11  
 
 
 
Appendix 10. Figure 3. Interval between the first dose and the second dose in year 
2011/12 
 
 
 
Appendix 11. Interval between administration of the first dose and the third dose 
 
Using the date of immunization for the first dose and the third dose, I calculated the 
interval between administration of the first and the third dose for each academic year, 
which is presented in days. The schedule for the third dose is at six months after the first 
dose. I considered this interval to be equal to 180 days. Table 1 shows that from 2008 
and 2012, the interval varied between 143 and 234 days. I divided this interval in three 
periods as follows. A period less than 180 days indicated that the vaccinations were 
given earlier than the schedule. The time corresponding to 180 -185 days suggested that 
the programme was delivered according to standard vaccination schedule (in five 
working days within a week). The interval, which exceeded 185 days, pointed to a delay 
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in delivery of HPV immunizations. Because the way the programme was delivered in 
practice as mentioned previously, a period corresponding to 186-200 days could still be 
considered to fall into the recommended vaccination schedule because of the extra time 
the vaccination team needed to cover all the schools with the third dose of HPV vaccine 
(additional ten working days within two weeks). Across the years, a few schools, 
between two and four schools, administered the third dose between 5 and 37 days 
(within one week – one month) earlier than the schedule. Almost half of the schools (8 
schools) administered the third dose at six months after the first dose in the academic 
year 2008/09. More than half of the schools (12-13 schools) administered the third dose 
36-48 days later than the schedule (equal to seven or more months from the date when 
the first dose was given) in three academic years (2009/10, 2010/11 and 2011/12). 
 
Appendix 11. Table 1. Interval between administration of the first and the third 
dose of HPV vaccine by academic years 
 
 
 
Academic 
year 
3
rd
 dose given 
< 6 months after 1
st
 dose 
3
rd
 dose given at 
6 months after 1
st
 dose 
(standard immunization 
schedule) 
3
rd
 dose given 
> 6 months after 1
st
 dose 
 Interval  
1
st
  –3rd dose * 
N schools Interval 
1
st
  –3rd dose* 
N 
schools 
Interval 
1
st
  –3rd dose* 
N 
schools 
2008/09 143-179  3 
4 
2 
2 
180-185  8 186-212  9 
2009/10 148-179  180-185  3 186-234  13 
2010/11 145-179  180-185  5 186-222  13 
2011/12 175-179  180-185  6 186-231  12 
*days 
In Figures 1-4 the interval between administration of the first and the third dose are 
represented graphically by bar charts by schools in each academic year. I made a 
comparison across the years to understand the pattern of the third dose delivery. A 
consistent observation was that year after year the same six schools gave the third dose 
later than six months. School 14 administered the third dose at more than six months 
after the first dose in all four academic years. Three schools (schools 5, 6, 8) gave the 
third dose later than the schedule for three consecutive years in 2008/09, 2009/10 and 
2010/11. Other two schools (schools 18, 20) administered the third dose beyond 180 
days in 2009/10, 2010/11 and 2011/12. Two schools (11 and 19) vaccinated the girls 
with the third dose later than the schedule in the first and the last two years of the 
programme (2008/09, 2010/11 and 2011/12).  
As mentioned before, the vaccination team gave the third dose at six – seven months 
(180-200 days) as recommended schedule. Figures 1-4 show that there were schools 
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which offered the third dose later than this schedule (delay by 2 and 34 days).  Thus, in 
2008/09 there were four schools (2, 3, 8, 19), in 2009/10 eight schools (1, 4, 5, 8, 14, 
15, 16, 18), in 2010/11 ten schools (4, 5, 6, 8, 9, 11, 12, 14, 18, 20), and in 2011/12 
eight schools (7, 14, 15, 16, 17, 18, 19, 20). 
 
Appendix 11. Figure 1. Interval between the first dose and the third dose in year 
2008/09 
 
 
 
Appendix 11. Figure 2. Interval between the first dose and the third dose in year 
2009/10 
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Appendix 11. Figure 3. Interval between the first dose and the third dose in year 
2010/11 
 
 
 
Appendix 11. Figure 4. Interval between the first dose and the third dose in year 
2011/12 
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Appendix 12. Table 1. Distribution of IMD score for school catchment area and 
school address postcode 
 
school average IMD score SCA IMD score SAP 
1 NA 48.93 
2 32.21 36.44 
3 17.13 9.71 
4 14.94 33.21 
5 14.92 22.57 
6 20.50 26.27 
7 31.48 59.12 
8 15.74 11.66 
9 36.93 34.24 
10 8.64 9.71 
11 33.27 28.29 
12 30.55 11.27 
13 NA 11.08 
14 33.50 23.54 
15 28.31 20.08 
16 42.61 66.63 
17 26.68 27.51 
18 24.15 29.52 
19 15.68 30.07 
20 33.01 31.97 
NA= not available 
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Appendix 13. Religious affiliation of the schools 
 
Appendix 13. Figure 1. Distribution of average uptake by religious affiliation in all 
academic years 
 
 
Mann-Whitney test (z = -0.14, p value = 0.88) 
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Appendix 14. Deprivation of school address postcode in 2008/09, 2009/10, 2010/11, 2011/12 
and all years 
 
Appendix 14. Figure 1.   Appendix 14. Figure 2. 
Distribution of average uptake by              Distribution of average uptake by 
deprivation of SAP in year 2008/09             deprivation of SAP in year 2009/10 
 
/Mann-Whitney test (z = 1.14, p value = 0.25)         Mann-Whitney test (z = 2.01, p value = 0.04) 
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Appendix 14. Figure 3.   Appendix 14. Figure 4. 
Distribution of average uptake by                Distribution of average uptake by 
deprivation of SAP in year 2010/11               deprivation of SAP in year 2011/12 
 
Mann-Whitney test (z = 1.06, p value = 0.28)            Mann-Whitney test (z = 1.71, p value = 0.08) 
 
Appendix 14. Figure 5.  
Distribution of average uptake by deprivation of SAP in all academic years 
Mann-Whitney test (z = 2.80, p value = 0.005) 
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Appendix 15. Deprivation of school catchment area in 2008/09, 2009/10, 2010/11, 2011/12 and 
all years 
 
Appendix 15. Figure 1.                         Appendix 15. Figure 2. 
Distribution of average uptake by          Distribution of average uptake by 
deprivation of SCA in 2008/09   deprivation of SCA in 2009/10 
 
Mann-Whitney test (z = 3.28, p value = 0.001)               Mann-Whitney test (z = 0.53, p value = 0.59) 
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Appendix 15. Figure 3.                                   Appendix 15. Figure 4. 
Distribution of average uptake by                Distribution of average uptake by 
deprivation of SCA in 2010/11                       deprivation of SCA in 2011/12 
 
Mann-Whitney test (z = 0.35, p value = 0.72)           Mann-Whitney test (z = 0.44, p value = 0.65) 
 
Appendix 15. Figure 5. Distribution of average uptake by deprivation of SCA in all academic years   
 
Mann-Whitney test (z = 1.53, p value = 0.12) 
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Appendix 16. Distribution of average uptake by ethnicity in school catchment area in 2008/09, 
2009/10, 2010/11, 2011/12 and all years 
 
Appendix 16. Figure 1.                           Appendix 16. Figure 2. 
Distribution of average uptake by   Distribution of average uptake by 
ethnicity in SCA in 2008/09                   ethnicity in SCA in 2009/10 
 
Mann-Whitney test (z = -0.88, p value = 0.37)  Mann-Whitney test (z = 2.12, p value = 0.03) 
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Appendix 16. Figure 3.                                  Appendix 16. Figure 4. 
 Distribution of average uptake by          Distribution of average uptake by 
ethnicity in SCA in 2010/11                         ethnicity in SCA in 2011/12 
 
Mann-Whitney test (z = -2.21, p value = 0.02)  Mann-Whitney test (z = -0.48, p value = 0.62) 
 
Appendix 16. Figure 5. Distribution of average uptake by ethnicity in SCA in all academic years 
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Appendix 17. Figure 1. Age composition of ethnic groups in the UK in 2011 Census 
 
 
Source: Centre on Dynamics of Ethnicity, 2013 
 
Appendix 17. Table 1. Percentage of under 15s by ethnic group in 2011 Census 
 
Ethnic group Number under 15s Percentage under 15s 
White Irish 25000 0.25 
Gypsy  30000 0.30 
Chinese  48000 0.49 
Arab 54000 0.55 
Other 57000 0.58 
Mixed White African 94000 0.96 
Carribean 96000 0.99 
Other Black 108000 1.11 
Other Mixed  117000 1.20 
Bangladeshi 132000 1.36 
Mixed White Asian 135000 1.39 
Mixed White Carribean 164000 1.69 
Other Asian 168000 1.73 
Indian 252000 2.60 
African 280000 2.88 
Pakistani 341000 3.51 
Other White 375000 3.86 
White British 7216000 74.45 
TOTAL  9692000 100 
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Appendix 18. Assessment of correlations between dependent and independent 
continuous variables and between independent continuous variables 
 
Appendix 18. Figure 1.                      Appendix 18. Figure 2. 
Scatter plot matrix for 2008/09                        Scatter plot matrix for 2009/10 
 
Appendix 18. Figure 3.   Appendix 18. Figure 4. 
Scatter plot matrix for 2010/11          Scatter plot matrix for 2011/12 
 
Appendix 18. Figure 5. Scatter plot matrix for all years 
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Appendix 19. Dot plot for uptake of the third dose by school type 
 
 
 
Appendix 20. 
Multilevel regression analysis 
 
Appendix 20. Table 1. Data required for multilevel regression analysis 
 
Girl 
vaccinated 
3rd dose 
Girl not 
vaccinated 
3rd dose* 
Year 
Ethnicity*
* 
Postcode 
individual 
*** 
LSOA1 
IMD 
score1 
School 
Postcode 
school 
LSOA2 
IMD 
score2 
n = 5676 N = ?          
*currently data is not available 
** currently data is not available 
***currently 3 digits of postcodes are available  
currently incorrect  match individual postcode to LSOA1 
LSOAs in the city of study = 194 
 
Multilevel regression analysis 
Multilevel analysis has different terms such as hierarchical modeling, random effects 
models, variance heterogeneity to name a few. It is used when data can be clustered or 
organized in a hierarchical structure. For example, individuals could be nested within 
geographical areas or institutions such as schools (University of Bristol, 2011a).  
 
Types of models 
Ideally, data, which I received from the community Trust and I presented in the Table 1 
above, could have been used to create different hierarchical structures such as two level 
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nested models, three level nested models and non-nested models proposed by the Centre 
for Multilevel Modelling in the University of Bristol which are shown in Figures 1-4 
below. The simplest and commonest model used is two level nested models. Examples 
of two level nested models are pupils within schools as well as pupils within areas. I 
could have created these two types of models and for areas I could have used SCAs. 
More complex models such as a three level nested model would have the following 
structure: pupils within cohorts within schools (University of Bristol, 2011a) with 
repeated measures of outcome made on the schools over time (University of Bristol, 
2011d). My data included four cohorts of pupils in each school from four academic 
years. Another possible three level nested model is pupils within schools within areas. 
The structure of a non-nested model is pupils nested within school and pupils nested 
within areas
36
. This model is appropriate when pupils who attend the same school come 
from different areas (University of Bristol, 2011a).  
 
Appendix 20. Figure 1. Two level nested model - pupils within schools 
 
 
Source: (University of Bristol, 2011a)  
                                                          
36
 The assumption is that the pupils live in different administrative areas which could be determined 
according to the postcode of their addresses (for example using the first 3 digits of the postcode) 
370 
  
Appendix 20. Figure 2. Three level nested model - pupils within cohorts within 
schools 
 
 
Source: (University of Bristol, 2011a) 
 
Appendix 20. Figure 3. Three level nested model - pupils within schools within 
areas 
 
 
Source: (University of Bristol, 2011a) 
 
Appendix 20 Figure 4. Three level non-nested model - pupils nested within school 
and pupils nested within areas 
 
 
Source: (University of Bristol, 2011a) 
2008 2009 2008 2009 2008 2009 
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Assumptions 
The advantage of using multilevel analysis instead of multiple regression model is that 
it gives accurate estimate of standard errors of coefficients. For example, multiple 
regression model ignores the clustering and as a result standard errors of regression 
coefficients are underestimated, leading to an overstatement of statistical significance 
(University of Bristol, 2011a).  
Three factors affect the estimates multilevel analysis: number of groups, number of 
level-one units, and the intra class correlation (Maas and Hox, 2005). The latter will be 
discussed later. In order to do multilevel analysis two assumptions have to be made. 
First, the units of data vary randomly according to a distribution (i.e., Normal, Poisson, 
etc.). Second, the units of data level can be regarded as a random sample from a wider 
population of units. For example, in the model with pupils within schools, the pupils are 
a random sample from a wider population of students. Similarly, the schools are a 
random sample from a wider population of schools (University of Bristol, 2011c).  
 
Sample size 
In multilevel studies, an important aspect to be taken into account is usually the sample 
size at the group level, because the group-level sample size is always smaller than the 
individual-level sample size (Maas and Hox, 2005). There is some debate in the 
literature related to the number of units to be sampled. The Centre for Multilevel 
Modelling in the University of Bristol suggested that at least 20 higher-level units (i.e, 
schools) are required (University of Bristol, 2011c). Maas and Hox mentioned that in 
practice 50 groups are usually recommended in organizational and school research, and 
the smallest acceptable number is 30 (Maas and Hox, 2005). Another important issue is 
to have sufficient statistical power to find significance (Newsom, 2013). Statistical 
power in multilevel models depends on effect size and intra class correlations. It is 
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different for fixed effect model and random effect model, and it changes according to 
the number of groups and the number of individuals per group  (Leeuw and Kreft, 
1998). A group size of 30 is normal in educational research, and a group size of 5 is 
normal in family research and in longitudinal research (Maas and Hox, 2005). Fixed 
effects, in general, require fewer cases to have sufficient power. 50 groups with 5 cases 
per group are needed for sufficient power to test fixed effects.  Random effects 
generally require more cases than to test fixed effects. 100 to 200 groups with 
approximately 10 cases per group are needed for sufficient power to test random effects. 
Significance tests of intercept variances require fewer cases than variance tests of 
random slopes (Newsom, 2013). If the number of cases in different groups is unequal, 
the multilevel estimates or their standard errors are not affected (Maas and Hox, 2005).  
 
Variance 
Multilevel regression analysis uses measures of outcome variation to understand 
contextual determinants of individual health outcome such as social, cultural and 
economic factors. For example, if the health of the people within a neighbourhood is 
similar, in comparison to the health of people from other neighbourhoods, it is more 
likely that the determinants of individual health are directly related to the contextual 
environment of the neighbourhood and geographical segregation (Merlo et al., 2005b). 
Contextual phenomenon corresponds to the statistical concept of clustering (Merlo et 
al., 2005a). Using measures of clustering of individual outcome within neighbourhoods 
is important to evaluate the relative significance of the neighbourhood effect on 
outcomes, and consequently to promote interventions at neighbourhood level. This is 
important to determine the efficacy of intervention on places. When the clustering of 
individual outcome within neighbourhoods is small, focusing intervention on places is 
an inefficient strategy (Merlo et al., 2005b).  
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It has been argued that single level individual analyses as well as ecological studies are 
not suitable for investigating contextual effects. A single level individual analysis does 
not consider that there is variability within groups (i.e., neighbourhoods) (Merlo et al., 
2005a). In the ecological analysis the units of analysis are groups of people rather than 
individuals. The results are difficult to interpret because it is not possible to examine 
directly the explanations for findings (Bonita et al., 2006). For example, the mean of 
health outcome for each group (i.e., neighbourhood) is estimated from the sample of 
people in each neighbourhood. These estimated means are used to calculate the 
ecological variance which corresponds to the between neighbourhood variance of health 
outcome in multilevel analysis. But, the ecological variance overstates the 
neighbourhood variance because it also includes variation attributable to sampling error 
in the estimates of each neighbourhood mean (Merlo et al., 2005a).   
In multilevel analysis, cluster effects can be assessed by quantifying and modelling 
variance (Merlo et al., 2005b). The variations in outcome between groups are assumed 
to be the same for every individual, whatever their individual characteristics (Merlo et 
al., 2005c). 
In a multilevel model, the individual and the cluster variance components represent the 
total variance in outcome (Merlo et al., 2005a; Day and Rasbash, 2006). For example, 
in a two level model with pupils nested within schools, it could be determined how 
much of the total variation of individual outcome is attributable to school level factors 
and how much of the total variation of individual outcome is attributable to pupil level 
factors (Day and Rasbash, 2006). 
The multilevel model assumes Normality for the distribution of means of outcome at 
cluster level and the distribution of the individual values around each mean of outcome 
at cluster level (Day and Rasbash, 2006). It also assumes that there is independence 
between the individual and cluster residuals (Merlo et al., 2005b).  
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Multilevel regression model 1 - Intra class correlation 
Intra class correlation (ICC) is a measure of clustering that is correlation between units 
within a group (i.e., school). Grouped data violate the assumption of independence of 
all observations. The amount of dependence can be expressed as the ICC (Maas and 
Hox, 2005). Correlation suggests that the ICC expresses the similarity in outcome 
between two individuals in the same group (Merlo et al., 2005a). The ICC is quantified 
in the ‘‘empty’’ model which does not include any explanatory variables. This model 
does not explain any variance in outcome. It only decomposes the variance of outcome 
into two independent components (Maas and Hox, 2005). 
When data is clustered there are residual components at each level in the hierarchy. A 
two-level model with children grouped within schools would include residuals at the 
child and school level. Thus, the residual variance is partitioned into a between-school 
component (the variance of the school-level residuals) and a within-school component 
(the variance of the child-level residuals). The school residuals are called “school 
effects’’ and represent unobserved school characteristics that affect child outcomes. It is 
these unobserved variables which lead to correlation between outcomes for children 
from the same school (University of Bristol, 2011a). This two level model is called 
variance components model because there is a single residual term for each level, for 
example student (level 1) residuals and school (level 2) residuals. This model is also 
called a random intercept model because only the intercept term in the regression 
equation is assumed to vary randomly across schools (University of Bristol, 2011d). For 
a two-level model the ICC represents the proportion of variance at the higher level 
(cluster) (University of Bristol, 2011b) .   
To know if the ICC is statistically different from 0 a statistical test of the cluster 
variance could be used. When the cluster level variance is not significant, there is no 
justification for computing the ICC (Merlo et al., 2006). If the ICC is close to 0 suggests 
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that the context defined by the clusters is not important in understanding the differences 
in outcome at individual level (Merlo et al., 2005b).  
 
Multilevel regression model 2 with individual variables  
This is an extension of the empty model which includes individual variables. No cluster 
variable is investigated (Merlo et al., 2005b). This multilevel model assumes that the 
explanatory variables are fixed which means that they have a standard normal 
distribution (Maas and Hox, 2005). From data presented in Table 1 above, I could have 
included in this model ethnicity as an individual variable. 
As in simple regression analysis, the regression coefficients of the individual variables 
in multilevel regression analysis describe the association between the individual level 
variables and outcome. The presence of cluster and individual residuals in the model 
reflects that outcome varies at both levels. The variance is a summary of the differences, 
and including individual variables in the statistical models allows us to obtain values of 
variances that are adjusted for those individual variables. The adjusted total outcome 
variance between people in the city can be partitioned into a variance between clusters 
and a variance between people within clusters. The cluster variance in this model is the 
same for all the individuals, whatever their individual characteristics (variables). Cluster 
differences in mean outcome may be attributable to contextual influences or to 
differences in the individual composition of cluster in terms of individual variables. By 
adjusting for individual variables in this model, some part of the compositional 
differences is taken into account and some of the cluster variance detected in the empty 
model is explained (Merlo et al., 2005c). 
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Multilevel regression model 3 with individual and cluster variables 
In this model, which is an extension of model 2, individual and cluster variables are 
investigated at the same time (Merlo et al., 2005b). Two functions are used in multilevel 
estimation: fixed effects and random effects (Maas and Hox, 2005). Fixed effects are 
used to model averages (means or regression coefficients) whereas random effects are 
used to model variance (Merlo et al., 2006). In a fixed effects model, it is not possible to 
separate out the effects of group variables and the effects of the group dummies, due to 
observed and unobserved group characteristics. However, this is possible in a random 
effects model (University of Bristol, 2011a). 
 
Multilevel regression model with individual variables and random slopes 
 
The random slope model allows the explanatory variable to have a different effect for 
each group. The assumption is that the effect of an individual variable on outcome may 
vary depending on the cluster context. In other words, for some groups, the explanatory 
variable has a large effect on the outcome; for others it has a small effect (Merlo et al., 
2005c). The random slope analysis examines whether the cluster context as a whole 
modifies the association between individual variables without specifying any cluster 
variables (Merlo et al., 2005b). 
 
Multilevel regression analysis could be done using MLwiN software developed by 
Goldstein’s research group (http://www.mlwin.com ). 
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Appendix 21. Documents for ethical approval 
 
Ethical approval from NRES 
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Ethical approval from the NHS Trust in the city of study 
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Topic guide for interview with girls 
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Topic guide for interview with nurses 
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Topic guide for interview with teachers 
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Invitation letter to Head teacher 
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Head teacher information sheet 
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391 
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Head teacher consent form 
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Teacher information sheet 
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Teacher consent form 
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Parent information sheet and consent (opt out) form 
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Student information sheet 
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Student consent form 
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Nurse information sheet 
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Nurse consent form 
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Appendix 22. Table 1 Interviews with nursing staff 
 
Coordinators Vaccinators 
1 Lead nurse 3 Vaccinators 
1 Senior nurse 1 School nurse 
 1 Health visitor 
 1 Practice nurse 
 1Sexual health nurse 
Total 9 nurses 
 
 
Appendix 23. Table 1 School characteristics 
 
School 
Deprivation 
in the list of 20 schools 
 
Uptake 
3
rd
 dose 
all years 
combined  
School size 
N pupils on 
roll** 
N year 8 
girls  
on roll*** 
IMD SAP IMD SCA 
School 1* 
(religious) 
1200 88 
mid level 
rank**** 12 
mid level 
rank 14 
87% 
School 2* (Academy) 530 49 
mid level 
rank 9 
mid level 
rank 13 
83% 
School 3*(Academy) 
(multiethnic) 
1400 97 
highest level 
rank 1 
highest level 
rank 1 
76% 
School 4*(Academy) 
(school for girls) 
1350 175 
mid level 
rank 8 
low level 
rank 17 
86% 
* The number of the school corresponds to the time the school accepted to participate in the   
research 
**N pupils on roll in 2007/2008  
***N year 8 girls on roll in 2012/2013 
****rank 1 = highest level of IMD; 20 = lowest level of IMD  
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Appendix 24. 
Appendix 24 Table 1. Summary of socio-demographics of 34 girls interviewed  
 
School 1 School 2 School 3 School 4 
Ethnicity Religion N
  
Ethnicity Religion N
  
Ethnicity Religion N
  
Ethnicity Religion N
  
White British                               Catholic 4 White British            
 
no 
religion 
1 White 
British 
Christian 2 White British no 
religion 
1 
British Black 
African*    
Catholic 1 White British            Christian 1 Indian Hindu 1 White British 
Welsh  
no 
religion 
1 
British Indian                     Hindu 1 British  (mixed  
Kenya-
Malawi)  
Muslim 1 Sri Lankan  Buddhism 1 British 
Pakistani 
Muslim 1 
Nigerian Black 
African  
Catholic 1 British  
Bangladeshi      
Muslim 1 White 
British 
no 
religion 
6 Slovakian Catholic 1 
Polish*  Catholic 2 British Libyan                       Muslim 1       
   British Indian                          Muslim 1       
   British Indian  
(mixed Kenya-
India)                                                   
Hindu 1       
   Tanzanian                 Muslim 1       
   Pakistani                  Muslim 1       
   Bangladeshi             Muslim 1       
   Indian Christian 1       
                                            Total 
9 
                                                
Total 11 
                                          
Total 10 
 
Total 4 
4 = ethnic non white 
2 out of 4=British non white 
 
*2 out of 9 = not vaccinated 
9 = ethnic non white  
5 out of 9= British non white   
2 ethnic non white 2 ethnic non white 
1 out of 2=British non white   
 
 
Total  
17 = ethnic white 
17 = ethnic non-white – 8 out of 17 = British non white   
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Appendix 25. Thematic analysis 
 
Theme Category Codes 
Source - 
interviews 
Introduction 
 
A school-based 
HPV 
vaccination 
programme 
  
 1. local policy nurses nurses 
 2. GP nurses 
 3. data management nurses 
    
School 
School policy 
and HPV 
vaccine 
4. school policy teachers 
  5. school attitude teachers 
  6. school attitude nurses 
  7. negative school attitude nurses 
    
 
Organization of 
delivery of 
HPV 
vaccination 
programme 
  
 8. school-teachers girls 
 9. school-embarrassment girls 
 10. tutor girls 
 11. school-barrier nurses 
 12. school organization nurse 
 13. school nurse nurses 
 14. ethnicity nurses 
 15. school responsibility for HPV vaccination teachers 
 16. organization delivery on the day teachers 
  17. organizer’s role (interviewee) teachers 
  18. tutor teachers 
  19. interpreter teachers 
  20. girl-teacher communication teachers 
  21. teacher-parent communication teachers 
  22. teacher-nurse communication teachers 
    
 
Information 
about HPV 
vaccine in the 
schools 
  
 23. sex education teachers 
 24. no information teachers 
 25. assembly teachers 
 26. school-teachers girls 
 27. school girls 
 28. nurses in assembly girls 
    
Facilitators 
Consent for 
HPV vaccine 
29. parental consent nurses 
  30. girls' competence nurses 
  31. form nurses 
    
 Parental 
involvement in 
decision-
making on HPV 
vaccine 
  
 32. girl-parent communication teachers 
 33. siblings vaccinated teachers 
 34. belief - protection from cancer teachers 
 35. girl-family communication girls 
419 
  
 36. parents' decision or beliefs girls 
 37. self-management girls 
 38. own decision girls 
 39. girl's beliefs - what think about vaccine girls 
 40. parent-girl communication nurses 
    
 
Girls’ views 
about the HPV 
vaccine 
  
 41. reassurance girls 
 42. girl-girls communication girls 
 43. girl-mother communication girls 
 44. girl-father communication girls 
 45. girl-nurse communication girls 
 46. clinic & NHS girls 
 47. clinic teachers 
  48. girls-girls communication teachers 
  49. communication nurses 
  50. clinic nurses 
  51. nurse-parent communication nurses 
  52. nurse’s role nurses 
    
Barriers 
Fear of 
injections 
  
  53. girl's fear girls 
  54. rumors girls 
  55. girl’s fear teachers 
  56. rumors teachers 
  57. girls' beliefs nurses 
  58. fear nurses 
  59. daughter's refusal nurses 
    
 
Attitudes about 
the 
effectiveness of 
HPV vaccine 
  
 60. girl's knowledge girls 
 61. relationships - behavior girls 
 62. HIV not HPV girls 
 63. not read letter girls 
    
 
Parental refusal 
of HPV vaccine 
64. religion culture teachers 
  65. parents’ beliefs teachers 
  66. religion and culture and language girls 
  67. parents' knowledge girls 
  68. parents' decision girls 
  69. parents' beliefs girls 
  70. parental refusal nurses 
  71. male dominance nurses 
  72. language nurses 
  73. parents' beliefs nurses 
  74. safety nurses 
  75. husband nurses 
  76. HPV as STI nurses 
  77. parents' education nurses 
  78. girl's health condition nurses 
420 
  
  79. girl's death nurses 
Total 
3 themes 
Total 
9 categories 
Total 
79 codes 
 
 
 
Appendix 26. Correspondence between the number of a school in quantitative 
study and the number of the same school in qualitative study 
 
Mixed methods research 
Number school in quantitative study Number school in qualitative study 
6 6 
16 7 
18 14 
19 9 
 
 
Appendix 27. Definition of free school meals 
 
Free school meals are a statutory benefit and are available to children of parents who 
start working less than 16 hours per week as well as to children of families who receive 
income Support, income Based Jobseekers Allowance, an income-related employment 
and support allowance, support under part V1 of the Immigration and Asylum Act 
1999, the Guarantee element of State Pension Credit, child Tax Credit, provided they 
are not entitled to Working Tax Credit and have an annual income that does not exceed 
£16,190, Working Tax Credit for four weeks after their employment finishes, during the 
initial roll out of the benefit, Universal Credit (Coventry City Council, 2014). Children 
who are on receipt of full-time education or education both before and after the lunch 
period could benefit from free school meals. From September 2014 all pupils in year 1 
and year 2 in state-funded schools in England became eligible for FSMs (Department 
for Education, 2014) to improve academic attainment and save families money.State-
funded schools include academies, free schools, pupil referral units and alternative 
provision as well as maintained schools (GOV.UK, 2013b). Students at school sixth 
forms, disadvantaged students at sixth form colleges and further education colleges are 
eligible for free school meals (GOV.UK, 2013b).  
Young children who are educated in a private or voluntary early year’s provider – for 
example a full day care nursery, or play group – or an independent school are not 
entitled to a FSM even if they meet the eligibility criteria (Department for Education, 
2014).  
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Appendix 28. Published article based on the national study 
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